{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "b0b80eea-d6d0-413c-b2e0-dfb771584880",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: opacus in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (1.5.2)\n",
      "Requirement already satisfied: numpy<2.0,>=1.15 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from opacus) (1.26.4)\n",
      "Requirement already satisfied: torch>=2.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from opacus) (2.5.1)\n",
      "Requirement already satisfied: scipy>=1.2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from opacus) (1.14.1)\n",
      "Requirement already satisfied: opt-einsum>=3.3.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from opacus) (3.4.0)\n",
      "Requirement already satisfied: filelock in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=2.0->opacus) (3.13.1)\n",
      "Requirement already satisfied: typing-extensions>=4.8.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=2.0->opacus) (4.11.0)\n",
      "Requirement already satisfied: setuptools in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=2.0->opacus) (75.1.0)\n",
      "Requirement already satisfied: sympy==1.13.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=2.0->opacus) (1.13.1)\n",
      "Requirement already satisfied: networkx in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=2.0->opacus) (3.2.1)\n",
      "Requirement already satisfied: jinja2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=2.0->opacus) (3.1.4)\n",
      "Requirement already satisfied: fsspec in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=2.0->opacus) (2024.9.0)\n",
      "Requirement already satisfied: mpmath<1.4,>=1.1.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from sympy==1.13.1->torch>=2.0->opacus) (1.3.0)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from jinja2->torch>=2.0->opacus) (2.1.3)\n",
      "Requirement already satisfied: transformers in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (4.46.2)\n",
      "Requirement already satisfied: datasets in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (3.2.0)\n",
      "Requirement already satisfied: accelerate in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (1.2.1)\n",
      "Requirement already satisfied: peft in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.17.1)\n",
      "Requirement already satisfied: torch in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (2.5.1)\n",
      "Requirement already satisfied: rouge-score in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.1.2)\n",
      "Requirement already satisfied: bert-score in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.3.13)\n",
      "Requirement already satisfied: nltk in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (3.9.1)\n",
      "Requirement already satisfied: pandas in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (2.2.3)\n",
      "Requirement already satisfied: scikit-learn in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (1.5.2)\n",
      "Requirement already satisfied: bitsandbytes in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.45.0)\n",
      "Requirement already satisfied: shap in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.46.0)\n",
      "Requirement already satisfied: auto-gptq in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.3.1)\n",
      "Requirement already satisfied: filelock in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (3.13.1)\n",
      "Requirement already satisfied: huggingface-hub<1.0,>=0.23.2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (0.26.2)\n",
      "Requirement already satisfied: numpy>=1.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (1.26.4)\n",
      "Requirement already satisfied: packaging>=20.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (24.1)\n",
      "Requirement already satisfied: pyyaml>=5.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (6.0.2)\n",
      "Requirement already satisfied: regex!=2019.12.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (2024.11.6)\n",
      "Requirement already satisfied: requests in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (2.32.3)\n",
      "Requirement already satisfied: safetensors>=0.4.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (0.4.5)\n",
      "Requirement already satisfied: tokenizers<0.21,>=0.20 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (0.20.3)\n",
      "Requirement already satisfied: tqdm>=4.27 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers) (4.67.0)\n",
      "Requirement already satisfied: pyarrow>=15.0.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from datasets) (18.1.0)\n",
      "Requirement already satisfied: dill<0.3.9,>=0.3.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from datasets) (0.3.8)\n",
      "Requirement already satisfied: xxhash in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from datasets) (3.5.0)\n",
      "Requirement already satisfied: multiprocess<0.70.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from datasets) (0.70.16)\n",
      "Requirement already satisfied: fsspec<=2024.9.0,>=2023.1.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from fsspec[http]<=2024.9.0,>=2023.1.0->datasets) (2024.9.0)\n",
      "Requirement already satisfied: aiohttp in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from datasets) (3.11.10)\n",
      "Requirement already satisfied: psutil in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from accelerate) (5.9.0)\n",
      "Requirement already satisfied: typing-extensions>=4.8.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch) (4.11.0)\n",
      "Requirement already satisfied: setuptools in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch) (75.1.0)\n",
      "Requirement already satisfied: sympy==1.13.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch) (1.13.1)\n",
      "Requirement already satisfied: networkx in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch) (3.2.1)\n",
      "Requirement already satisfied: jinja2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch) (3.1.4)\n",
      "Requirement already satisfied: mpmath<1.4,>=1.1.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from sympy==1.13.1->torch) (1.3.0)\n",
      "Requirement already satisfied: absl-py in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from rouge-score) (2.1.0)\n",
      "Requirement already satisfied: six>=1.14.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from rouge-score) (1.16.0)\n",
      "Requirement already satisfied: matplotlib in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from bert-score) (3.9.3)\n",
      "Requirement already satisfied: click in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from nltk) (8.1.7)\n",
      "Requirement already satisfied: joblib in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from nltk) (1.4.2)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from pandas) (2.9.0.post0)\n",
      "Requirement already satisfied: pytz>=2020.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from pandas) (2024.1)\n",
      "Requirement already satisfied: tzdata>=2022.7 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from pandas) (2024.2)\n",
      "Requirement already satisfied: scipy>=1.6.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from scikit-learn) (1.14.1)\n",
      "Requirement already satisfied: threadpoolctl>=3.1.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from scikit-learn) (3.5.0)\n",
      "Requirement already satisfied: slicer==0.0.8 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (0.0.8)\n",
      "Requirement already satisfied: numba in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (0.60.0)\n",
      "Requirement already satisfied: cloudpickle in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (3.1.0)\n",
      "Requirement already satisfied: rouge in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from auto-gptq) (1.0.1)\n",
      "Requirement already satisfied: aiohappyeyeballs>=2.3.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from aiohttp->datasets) (2.4.4)\n",
      "Requirement already satisfied: aiosignal>=1.1.2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from aiohttp->datasets) (1.3.2)\n",
      "Requirement already satisfied: attrs>=17.3.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from aiohttp->datasets) (24.2.0)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from aiohttp->datasets) (1.5.0)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from aiohttp->datasets) (6.1.0)\n",
      "Requirement already satisfied: propcache>=0.2.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from aiohttp->datasets) (0.2.1)\n",
      "Requirement already satisfied: yarl<2.0,>=1.17.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from aiohttp->datasets) (1.18.3)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->transformers) (3.3.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->transformers) (3.7)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->transformers) (2.2.3)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->transformers) (2025.1.31)\n",
      "Requirement already satisfied: colorama in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from tqdm>=4.27->transformers) (0.4.6)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from jinja2->torch) (2.1.3)\n",
      "Requirement already satisfied: contourpy>=1.0.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib->bert-score) (1.3.1)\n",
      "Requirement already satisfied: cycler>=0.10 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib->bert-score) (0.12.1)\n",
      "Requirement already satisfied: fonttools>=4.22.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib->bert-score) (4.55.2)\n",
      "Requirement already satisfied: kiwisolver>=1.3.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib->bert-score) (1.4.7)\n",
      "Requirement already satisfied: pillow>=8 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib->bert-score) (10.4.0)\n",
      "Requirement already satisfied: pyparsing>=2.3.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib->bert-score) (3.2.0)\n",
      "Requirement already satisfied: llvmlite<0.44,>=0.43.0dev0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from numba->shap) (0.43.0)\n",
      "Collecting peft==0.6.0\n",
      "  Using cached peft-0.6.0-py3-none-any.whl.metadata (23 kB)\n",
      "Requirement already satisfied: numpy>=1.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (1.26.4)\n",
      "Requirement already satisfied: packaging>=20.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (24.1)\n",
      "Requirement already satisfied: psutil in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (5.9.0)\n",
      "Requirement already satisfied: pyyaml in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (6.0.2)\n",
      "Requirement already satisfied: torch>=1.13.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (2.5.1)\n",
      "Requirement already satisfied: transformers in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (4.46.2)\n",
      "Requirement already satisfied: tqdm in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (4.67.0)\n",
      "Requirement already satisfied: accelerate>=0.21.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (1.2.1)\n",
      "Requirement already satisfied: safetensors in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft==0.6.0) (0.4.5)\n",
      "Requirement already satisfied: huggingface-hub>=0.21.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from accelerate>=0.21.0->peft==0.6.0) (0.26.2)\n",
      "Requirement already satisfied: filelock in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft==0.6.0) (3.13.1)\n",
      "Requirement already satisfied: typing-extensions>=4.8.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft==0.6.0) (4.11.0)\n",
      "Requirement already satisfied: setuptools in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft==0.6.0) (75.1.0)\n",
      "Requirement already satisfied: sympy==1.13.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft==0.6.0) (1.13.1)\n",
      "Requirement already satisfied: networkx in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft==0.6.0) (3.2.1)\n",
      "Requirement already satisfied: jinja2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft==0.6.0) (3.1.4)\n",
      "Requirement already satisfied: fsspec in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft==0.6.0) (2024.9.0)\n",
      "Requirement already satisfied: mpmath<1.4,>=1.1.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from sympy==1.13.1->torch>=1.13.0->peft==0.6.0) (1.3.0)\n",
      "Requirement already satisfied: colorama in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from tqdm->peft==0.6.0) (0.4.6)\n",
      "Requirement already satisfied: regex!=2019.12.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers->peft==0.6.0) (2024.11.6)\n",
      "Requirement already satisfied: requests in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers->peft==0.6.0) (2.32.3)\n",
      "Requirement already satisfied: tokenizers<0.21,>=0.20 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers->peft==0.6.0) (0.20.3)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from jinja2->torch>=1.13.0->peft==0.6.0) (2.1.3)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->transformers->peft==0.6.0) (3.3.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->transformers->peft==0.6.0) (3.7)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->transformers->peft==0.6.0) (2.2.3)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->transformers->peft==0.6.0) (2025.1.31)\n",
      "Using cached peft-0.6.0-py3-none-any.whl (134 kB)\n",
      "Installing collected packages: peft\n",
      "  Attempting uninstall: peft\n",
      "    Found existing installation: peft 0.17.1\n",
      "    Uninstalling peft-0.17.1:\n",
      "      Successfully uninstalled peft-0.17.1\n",
      "Successfully installed peft-0.6.0\n",
      "Requirement already satisfied: peft in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.6.0)\n",
      "Collecting peft\n",
      "  Using cached peft-0.17.1-py3-none-any.whl.metadata (14 kB)\n",
      "Requirement already satisfied: numpy>=1.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (1.26.4)\n",
      "Requirement already satisfied: packaging>=20.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (24.1)\n",
      "Requirement already satisfied: psutil in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (5.9.0)\n",
      "Requirement already satisfied: pyyaml in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (6.0.2)\n",
      "Requirement already satisfied: torch>=1.13.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (2.5.1)\n",
      "Requirement already satisfied: transformers in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (4.46.2)\n",
      "Requirement already satisfied: tqdm in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (4.67.0)\n",
      "Requirement already satisfied: accelerate>=0.21.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (1.2.1)\n",
      "Requirement already satisfied: safetensors in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (0.4.5)\n",
      "Requirement already satisfied: huggingface_hub>=0.25.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from peft) (0.26.2)\n",
      "Requirement already satisfied: filelock in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub>=0.25.0->peft) (3.13.1)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub>=0.25.0->peft) (2024.9.0)\n",
      "Requirement already satisfied: requests in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub>=0.25.0->peft) (2.32.3)\n",
      "Requirement already satisfied: typing-extensions>=3.7.4.3 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub>=0.25.0->peft) (4.11.0)\n",
      "Requirement already satisfied: setuptools in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft) (75.1.0)\n",
      "Requirement already satisfied: sympy==1.13.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft) (1.13.1)\n",
      "Requirement already satisfied: networkx in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft) (3.2.1)\n",
      "Requirement already satisfied: jinja2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from torch>=1.13.0->peft) (3.1.4)\n",
      "Requirement already satisfied: mpmath<1.4,>=1.1.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from sympy==1.13.1->torch>=1.13.0->peft) (1.3.0)\n",
      "Requirement already satisfied: colorama in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from tqdm->peft) (0.4.6)\n",
      "Requirement already satisfied: regex!=2019.12.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers->peft) (2024.11.6)\n",
      "Requirement already satisfied: tokenizers<0.21,>=0.20 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from transformers->peft) (0.20.3)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from jinja2->torch>=1.13.0->peft) (2.1.3)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->huggingface_hub>=0.25.0->peft) (3.3.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->huggingface_hub>=0.25.0->peft) (3.7)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->huggingface_hub>=0.25.0->peft) (2.2.3)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->huggingface_hub>=0.25.0->peft) (2025.1.31)\n",
      "Using cached peft-0.17.1-py3-none-any.whl (504 kB)\n",
      "Installing collected packages: peft\n",
      "  Attempting uninstall: peft\n",
      "    Found existing installation: peft 0.6.0\n",
      "    Uninstalling peft-0.6.0:\n",
      "      Successfully uninstalled peft-0.6.0\n",
      "Successfully installed peft-0.17.1\n",
      "Requirement already satisfied: shap in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.46.0)\n",
      "Requirement already satisfied: numpy in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (1.26.4)\n",
      "Requirement already satisfied: scipy in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (1.14.1)\n",
      "Requirement already satisfied: scikit-learn in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (1.5.2)\n",
      "Requirement already satisfied: pandas in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (2.2.3)\n",
      "Requirement already satisfied: tqdm>=4.27.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (4.67.0)\n",
      "Requirement already satisfied: packaging>20.9 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (24.1)\n",
      "Requirement already satisfied: slicer==0.0.8 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (0.0.8)\n",
      "Requirement already satisfied: numba in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (0.60.0)\n",
      "Requirement already satisfied: cloudpickle in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from shap) (3.1.0)\n",
      "Requirement already satisfied: colorama in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from tqdm>=4.27.0->shap) (0.4.6)\n",
      "Requirement already satisfied: llvmlite<0.44,>=0.43.0dev0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from numba->shap) (0.43.0)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from pandas->shap) (2.9.0.post0)\n",
      "Requirement already satisfied: pytz>=2020.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from pandas->shap) (2024.1)\n",
      "Requirement already satisfied: tzdata>=2022.7 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from pandas->shap) (2024.2)\n",
      "Requirement already satisfied: joblib>=1.2.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from scikit-learn->shap) (1.4.2)\n",
      "Requirement already satisfied: threadpoolctl>=3.1.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from scikit-learn->shap) (3.5.0)\n",
      "Requirement already satisfied: six>=1.5 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from python-dateutil>=2.8.2->pandas->shap) (1.16.0)\n",
      "Requirement already satisfied: rouge in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (1.0.1)\n",
      "Requirement already satisfied: six in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from rouge) (1.16.0)\n",
      "Requirement already satisfied: lightgbm in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (4.5.0)\n",
      "Requirement already satisfied: numpy>=1.17.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from lightgbm) (1.26.4)\n",
      "Requirement already satisfied: scipy in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from lightgbm) (1.14.1)\n",
      "Requirement already satisfied: huggingface_hub in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.26.2)\n",
      "Requirement already satisfied: ipywidgets in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (8.1.5)\n",
      "Requirement already satisfied: filelock in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub) (3.13.1)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub) (2024.9.0)\n",
      "Requirement already satisfied: packaging>=20.9 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub) (24.1)\n",
      "Requirement already satisfied: pyyaml>=5.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub) (6.0.2)\n",
      "Requirement already satisfied: requests in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub) (2.32.3)\n",
      "Requirement already satisfied: tqdm>=4.42.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub) (4.67.0)\n",
      "Requirement already satisfied: typing-extensions>=3.7.4.3 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from huggingface_hub) (4.11.0)\n",
      "Requirement already satisfied: comm>=0.1.3 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipywidgets) (0.2.1)\n",
      "Requirement already satisfied: ipython>=6.1.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipywidgets) (8.27.0)\n",
      "Requirement already satisfied: traitlets>=4.3.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipywidgets) (5.14.3)\n",
      "Requirement already satisfied: widgetsnbextension~=4.0.12 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipywidgets) (4.0.13)\n",
      "Requirement already satisfied: jupyterlab-widgets~=3.0.12 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipywidgets) (3.0.13)\n",
      "Requirement already satisfied: decorator in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipython>=6.1.0->ipywidgets) (5.1.1)\n",
      "Requirement already satisfied: jedi>=0.16 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipython>=6.1.0->ipywidgets) (0.19.1)\n",
      "Requirement already satisfied: matplotlib-inline in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipython>=6.1.0->ipywidgets) (0.1.6)\n",
      "Requirement already satisfied: prompt-toolkit<3.1.0,>=3.0.41 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipython>=6.1.0->ipywidgets) (3.0.43)\n",
      "Requirement already satisfied: pygments>=2.4.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipython>=6.1.0->ipywidgets) (2.15.1)\n",
      "Requirement already satisfied: stack-data in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipython>=6.1.0->ipywidgets) (0.2.0)\n",
      "Requirement already satisfied: colorama in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from ipython>=6.1.0->ipywidgets) (0.4.6)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->huggingface_hub) (3.3.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->huggingface_hub) (3.7)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->huggingface_hub) (2.2.3)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->huggingface_hub) (2025.1.31)\n",
      "Requirement already satisfied: parso<0.9.0,>=0.8.3 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from jedi>=0.16->ipython>=6.1.0->ipywidgets) (0.8.3)\n",
      "Requirement already satisfied: wcwidth in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from prompt-toolkit<3.1.0,>=3.0.41->ipython>=6.1.0->ipywidgets) (0.2.5)\n",
      "Requirement already satisfied: executing in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from stack-data->ipython>=6.1.0->ipywidgets) (0.8.3)\n",
      "Requirement already satisfied: asttokens in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from stack-data->ipython>=6.1.0->ipywidgets) (2.0.5)\n",
      "Requirement already satisfied: pure-eval in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from stack-data->ipython>=6.1.0->ipywidgets) (0.2.2)\n",
      "Requirement already satisfied: six in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from asttokens->stack-data->ipython>=6.1.0->ipywidgets) (1.16.0)\n"
     ]
    }
   ],
   "source": [
    "!pip install opacus \n",
    "!pip install transformers datasets accelerate peft torch rouge-score bert-score nltk pandas scikit-learn bitsandbytes shap auto-gptq\n",
    "!pip install peft==0.6.0\n",
    "!pip install --upgrade peft\n",
    "!pip install shap\n",
    "!pip install rouge\n",
    "!pip install lightgbm\n",
    "!pip install huggingface_hub ipywidgets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "cf01e6d3-8968-4626-831e-652c93e09413",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package wordnet to C:\\Users\\my pc/nltk_data...\n",
      "[nltk_data]   Package wordnet is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import nltk\n",
    "nltk.download('wordnet')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "d98f14ce-09eb-40fc-b2ca-d214533192af",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "262746444424419e99023cbf788e7f58",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Loading dataset shards:   0%|          | 0/32 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DatasetDict({\n",
      "    train: Dataset({\n",
      "        features: ['abstract_id', 'text', 'location', 'label'],\n",
      "        num_rows: 3000000\n",
      "    })\n",
      "    test: Dataset({\n",
      "        features: ['abstract_id', 'text', 'location', 'label'],\n",
      "        num_rows: 1000000\n",
      "    })\n",
      "    validation: Dataset({\n",
      "        features: ['abstract_id', 'text', 'location', 'label'],\n",
      "        num_rows: 1000000\n",
      "    })\n",
      "    full: Dataset({\n",
      "        features: ['abstract_id', 'text', 'location', 'label'],\n",
      "        num_rows: 14393619\n",
      "    })\n",
      "})\n"
     ]
    }
   ],
   "source": [
    "from huggingface_hub import login\n",
    "\n",
    "# Replace 'your_access_token' with your actual Hugging Face token\n",
    "login(token=\"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\")\n",
    "\n",
    "from datasets import load_dataset\n",
    "\n",
    "dataset = load_dataset(\"McGill-NLP/medal\",trust_remote_code=True)\n",
    "print(dataset)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "3a7f5aa4-eee9-40c4-a656-01e69f71311f",
   "metadata": {},
   "outputs": [
    {
     "ename": "RuntimeError",
     "evalue": "Failed to import transformers.trainer because of the following error (look up to see its traceback):\nFailed to import transformers.integrations.integration_utils because of the following error (look up to see its traceback):\nFailed to import transformers.modeling_tf_utils because of the following error (look up to see its traceback):\nYour currently installed version of Keras is Keras 3, but this is not yet supported in Transformers. Please install the backwards-compatible tf-keras package with `pip install tf-keras`.",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\activations_tf.py:22\u001b[0m\n\u001b[0;32m     21\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m---> 22\u001b[0m     \u001b[38;5;28;01mimport\u001b[39;00m \u001b[38;5;21;01mtf_keras\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m \u001b[38;5;21;01mkeras\u001b[39;00m\n\u001b[0;32m     23\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m (\u001b[38;5;167;01mModuleNotFoundError\u001b[39;00m, \u001b[38;5;167;01mImportError\u001b[39;00m):\n",
      "\u001b[1;31mModuleNotFoundError\u001b[0m: No module named 'tf_keras'",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[1;31mValueError\u001b[0m                                Traceback (most recent call last)",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1778\u001b[0m, in \u001b[0;36m_LazyModule._get_module\u001b[1;34m(self, module_name)\u001b[0m\n\u001b[0;32m   1777\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m-> 1778\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m importlib\u001b[38;5;241m.\u001b[39mimport_module(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m.\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m+\u001b[39m module_name, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m)\n\u001b[0;32m   1779\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m e:\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\importlib\\__init__.py:90\u001b[0m, in \u001b[0;36mimport_module\u001b[1;34m(name, package)\u001b[0m\n\u001b[0;32m     89\u001b[0m         level \u001b[38;5;241m+\u001b[39m\u001b[38;5;241m=\u001b[39m \u001b[38;5;241m1\u001b[39m\n\u001b[1;32m---> 90\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m _bootstrap\u001b[38;5;241m.\u001b[39m_gcd_import(name[level:], package, level)\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1387\u001b[0m, in \u001b[0;36m_gcd_import\u001b[1;34m(name, package, level)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1360\u001b[0m, in \u001b[0;36m_find_and_load\u001b[1;34m(name, import_)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1331\u001b[0m, in \u001b[0;36m_find_and_load_unlocked\u001b[1;34m(name, import_)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:935\u001b[0m, in \u001b[0;36m_load_unlocked\u001b[1;34m(spec)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap_external>:995\u001b[0m, in \u001b[0;36mexec_module\u001b[1;34m(self, module)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:488\u001b[0m, in \u001b[0;36m_call_with_frames_removed\u001b[1;34m(f, *args, **kwds)\u001b[0m\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\modeling_tf_utils.py:38\u001b[0m\n\u001b[0;32m     37\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01m.\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m DataCollatorWithPadding, DefaultDataCollator\n\u001b[1;32m---> 38\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mactivations_tf\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m get_tf_activation\n\u001b[0;32m     39\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mconfiguration_utils\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m PretrainedConfig\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\activations_tf.py:27\u001b[0m\n\u001b[0;32m     26\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m parse(keras\u001b[38;5;241m.\u001b[39m__version__)\u001b[38;5;241m.\u001b[39mmajor \u001b[38;5;241m>\u001b[39m \u001b[38;5;241m2\u001b[39m:\n\u001b[1;32m---> 27\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mValueError\u001b[39;00m(\n\u001b[0;32m     28\u001b[0m             \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mYour currently installed version of Keras is Keras 3, but this is not yet supported in \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m     29\u001b[0m             \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mTransformers. Please install the backwards-compatible tf-keras package with \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m     30\u001b[0m             \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m`pip install tf-keras`.\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m     31\u001b[0m         )\n\u001b[0;32m     34\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m_gelu\u001b[39m(x):\n",
      "\u001b[1;31mValueError\u001b[0m: Your currently installed version of Keras is Keras 3, but this is not yet supported in Transformers. Please install the backwards-compatible tf-keras package with `pip install tf-keras`.",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001b[1;31mRuntimeError\u001b[0m                              Traceback (most recent call last)",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1778\u001b[0m, in \u001b[0;36m_LazyModule._get_module\u001b[1;34m(self, module_name)\u001b[0m\n\u001b[0;32m   1777\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m-> 1778\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m importlib\u001b[38;5;241m.\u001b[39mimport_module(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m.\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m+\u001b[39m module_name, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m)\n\u001b[0;32m   1779\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m e:\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\importlib\\__init__.py:90\u001b[0m, in \u001b[0;36mimport_module\u001b[1;34m(name, package)\u001b[0m\n\u001b[0;32m     89\u001b[0m         level \u001b[38;5;241m+\u001b[39m\u001b[38;5;241m=\u001b[39m \u001b[38;5;241m1\u001b[39m\n\u001b[1;32m---> 90\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m _bootstrap\u001b[38;5;241m.\u001b[39m_gcd_import(name[level:], package, level)\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1387\u001b[0m, in \u001b[0;36m_gcd_import\u001b[1;34m(name, package, level)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1360\u001b[0m, in \u001b[0;36m_find_and_load\u001b[1;34m(name, import_)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1331\u001b[0m, in \u001b[0;36m_find_and_load_unlocked\u001b[1;34m(name, import_)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:935\u001b[0m, in \u001b[0;36m_load_unlocked\u001b[1;34m(spec)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap_external>:995\u001b[0m, in \u001b[0;36mexec_module\u001b[1;34m(self, module)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:488\u001b[0m, in \u001b[0;36m_call_with_frames_removed\u001b[1;34m(f, *args, **kwds)\u001b[0m\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\integrations\\integration_utils.py:36\u001b[0m\n\u001b[0;32m     34\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m \u001b[38;5;21;01mpackaging\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mversion\u001b[39;00m\n\u001b[1;32m---> 36\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m PreTrainedModel, TFPreTrainedModel\n\u001b[0;32m     37\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m __version__ \u001b[38;5;28;01mas\u001b[39;00m version\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1412\u001b[0m, in \u001b[0;36m_handle_fromlist\u001b[1;34m(module, fromlist, import_, recursive)\u001b[0m\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1766\u001b[0m, in \u001b[0;36m_LazyModule.__getattr__\u001b[1;34m(self, name)\u001b[0m\n\u001b[0;32m   1765\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m name \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_class_to_module\u001b[38;5;241m.\u001b[39mkeys():\n\u001b[1;32m-> 1766\u001b[0m     module \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_get_module(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_class_to_module[name])\n\u001b[0;32m   1767\u001b[0m     value \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mgetattr\u001b[39m(module, name)\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1780\u001b[0m, in \u001b[0;36m_LazyModule._get_module\u001b[1;34m(self, module_name)\u001b[0m\n\u001b[0;32m   1779\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[1;32m-> 1780\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\n\u001b[0;32m   1781\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mFailed to import \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m.\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mmodule_name\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m because of the following error (look up to see its\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m   1782\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m traceback):\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;132;01m{\u001b[39;00me\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m   1783\u001b[0m     ) \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01me\u001b[39;00m\n",
      "\u001b[1;31mRuntimeError\u001b[0m: Failed to import transformers.modeling_tf_utils because of the following error (look up to see its traceback):\nYour currently installed version of Keras is Keras 3, but this is not yet supported in Transformers. Please install the backwards-compatible tf-keras package with `pip install tf-keras`.",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001b[1;31mRuntimeError\u001b[0m                              Traceback (most recent call last)",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1778\u001b[0m, in \u001b[0;36m_LazyModule._get_module\u001b[1;34m(self, module_name)\u001b[0m\n\u001b[0;32m   1777\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m-> 1778\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m importlib\u001b[38;5;241m.\u001b[39mimport_module(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m.\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m+\u001b[39m module_name, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m)\n\u001b[0;32m   1779\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m e:\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\importlib\\__init__.py:90\u001b[0m, in \u001b[0;36mimport_module\u001b[1;34m(name, package)\u001b[0m\n\u001b[0;32m     89\u001b[0m         level \u001b[38;5;241m+\u001b[39m\u001b[38;5;241m=\u001b[39m \u001b[38;5;241m1\u001b[39m\n\u001b[1;32m---> 90\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m _bootstrap\u001b[38;5;241m.\u001b[39m_gcd_import(name[level:], package, level)\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1387\u001b[0m, in \u001b[0;36m_gcd_import\u001b[1;34m(name, package, level)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1360\u001b[0m, in \u001b[0;36m_find_and_load\u001b[1;34m(name, import_)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1331\u001b[0m, in \u001b[0;36m_find_and_load_unlocked\u001b[1;34m(name, import_)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:935\u001b[0m, in \u001b[0;36m_load_unlocked\u001b[1;34m(spec)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap_external>:995\u001b[0m, in \u001b[0;36mexec_module\u001b[1;34m(self, module)\u001b[0m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:488\u001b[0m, in \u001b[0;36m_call_with_frames_removed\u001b[1;34m(f, *args, **kwds)\u001b[0m\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\trainer.py:42\u001b[0m\n\u001b[0;32m     40\u001b[0m \u001b[38;5;66;03m# Integrations must be imported before ML frameworks:\u001b[39;00m\n\u001b[0;32m     41\u001b[0m \u001b[38;5;66;03m# isort: off\u001b[39;00m\n\u001b[1;32m---> 42\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mintegrations\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m (\n\u001b[0;32m     43\u001b[0m     get_reporting_integration_callbacks,\n\u001b[0;32m     44\u001b[0m     hp_params,\n\u001b[0;32m     45\u001b[0m )\n\u001b[0;32m     47\u001b[0m \u001b[38;5;66;03m# isort: on\u001b[39;00m\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1412\u001b[0m, in \u001b[0;36m_handle_fromlist\u001b[1;34m(module, fromlist, import_, recursive)\u001b[0m\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1766\u001b[0m, in \u001b[0;36m_LazyModule.__getattr__\u001b[1;34m(self, name)\u001b[0m\n\u001b[0;32m   1765\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m name \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_class_to_module\u001b[38;5;241m.\u001b[39mkeys():\n\u001b[1;32m-> 1766\u001b[0m     module \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_get_module(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_class_to_module[name])\n\u001b[0;32m   1767\u001b[0m     value \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mgetattr\u001b[39m(module, name)\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1780\u001b[0m, in \u001b[0;36m_LazyModule._get_module\u001b[1;34m(self, module_name)\u001b[0m\n\u001b[0;32m   1779\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[1;32m-> 1780\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\n\u001b[0;32m   1781\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mFailed to import \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m.\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mmodule_name\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m because of the following error (look up to see its\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m   1782\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m traceback):\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;132;01m{\u001b[39;00me\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m   1783\u001b[0m     ) \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01me\u001b[39;00m\n",
      "\u001b[1;31mRuntimeError\u001b[0m: Failed to import transformers.integrations.integration_utils because of the following error (look up to see its traceback):\nFailed to import transformers.modeling_tf_utils because of the following error (look up to see its traceback):\nYour currently installed version of Keras is Keras 3, but this is not yet supported in Transformers. Please install the backwards-compatible tf-keras package with `pip install tf-keras`.",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001b[1;31mRuntimeError\u001b[0m                              Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[4], line 5\u001b[0m\n\u001b[0;32m      3\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mtransformers\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m pipeline\n\u001b[0;32m      4\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mtransformers\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m DataCollatorForLanguageModeling\n\u001b[1;32m----> 5\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mtransformers\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m Trainer, TrainingArguments\n\u001b[0;32m      6\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m \u001b[38;5;21;01mtorch\u001b[39;00m\n\u001b[0;32m      7\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mtorch\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m nn, optim\n",
      "File \u001b[1;32m<frozen importlib._bootstrap>:1412\u001b[0m, in \u001b[0;36m_handle_fromlist\u001b[1;34m(module, fromlist, import_, recursive)\u001b[0m\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1766\u001b[0m, in \u001b[0;36m_LazyModule.__getattr__\u001b[1;34m(self, name)\u001b[0m\n\u001b[0;32m   1764\u001b[0m     value \u001b[38;5;241m=\u001b[39m Placeholder\n\u001b[0;32m   1765\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m name \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_class_to_module\u001b[38;5;241m.\u001b[39mkeys():\n\u001b[1;32m-> 1766\u001b[0m     module \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_get_module(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_class_to_module[name])\n\u001b[0;32m   1767\u001b[0m     value \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mgetattr\u001b[39m(module, name)\n\u001b[0;32m   1768\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m name \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_modules:\n",
      "File \u001b[1;32m~\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\transformers\\utils\\import_utils.py:1780\u001b[0m, in \u001b[0;36m_LazyModule._get_module\u001b[1;34m(self, module_name)\u001b[0m\n\u001b[0;32m   1778\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m importlib\u001b[38;5;241m.\u001b[39mimport_module(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m.\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m+\u001b[39m module_name, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m)\n\u001b[0;32m   1779\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[1;32m-> 1780\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\n\u001b[0;32m   1781\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mFailed to import \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__name__\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m.\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mmodule_name\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m because of the following error (look up to see its\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m   1782\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m traceback):\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;132;01m{\u001b[39;00me\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m   1783\u001b[0m     ) \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01me\u001b[39;00m\n",
      "\u001b[1;31mRuntimeError\u001b[0m: Failed to import transformers.trainer because of the following error (look up to see its traceback):\nFailed to import transformers.integrations.integration_utils because of the following error (look up to see its traceback):\nFailed to import transformers.modeling_tf_utils because of the following error (look up to see its traceback):\nYour currently installed version of Keras is Keras 3, but this is not yet supported in Transformers. Please install the backwards-compatible tf-keras package with `pip install tf-keras`."
     ]
    }
   ],
   "source": [
    "from transformers import GPT2Tokenizer, GPT2LMHeadModel, AutoConfig\n",
    "from peft import LoraConfig, get_peft_model, prepare_model_for_kbit_training\n",
    "from transformers import pipeline\n",
    "from transformers import DataCollatorForLanguageModeling\n",
    "from transformers import Trainer, TrainingArguments\n",
    "import torch\n",
    "from torch import nn, optim\n",
    "from transformers import AutoModelForCausalLM, AutoTokenizer, get_scheduler\n",
    "from opacus import PrivacyEngine\n",
    "from torch.utils.data import DataLoader\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "e4c9c592-379b-4e85-91c5-e47485d9479d",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\peft\\tuners\\lora\\layer.py:1768: UserWarning: fan_in_fan_out is set to False but the target module is `Conv1D`. Setting fan_in_fan_out to True.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Dataset({\n",
      "    features: ['abstract_id', 'text', 'location', 'label', 'input_ids', 'attention_mask'],\n",
      "    num_rows: 100000\n",
      "})\n",
      "Dataset({\n",
      "    features: ['abstract_id', 'text', 'location', 'label', 'input_ids', 'attention_mask'],\n",
      "    num_rows: 1000\n",
      "})\n"
     ]
    }
   ],
   "source": [
    "# Device setup\n",
    "device = torch.device(\"cuda\" if torch.cuda.is_available() else \"cpu\")\n",
    "\n",
    "# Model and LoRA configuration\n",
    "model_name = \"gpt2-large\"\n",
    "tokenizer = GPT2Tokenizer.from_pretrained(model_name)\n",
    "tokenizer.pad_token = tokenizer.eos_token\n",
    "config = AutoConfig.from_pretrained(model_name)\n",
    "model = GPT2LMHeadModel.from_pretrained(model_name, config=config)\n",
    "\n",
    "# Prepare for LoRA adaptation\n",
    "model = prepare_model_for_kbit_training(model)\n",
    "lora_config = LoraConfig(\n",
    "    task_type=\"CAUSAL_LM\",\n",
    "    r=8,\n",
    "    lora_alpha=32,\n",
    "    lora_dropout=0.1,\n",
    "    target_modules=[\"c_attn\", \"c_proj\"]\n",
    ")\n",
    "model = get_peft_model(model, lora_config)\n",
    "# Move to device\n",
    "model.to(device)\n",
    "train_dataset = dataset[\"train\"]\n",
    "test_dataset = dataset[\"test\"]\n",
    "\n",
    "# Tokenization function\n",
    "def tokenize_function(examples):\n",
    "    return tokenizer(examples[\"text\"], truncation=True, padding=\"max_length\", max_length=128)\n",
    "\n",
    "# Apply tokenization\n",
    "train_data = train_dataset.map(tokenize_function, batched=True)\n",
    "test_data = test_dataset.map(tokenize_function, batched=True)\n",
    "\n",
    "# Reduce dataset size\n",
    "train_data = train_data.shuffle(seed=42).select(range(min(100000, len(train_data))))\n",
    "test_data = test_data.shuffle(seed=42).select(range(min(1000, len(test_data))))\n",
    "\n",
    "# Set format for PyTorch\n",
    "train_data.set_format(type=\"torch\", columns=['input_ids', 'attention_mask'])\n",
    "test_data.set_format(type=\"torch\", columns=['input_ids', 'attention_mask'])\n",
    "\n",
    "print(train_data)\n",
    "print(test_data)\n",
    "\n",
    "# DataLoader\n",
    "train_dataloader = DataLoader(train_data, batch_size=16, shuffle=True)\n",
    "test_dataloader = DataLoader(test_data, batch_size=16)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "a2f77fce-d5ed-4774-94c7-5babe441ebef",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\opacus\\privacy_engine.py:95: UserWarning: Secure RNG turned off. This is perfectly fine for experimentation as it allows for much faster training performance, but remember to turn it on and retrain one last time before production with ``secure_mode`` turned on.\n",
      "  warnings.warn(\n",
      "C:\\Users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\opacus\\accountants\\analysis\\rdp.py:332: UserWarning: Optimal order is the largest alpha. Please consider expanding the range of alphas to get a tighter privacy bound.\n",
      "  warnings.warn(\n",
      "C:\\Users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\Lib\\site-packages\\torch\\nn\\modules\\module.py:1827: FutureWarning: Using a non-full backward hook when the forward contains multiple autograd Nodes is deprecated and will be removed in future versions. This hook will be missing some grad_input. Please use register_full_backward_hook to get the documented behavior.\n",
      "  self._maybe_warn_non_full_backward_hook(args, result, grad_fn)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Epoch [1/3], Step [0], Loss: 4.8387\n",
      "Epoch [1/3], Step [10], Loss: 4.6164\n",
      "Epoch [1/3], Step [20], Loss: 5.0573\n",
      "Epoch [1/3], Step [30], Loss: 4.4287\n",
      "Epoch [1/3], Step [40], Loss: 5.0907\n",
      "Epoch [1/3], Step [50], Loss: 4.5101\n",
      "Epoch [1/3], Step [60], Loss: 4.7888\n",
      "Epoch [1/3], Step [70], Loss: 5.1125\n",
      "Epoch [1/3], Step [80], Loss: 5.2912\n",
      "Epoch [1/3], Step [90], Loss: 4.8490\n",
      "Epoch [1/3], Step [100], Loss: 5.2163\n",
      "Epoch [1/3], Step [110], Loss: 5.3473\n",
      "Epoch [1/3], Step [120], Loss: 4.8797\n",
      "Epoch [1/3], Step [130], Loss: 4.5322\n",
      "Epoch [1/3], Step [140], Loss: 4.2136\n",
      "Epoch [1/3], Step [150], Loss: 4.7025\n",
      "Epoch [1/3], Step [160], Loss: 4.4207\n",
      "Epoch [1/3], Step [170], Loss: 4.8697\n",
      "Epoch [1/3], Step [180], Loss: 4.8986\n",
      "Epoch [1/3], Step [190], Loss: 4.7767\n",
      "Epoch [1/3], Step [200], Loss: 4.7090\n",
      "Epoch [1/3], Step [210], Loss: 5.4216\n",
      "Epoch [1/3], Step [220], Loss: 4.9282\n",
      "Epoch [1/3], Step [230], Loss: 4.7183\n",
      "Epoch [1/3], Step [240], Loss: 4.9014\n",
      "Epoch [1/3], Step [250], Loss: 4.3505\n",
      "Epoch [1/3], Step [260], Loss: 4.4371\n",
      "Epoch [1/3], Step [270], Loss: 4.5675\n",
      "Epoch [1/3], Step [280], Loss: 4.5402\n",
      "Epoch [1/3], Step [290], Loss: 4.8165\n",
      "Epoch [1/3], Step [300], Loss: 4.7771\n",
      "Epoch [1/3], Step [310], Loss: 4.3785\n",
      "Epoch [1/3], Step [320], Loss: 4.4457\n",
      "Epoch [1/3], Step [330], Loss: 4.5290\n",
      "Epoch [1/3], Step [340], Loss: 4.6992\n",
      "Epoch [1/3], Step [350], Loss: 4.3346\n",
      "Epoch [1/3], Step [360], Loss: 4.5846\n",
      "Epoch [1/3], Step [370], Loss: 4.2794\n",
      "Epoch [1/3], Step [380], Loss: 4.7710\n",
      "Epoch [1/3], Step [390], Loss: 4.3178\n",
      "Epoch [1/3], Step [400], Loss: 4.7213\n",
      "Epoch [1/3], Step [410], Loss: 4.4486\n",
      "Epoch [1/3], Step [420], Loss: 4.4037\n",
      "Epoch [1/3], Step [430], Loss: 4.4333\n",
      "Epoch [1/3], Step [440], Loss: 4.2845\n",
      "Epoch [1/3], Step [450], Loss: 4.6095\n",
      "Epoch [1/3], Step [460], Loss: 4.2327\n",
      "Epoch [1/3], Step [470], Loss: 4.4042\n",
      "Epoch [1/3], Step [480], Loss: 4.4780\n",
      "Epoch [1/3], Step [490], Loss: 4.1909\n",
      "Epoch [1/3], Step [500], Loss: 4.4737\n",
      "Epoch [1/3], Step [510], Loss: 4.2623\n",
      "Epoch [1/3], Step [520], Loss: 4.1913\n",
      "Epoch [1/3], Step [530], Loss: 4.2311\n",
      "Epoch [1/3], Step [540], Loss: 4.2904\n",
      "Epoch [1/3], Step [550], Loss: 4.3859\n",
      "Epoch [1/3], Step [560], Loss: 4.2602\n",
      "Epoch [1/3], Step [570], Loss: 4.5089\n",
      "Epoch [1/3], Step [580], Loss: 4.3120\n",
      "Epoch [1/3], Step [590], Loss: 4.3044\n",
      "Epoch [1/3], Step [600], Loss: 4.4284\n",
      "Epoch [1/3], Step [610], Loss: 4.7817\n",
      "Epoch [1/3], Step [620], Loss: 4.3187\n",
      "Epoch [1/3], Step [630], Loss: 4.3705\n",
      "Epoch [1/3], Step [640], Loss: 4.4963\n",
      "Epoch [1/3], Step [650], Loss: 4.2816\n",
      "Epoch [1/3], Step [660], Loss: 4.5538\n",
      "Epoch [1/3], Step [670], Loss: 4.0943\n",
      "Epoch [1/3], Step [680], Loss: 4.5237\n",
      "Epoch [1/3], Step [690], Loss: 4.1397\n",
      "Epoch [1/3], Step [700], Loss: 4.2272\n",
      "Epoch [1/3], Step [710], Loss: 4.4401\n",
      "Epoch [1/3], Step [720], Loss: 4.1414\n",
      "Epoch [1/3], Step [730], Loss: 4.0565\n",
      "Epoch [1/3], Step [740], Loss: 4.0890\n",
      "Epoch [1/3], Step [750], Loss: 4.2369\n",
      "Epoch [1/3], Step [760], Loss: 4.2668\n",
      "Epoch [1/3], Step [770], Loss: 4.1675\n",
      "Epoch [1/3], Step [780], Loss: 4.1843\n",
      "Epoch [1/3], Step [790], Loss: 4.1702\n",
      "Epoch [1/3], Step [800], Loss: 4.3550\n",
      "Epoch [1/3], Step [810], Loss: 4.3140\n",
      "Epoch [1/3], Step [820], Loss: 4.2859\n",
      "Epoch [1/3], Step [830], Loss: 4.0091\n",
      "Epoch [1/3], Step [840], Loss: 4.2270\n",
      "Epoch [1/3], Step [850], Loss: 4.0253\n",
      "Epoch [1/3], Step [860], Loss: 4.3309\n",
      "Epoch [1/3], Step [870], Loss: 4.2504\n",
      "Epoch [1/3], Step [880], Loss: 4.1573\n",
      "Epoch [1/3], Step [890], Loss: 4.4248\n",
      "Epoch [1/3], Step [900], Loss: 3.9482\n",
      "Epoch [1/3], Step [910], Loss: 4.2542\n",
      "Epoch [1/3], Step [920], Loss: 4.0080\n",
      "Epoch [1/3], Step [930], Loss: 4.2504\n",
      "Epoch [1/3], Step [940], Loss: 4.2239\n",
      "Epoch [1/3], Step [950], Loss: 4.2675\n",
      "Epoch [1/3], Step [960], Loss: 3.9365\n",
      "Epoch [1/3], Step [970], Loss: 4.0871\n",
      "Epoch [1/3], Step [980], Loss: 3.8850\n",
      "Epoch [1/3], Step [990], Loss: 4.0740\n",
      "Epoch [1/3], Step [1000], Loss: 4.0578\n",
      "Epoch [1/3], Step [1010], Loss: 3.9382\n",
      "Epoch [1/3], Step [1020], Loss: 3.8935\n",
      "Epoch [1/3], Step [1030], Loss: 4.1561\n",
      "Epoch [1/3], Step [1040], Loss: 4.0071\n",
      "Epoch [1/3], Step [1050], Loss: 3.9033\n",
      "Epoch [1/3], Step [1060], Loss: 3.9359\n",
      "Epoch [1/3], Step [1070], Loss: 4.0427\n",
      "Epoch [1/3], Step [1080], Loss: 4.1280\n",
      "Epoch [1/3], Step [1090], Loss: 4.3751\n",
      "Epoch [1/3], Step [1100], Loss: 4.0500\n",
      "Epoch [1/3], Step [1110], Loss: 4.1420\n",
      "Epoch [1/3], Step [1120], Loss: 3.9882\n",
      "Epoch [1/3], Step [1130], Loss: 4.3280\n",
      "Epoch [1/3], Step [1140], Loss: 4.0135\n",
      "Epoch [1/3], Step [1150], Loss: 4.1001\n",
      "Epoch [1/3], Step [1160], Loss: 3.8738\n",
      "Epoch [1/3], Step [1170], Loss: 3.8951\n",
      "Epoch [1/3], Step [1180], Loss: 3.9824\n",
      "Epoch [1/3], Step [1190], Loss: 4.0981\n",
      "Epoch [1/3], Step [1200], Loss: 4.1263\n",
      "Epoch [1/3], Step [1210], Loss: 3.9224\n",
      "Epoch [1/3], Step [1220], Loss: 3.7969\n",
      "Epoch [1/3], Step [1230], Loss: 3.8178\n",
      "Epoch [1/3], Step [1240], Loss: 4.0618\n",
      "Epoch [1/3], Step [1250], Loss: 3.6388\n",
      "Epoch [1/3], Step [1260], Loss: 4.1502\n",
      "Epoch [1/3], Step [1270], Loss: 3.9163\n",
      "Epoch [1/3], Step [1280], Loss: 3.9307\n",
      "Epoch [1/3], Step [1290], Loss: 3.9965\n",
      "Epoch [1/3], Step [1300], Loss: 4.0652\n",
      "Epoch [1/3], Step [1310], Loss: 4.0209\n",
      "Epoch [1/3], Step [1320], Loss: 4.1073\n",
      "Epoch [1/3], Step [1330], Loss: 3.9245\n",
      "Epoch [1/3], Step [1340], Loss: 4.1667\n",
      "Epoch [1/3], Step [1350], Loss: 3.7603\n",
      "Epoch [1/3], Step [1360], Loss: 4.1403\n",
      "Epoch [1/3], Step [1370], Loss: 4.0666\n",
      "Epoch [1/3], Step [1380], Loss: 3.9290\n",
      "Epoch [1/3], Step [1390], Loss: 3.8294\n",
      "Epoch [1/3], Step [1400], Loss: 3.8711\n",
      "Epoch [1/3], Step [1410], Loss: 3.8962\n",
      "Epoch [1/3], Step [1420], Loss: 3.8521\n",
      "Epoch [1/3], Step [1430], Loss: 3.9238\n",
      "Epoch [1/3], Step [1440], Loss: 3.8640\n",
      "Epoch [1/3], Step [1450], Loss: 3.9835\n",
      "Epoch [1/3], Step [1460], Loss: 3.8904\n",
      "Epoch [1/3], Step [1470], Loss: 4.0457\n",
      "Epoch [1/3], Step [1480], Loss: 3.7966\n",
      "Epoch [1/3], Step [1490], Loss: 3.8908\n",
      "Epoch [1/3], Step [1500], Loss: 4.0805\n",
      "Epoch [1/3], Step [1510], Loss: 3.8558\n",
      "Epoch [1/3], Step [1520], Loss: 3.7237\n",
      "Epoch [1/3], Step [1530], Loss: 3.8280\n",
      "Epoch [1/3], Step [1540], Loss: 3.6478\n",
      "Epoch [1/3], Step [1550], Loss: 4.0929\n",
      "Epoch [1/3], Step [1560], Loss: 4.0651\n",
      "Epoch [1/3], Step [1570], Loss: 3.7598\n",
      "Epoch [1/3], Step [1580], Loss: 4.1119\n",
      "Epoch [1/3], Step [1590], Loss: 4.0605\n",
      "Epoch [1/3], Step [1600], Loss: 3.9943\n",
      "Epoch [1/3], Step [1610], Loss: 3.6691\n",
      "Epoch [1/3], Step [1620], Loss: 3.6781\n",
      "Epoch [1/3], Step [1630], Loss: 3.8506\n",
      "Epoch [1/3], Step [1640], Loss: 3.7496\n",
      "Epoch [1/3], Step [1650], Loss: 4.0647\n",
      "Epoch [1/3], Step [1660], Loss: 3.7034\n",
      "Epoch [1/3], Step [1670], Loss: 3.7542\n",
      "Epoch [1/3], Step [1680], Loss: 4.0076\n",
      "Epoch [1/3], Step [1690], Loss: 3.7676\n",
      "Epoch [1/3], Step [1700], Loss: 3.9363\n",
      "Epoch [1/3], Step [1710], Loss: 3.9401\n",
      "Epoch [1/3], Step [1720], Loss: 4.0809\n",
      "Epoch [1/3], Step [1730], Loss: 3.9926\n",
      "Epoch [1/3], Step [1740], Loss: 4.0080\n",
      "Epoch [1/3], Step [1750], Loss: 3.7225\n",
      "Epoch [1/3], Step [1760], Loss: 3.8555\n",
      "Epoch [1/3], Step [1770], Loss: 3.8916\n",
      "Epoch [1/3], Step [1780], Loss: 3.8400\n",
      "Epoch [1/3], Step [1790], Loss: 3.8373\n",
      "Epoch [1/3], Step [1800], Loss: 4.1113\n",
      "Epoch [1/3], Step [1810], Loss: 3.8726\n",
      "Epoch [1/3], Step [1820], Loss: 3.9394\n",
      "Epoch [1/3], Step [1830], Loss: 3.8688\n",
      "Epoch [1/3], Step [1840], Loss: 4.0039\n",
      "Epoch [1/3], Step [1850], Loss: 3.8357\n",
      "Epoch [1/3], Step [1860], Loss: 4.0723\n",
      "Epoch [1/3], Step [1870], Loss: 4.3468\n",
      "Epoch [1/3], Step [1880], Loss: 3.7191\n",
      "Epoch [1/3], Step [1890], Loss: 3.4754\n",
      "Epoch [1/3], Step [1900], Loss: 3.7192\n",
      "Epoch [1/3], Step [1910], Loss: 3.9582\n",
      "Epoch [1/3], Step [1920], Loss: 4.0149\n",
      "Epoch [1/3], Step [1930], Loss: 3.8459\n",
      "Epoch [1/3], Step [1940], Loss: 3.9652\n",
      "Epoch [1/3], Step [1950], Loss: 3.8137\n",
      "Epoch [1/3], Step [1960], Loss: 4.0264\n",
      "Epoch [1/3], Step [1970], Loss: 4.0987\n",
      "Epoch [1/3], Step [1980], Loss: 3.9782\n",
      "Epoch [1/3], Step [1990], Loss: 3.9826\n",
      "Epoch [1/3], Step [2000], Loss: 3.7811\n",
      "Epoch [1/3], Step [2010], Loss: 3.6953\n",
      "Epoch [1/3], Step [2020], Loss: 3.7948\n",
      "Epoch [1/3], Step [2030], Loss: 3.9282\n",
      "Epoch [1/3], Step [2040], Loss: 4.1547\n",
      "Epoch [1/3], Step [2050], Loss: 3.8022\n",
      "Epoch [1/3], Step [2060], Loss: 3.7319\n",
      "Epoch [1/3], Step [2070], Loss: 4.2223\n",
      "Epoch [1/3], Step [2080], Loss: 3.8107\n",
      "Epoch [1/3], Step [2090], Loss: 3.8510\n",
      "Epoch [1/3], Step [2100], Loss: 3.9464\n",
      "Epoch [1/3], Step [2110], Loss: 3.6538\n",
      "Epoch [1/3], Step [2120], Loss: 4.0723\n",
      "Epoch [1/3], Step [2130], Loss: 3.5310\n",
      "Epoch [1/3], Step [2140], Loss: 4.0165\n",
      "Epoch [1/3], Step [2150], Loss: 3.9199\n",
      "Epoch [1/3], Step [2160], Loss: 4.0488\n",
      "Epoch [1/3], Step [2170], Loss: 3.5503\n",
      "Epoch [1/3], Step [2180], Loss: 4.1502\n",
      "Epoch [1/3], Step [2190], Loss: 4.0477\n",
      "Epoch [1/3], Step [2200], Loss: 3.7100\n",
      "Epoch [1/3], Step [2210], Loss: 4.1329\n",
      "Epoch [1/3], Step [2220], Loss: 3.8053\n",
      "Epoch [1/3], Step [2230], Loss: 4.0449\n",
      "Epoch [1/3], Step [2240], Loss: 3.8332\n",
      "Epoch [1/3], Step [2250], Loss: 3.9135\n",
      "Epoch [1/3], Step [2260], Loss: 3.9194\n",
      "Epoch [1/3], Step [2270], Loss: 3.7620\n",
      "Epoch [1/3], Step [2280], Loss: 3.7655\n",
      "Epoch [1/3], Step [2290], Loss: 3.9247\n",
      "Epoch [1/3], Step [2300], Loss: 3.8854\n",
      "Epoch [1/3], Step [2310], Loss: 3.4735\n",
      "Epoch [1/3], Step [2320], Loss: 3.6995\n",
      "Epoch [1/3], Step [2330], Loss: 3.6133\n",
      "Epoch [1/3], Step [2340], Loss: 3.9715\n",
      "Epoch [1/3], Step [2350], Loss: 3.9730\n",
      "Epoch [1/3], Step [2360], Loss: 4.0434\n",
      "Epoch [1/3], Step [2370], Loss: 3.8096\n",
      "Epoch [1/3], Step [2380], Loss: 3.9876\n",
      "Epoch [1/3], Step [2390], Loss: 4.0559\n",
      "Epoch [1/3], Step [2400], Loss: 3.3640\n",
      "Epoch [1/3], Step [2410], Loss: 3.5907\n",
      "Epoch [1/3], Step [2420], Loss: 4.3243\n",
      "Epoch [1/3], Step [2430], Loss: 4.2213\n",
      "Epoch [1/3], Step [2440], Loss: 3.7243\n",
      "Epoch [1/3], Step [2450], Loss: 3.4862\n",
      "Epoch [1/3], Step [2460], Loss: 3.6720\n",
      "Epoch [1/3], Step [2470], Loss: 4.0999\n",
      "Epoch [1/3], Step [2480], Loss: 3.8585\n",
      "Epoch [1/3], Step [2490], Loss: 3.9885\n",
      "Epoch [1/3], Step [2500], Loss: 3.6802\n",
      "Epoch [1/3], Step [2510], Loss: 4.0051\n",
      "Epoch [1/3], Step [2520], Loss: 3.6395\n",
      "Epoch [1/3], Step [2530], Loss: 3.4227\n",
      "Epoch [1/3], Step [2540], Loss: 4.0679\n",
      "Epoch [1/3], Step [2550], Loss: 3.7187\n",
      "Epoch [1/3], Step [2560], Loss: 3.6154\n",
      "Epoch [1/3], Step [2570], Loss: 3.8389\n",
      "Epoch [1/3], Step [2580], Loss: 3.7768\n",
      "Epoch [1/3], Step [2590], Loss: 4.2014\n",
      "Epoch [1/3], Step [2600], Loss: 4.2816\n",
      "Epoch [1/3], Step [2610], Loss: 3.8377\n",
      "Epoch [1/3], Step [2620], Loss: 3.5491\n",
      "Epoch [1/3], Step [2630], Loss: 3.7907\n",
      "Epoch [1/3], Step [2640], Loss: 3.8912\n",
      "Epoch [1/3], Step [2650], Loss: 3.8795\n",
      "Epoch [1/3], Step [2660], Loss: 3.6019\n",
      "Epoch [1/3], Step [2670], Loss: 4.2704\n",
      "Epoch [1/3], Step [2680], Loss: 3.7517\n",
      "Epoch [1/3], Step [2690], Loss: 3.7929\n",
      "Epoch [1/3], Step [2700], Loss: 3.3433\n",
      "Epoch [1/3], Step [2710], Loss: 4.0084\n",
      "Epoch [1/3], Step [2720], Loss: 3.9136\n",
      "Epoch [1/3], Step [2730], Loss: 3.8051\n",
      "Epoch [1/3], Step [2740], Loss: 3.9623\n",
      "Epoch [1/3], Step [2750], Loss: 3.9240\n",
      "Epoch [1/3], Step [2760], Loss: 3.9742\n",
      "Epoch [1/3], Step [2770], Loss: 3.9551\n",
      "Epoch [1/3], Step [2780], Loss: 3.3133\n",
      "Epoch [1/3], Step [2790], Loss: 4.0160\n",
      "Epoch [1/3], Step [2800], Loss: 3.9665\n",
      "Epoch [1/3], Step [2810], Loss: 3.9826\n",
      "Epoch [1/3], Step [2820], Loss: 3.6720\n",
      "Epoch [1/3], Step [2830], Loss: 4.0770\n",
      "Epoch [1/3], Step [2840], Loss: 3.7665\n",
      "Epoch [1/3], Step [2850], Loss: 3.7657\n",
      "Epoch [1/3], Step [2860], Loss: 3.5153\n",
      "Epoch [1/3], Step [2870], Loss: 3.7975\n",
      "Epoch [1/3], Step [2880], Loss: 4.3453\n",
      "Epoch [1/3], Step [2890], Loss: 4.2544\n",
      "Epoch [1/3], Step [2900], Loss: 3.9103\n",
      "Epoch [1/3], Step [2910], Loss: 3.9474\n",
      "Epoch [1/3], Step [2920], Loss: 3.9465\n",
      "Epoch [1/3], Step [2930], Loss: 3.7928\n",
      "Epoch [1/3], Step [2940], Loss: 3.6722\n",
      "Epoch [1/3], Step [2950], Loss: 3.9393\n",
      "Epoch [1/3], Step [2960], Loss: 3.9069\n",
      "Epoch [1/3], Step [2970], Loss: 3.6566\n",
      "Epoch [1/3], Step [2980], Loss: 3.9697\n",
      "Epoch [1/3], Step [2990], Loss: 3.8496\n",
      "Epoch [1/3], Step [3000], Loss: 3.9591\n",
      "Epoch [1/3], Step [3010], Loss: 3.9116\n",
      "Epoch [1/3], Step [3020], Loss: 3.9107\n",
      "Epoch [1/3], Step [3030], Loss: 3.7730\n",
      "Epoch [1/3], Step [3040], Loss: 3.6325\n",
      "Epoch [1/3], Step [3050], Loss: 3.7655\n",
      "Epoch [1/3], Step [3060], Loss: 3.4437\n",
      "Epoch [1/3], Step [3070], Loss: 3.8025\n",
      "Epoch [1/3], Step [3080], Loss: 4.0101\n",
      "Epoch [1/3], Step [3090], Loss: 3.8784\n",
      "Epoch [1/3], Step [3100], Loss: 3.9335\n",
      "Epoch [1/3], Step [3110], Loss: 3.6842\n",
      "Epoch [1/3], Step [3120], Loss: 4.0539\n",
      "Epoch [1/3], Step [3130], Loss: 3.6732\n",
      "Epoch [1/3], Step [3140], Loss: 3.9701\n",
      "Epoch [1/3], Step [3150], Loss: 3.7294\n",
      "Epoch [1/3], Step [3160], Loss: 4.0463\n",
      "Epoch [1/3], Step [3170], Loss: 3.4284\n",
      "Epoch [1/3], Step [3180], Loss: 3.4285\n",
      "Epoch [1/3], Step [3190], Loss: 3.9935\n",
      "Epoch [1/3], Step [3200], Loss: 3.7262\n",
      "Epoch [1/3], Step [3210], Loss: 4.0172\n",
      "Epoch [1/3], Step [3220], Loss: 3.8211\n",
      "Epoch [1/3], Step [3230], Loss: 3.8213\n",
      "Epoch [1/3], Step [3240], Loss: 3.5247\n",
      "Epoch [1/3], Step [3250], Loss: 3.7939\n",
      "Epoch [1/3], Step [3260], Loss: 3.4509\n",
      "Epoch [1/3], Step [3270], Loss: 3.5636\n",
      "Epoch [1/3], Step [3280], Loss: 3.7863\n",
      "Epoch [1/3], Step [3290], Loss: 4.1909\n",
      "Epoch [1/3], Step [3300], Loss: 3.6548\n",
      "Epoch [1/3], Step [3310], Loss: 3.9678\n",
      "Epoch [1/3], Step [3320], Loss: 3.9991\n",
      "Epoch [1/3], Step [3330], Loss: 3.5226\n",
      "Epoch [1/3], Step [3340], Loss: 3.4698\n",
      "Epoch [1/3], Step [3350], Loss: 3.4629\n",
      "Epoch [1/3], Step [3360], Loss: 3.6816\n",
      "Epoch [1/3], Step [3370], Loss: 3.8986\n",
      "Epoch [1/3], Step [3380], Loss: 3.6395\n",
      "Epoch [1/3], Step [3390], Loss: 3.8390\n",
      "Epoch [1/3], Step [3400], Loss: 3.7181\n",
      "Epoch [1/3], Step [3410], Loss: 4.0737\n",
      "Epoch [1/3], Step [3420], Loss: 3.7461\n",
      "Epoch [1/3], Step [3430], Loss: 3.8154\n",
      "Epoch [1/3], Step [3440], Loss: 4.1136\n",
      "Epoch [1/3], Step [3450], Loss: 3.8923\n",
      "Epoch [1/3], Step [3460], Loss: 3.8906\n",
      "Epoch [1/3], Step [3470], Loss: 4.0990\n",
      "Epoch [1/3], Step [3480], Loss: 3.9560\n",
      "Epoch [1/3], Step [3490], Loss: 3.6681\n",
      "Epoch [1/3], Step [3500], Loss: 3.9823\n",
      "Epoch [1/3], Step [3510], Loss: 3.4245\n",
      "Epoch [1/3], Step [3520], Loss: 3.8048\n",
      "Epoch [1/3], Step [3530], Loss: 3.5817\n",
      "Epoch [1/3], Step [3540], Loss: 4.0661\n",
      "Epoch [1/3], Step [3550], Loss: 3.8127\n",
      "Epoch [1/3], Step [3560], Loss: 3.7438\n",
      "Epoch [1/3], Step [3570], Loss: 3.5192\n",
      "Epoch [1/3], Step [3580], Loss: 3.8984\n",
      "Epoch [1/3], Step [3590], Loss: 3.6762\n",
      "Epoch [1/3], Step [3600], Loss: 3.7415\n",
      "Epoch [1/3], Step [3610], Loss: 4.2513\n",
      "Epoch [1/3], Step [3620], Loss: 3.9566\n",
      "Epoch [1/3], Step [3630], Loss: 4.2293\n",
      "Epoch [1/3], Step [3640], Loss: 3.8051\n",
      "Epoch [1/3], Step [3650], Loss: 3.7967\n",
      "Epoch [1/3], Step [3660], Loss: 3.9705\n",
      "Epoch [1/3], Step [3670], Loss: 3.9550\n",
      "Epoch [1/3], Step [3680], Loss: 3.8273\n",
      "Epoch [1/3], Step [3690], Loss: 4.0436\n",
      "Epoch [1/3], Step [3700], Loss: 3.3900\n",
      "Epoch [1/3], Step [3710], Loss: 3.8198\n",
      "Epoch [1/3], Step [3720], Loss: 4.1079\n",
      "Epoch [1/3], Step [3730], Loss: 3.9133\n",
      "Epoch [1/3], Step [3740], Loss: 3.9216\n",
      "Epoch [1/3], Step [3750], Loss: 3.7900\n",
      "Epoch [1/3], Step [3760], Loss: 3.6100\n",
      "Epoch [1/3], Step [3770], Loss: 3.9293\n",
      "Epoch [1/3], Step [3780], Loss: 3.5128\n",
      "Epoch [1/3], Step [3790], Loss: 3.6499\n",
      "Epoch [1/3], Step [3800], Loss: 3.9683\n",
      "Epoch [1/3], Step [3810], Loss: 3.8207\n",
      "Epoch [1/3], Step [3820], Loss: 4.0142\n",
      "Epoch [1/3], Step [3830], Loss: 3.4995\n",
      "Epoch [1/3], Step [3840], Loss: 3.7906\n",
      "Epoch [1/3], Step [3850], Loss: 3.5499\n",
      "Epoch [1/3], Step [3860], Loss: 3.8430\n",
      "Epoch [1/3], Step [3870], Loss: 3.5489\n",
      "Epoch [1/3], Step [3880], Loss: 3.8026\n",
      "Epoch [1/3], Step [3890], Loss: 3.7432\n",
      "Epoch [1/3], Step [3900], Loss: 3.8654\n",
      "Epoch [1/3], Step [3910], Loss: 3.6254\n",
      "Epoch [1/3], Step [3920], Loss: 3.2756\n",
      "Epoch [1/3], Step [3930], Loss: 3.6729\n",
      "Epoch [1/3], Step [3940], Loss: 3.6950\n",
      "Epoch [1/3], Step [3950], Loss: 3.6864\n",
      "Epoch [1/3], Step [3960], Loss: 3.5552\n",
      "Epoch [1/3], Step [3970], Loss: 3.7648\n",
      "Epoch [1/3], Step [3980], Loss: 3.8754\n",
      "Epoch [1/3], Step [3990], Loss: 3.6147\n",
      "Epoch [1/3], Step [4000], Loss: 3.9395\n",
      "Epoch [1/3], Step [4010], Loss: 3.7708\n",
      "Epoch [1/3], Step [4020], Loss: 3.7555\n",
      "Epoch [1/3], Step [4030], Loss: 3.2827\n",
      "Epoch [1/3], Step [4040], Loss: 3.4787\n",
      "Epoch [1/3], Step [4050], Loss: 4.3384\n",
      "Epoch [1/3], Step [4060], Loss: 3.9330\n",
      "Epoch [1/3], Step [4070], Loss: 3.7035\n",
      "Epoch [1/3], Step [4080], Loss: 3.7589\n",
      "Epoch [1/3], Step [4090], Loss: 3.3300\n",
      "Epoch [1/3], Step [4100], Loss: 3.9188\n",
      "Epoch [1/3], Step [4110], Loss: 3.8638\n",
      "Epoch [1/3], Step [4120], Loss: 3.7566\n",
      "Epoch [1/3], Step [4130], Loss: 3.9843\n",
      "Epoch [1/3], Step [4140], Loss: 3.7184\n",
      "Epoch [1/3], Step [4150], Loss: 3.7226\n",
      "Epoch [1/3], Step [4160], Loss: 3.8180\n",
      "Epoch [1/3], Step [4170], Loss: 3.5838\n",
      "Epoch [1/3], Step [4180], Loss: 3.5675\n",
      "Epoch [1/3], Step [4190], Loss: 3.7060\n",
      "Epoch [1/3], Step [4200], Loss: 4.0459\n",
      "Epoch [1/3], Step [4210], Loss: 3.9327\n",
      "Epoch [1/3], Step [4220], Loss: 3.5866\n",
      "Epoch [1/3], Step [4230], Loss: 3.7401\n",
      "Epoch [1/3], Step [4240], Loss: 3.8122\n",
      "Epoch [1/3], Step [4250], Loss: 3.9765\n",
      "Epoch [1/3], Step [4260], Loss: 3.6615\n",
      "Epoch [1/3], Step [4270], Loss: 3.5650\n",
      "Epoch [1/3], Step [4280], Loss: 3.7542\n",
      "Epoch [1/3], Step [4290], Loss: 4.1266\n",
      "Epoch [1/3], Step [4300], Loss: 3.7833\n",
      "Epoch [1/3], Step [4310], Loss: 3.9735\n",
      "Epoch [1/3], Step [4320], Loss: 3.9983\n",
      "Epoch [1/3], Step [4330], Loss: 3.5231\n",
      "Epoch [1/3], Step [4340], Loss: 3.8344\n",
      "Epoch [1/3], Step [4350], Loss: 3.7305\n",
      "Epoch [1/3], Step [4360], Loss: 3.7552\n",
      "Epoch [1/3], Step [4370], Loss: 3.5948\n",
      "Epoch [1/3], Step [4380], Loss: 3.8298\n",
      "Epoch [1/3], Step [4390], Loss: 3.6787\n",
      "Epoch [1/3], Step [4400], Loss: 3.3913\n",
      "Epoch [1/3], Step [4410], Loss: 3.0263\n",
      "Epoch [1/3], Step [4420], Loss: 3.6789\n",
      "Epoch [1/3], Step [4430], Loss: 3.2297\n",
      "Epoch [1/3], Step [4440], Loss: 3.9810\n",
      "Epoch [1/3], Step [4450], Loss: 3.8380\n",
      "Epoch [1/3], Step [4460], Loss: 3.6717\n",
      "Epoch [1/3], Step [4470], Loss: 3.9108\n",
      "Epoch [1/3], Step [4480], Loss: 3.4873\n",
      "Epoch [1/3], Step [4490], Loss: 3.9526\n",
      "Epoch [1/3], Step [4500], Loss: 3.7496\n",
      "Epoch [1/3], Step [4510], Loss: 4.0323\n",
      "Epoch [1/3], Step [4520], Loss: 3.6441\n",
      "Epoch [1/3], Step [4530], Loss: 3.3873\n",
      "Epoch [1/3], Step [4540], Loss: 3.3202\n",
      "Epoch [1/3], Step [4550], Loss: 3.8239\n",
      "Epoch [1/3], Step [4560], Loss: 3.7568\n",
      "Epoch [1/3], Step [4570], Loss: 3.8677\n",
      "Epoch [1/3], Step [4580], Loss: 3.7704\n",
      "Epoch [1/3], Step [4590], Loss: 3.4354\n",
      "Epoch [1/3], Step [4600], Loss: 3.8529\n",
      "Epoch [1/3], Step [4610], Loss: 3.7389\n",
      "Epoch [1/3], Step [4620], Loss: 4.0029\n",
      "Epoch [1/3], Step [4630], Loss: 3.7598\n",
      "Epoch [1/3], Step [4640], Loss: 3.8166\n",
      "Epoch [1/3], Step [4650], Loss: 3.6426\n",
      "Epoch [1/3], Step [4660], Loss: 3.3056\n",
      "Epoch [1/3], Step [4670], Loss: 3.6393\n",
      "Epoch [1/3], Step [4680], Loss: 3.5488\n",
      "Epoch [1/3], Step [4690], Loss: 3.5856\n",
      "Epoch [1/3], Step [4700], Loss: 3.7973\n",
      "Epoch [1/3], Step [4710], Loss: 4.0498\n",
      "Epoch [1/3], Step [4720], Loss: 3.5124\n",
      "Epoch [1/3], Step [4730], Loss: 3.3814\n",
      "Epoch [1/3], Step [4740], Loss: 3.8105\n",
      "Epoch [1/3], Step [4750], Loss: 3.9323\n",
      "Epoch [1/3], Step [4760], Loss: 3.5658\n",
      "Epoch [1/3], Step [4770], Loss: 3.9018\n",
      "Epoch [1/3], Step [4780], Loss: 3.8124\n",
      "Epoch [1/3], Step [4790], Loss: 3.9879\n",
      "Epoch [1/3], Step [4800], Loss: 3.7098\n",
      "Epoch [1/3], Step [4810], Loss: 3.9633\n",
      "Epoch [1/3], Step [4820], Loss: 3.6769\n",
      "Epoch [1/3], Step [4830], Loss: 3.8602\n",
      "Epoch [1/3], Step [4840], Loss: 3.9974\n",
      "Epoch [1/3], Step [4850], Loss: 3.9149\n",
      "Epoch [1/3], Step [4860], Loss: 3.9933\n",
      "Epoch [1/3], Step [4870], Loss: 3.6358\n",
      "Epoch [1/3], Step [4880], Loss: 4.0389\n",
      "Epoch [1/3], Step [4890], Loss: 3.7914\n",
      "Epoch [1/3], Step [4900], Loss: 4.0112\n",
      "Epoch [1/3], Step [4910], Loss: 3.7538\n",
      "Epoch [1/3], Step [4920], Loss: 3.5078\n",
      "Epoch [1/3], Step [4930], Loss: 4.0908\n",
      "Epoch [1/3], Step [4940], Loss: 3.7870\n",
      "Epoch [1/3], Step [4950], Loss: 3.9891\n",
      "Epoch [1/3], Step [4960], Loss: 3.8120\n",
      "Epoch [1/3], Step [4970], Loss: 3.8183\n",
      "Epoch [1/3], Step [4980], Loss: 3.8324\n",
      "Epoch [1/3], Step [4990], Loss: 3.7906\n",
      "Epoch [1/3], Step [5000], Loss: 3.7287\n",
      "Epoch [1/3], Step [5010], Loss: 3.8167\n",
      "Epoch [1/3], Step [5020], Loss: 3.8992\n",
      "Epoch [1/3], Step [5030], Loss: 3.8003\n",
      "Epoch [1/3], Step [5040], Loss: 3.8723\n",
      "Epoch [1/3], Step [5050], Loss: 3.2722\n",
      "Epoch [1/3], Step [5060], Loss: 3.8473\n",
      "Epoch [1/3], Step [5070], Loss: 3.9532\n",
      "Epoch [1/3], Step [5080], Loss: 3.6098\n",
      "Epoch [1/3], Step [5090], Loss: 3.8073\n",
      "Epoch [1/3], Step [5100], Loss: 3.5491\n",
      "Epoch [1/3], Step [5110], Loss: 3.7499\n",
      "Epoch [1/3], Step [5120], Loss: 3.9309\n",
      "Epoch [1/3], Step [5130], Loss: 3.9541\n",
      "Epoch [1/3], Step [5140], Loss: 3.9492\n",
      "Epoch [1/3], Step [5150], Loss: 3.5657\n",
      "Epoch [1/3], Step [5160], Loss: 2.9445\n",
      "Epoch [1/3], Step [5170], Loss: 3.8748\n",
      "Epoch [1/3], Step [5180], Loss: 3.8939\n",
      "Epoch [1/3], Step [5190], Loss: 3.6060\n",
      "Epoch [1/3], Step [5200], Loss: 3.9427\n",
      "Epoch [1/3], Step [5210], Loss: 4.2127\n",
      "Epoch [1/3], Step [5220], Loss: 3.7311\n",
      "Epoch [1/3], Step [5230], Loss: 3.5820\n",
      "Epoch [1/3], Step [5240], Loss: 4.0264\n",
      "Epoch [1/3], Step [5250], Loss: 3.7317\n",
      "Epoch [1/3], Step [5260], Loss: 3.7849\n",
      "Epoch [1/3], Step [5270], Loss: 3.8961\n",
      "Epoch [1/3], Step [5280], Loss: 3.8100\n",
      "Epoch [1/3], Step [5290], Loss: 3.8117\n",
      "Epoch [1/3], Step [5300], Loss: 3.6372\n",
      "Epoch [1/3], Step [5310], Loss: 3.9427\n",
      "Epoch [1/3], Step [5320], Loss: 3.1689\n",
      "Epoch [1/3], Step [5330], Loss: 3.5885\n",
      "Epoch [1/3], Step [5340], Loss: 3.8847\n",
      "Epoch [1/3], Step [5350], Loss: 3.7380\n",
      "Epoch [1/3], Step [5360], Loss: 3.8182\n",
      "Epoch [1/3], Step [5370], Loss: 3.5868\n",
      "Epoch [1/3], Step [5380], Loss: 3.7464\n",
      "Epoch [1/3], Step [5390], Loss: 3.9213\n",
      "Epoch [1/3], Step [5400], Loss: 3.6839\n",
      "Epoch [1/3], Step [5410], Loss: 3.5545\n",
      "Epoch [1/3], Step [5420], Loss: 3.9473\n",
      "Epoch [1/3], Step [5430], Loss: 3.9791\n",
      "Epoch [1/3], Step [5440], Loss: 3.8058\n",
      "Epoch [1/3], Step [5450], Loss: 3.6894\n",
      "Epoch [1/3], Step [5460], Loss: 3.7051\n",
      "Epoch [1/3], Step [5470], Loss: 3.9787\n",
      "Epoch [1/3], Step [5480], Loss: 3.8084\n",
      "Epoch [1/3], Step [5490], Loss: 3.8309\n",
      "Epoch [1/3], Step [5500], Loss: 3.8551\n",
      "Epoch [1/3], Step [5510], Loss: 3.8791\n",
      "Epoch [1/3], Step [5520], Loss: 3.4839\n",
      "Epoch [1/3], Step [5530], Loss: 3.4944\n",
      "Epoch [1/3], Step [5540], Loss: 3.5888\n",
      "Epoch [1/3], Step [5550], Loss: 3.9595\n",
      "Epoch [1/3], Step [5560], Loss: 3.5263\n",
      "Epoch [1/3], Step [5570], Loss: 3.7347\n",
      "Epoch [1/3], Step [5580], Loss: 3.5504\n",
      "Epoch [1/3], Step [5590], Loss: 3.9082\n",
      "Epoch [1/3], Step [5600], Loss: 3.9617\n",
      "Epoch [1/3], Step [5610], Loss: 3.7478\n",
      "Epoch [1/3], Step [5620], Loss: 3.8599\n",
      "Epoch [1/3], Step [5630], Loss: 4.0041\n",
      "Epoch [1/3], Step [5640], Loss: 3.3483\n",
      "Epoch [1/3], Step [5650], Loss: 3.7185\n",
      "Epoch [1/3], Step [5660], Loss: 3.7745\n",
      "Epoch [1/3], Step [5670], Loss: 3.7127\n",
      "Epoch [1/3], Step [5680], Loss: 3.8521\n",
      "Epoch [1/3], Step [5690], Loss: 3.8639\n",
      "Epoch [1/3], Step [5700], Loss: 3.8297\n",
      "Epoch [1/3], Step [5710], Loss: 3.7689\n",
      "Epoch [1/3], Step [5720], Loss: 4.0782\n",
      "Epoch [1/3], Step [5730], Loss: 3.9251\n",
      "Epoch [1/3], Step [5740], Loss: 3.8598\n",
      "Epoch [1/3], Step [5750], Loss: 3.7892\n",
      "Epoch [1/3], Step [5760], Loss: 3.7390\n",
      "Epoch [1/3], Step [5770], Loss: 3.7915\n",
      "Epoch [1/3], Step [5780], Loss: 3.7570\n",
      "Epoch [1/3], Step [5790], Loss: 3.5199\n",
      "Epoch [1/3], Step [5800], Loss: 3.7219\n",
      "Epoch [1/3], Step [5810], Loss: 3.8591\n",
      "Epoch [1/3], Step [5820], Loss: 3.6297\n",
      "Epoch [1/3], Step [5830], Loss: 3.5058\n",
      "Epoch [1/3], Step [5840], Loss: 3.7920\n",
      "Epoch [1/3], Step [5850], Loss: 3.8047\n",
      "Epoch [1/3], Step [5860], Loss: 3.8768\n",
      "Epoch [1/3], Step [5870], Loss: 3.8095\n",
      "Epoch [1/3], Step [5880], Loss: 3.9849\n",
      "Epoch [1/3], Step [5890], Loss: 3.8799\n",
      "Epoch [1/3], Step [5900], Loss: 3.8856\n",
      "Epoch [1/3], Step [5910], Loss: 3.7247\n",
      "Epoch [1/3], Step [5920], Loss: 3.8465\n",
      "Epoch [1/3], Step [5930], Loss: 3.5714\n",
      "Epoch [1/3], Step [5940], Loss: 3.3642\n",
      "Epoch [1/3], Step [5950], Loss: 3.6898\n",
      "Epoch [1/3], Step [5960], Loss: 3.7705\n",
      "Epoch [1/3], Step [5970], Loss: 3.8676\n",
      "Epoch [1/3], Step [5980], Loss: 3.7416\n",
      "Epoch [1/3], Step [5990], Loss: 3.8984\n",
      "Epoch [1/3], Step [6000], Loss: 3.8190\n",
      "Epoch [1/3], Step [6010], Loss: 3.9724\n",
      "Epoch [1/3], Step [6020], Loss: 3.7379\n",
      "Epoch [1/3], Step [6030], Loss: 3.9573\n",
      "Epoch [1/3], Step [6040], Loss: 3.9851\n",
      "Epoch [1/3], Step [6050], Loss: 3.6310\n",
      "Epoch [1/3], Step [6060], Loss: 3.7238\n",
      "Epoch [1/3], Step [6070], Loss: 3.5793\n",
      "Epoch [1/3], Step [6080], Loss: 3.8059\n",
      "Epoch [1/3], Step [6090], Loss: 3.6913\n",
      "Epoch [1/3], Step [6100], Loss: 3.6481\n",
      "Epoch [1/3], Step [6110], Loss: 3.6169\n",
      "Epoch [1/3], Step [6120], Loss: 3.7813\n",
      "Epoch [1/3], Step [6130], Loss: 3.6582\n",
      "Epoch [1/3], Step [6140], Loss: 4.3789\n",
      "Epoch [1/3], Step [6150], Loss: 3.2442\n",
      "Epoch [1/3], Step [6160], Loss: 3.7781\n",
      "Epoch [1/3], Step [6170], Loss: 3.6398\n",
      "Epoch [1/3], Step [6180], Loss: 3.8785\n",
      "Epoch [1/3], Step [6190], Loss: 3.8772\n",
      "Epoch [1/3], Step [6200], Loss: 4.0384\n",
      "Epoch [1/3], Step [6210], Loss: 3.5989\n",
      "Epoch [1/3], Step [6220], Loss: 3.8915\n",
      "Epoch [1/3], Step [6230], Loss: 3.8227\n",
      "Epoch [1/3], Step [6240], Loss: 3.9789\n",
      "Epoch [1/3], Train Loss: 3.9187, Validation Loss: 3.6660\n",
      "Epoch [1/3], : 7.94\n",
      "Epoch [2/3], Step [0], Loss: 3.8052\n",
      "Epoch [2/3], Step [10], Loss: 3.8588\n",
      "Epoch [2/3], Step [20], Loss: 3.5745\n",
      "Epoch [2/3], Step [30], Loss: 3.6191\n",
      "Epoch [2/3], Step [40], Loss: 3.0951\n",
      "Epoch [2/3], Step [50], Loss: 3.8199\n",
      "Epoch [2/3], Step [60], Loss: 3.5600\n",
      "Epoch [2/3], Step [70], Loss: 3.9622\n",
      "Epoch [2/3], Step [80], Loss: 4.0763\n",
      "Epoch [2/3], Step [90], Loss: 3.7203\n",
      "Epoch [2/3], Step [100], Loss: 3.7364\n",
      "Epoch [2/3], Step [110], Loss: 3.6770\n",
      "Epoch [2/3], Step [120], Loss: 3.7983\n",
      "Epoch [2/3], Step [130], Loss: 3.8742\n",
      "Epoch [2/3], Step [140], Loss: 3.7965\n",
      "Epoch [2/3], Step [150], Loss: 3.4412\n",
      "Epoch [2/3], Step [160], Loss: 3.9617\n",
      "Epoch [2/3], Step [170], Loss: 3.7280\n",
      "Epoch [2/3], Step [180], Loss: 3.5793\n",
      "Epoch [2/3], Step [190], Loss: 3.7828\n",
      "Epoch [2/3], Step [200], Loss: 3.6625\n",
      "Epoch [2/3], Step [210], Loss: 3.8203\n",
      "Epoch [2/3], Step [220], Loss: 3.8290\n",
      "Epoch [2/3], Step [230], Loss: 3.7397\n",
      "Epoch [2/3], Step [240], Loss: 3.8966\n",
      "Epoch [2/3], Step [250], Loss: 4.0373\n",
      "Epoch [2/3], Step [260], Loss: 3.0886\n",
      "Epoch [2/3], Step [270], Loss: 4.0200\n",
      "Epoch [2/3], Step [280], Loss: 3.7619\n",
      "Epoch [2/3], Step [290], Loss: 3.7050\n",
      "Epoch [2/3], Step [300], Loss: 3.8782\n",
      "Epoch [2/3], Step [310], Loss: 3.8580\n",
      "Epoch [2/3], Step [320], Loss: 3.5248\n",
      "Epoch [2/3], Step [330], Loss: 3.6579\n",
      "Epoch [2/3], Step [340], Loss: 3.6945\n",
      "Epoch [2/3], Step [350], Loss: 3.7843\n",
      "Epoch [2/3], Step [360], Loss: 3.4795\n",
      "Epoch [2/3], Step [370], Loss: 3.9246\n",
      "Epoch [2/3], Step [380], Loss: 3.5300\n",
      "Epoch [2/3], Step [390], Loss: 3.5483\n",
      "Epoch [2/3], Step [400], Loss: 3.3940\n",
      "Epoch [2/3], Step [410], Loss: 3.1848\n",
      "Epoch [2/3], Step [420], Loss: 3.7905\n",
      "Epoch [2/3], Step [430], Loss: 3.6018\n",
      "Epoch [2/3], Step [440], Loss: 3.5505\n",
      "Epoch [2/3], Step [450], Loss: 3.7870\n",
      "Epoch [2/3], Step [460], Loss: 3.1737\n",
      "Epoch [2/3], Step [470], Loss: 3.6535\n",
      "Epoch [2/3], Step [480], Loss: 4.0283\n",
      "Epoch [2/3], Step [490], Loss: 3.7278\n",
      "Epoch [2/3], Step [500], Loss: 3.7721\n",
      "Epoch [2/3], Step [510], Loss: 4.0969\n",
      "Epoch [2/3], Step [520], Loss: 3.4660\n",
      "Epoch [2/3], Step [530], Loss: 3.7889\n",
      "Epoch [2/3], Step [540], Loss: 3.7165\n",
      "Epoch [2/3], Step [550], Loss: 3.5998\n",
      "Epoch [2/3], Step [560], Loss: 3.5790\n",
      "Epoch [2/3], Step [570], Loss: 3.8044\n",
      "Epoch [2/3], Step [580], Loss: 3.5225\n",
      "Epoch [2/3], Step [590], Loss: 3.8252\n",
      "Epoch [2/3], Step [600], Loss: 3.5289\n",
      "Epoch [2/3], Step [610], Loss: 3.7707\n",
      "Epoch [2/3], Step [620], Loss: 3.9952\n",
      "Epoch [2/3], Step [630], Loss: 3.6638\n",
      "Epoch [2/3], Step [640], Loss: 3.6273\n",
      "Epoch [2/3], Step [650], Loss: 3.6687\n",
      "Epoch [2/3], Step [660], Loss: 3.9897\n",
      "Epoch [2/3], Step [670], Loss: 3.4959\n",
      "Epoch [2/3], Step [680], Loss: 3.6714\n",
      "Epoch [2/3], Step [690], Loss: 3.6838\n",
      "Epoch [2/3], Step [700], Loss: 3.8407\n",
      "Epoch [2/3], Step [710], Loss: 4.0330\n",
      "Epoch [2/3], Step [720], Loss: 4.0416\n",
      "Epoch [2/3], Step [730], Loss: 3.6259\n",
      "Epoch [2/3], Step [740], Loss: 3.8754\n",
      "Epoch [2/3], Step [750], Loss: 3.7005\n",
      "Epoch [2/3], Step [760], Loss: 3.9310\n",
      "Epoch [2/3], Step [770], Loss: 4.0737\n",
      "Epoch [2/3], Step [780], Loss: 3.9210\n",
      "Epoch [2/3], Step [790], Loss: 3.7258\n",
      "Epoch [2/3], Step [800], Loss: 3.3789\n",
      "Epoch [2/3], Step [810], Loss: 3.7136\n",
      "Epoch [2/3], Step [820], Loss: 3.8773\n",
      "Epoch [2/3], Step [830], Loss: 3.6931\n",
      "Epoch [2/3], Step [840], Loss: 3.7067\n",
      "Epoch [2/3], Step [850], Loss: 3.9931\n",
      "Epoch [2/3], Step [860], Loss: 3.6179\n",
      "Epoch [2/3], Step [870], Loss: 3.8800\n",
      "Epoch [2/3], Step [880], Loss: 4.2688\n",
      "Epoch [2/3], Step [890], Loss: 3.3117\n",
      "Epoch [2/3], Step [900], Loss: 3.6834\n",
      "Epoch [2/3], Step [910], Loss: 3.5574\n",
      "Epoch [2/3], Step [920], Loss: 3.7116\n",
      "Epoch [2/3], Step [930], Loss: 4.0325\n",
      "Epoch [2/3], Step [940], Loss: 3.6862\n",
      "Epoch [2/3], Step [950], Loss: 3.4451\n",
      "Epoch [2/3], Step [960], Loss: 3.6655\n",
      "Epoch [2/3], Step [970], Loss: 3.9746\n",
      "Epoch [2/3], Step [980], Loss: 3.5811\n",
      "Epoch [2/3], Step [990], Loss: 3.7659\n",
      "Epoch [2/3], Step [1000], Loss: 3.9261\n",
      "Epoch [2/3], Step [1010], Loss: 3.4599\n",
      "Epoch [2/3], Step [1020], Loss: 3.1926\n",
      "Epoch [2/3], Step [1030], Loss: 3.6239\n",
      "Epoch [2/3], Step [1040], Loss: 3.9344\n",
      "Epoch [2/3], Step [1050], Loss: 3.5665\n",
      "Epoch [2/3], Step [1060], Loss: 4.1403\n",
      "Epoch [2/3], Step [1070], Loss: 3.5665\n",
      "Epoch [2/3], Step [1080], Loss: 4.0339\n",
      "Epoch [2/3], Step [1090], Loss: 3.7264\n",
      "Epoch [2/3], Step [1100], Loss: 3.4611\n",
      "Epoch [2/3], Step [1110], Loss: 3.6327\n",
      "Epoch [2/3], Step [1120], Loss: 3.3897\n",
      "Epoch [2/3], Step [1130], Loss: 3.2944\n",
      "Epoch [2/3], Step [1140], Loss: 3.7215\n",
      "Epoch [2/3], Step [1150], Loss: 3.8423\n",
      "Epoch [2/3], Step [1160], Loss: 3.4731\n",
      "Epoch [2/3], Step [1170], Loss: 3.8361\n",
      "Epoch [2/3], Step [1180], Loss: 3.6900\n",
      "Epoch [2/3], Step [1190], Loss: 3.9871\n",
      "Epoch [2/3], Step [1200], Loss: 3.8161\n",
      "Epoch [2/3], Step [1210], Loss: 3.7360\n",
      "Epoch [2/3], Step [1220], Loss: 3.4156\n",
      "Epoch [2/3], Step [1230], Loss: 3.8642\n",
      "Epoch [2/3], Step [1240], Loss: 3.8320\n",
      "Epoch [2/3], Step [1250], Loss: 3.4442\n",
      "Epoch [2/3], Step [1260], Loss: 3.5746\n",
      "Epoch [2/3], Step [1270], Loss: 3.8767\n",
      "Epoch [2/3], Step [1280], Loss: 3.9937\n",
      "Epoch [2/3], Step [1290], Loss: 4.0669\n",
      "Epoch [2/3], Step [1300], Loss: 3.8153\n",
      "Epoch [2/3], Step [1310], Loss: 3.7325\n",
      "Epoch [2/3], Step [1320], Loss: 3.2837\n",
      "Epoch [2/3], Step [1330], Loss: 3.5158\n",
      "Epoch [2/3], Step [1340], Loss: 3.2216\n",
      "Epoch [2/3], Step [1350], Loss: 3.2553\n",
      "Epoch [2/3], Step [1360], Loss: 3.3399\n",
      "Epoch [2/3], Step [1370], Loss: 3.9280\n",
      "Epoch [2/3], Step [1380], Loss: 3.7905\n",
      "Epoch [2/3], Step [1390], Loss: 3.7845\n",
      "Epoch [2/3], Step [1400], Loss: 3.8708\n",
      "Epoch [2/3], Step [1410], Loss: 3.5122\n",
      "Epoch [2/3], Step [1420], Loss: 3.1803\n",
      "Epoch [2/3], Step [1430], Loss: 3.8429\n",
      "Epoch [2/3], Step [1440], Loss: 3.7035\n",
      "Epoch [2/3], Step [1450], Loss: 4.0993\n",
      "Epoch [2/3], Step [1460], Loss: 3.7866\n",
      "Epoch [2/3], Step [1470], Loss: 3.9726\n",
      "Epoch [2/3], Step [1480], Loss: 3.9755\n",
      "Epoch [2/3], Step [1490], Loss: 3.8195\n",
      "Epoch [2/3], Step [1500], Loss: 3.6360\n",
      "Epoch [2/3], Step [1510], Loss: 3.5691\n",
      "Epoch [2/3], Step [1520], Loss: 3.7056\n",
      "Epoch [2/3], Step [1530], Loss: 3.8584\n",
      "Epoch [2/3], Step [1540], Loss: 3.9124\n",
      "Epoch [2/3], Step [1550], Loss: 3.9611\n",
      "Epoch [2/3], Step [1560], Loss: 3.2806\n",
      "Epoch [2/3], Step [1570], Loss: 3.8444\n",
      "Epoch [2/3], Step [1580], Loss: 4.0544\n",
      "Epoch [2/3], Step [1590], Loss: 3.7157\n",
      "Epoch [2/3], Step [1600], Loss: 3.8135\n",
      "Epoch [2/3], Step [1610], Loss: 3.9370\n",
      "Epoch [2/3], Step [1620], Loss: 3.4090\n",
      "Epoch [2/3], Step [1630], Loss: 3.5719\n",
      "Epoch [2/3], Step [1640], Loss: 3.6280\n",
      "Epoch [2/3], Step [1650], Loss: 3.6800\n",
      "Epoch [2/3], Step [1660], Loss: 3.9907\n",
      "Epoch [2/3], Step [1670], Loss: 3.7850\n",
      "Epoch [2/3], Step [1680], Loss: 3.7052\n",
      "Epoch [2/3], Step [1690], Loss: 4.0416\n",
      "Epoch [2/3], Step [1700], Loss: 3.8245\n",
      "Epoch [2/3], Step [1710], Loss: 3.7980\n",
      "Epoch [2/3], Step [1720], Loss: 3.8607\n",
      "Epoch [2/3], Step [1730], Loss: 3.9768\n",
      "Epoch [2/3], Step [1740], Loss: 3.6312\n",
      "Epoch [2/3], Step [1750], Loss: 3.7524\n",
      "Epoch [2/3], Step [1760], Loss: 3.9038\n",
      "Epoch [2/3], Step [1770], Loss: 4.0170\n",
      "Epoch [2/3], Step [1780], Loss: 3.9308\n",
      "Epoch [2/3], Step [1790], Loss: 3.9286\n",
      "Epoch [2/3], Step [1800], Loss: 3.6075\n",
      "Epoch [2/3], Step [1810], Loss: 3.4513\n",
      "Epoch [2/3], Step [1820], Loss: 3.8075\n",
      "Epoch [2/3], Step [1830], Loss: 3.8991\n",
      "Epoch [2/3], Step [1840], Loss: 3.7285\n",
      "Epoch [2/3], Step [1850], Loss: 3.5543\n",
      "Epoch [2/3], Step [1860], Loss: 3.8032\n",
      "Epoch [2/3], Step [1870], Loss: 4.0218\n",
      "Epoch [2/3], Step [1880], Loss: 3.6088\n",
      "Epoch [2/3], Step [1890], Loss: 4.1001\n",
      "Epoch [2/3], Step [1900], Loss: 3.6671\n",
      "Epoch [2/3], Step [1910], Loss: 3.8761\n",
      "Epoch [2/3], Step [1920], Loss: 3.9561\n",
      "Epoch [2/3], Step [1930], Loss: 3.9130\n",
      "Epoch [2/3], Step [1940], Loss: 3.7525\n",
      "Epoch [2/3], Step [1950], Loss: 3.4769\n",
      "Epoch [2/3], Step [1960], Loss: 3.8876\n",
      "Epoch [2/3], Step [1970], Loss: 3.8343\n",
      "Epoch [2/3], Step [1980], Loss: 3.9881\n",
      "Epoch [2/3], Step [1990], Loss: 3.8146\n",
      "Epoch [2/3], Step [2000], Loss: 3.5478\n",
      "Epoch [2/3], Step [2010], Loss: 3.8882\n",
      "Epoch [2/3], Step [2020], Loss: 3.3668\n",
      "Epoch [2/3], Step [2030], Loss: 3.7678\n",
      "Epoch [2/3], Step [2040], Loss: 3.8801\n",
      "Epoch [2/3], Step [2050], Loss: 3.8130\n",
      "Epoch [2/3], Step [2060], Loss: 3.6381\n",
      "Epoch [2/3], Step [2070], Loss: 3.9751\n",
      "Epoch [2/3], Step [2080], Loss: 3.6901\n",
      "Epoch [2/3], Step [2090], Loss: 3.6020\n",
      "Epoch [2/3], Step [2100], Loss: 3.3358\n",
      "Epoch [2/3], Step [2110], Loss: 3.5857\n",
      "Epoch [2/3], Step [2120], Loss: 3.3658\n",
      "Epoch [2/3], Step [2130], Loss: 3.9664\n",
      "Epoch [2/3], Step [2140], Loss: 3.3765\n",
      "Epoch [2/3], Step [2150], Loss: 3.5539\n",
      "Epoch [2/3], Step [2160], Loss: 3.7791\n",
      "Epoch [2/3], Step [2170], Loss: 3.3623\n",
      "Epoch [2/3], Step [2180], Loss: 4.1302\n",
      "Epoch [2/3], Step [2190], Loss: 3.8895\n",
      "Epoch [2/3], Step [2200], Loss: 3.8308\n",
      "Epoch [2/3], Step [2210], Loss: 3.7335\n",
      "Epoch [2/3], Step [2220], Loss: 3.8488\n",
      "Epoch [2/3], Step [2230], Loss: 3.7385\n",
      "Epoch [2/3], Step [2240], Loss: 3.7420\n",
      "Epoch [2/3], Step [2250], Loss: 3.7074\n",
      "Epoch [2/3], Step [2260], Loss: 3.7733\n",
      "Epoch [2/3], Step [2270], Loss: 3.8841\n",
      "Epoch [2/3], Step [2280], Loss: 3.9362\n",
      "Epoch [2/3], Step [2290], Loss: 3.4900\n",
      "Epoch [2/3], Step [2300], Loss: 3.7714\n",
      "Epoch [2/3], Step [2310], Loss: 3.8864\n",
      "Epoch [2/3], Step [2320], Loss: 3.9416\n",
      "Epoch [2/3], Step [2330], Loss: 3.3501\n",
      "Epoch [2/3], Step [2340], Loss: 3.6780\n",
      "Epoch [2/3], Step [2350], Loss: 3.7147\n",
      "Epoch [2/3], Step [2360], Loss: 3.6262\n",
      "Epoch [2/3], Step [2370], Loss: 3.7959\n",
      "Epoch [2/3], Step [2380], Loss: 3.1601\n",
      "Epoch [2/3], Step [2390], Loss: 3.4460\n",
      "Epoch [2/3], Step [2400], Loss: 3.8805\n",
      "Epoch [2/3], Step [2410], Loss: 3.4585\n",
      "Epoch [2/3], Step [2420], Loss: 3.9181\n",
      "Epoch [2/3], Step [2430], Loss: 4.0483\n",
      "Epoch [2/3], Step [2440], Loss: 3.8782\n",
      "Epoch [2/3], Step [2450], Loss: 3.4870\n",
      "Epoch [2/3], Step [2460], Loss: 3.9073\n",
      "Epoch [2/3], Step [2470], Loss: 3.7679\n",
      "Epoch [2/3], Step [2480], Loss: 3.9360\n",
      "Epoch [2/3], Step [2490], Loss: 3.6710\n",
      "Epoch [2/3], Step [2500], Loss: 4.0746\n",
      "Epoch [2/3], Step [2510], Loss: 3.7993\n",
      "Epoch [2/3], Step [2520], Loss: 3.5546\n",
      "Epoch [2/3], Step [2530], Loss: 3.9767\n",
      "Epoch [2/3], Step [2540], Loss: 3.7123\n",
      "Epoch [2/3], Step [2550], Loss: 3.9338\n",
      "Epoch [2/3], Step [2560], Loss: 3.7554\n",
      "Epoch [2/3], Step [2570], Loss: 3.6475\n",
      "Epoch [2/3], Step [2580], Loss: 3.9852\n",
      "Epoch [2/3], Step [2590], Loss: 3.8779\n",
      "Epoch [2/3], Step [2600], Loss: 3.7046\n",
      "Epoch [2/3], Step [2610], Loss: 3.6087\n",
      "Epoch [2/3], Step [2620], Loss: 3.8341\n",
      "Epoch [2/3], Step [2630], Loss: 3.8249\n",
      "Epoch [2/3], Step [2640], Loss: 3.7911\n",
      "Epoch [2/3], Step [2650], Loss: 3.6703\n",
      "Epoch [2/3], Step [2660], Loss: 3.8369\n",
      "Epoch [2/3], Step [2670], Loss: 3.3039\n",
      "Epoch [2/3], Step [2680], Loss: 4.1732\n",
      "Epoch [2/3], Step [2690], Loss: 3.7159\n",
      "Epoch [2/3], Step [2700], Loss: 3.7796\n",
      "Epoch [2/3], Step [2710], Loss: 3.7164\n",
      "Epoch [2/3], Step [2720], Loss: 3.5976\n",
      "Epoch [2/3], Step [2730], Loss: 3.7742\n",
      "Epoch [2/3], Step [2740], Loss: 3.6164\n",
      "Epoch [2/3], Step [2750], Loss: 3.6581\n",
      "Epoch [2/3], Step [2760], Loss: 3.0878\n",
      "Epoch [2/3], Step [2770], Loss: 3.8044\n",
      "Epoch [2/3], Step [2780], Loss: 3.8817\n",
      "Epoch [2/3], Step [2790], Loss: 3.5016\n",
      "Epoch [2/3], Step [2800], Loss: 3.8755\n",
      "Epoch [2/3], Step [2810], Loss: 3.8344\n",
      "Epoch [2/3], Step [2820], Loss: 3.9675\n",
      "Epoch [2/3], Step [2830], Loss: 3.4546\n",
      "Epoch [2/3], Step [2840], Loss: 3.7363\n",
      "Epoch [2/3], Step [2850], Loss: 3.9099\n",
      "Epoch [2/3], Step [2860], Loss: 3.9395\n",
      "Epoch [2/3], Step [2870], Loss: 4.0899\n",
      "Epoch [2/3], Step [2880], Loss: 3.3842\n",
      "Epoch [2/3], Step [2890], Loss: 3.4242\n",
      "Epoch [2/3], Step [2900], Loss: 3.7600\n",
      "Epoch [2/3], Step [2910], Loss: 3.9682\n",
      "Epoch [2/3], Step [2920], Loss: 3.5309\n",
      "Epoch [2/3], Step [2930], Loss: 3.8101\n",
      "Epoch [2/3], Step [2940], Loss: 3.6416\n",
      "Epoch [2/3], Step [2950], Loss: 3.5161\n",
      "Epoch [2/3], Step [2960], Loss: 3.8158\n",
      "Epoch [2/3], Step [2970], Loss: 3.7415\n",
      "Epoch [2/3], Step [2980], Loss: 3.9603\n",
      "Epoch [2/3], Step [2990], Loss: 3.9510\n",
      "Epoch [2/3], Step [3000], Loss: 2.9600\n",
      "Epoch [2/3], Step [3010], Loss: 3.6344\n",
      "Epoch [2/3], Step [3020], Loss: 3.4671\n",
      "Epoch [2/3], Step [3030], Loss: 3.9130\n",
      "Epoch [2/3], Step [3040], Loss: 3.5427\n",
      "Epoch [2/3], Step [3050], Loss: 3.8290\n",
      "Epoch [2/3], Step [3060], Loss: 3.8230\n",
      "Epoch [2/3], Step [3070], Loss: 3.4862\n",
      "Epoch [2/3], Step [3080], Loss: 3.7642\n",
      "Epoch [2/3], Step [3090], Loss: 3.9064\n",
      "Epoch [2/3], Step [3100], Loss: 3.8383\n",
      "Epoch [2/3], Step [3110], Loss: 3.2785\n",
      "Epoch [2/3], Step [3120], Loss: 3.7629\n",
      "Epoch [2/3], Step [3130], Loss: 3.5419\n",
      "Epoch [2/3], Step [3140], Loss: 3.6914\n",
      "Epoch [2/3], Step [3150], Loss: 3.6474\n",
      "Epoch [2/3], Step [3160], Loss: 3.7632\n",
      "Epoch [2/3], Step [3170], Loss: 3.3394\n",
      "Epoch [2/3], Step [3180], Loss: 3.8035\n",
      "Epoch [2/3], Step [3190], Loss: 3.8446\n",
      "Epoch [2/3], Step [3200], Loss: 3.5962\n",
      "Epoch [2/3], Step [3210], Loss: 3.7958\n",
      "Epoch [2/3], Step [3220], Loss: 3.9219\n",
      "Epoch [2/3], Step [3230], Loss: 3.6772\n",
      "Epoch [2/3], Step [3240], Loss: 3.6671\n",
      "Epoch [2/3], Step [3250], Loss: 3.7179\n",
      "Epoch [2/3], Step [3260], Loss: 3.7331\n",
      "Epoch [2/3], Step [3270], Loss: 3.8142\n",
      "Epoch [2/3], Step [3280], Loss: 3.3903\n",
      "Epoch [2/3], Step [3290], Loss: 3.8933\n",
      "Epoch [2/3], Step [3300], Loss: 3.8308\n",
      "Epoch [2/3], Step [3310], Loss: 4.0951\n",
      "Epoch [2/3], Step [3320], Loss: 3.5423\n",
      "Epoch [2/3], Step [3330], Loss: 3.7054\n",
      "Epoch [2/3], Step [3340], Loss: 3.8420\n",
      "Epoch [2/3], Step [3350], Loss: 3.8249\n",
      "Epoch [2/3], Step [3360], Loss: 4.0980\n",
      "Epoch [2/3], Step [3370], Loss: 3.6974\n",
      "Epoch [2/3], Step [3380], Loss: 3.9418\n",
      "Epoch [2/3], Step [3390], Loss: 3.5282\n",
      "Epoch [2/3], Step [3400], Loss: 3.8225\n",
      "Epoch [2/3], Step [3410], Loss: 3.9622\n",
      "Epoch [2/3], Step [3420], Loss: 3.8191\n",
      "Epoch [2/3], Step [3430], Loss: 3.7202\n",
      "Epoch [2/3], Step [3440], Loss: 3.8657\n",
      "Epoch [2/3], Step [3450], Loss: 3.2126\n",
      "Epoch [2/3], Step [3460], Loss: 3.4573\n",
      "Epoch [2/3], Step [3470], Loss: 3.9214\n",
      "Epoch [2/3], Step [3480], Loss: 4.0837\n",
      "Epoch [2/3], Step [3490], Loss: 3.7755\n",
      "Epoch [2/3], Step [3500], Loss: 4.0669\n",
      "Epoch [2/3], Step [3510], Loss: 3.1987\n",
      "Epoch [2/3], Step [3520], Loss: 3.9929\n",
      "Epoch [2/3], Step [3530], Loss: 3.5652\n",
      "Epoch [2/3], Step [3540], Loss: 3.7328\n",
      "Epoch [2/3], Step [3550], Loss: 3.7486\n",
      "Epoch [2/3], Step [3560], Loss: 3.7472\n",
      "Epoch [2/3], Step [3570], Loss: 3.8587\n",
      "Epoch [2/3], Step [3580], Loss: 3.2090\n",
      "Epoch [2/3], Step [3590], Loss: 3.7358\n",
      "Epoch [2/3], Step [3600], Loss: 3.7250\n",
      "Epoch [2/3], Step [3610], Loss: 4.0519\n",
      "Epoch [2/3], Step [3620], Loss: 3.9486\n",
      "Epoch [2/3], Step [3630], Loss: 3.4531\n",
      "Epoch [2/3], Step [3640], Loss: 3.7856\n",
      "Epoch [2/3], Step [3650], Loss: 3.8427\n",
      "Epoch [2/3], Step [3660], Loss: 3.8022\n",
      "Epoch [2/3], Step [3670], Loss: 3.5516\n",
      "Epoch [2/3], Step [3680], Loss: 3.8993\n",
      "Epoch [2/3], Step [3690], Loss: 3.8690\n",
      "Epoch [2/3], Step [3700], Loss: 3.9234\n",
      "Epoch [2/3], Step [3710], Loss: 3.9441\n",
      "Epoch [2/3], Step [3720], Loss: 3.8081\n",
      "Epoch [2/3], Step [3730], Loss: 3.7157\n",
      "Epoch [2/3], Step [3740], Loss: 3.5440\n",
      "Epoch [2/3], Step [3750], Loss: 3.4298\n",
      "Epoch [2/3], Step [3760], Loss: 3.6502\n",
      "Epoch [2/3], Step [3770], Loss: 3.3816\n",
      "Epoch [2/3], Step [3780], Loss: 3.9185\n",
      "Epoch [2/3], Step [3790], Loss: 3.3685\n",
      "Epoch [2/3], Step [3800], Loss: 3.7170\n",
      "Epoch [2/3], Step [3810], Loss: 3.5837\n",
      "Epoch [2/3], Step [3820], Loss: 3.2526\n",
      "Epoch [2/3], Step [3830], Loss: 3.7720\n",
      "Epoch [2/3], Step [3840], Loss: 3.1993\n",
      "Epoch [2/3], Step [3850], Loss: 3.7964\n",
      "Epoch [2/3], Step [3860], Loss: 3.6069\n",
      "Epoch [2/3], Step [3870], Loss: 3.6442\n",
      "Epoch [2/3], Step [3880], Loss: 4.0718\n",
      "Epoch [2/3], Step [3890], Loss: 3.5292\n",
      "Epoch [2/3], Step [3900], Loss: 3.7899\n",
      "Epoch [2/3], Step [3910], Loss: 3.6412\n",
      "Epoch [2/3], Step [3920], Loss: 3.8978\n",
      "Epoch [2/3], Step [3930], Loss: 4.1088\n",
      "Epoch [2/3], Step [3940], Loss: 3.5571\n",
      "Epoch [2/3], Step [3950], Loss: 3.8697\n",
      "Epoch [2/3], Step [3960], Loss: 3.5541\n",
      "Epoch [2/3], Step [3970], Loss: 3.6963\n",
      "Epoch [2/3], Step [3980], Loss: 3.5259\n",
      "Epoch [2/3], Step [3990], Loss: 3.7638\n",
      "Epoch [2/3], Step [4000], Loss: 3.5599\n",
      "Epoch [2/3], Step [4010], Loss: 3.6129\n",
      "Epoch [2/3], Step [4020], Loss: 3.6326\n",
      "Epoch [2/3], Step [4030], Loss: 3.9401\n",
      "Epoch [2/3], Step [4040], Loss: 3.5193\n",
      "Epoch [2/3], Step [4050], Loss: 3.4839\n",
      "Epoch [2/3], Step [4060], Loss: 4.1845\n",
      "Epoch [2/3], Step [4070], Loss: 3.8094\n",
      "Epoch [2/3], Step [4080], Loss: 3.9597\n",
      "Epoch [2/3], Step [4090], Loss: 3.3139\n",
      "Epoch [2/3], Step [4100], Loss: 3.8229\n",
      "Epoch [2/3], Step [4110], Loss: 4.3074\n",
      "Epoch [2/3], Step [4120], Loss: 3.7052\n",
      "Epoch [2/3], Step [4130], Loss: 3.6371\n",
      "Epoch [2/3], Step [4140], Loss: 3.7475\n",
      "Epoch [2/3], Step [4150], Loss: 3.9235\n",
      "Epoch [2/3], Step [4160], Loss: 3.3823\n",
      "Epoch [2/3], Step [4170], Loss: 3.7345\n",
      "Epoch [2/3], Step [4180], Loss: 3.9044\n",
      "Epoch [2/3], Step [4190], Loss: 3.3863\n",
      "Epoch [2/3], Step [4200], Loss: 3.5495\n",
      "Epoch [2/3], Step [4210], Loss: 3.5221\n",
      "Epoch [2/3], Step [4220], Loss: 3.8467\n",
      "Epoch [2/3], Step [4230], Loss: 3.7276\n",
      "Epoch [2/3], Step [4240], Loss: 3.4636\n",
      "Epoch [2/3], Step [4250], Loss: 3.7422\n",
      "Epoch [2/3], Step [4260], Loss: 3.7799\n",
      "Epoch [2/3], Step [4270], Loss: 3.8130\n",
      "Epoch [2/3], Step [4280], Loss: 3.7857\n",
      "Epoch [2/3], Step [4290], Loss: 3.6808\n",
      "Epoch [2/3], Step [4300], Loss: 3.7465\n",
      "Epoch [2/3], Step [4310], Loss: 3.9551\n",
      "Epoch [2/3], Step [4320], Loss: 3.6348\n",
      "Epoch [2/3], Step [4330], Loss: 3.9810\n",
      "Epoch [2/3], Step [4340], Loss: 3.3711\n",
      "Epoch [2/3], Step [4350], Loss: 3.8723\n",
      "Epoch [2/3], Step [4360], Loss: 3.6269\n",
      "Epoch [2/3], Step [4370], Loss: 3.6961\n",
      "Epoch [2/3], Step [4380], Loss: 3.7544\n",
      "Epoch [2/3], Step [4390], Loss: 3.6693\n",
      "Epoch [2/3], Step [4400], Loss: 3.7541\n",
      "Epoch [2/3], Step [4410], Loss: 3.6702\n",
      "Epoch [2/3], Step [4420], Loss: 3.8866\n",
      "Epoch [2/3], Step [4430], Loss: 3.7766\n",
      "Epoch [2/3], Step [4440], Loss: 3.4093\n",
      "Epoch [2/3], Step [4450], Loss: 3.5730\n",
      "Epoch [2/3], Step [4460], Loss: 3.8196\n",
      "Epoch [2/3], Step [4470], Loss: 3.5603\n",
      "Epoch [2/3], Step [4480], Loss: 3.6542\n",
      "Epoch [2/3], Step [4490], Loss: 3.6158\n",
      "Epoch [2/3], Step [4500], Loss: 3.8225\n",
      "Epoch [2/3], Step [4510], Loss: 3.5528\n",
      "Epoch [2/3], Step [4520], Loss: 3.6721\n",
      "Epoch [2/3], Step [4530], Loss: 3.7439\n",
      "Epoch [2/3], Step [4540], Loss: 3.5547\n",
      "Epoch [2/3], Step [4550], Loss: 3.8995\n",
      "Epoch [2/3], Step [4560], Loss: 3.8710\n",
      "Epoch [2/3], Step [4570], Loss: 3.4622\n",
      "Epoch [2/3], Step [4580], Loss: 3.7008\n",
      "Epoch [2/3], Step [4590], Loss: 3.5476\n",
      "Epoch [2/3], Step [4600], Loss: 3.3482\n",
      "Epoch [2/3], Step [4610], Loss: 3.7037\n",
      "Epoch [2/3], Step [4620], Loss: 3.6524\n",
      "Epoch [2/3], Step [4630], Loss: 3.9144\n",
      "Epoch [2/3], Step [4640], Loss: 3.8727\n",
      "Epoch [2/3], Step [4650], Loss: 4.0234\n",
      "Epoch [2/3], Step [4660], Loss: 3.5188\n",
      "Epoch [2/3], Step [4670], Loss: 3.4964\n",
      "Epoch [2/3], Step [4680], Loss: 3.6644\n",
      "Epoch [2/3], Step [4690], Loss: 3.6408\n",
      "Epoch [2/3], Step [4700], Loss: 3.9578\n",
      "Epoch [2/3], Step [4710], Loss: 3.8954\n",
      "Epoch [2/3], Step [4720], Loss: 3.5753\n",
      "Epoch [2/3], Step [4730], Loss: 3.9140\n",
      "Epoch [2/3], Step [4740], Loss: 3.8443\n",
      "Epoch [2/3], Step [4750], Loss: 3.7255\n",
      "Epoch [2/3], Step [4760], Loss: 3.5529\n",
      "Epoch [2/3], Step [4770], Loss: 3.7955\n",
      "Epoch [2/3], Step [4780], Loss: 4.3098\n",
      "Epoch [2/3], Step [4790], Loss: 3.6915\n",
      "Epoch [2/3], Step [4800], Loss: 3.7258\n",
      "Epoch [2/3], Step [4810], Loss: 4.0691\n",
      "Epoch [2/3], Step [4820], Loss: 3.5575\n",
      "Epoch [2/3], Step [4830], Loss: 3.8957\n",
      "Epoch [2/3], Step [4840], Loss: 3.5139\n",
      "Epoch [2/3], Step [4850], Loss: 3.7655\n",
      "Epoch [2/3], Step [4860], Loss: 3.5609\n",
      "Epoch [2/3], Step [4870], Loss: 3.6134\n",
      "Epoch [2/3], Step [4880], Loss: 3.8396\n",
      "Epoch [2/3], Step [4890], Loss: 3.8446\n",
      "Epoch [2/3], Step [4900], Loss: 3.7171\n",
      "Epoch [2/3], Step [4910], Loss: 3.8817\n",
      "Epoch [2/3], Step [4920], Loss: 3.6991\n",
      "Epoch [2/3], Step [4930], Loss: 3.7359\n",
      "Epoch [2/3], Step [4940], Loss: 3.3979\n",
      "Epoch [2/3], Step [4950], Loss: 3.7368\n",
      "Epoch [2/3], Step [4960], Loss: 3.4263\n",
      "Epoch [2/3], Step [4970], Loss: 3.7938\n",
      "Epoch [2/3], Step [4980], Loss: 3.6962\n",
      "Epoch [2/3], Step [4990], Loss: 4.0239\n",
      "Epoch [2/3], Step [5000], Loss: 3.7917\n",
      "Epoch [2/3], Step [5010], Loss: 3.7702\n",
      "Epoch [2/3], Step [5020], Loss: 3.9731\n",
      "Epoch [2/3], Step [5030], Loss: 3.7657\n",
      "Epoch [2/3], Step [5040], Loss: 4.2816\n",
      "Epoch [2/3], Step [5050], Loss: 3.1463\n",
      "Epoch [2/3], Step [5060], Loss: 3.6560\n",
      "Epoch [2/3], Step [5070], Loss: 3.7913\n",
      "Epoch [2/3], Step [5080], Loss: 3.1700\n",
      "Epoch [2/3], Step [5090], Loss: 3.6994\n",
      "Epoch [2/3], Step [5100], Loss: 3.6763\n",
      "Epoch [2/3], Step [5110], Loss: 3.9811\n",
      "Epoch [2/3], Step [5120], Loss: 3.9694\n",
      "Epoch [2/3], Step [5130], Loss: 3.9254\n",
      "Epoch [2/3], Step [5140], Loss: 3.8272\n",
      "Epoch [2/3], Step [5150], Loss: 3.3528\n",
      "Epoch [2/3], Step [5160], Loss: 4.1704\n",
      "Epoch [2/3], Step [5170], Loss: 3.9316\n",
      "Epoch [2/3], Step [5180], Loss: 3.9115\n",
      "Epoch [2/3], Step [5190], Loss: 3.6727\n",
      "Epoch [2/3], Step [5200], Loss: 3.6607\n",
      "Epoch [2/3], Step [5210], Loss: 4.0949\n",
      "Epoch [2/3], Step [5220], Loss: 3.7481\n",
      "Epoch [2/3], Step [5230], Loss: 3.5166\n",
      "Epoch [2/3], Step [5240], Loss: 3.7683\n",
      "Epoch [2/3], Step [5250], Loss: 3.8718\n",
      "Epoch [2/3], Step [5260], Loss: 3.2107\n",
      "Epoch [2/3], Step [5270], Loss: 3.9589\n",
      "Epoch [2/3], Step [5280], Loss: 3.8716\n",
      "Epoch [2/3], Step [5290], Loss: 2.9557\n",
      "Epoch [2/3], Step [5300], Loss: 3.2961\n",
      "Epoch [2/3], Step [5310], Loss: 3.6410\n",
      "Epoch [2/3], Step [5320], Loss: 3.5490\n",
      "Epoch [2/3], Step [5330], Loss: 3.9168\n",
      "Epoch [2/3], Step [5340], Loss: 3.9310\n",
      "Epoch [2/3], Step [5350], Loss: 3.8854\n",
      "Epoch [2/3], Step [5360], Loss: 4.0132\n",
      "Epoch [2/3], Step [5370], Loss: 3.8114\n",
      "Epoch [2/3], Step [5380], Loss: 3.6496\n",
      "Epoch [2/3], Step [5390], Loss: 3.4883\n",
      "Epoch [2/3], Step [5400], Loss: 3.7884\n",
      "Epoch [2/3], Step [5410], Loss: 3.4621\n",
      "Epoch [2/3], Step [5420], Loss: 3.4399\n",
      "Epoch [2/3], Step [5430], Loss: 3.8946\n",
      "Epoch [2/3], Step [5440], Loss: 3.8813\n",
      "Epoch [2/3], Step [5450], Loss: 3.7432\n",
      "Epoch [2/3], Step [5460], Loss: 3.7061\n",
      "Epoch [2/3], Step [5470], Loss: 3.5454\n",
      "Epoch [2/3], Step [5480], Loss: 3.9703\n",
      "Epoch [2/3], Step [5490], Loss: 3.8781\n",
      "Epoch [2/3], Step [5500], Loss: 3.3970\n",
      "Epoch [2/3], Step [5510], Loss: 3.8046\n",
      "Epoch [2/3], Step [5520], Loss: 4.0729\n",
      "Epoch [2/3], Step [5530], Loss: 3.7710\n",
      "Epoch [2/3], Step [5540], Loss: 3.7919\n",
      "Epoch [2/3], Step [5550], Loss: 3.8164\n",
      "Epoch [2/3], Step [5560], Loss: 3.6214\n",
      "Epoch [2/3], Step [5570], Loss: 3.9367\n",
      "Epoch [2/3], Step [5580], Loss: 3.8427\n",
      "Epoch [2/3], Step [5590], Loss: 3.7283\n",
      "Epoch [2/3], Step [5600], Loss: 3.7072\n",
      "Epoch [2/3], Step [5610], Loss: 3.8229\n",
      "Epoch [2/3], Step [5620], Loss: 3.7374\n",
      "Epoch [2/3], Step [5630], Loss: 3.9201\n",
      "Epoch [2/3], Step [5640], Loss: 3.3263\n",
      "Epoch [2/3], Step [5650], Loss: 3.4506\n",
      "Epoch [2/3], Step [5660], Loss: 3.3292\n",
      "Epoch [2/3], Step [5670], Loss: 3.6043\n",
      "Epoch [2/3], Step [5680], Loss: 3.4567\n",
      "Epoch [2/3], Step [5690], Loss: 3.5615\n",
      "Epoch [2/3], Step [5700], Loss: 3.6083\n",
      "Epoch [2/3], Step [5710], Loss: 3.8540\n",
      "Epoch [2/3], Step [5720], Loss: 3.6767\n",
      "Epoch [2/3], Step [5730], Loss: 3.2665\n",
      "Epoch [2/3], Step [5740], Loss: 3.8696\n",
      "Epoch [2/3], Step [5750], Loss: 3.7628\n",
      "Epoch [2/3], Step [5760], Loss: 3.6997\n",
      "Epoch [2/3], Step [5770], Loss: 3.7074\n",
      "Epoch [2/3], Step [5780], Loss: 3.6713\n",
      "Epoch [2/3], Step [5790], Loss: 3.8805\n",
      "Epoch [2/3], Step [5800], Loss: 3.7783\n",
      "Epoch [2/3], Step [5810], Loss: 3.8923\n",
      "Epoch [2/3], Step [5820], Loss: 3.3553\n",
      "Epoch [2/3], Step [5830], Loss: 3.9352\n",
      "Epoch [2/3], Step [5840], Loss: 3.7880\n",
      "Epoch [2/3], Step [5850], Loss: 3.8018\n",
      "Epoch [2/3], Step [5860], Loss: 3.6759\n",
      "Epoch [2/3], Step [5870], Loss: 3.7929\n",
      "Epoch [2/3], Step [5880], Loss: 3.0965\n",
      "Epoch [2/3], Step [5890], Loss: 3.9442\n",
      "Epoch [2/3], Step [5900], Loss: 3.6950\n",
      "Epoch [2/3], Step [5910], Loss: 3.7363\n",
      "Epoch [2/3], Step [5920], Loss: 4.0009\n",
      "Epoch [2/3], Step [5930], Loss: 3.9632\n",
      "Epoch [2/3], Step [5940], Loss: 3.4495\n",
      "Epoch [2/3], Step [5950], Loss: 3.4754\n",
      "Epoch [2/3], Step [5960], Loss: 3.6737\n",
      "Epoch [2/3], Step [5970], Loss: 3.6549\n",
      "Epoch [2/3], Step [5980], Loss: 3.9414\n",
      "Epoch [2/3], Step [5990], Loss: 3.8536\n",
      "Epoch [2/3], Step [6000], Loss: 3.4368\n",
      "Epoch [2/3], Step [6010], Loss: 3.5979\n",
      "Epoch [2/3], Step [6020], Loss: 3.5987\n",
      "Epoch [2/3], Step [6030], Loss: 3.7958\n",
      "Epoch [2/3], Step [6040], Loss: 3.8781\n",
      "Epoch [2/3], Step [6050], Loss: 3.6643\n",
      "Epoch [2/3], Step [6060], Loss: 3.8093\n",
      "Epoch [2/3], Step [6070], Loss: 3.8649\n",
      "Epoch [2/3], Step [6080], Loss: 3.5995\n",
      "Epoch [2/3], Step [6090], Loss: 3.7452\n",
      "Epoch [2/3], Step [6100], Loss: 3.5092\n",
      "Epoch [2/3], Step [6110], Loss: 3.8901\n",
      "Epoch [2/3], Step [6120], Loss: 3.9978\n",
      "Epoch [2/3], Step [6130], Loss: 3.8951\n",
      "Epoch [2/3], Step [6140], Loss: 3.7433\n",
      "Epoch [2/3], Step [6150], Loss: 3.5582\n",
      "Epoch [2/3], Step [6160], Loss: 3.9942\n",
      "Epoch [2/3], Step [6170], Loss: 3.5952\n",
      "Epoch [2/3], Step [6180], Loss: 3.6215\n",
      "Epoch [2/3], Step [6190], Loss: 3.9682\n",
      "Epoch [2/3], Step [6200], Loss: 3.9054\n",
      "Epoch [2/3], Step [6210], Loss: 3.9953\n",
      "Epoch [2/3], Step [6220], Loss: 3.7157\n",
      "Epoch [2/3], Step [6230], Loss: 3.5130\n",
      "Epoch [2/3], Step [6240], Loss: 3.8545\n",
      "Epoch [2/3], Train Loss: 3.7311, Validation Loss: 3.6281\n",
      "Epoch [2/3], : 9.10\n",
      "Epoch [3/3], Step [0], Loss: 3.5124\n",
      "Epoch [3/3], Step [10], Loss: 3.7166\n",
      "Epoch [3/3], Step [20], Loss: 4.0017\n",
      "Epoch [3/3], Step [30], Loss: 3.7953\n",
      "Epoch [3/3], Step [40], Loss: 3.7726\n",
      "Epoch [3/3], Step [50], Loss: 3.6178\n",
      "Epoch [3/3], Step [60], Loss: 3.7604\n",
      "Epoch [3/3], Step [70], Loss: 3.7938\n",
      "Epoch [3/3], Step [80], Loss: 3.5317\n",
      "Epoch [3/3], Step [90], Loss: 4.0745\n",
      "Epoch [3/3], Step [100], Loss: 3.8226\n",
      "Epoch [3/3], Step [110], Loss: 3.7848\n",
      "Epoch [3/3], Step [120], Loss: 3.8233\n",
      "Epoch [3/3], Step [130], Loss: 3.7085\n",
      "Epoch [3/3], Step [140], Loss: 3.6190\n",
      "Epoch [3/3], Step [150], Loss: 4.1256\n",
      "Epoch [3/3], Step [160], Loss: 3.1777\n",
      "Epoch [3/3], Step [170], Loss: 3.6028\n",
      "Epoch [3/3], Step [180], Loss: 3.6145\n",
      "Epoch [3/3], Step [190], Loss: 3.9008\n",
      "Epoch [3/3], Step [200], Loss: 3.3175\n",
      "Epoch [3/3], Step [210], Loss: 3.8627\n",
      "Epoch [3/3], Step [220], Loss: 3.3865\n",
      "Epoch [3/3], Step [230], Loss: 4.0983\n",
      "Epoch [3/3], Step [240], Loss: 3.9239\n",
      "Epoch [3/3], Step [250], Loss: 3.8865\n",
      "Epoch [3/3], Step [260], Loss: 3.7169\n",
      "Epoch [3/3], Step [270], Loss: 3.9152\n",
      "Epoch [3/3], Step [280], Loss: 3.1556\n",
      "Epoch [3/3], Step [290], Loss: 3.7081\n",
      "Epoch [3/3], Step [300], Loss: 3.7621\n",
      "Epoch [3/3], Step [310], Loss: 3.9900\n",
      "Epoch [3/3], Step [320], Loss: 3.5574\n",
      "Epoch [3/3], Step [330], Loss: 3.6345\n",
      "Epoch [3/3], Step [340], Loss: 3.5589\n",
      "Epoch [3/3], Step [350], Loss: 3.3661\n",
      "Epoch [3/3], Step [360], Loss: 3.8487\n",
      "Epoch [3/3], Step [370], Loss: 3.7962\n",
      "Epoch [3/3], Step [380], Loss: 3.7015\n",
      "Epoch [3/3], Step [390], Loss: 3.7248\n",
      "Epoch [3/3], Step [400], Loss: 3.9102\n",
      "Epoch [3/3], Step [410], Loss: 3.6887\n",
      "Epoch [3/3], Step [420], Loss: 3.7666\n",
      "Epoch [3/3], Step [430], Loss: 3.8076\n",
      "Epoch [3/3], Step [440], Loss: 3.3086\n",
      "Epoch [3/3], Step [450], Loss: 3.4489\n",
      "Epoch [3/3], Step [460], Loss: 3.8600\n",
      "Epoch [3/3], Step [470], Loss: 3.8300\n",
      "Epoch [3/3], Step [480], Loss: 3.6778\n",
      "Epoch [3/3], Step [490], Loss: 3.9575\n",
      "Epoch [3/3], Step [500], Loss: 3.8515\n",
      "Epoch [3/3], Step [510], Loss: 3.5666\n",
      "Epoch [3/3], Step [520], Loss: 3.6884\n",
      "Epoch [3/3], Step [530], Loss: 3.7628\n",
      "Epoch [3/3], Step [540], Loss: 3.7550\n",
      "Epoch [3/3], Step [550], Loss: 3.8956\n",
      "Epoch [3/3], Step [560], Loss: 3.7458\n",
      "Epoch [3/3], Step [570], Loss: 3.8833\n",
      "Epoch [3/3], Step [580], Loss: 3.4770\n",
      "Epoch [3/3], Step [590], Loss: 3.7596\n",
      "Epoch [3/3], Step [600], Loss: 3.9327\n",
      "Epoch [3/3], Step [610], Loss: 3.6169\n",
      "Epoch [3/3], Step [620], Loss: 3.5867\n",
      "Epoch [3/3], Step [630], Loss: 3.8177\n",
      "Epoch [3/3], Step [640], Loss: 3.6403\n",
      "Epoch [3/3], Step [650], Loss: 3.5122\n",
      "Epoch [3/3], Step [660], Loss: 4.0336\n",
      "Epoch [3/3], Step [670], Loss: 3.6710\n",
      "Epoch [3/3], Step [680], Loss: 3.9031\n",
      "Epoch [3/3], Step [690], Loss: 3.8276\n",
      "Epoch [3/3], Step [700], Loss: 3.5979\n",
      "Epoch [3/3], Step [710], Loss: 3.5112\n",
      "Epoch [3/3], Step [720], Loss: 3.5966\n",
      "Epoch [3/3], Step [730], Loss: 3.5107\n",
      "Epoch [3/3], Step [740], Loss: 3.9681\n",
      "Epoch [3/3], Step [750], Loss: 3.6148\n",
      "Epoch [3/3], Step [760], Loss: 3.6731\n",
      "Epoch [3/3], Step [770], Loss: 3.7459\n",
      "Epoch [3/3], Step [780], Loss: 4.0814\n",
      "Epoch [3/3], Step [790], Loss: 3.7466\n",
      "Epoch [3/3], Step [800], Loss: 4.2286\n",
      "Epoch [3/3], Step [810], Loss: 3.9093\n",
      "Epoch [3/3], Step [820], Loss: 3.7559\n",
      "Epoch [3/3], Step [830], Loss: 3.6926\n",
      "Epoch [3/3], Step [840], Loss: 3.6257\n",
      "Epoch [3/3], Step [850], Loss: 3.6825\n",
      "Epoch [3/3], Step [860], Loss: 3.9684\n",
      "Epoch [3/3], Step [870], Loss: 3.2648\n",
      "Epoch [3/3], Step [880], Loss: 3.4955\n",
      "Epoch [3/3], Step [890], Loss: 3.4937\n",
      "Epoch [3/3], Step [900], Loss: 3.6361\n",
      "Epoch [3/3], Step [910], Loss: 3.8809\n",
      "Epoch [3/3], Step [920], Loss: 3.9639\n",
      "Epoch [3/3], Step [930], Loss: 3.8633\n",
      "Epoch [3/3], Step [940], Loss: 3.7901\n",
      "Epoch [3/3], Step [950], Loss: 3.9070\n",
      "Epoch [3/3], Step [960], Loss: 3.7860\n",
      "Epoch [3/3], Step [970], Loss: 4.0198\n",
      "Epoch [3/3], Step [980], Loss: 3.8738\n",
      "Epoch [3/3], Step [990], Loss: 3.9848\n",
      "Epoch [3/3], Step [1000], Loss: 3.3607\n",
      "Epoch [3/3], Step [1010], Loss: 3.4805\n",
      "Epoch [3/3], Step [1020], Loss: 3.6731\n",
      "Epoch [3/3], Step [1030], Loss: 3.8903\n",
      "Epoch [3/3], Step [1040], Loss: 3.5917\n",
      "Epoch [3/3], Step [1050], Loss: 3.5688\n",
      "Epoch [3/3], Step [1060], Loss: 3.9081\n",
      "Epoch [3/3], Step [1070], Loss: 3.7006\n",
      "Epoch [3/3], Step [1080], Loss: 3.7968\n",
      "Epoch [3/3], Step [1090], Loss: 3.9729\n",
      "Epoch [3/3], Step [1100], Loss: 3.7747\n",
      "Epoch [3/3], Step [1110], Loss: 3.7527\n",
      "Epoch [3/3], Step [1120], Loss: 3.5579\n",
      "Epoch [3/3], Step [1130], Loss: 3.7813\n",
      "Epoch [3/3], Step [1140], Loss: 3.4987\n",
      "Epoch [3/3], Step [1150], Loss: 3.3315\n",
      "Epoch [3/3], Step [1160], Loss: 3.5141\n",
      "Epoch [3/3], Step [1170], Loss: 4.1080\n",
      "Epoch [3/3], Step [1180], Loss: 3.0672\n",
      "Epoch [3/3], Step [1190], Loss: 3.9152\n",
      "Epoch [3/3], Step [1200], Loss: 3.8947\n",
      "Epoch [3/3], Step [1210], Loss: 3.2431\n",
      "Epoch [3/3], Step [1220], Loss: 3.5006\n",
      "Epoch [3/3], Step [1230], Loss: 3.4628\n",
      "Epoch [3/3], Step [1240], Loss: 4.0117\n",
      "Epoch [3/3], Step [1250], Loss: 3.7072\n",
      "Epoch [3/3], Step [1260], Loss: 3.6944\n",
      "Epoch [3/3], Step [1270], Loss: 3.7456\n",
      "Epoch [3/3], Step [1280], Loss: 3.8648\n",
      "Epoch [3/3], Step [1290], Loss: 3.5465\n",
      "Epoch [3/3], Step [1300], Loss: 3.1607\n",
      "Epoch [3/3], Step [1310], Loss: 3.9250\n",
      "Epoch [3/3], Step [1320], Loss: 3.5027\n",
      "Epoch [3/3], Step [1330], Loss: 3.6771\n",
      "Epoch [3/3], Step [1340], Loss: 3.9974\n",
      "Epoch [3/3], Step [1350], Loss: 3.9512\n",
      "Epoch [3/3], Step [1360], Loss: 3.2817\n",
      "Epoch [3/3], Step [1370], Loss: 3.7937\n",
      "Epoch [3/3], Step [1380], Loss: 3.8157\n",
      "Epoch [3/3], Step [1390], Loss: 3.9839\n",
      "Epoch [3/3], Step [1400], Loss: 3.6868\n",
      "Epoch [3/3], Step [1410], Loss: 3.8532\n",
      "Epoch [3/3], Step [1420], Loss: 3.4653\n",
      "Epoch [3/3], Step [1430], Loss: 3.7630\n",
      "Epoch [3/3], Step [1440], Loss: 3.6270\n",
      "Epoch [3/3], Step [1450], Loss: 3.5462\n",
      "Epoch [3/3], Step [1460], Loss: 3.8077\n",
      "Epoch [3/3], Step [1470], Loss: 4.0493\n",
      "Epoch [3/3], Step [1480], Loss: 3.6184\n",
      "Epoch [3/3], Step [1490], Loss: 3.5348\n",
      "Epoch [3/3], Step [1500], Loss: 3.7591\n",
      "Epoch [3/3], Step [1510], Loss: 3.7900\n",
      "Epoch [3/3], Step [1520], Loss: 3.9033\n",
      "Epoch [3/3], Step [1530], Loss: 3.4446\n",
      "Epoch [3/3], Step [1540], Loss: 3.9168\n",
      "Epoch [3/3], Step [1550], Loss: 3.9237\n",
      "Epoch [3/3], Step [1560], Loss: 3.6367\n",
      "Epoch [3/3], Step [1570], Loss: 3.3972\n",
      "Epoch [3/3], Step [1580], Loss: 3.9193\n",
      "Epoch [3/3], Step [1590], Loss: 3.4889\n",
      "Epoch [3/3], Step [1600], Loss: 3.5047\n",
      "Epoch [3/3], Step [1610], Loss: 3.8467\n",
      "Epoch [3/3], Step [1620], Loss: 3.6065\n",
      "Epoch [3/3], Step [1630], Loss: 3.9703\n",
      "Epoch [3/3], Step [1640], Loss: 3.9181\n",
      "Epoch [3/3], Step [1650], Loss: 4.0364\n",
      "Epoch [3/3], Step [1660], Loss: 3.7923\n",
      "Epoch [3/3], Step [1670], Loss: 3.5131\n",
      "Epoch [3/3], Step [1680], Loss: 3.8083\n",
      "Epoch [3/3], Step [1690], Loss: 3.4938\n",
      "Epoch [3/3], Step [1700], Loss: 3.7624\n",
      "Epoch [3/3], Step [1710], Loss: 3.2406\n",
      "Epoch [3/3], Step [1720], Loss: 3.8910\n",
      "Epoch [3/3], Step [1730], Loss: 3.8908\n",
      "Epoch [3/3], Step [1740], Loss: 3.8455\n",
      "Epoch [3/3], Step [1750], Loss: 3.8338\n",
      "Epoch [3/3], Step [1760], Loss: 3.4638\n",
      "Epoch [3/3], Step [1770], Loss: 3.5092\n",
      "Epoch [3/3], Step [1780], Loss: 3.5183\n",
      "Epoch [3/3], Step [1790], Loss: 3.8538\n",
      "Epoch [3/3], Step [1800], Loss: 3.6328\n",
      "Epoch [3/3], Step [1810], Loss: 3.6168\n",
      "Epoch [3/3], Step [1820], Loss: 3.7648\n",
      "Epoch [3/3], Step [1830], Loss: 3.3279\n",
      "Epoch [3/3], Step [1840], Loss: 3.5900\n",
      "Epoch [3/3], Step [1850], Loss: 3.9158\n",
      "Epoch [3/3], Step [1860], Loss: 3.8892\n",
      "Epoch [3/3], Step [1870], Loss: 3.5061\n",
      "Epoch [3/3], Step [1880], Loss: 3.6747\n",
      "Epoch [3/3], Step [1890], Loss: 3.8312\n",
      "Epoch [3/3], Step [1900], Loss: 3.7659\n",
      "Epoch [3/3], Step [1910], Loss: 3.8089\n",
      "Epoch [3/3], Step [1920], Loss: 3.6727\n",
      "Epoch [3/3], Step [1930], Loss: 3.7515\n",
      "Epoch [3/3], Step [1940], Loss: 3.8756\n",
      "Epoch [3/3], Step [1950], Loss: 3.6504\n",
      "Epoch [3/3], Step [1960], Loss: 3.6680\n",
      "Epoch [3/3], Step [1970], Loss: 4.0464\n",
      "Epoch [3/3], Step [1980], Loss: 3.5618\n",
      "Epoch [3/3], Step [1990], Loss: 3.7641\n",
      "Epoch [3/3], Step [2000], Loss: 3.7777\n",
      "Epoch [3/3], Step [2010], Loss: 3.8294\n",
      "Epoch [3/3], Step [2020], Loss: 3.8905\n",
      "Epoch [3/3], Step [2030], Loss: 4.0392\n",
      "Epoch [3/3], Step [2040], Loss: 3.8588\n",
      "Epoch [3/3], Step [2050], Loss: 3.6550\n",
      "Epoch [3/3], Step [2060], Loss: 3.9500\n",
      "Epoch [3/3], Step [2070], Loss: 3.8426\n",
      "Epoch [3/3], Step [2080], Loss: 4.1420\n",
      "Epoch [3/3], Step [2090], Loss: 3.6843\n",
      "Epoch [3/3], Step [2100], Loss: 3.6945\n",
      "Epoch [3/3], Step [2110], Loss: 3.2736\n",
      "Epoch [3/3], Step [2120], Loss: 3.5629\n",
      "Epoch [3/3], Step [2130], Loss: 3.6627\n",
      "Epoch [3/3], Step [2140], Loss: 3.4882\n",
      "Epoch [3/3], Step [2150], Loss: 4.1400\n",
      "Epoch [3/3], Step [2160], Loss: 3.6339\n",
      "Epoch [3/3], Step [2170], Loss: 3.8909\n",
      "Epoch [3/3], Step [2180], Loss: 3.6932\n",
      "Epoch [3/3], Step [2190], Loss: 3.8064\n",
      "Epoch [3/3], Step [2200], Loss: 3.6279\n",
      "Epoch [3/3], Step [2210], Loss: 3.9028\n",
      "Epoch [3/3], Step [2220], Loss: 3.6785\n",
      "Epoch [3/3], Step [2230], Loss: 3.2874\n",
      "Epoch [3/3], Step [2240], Loss: 3.4060\n",
      "Epoch [3/3], Step [2250], Loss: 3.6637\n",
      "Epoch [3/3], Step [2260], Loss: 3.7086\n",
      "Epoch [3/3], Step [2270], Loss: 3.8552\n",
      "Epoch [3/3], Step [2280], Loss: 3.3766\n",
      "Epoch [3/3], Step [2290], Loss: 3.5888\n",
      "Epoch [3/3], Step [2300], Loss: 3.4689\n",
      "Epoch [3/3], Step [2310], Loss: 3.7124\n",
      "Epoch [3/3], Step [2320], Loss: 3.5998\n",
      "Epoch [3/3], Step [2330], Loss: 3.6384\n",
      "Epoch [3/3], Step [2340], Loss: 3.9043\n",
      "Epoch [3/3], Step [2350], Loss: 3.7773\n",
      "Epoch [3/3], Step [2360], Loss: 3.6505\n",
      "Epoch [3/3], Step [2370], Loss: 3.8699\n",
      "Epoch [3/3], Step [2380], Loss: 3.7177\n",
      "Epoch [3/3], Step [2390], Loss: 3.5716\n",
      "Epoch [3/3], Step [2400], Loss: 3.7930\n",
      "Epoch [3/3], Step [2410], Loss: 3.6301\n",
      "Epoch [3/3], Step [2420], Loss: 3.5958\n",
      "Epoch [3/3], Step [2430], Loss: 3.5052\n",
      "Epoch [3/3], Step [2440], Loss: 3.7443\n",
      "Epoch [3/3], Step [2450], Loss: 4.0524\n",
      "Epoch [3/3], Step [2460], Loss: 3.4767\n",
      "Epoch [3/3], Step [2470], Loss: 3.7702\n",
      "Epoch [3/3], Step [2480], Loss: 3.8620\n",
      "Epoch [3/3], Step [2490], Loss: 3.6113\n",
      "Epoch [3/3], Step [2500], Loss: 3.7068\n",
      "Epoch [3/3], Step [2510], Loss: 3.9534\n",
      "Epoch [3/3], Step [2520], Loss: 4.0727\n",
      "Epoch [3/3], Step [2530], Loss: 3.8300\n",
      "Epoch [3/3], Step [2540], Loss: 3.8699\n",
      "Epoch [3/3], Step [2550], Loss: 3.5811\n",
      "Epoch [3/3], Step [2560], Loss: 3.3832\n",
      "Epoch [3/3], Step [2570], Loss: 3.5066\n",
      "Epoch [3/3], Step [2580], Loss: 3.5980\n",
      "Epoch [3/3], Step [2590], Loss: 4.0062\n",
      "Epoch [3/3], Step [2600], Loss: 3.8357\n",
      "Epoch [3/3], Step [2610], Loss: 3.8045\n",
      "Epoch [3/3], Step [2620], Loss: 3.5036\n",
      "Epoch [3/3], Step [2630], Loss: 3.2794\n",
      "Epoch [3/3], Step [2640], Loss: 3.9024\n",
      "Epoch [3/3], Step [2650], Loss: 3.4759\n",
      "Epoch [3/3], Step [2660], Loss: 3.1908\n",
      "Epoch [3/3], Step [2670], Loss: 3.8645\n",
      "Epoch [3/3], Step [2680], Loss: 3.7830\n",
      "Epoch [3/3], Step [2690], Loss: 3.6994\n",
      "Epoch [3/3], Step [2700], Loss: 4.0149\n",
      "Epoch [3/3], Step [2710], Loss: 3.7151\n",
      "Epoch [3/3], Step [2720], Loss: 3.6159\n",
      "Epoch [3/3], Step [2730], Loss: 3.9444\n",
      "Epoch [3/3], Step [2740], Loss: 3.7913\n",
      "Epoch [3/3], Step [2750], Loss: 3.8945\n",
      "Epoch [3/3], Step [2760], Loss: 4.1014\n",
      "Epoch [3/3], Step [2770], Loss: 3.7597\n",
      "Epoch [3/3], Step [2780], Loss: 3.6187\n",
      "Epoch [3/3], Step [2790], Loss: 3.5128\n",
      "Epoch [3/3], Step [2800], Loss: 3.6595\n",
      "Epoch [3/3], Step [2810], Loss: 3.5109\n",
      "Epoch [3/3], Step [2820], Loss: 3.4228\n",
      "Epoch [3/3], Step [2830], Loss: 3.6325\n",
      "Epoch [3/3], Step [2840], Loss: 3.9711\n",
      "Epoch [3/3], Step [2850], Loss: 3.9491\n",
      "Epoch [3/3], Step [2860], Loss: 3.4681\n",
      "Epoch [3/3], Step [2870], Loss: 3.8479\n",
      "Epoch [3/3], Step [2880], Loss: 3.5968\n",
      "Epoch [3/3], Step [2890], Loss: 3.4938\n",
      "Epoch [3/3], Step [2900], Loss: 3.8316\n",
      "Epoch [3/3], Step [2910], Loss: 4.0108\n",
      "Epoch [3/3], Step [2920], Loss: 4.0069\n",
      "Epoch [3/3], Step [2930], Loss: 3.8469\n",
      "Epoch [3/3], Step [2940], Loss: 3.6186\n",
      "Epoch [3/3], Step [2950], Loss: 3.7026\n",
      "Epoch [3/3], Step [2960], Loss: 3.4679\n",
      "Epoch [3/3], Step [2970], Loss: 3.7023\n",
      "Epoch [3/3], Step [2980], Loss: 3.9764\n",
      "Epoch [3/3], Step [2990], Loss: 3.8002\n",
      "Epoch [3/3], Step [3000], Loss: 3.6168\n",
      "Epoch [3/3], Step [3010], Loss: 3.7876\n",
      "Epoch [3/3], Step [3020], Loss: 3.5504\n",
      "Epoch [3/3], Step [3030], Loss: 3.6110\n",
      "Epoch [3/3], Step [3040], Loss: 3.5466\n",
      "Epoch [3/3], Step [3050], Loss: 3.6626\n",
      "Epoch [3/3], Step [3060], Loss: 3.1708\n",
      "Epoch [3/3], Step [3070], Loss: 3.7897\n",
      "Epoch [3/3], Step [3080], Loss: 3.7372\n",
      "Epoch [3/3], Step [3090], Loss: 3.9767\n",
      "Epoch [3/3], Step [3100], Loss: 3.3068\n",
      "Epoch [3/3], Step [3110], Loss: 3.8638\n",
      "Epoch [3/3], Step [3120], Loss: 3.6642\n",
      "Epoch [3/3], Step [3130], Loss: 3.8747\n",
      "Epoch [3/3], Step [3140], Loss: 3.1794\n",
      "Epoch [3/3], Step [3150], Loss: 3.5407\n",
      "Epoch [3/3], Step [3160], Loss: 3.8696\n",
      "Epoch [3/3], Step [3170], Loss: 4.1311\n",
      "Epoch [3/3], Step [3180], Loss: 3.8274\n",
      "Epoch [3/3], Step [3190], Loss: 3.6749\n",
      "Epoch [3/3], Step [3200], Loss: 3.8076\n",
      "Epoch [3/3], Step [3210], Loss: 3.6851\n",
      "Epoch [3/3], Step [3220], Loss: 3.8354\n",
      "Epoch [3/3], Step [3230], Loss: 4.3058\n",
      "Epoch [3/3], Step [3240], Loss: 3.7956\n",
      "Epoch [3/3], Step [3250], Loss: 3.6504\n",
      "Epoch [3/3], Step [3260], Loss: 3.6481\n",
      "Epoch [3/3], Step [3270], Loss: 3.7809\n",
      "Epoch [3/3], Step [3280], Loss: 3.5432\n",
      "Epoch [3/3], Step [3290], Loss: 3.8550\n",
      "Epoch [3/3], Step [3300], Loss: 3.6596\n",
      "Epoch [3/3], Step [3310], Loss: 3.9085\n",
      "Epoch [3/3], Step [3320], Loss: 3.7738\n",
      "Epoch [3/3], Step [3330], Loss: 3.5178\n",
      "Epoch [3/3], Step [3340], Loss: 3.8554\n",
      "Epoch [3/3], Step [3350], Loss: 3.8209\n",
      "Epoch [3/3], Step [3360], Loss: 3.7494\n",
      "Epoch [3/3], Step [3370], Loss: 3.9479\n",
      "Epoch [3/3], Step [3380], Loss: 3.9337\n",
      "Epoch [3/3], Step [3390], Loss: 3.7323\n",
      "Epoch [3/3], Step [3400], Loss: 3.7869\n",
      "Epoch [3/3], Step [3410], Loss: 3.6641\n",
      "Epoch [3/3], Step [3420], Loss: 3.2423\n",
      "Epoch [3/3], Step [3430], Loss: 3.9288\n",
      "Epoch [3/3], Step [3440], Loss: 3.2363\n",
      "Epoch [3/3], Step [3450], Loss: 3.8749\n",
      "Epoch [3/3], Step [3460], Loss: 3.8295\n",
      "Epoch [3/3], Step [3470], Loss: 3.7488\n",
      "Epoch [3/3], Step [3480], Loss: 3.8599\n",
      "Epoch [3/3], Step [3490], Loss: 3.7780\n",
      "Epoch [3/3], Step [3500], Loss: 3.8814\n",
      "Epoch [3/3], Step [3510], Loss: 3.6527\n",
      "Epoch [3/3], Step [3520], Loss: 3.7469\n",
      "Epoch [3/3], Step [3530], Loss: 3.5472\n",
      "Epoch [3/3], Step [3540], Loss: 3.5951\n",
      "Epoch [3/3], Step [3550], Loss: 3.7326\n",
      "Epoch [3/3], Step [3560], Loss: 3.8068\n",
      "Epoch [3/3], Step [3570], Loss: 3.6447\n",
      "Epoch [3/3], Step [3580], Loss: 3.9505\n",
      "Epoch [3/3], Step [3590], Loss: 3.6921\n",
      "Epoch [3/3], Step [3600], Loss: 3.6212\n",
      "Epoch [3/3], Step [3610], Loss: 3.4766\n",
      "Epoch [3/3], Step [3620], Loss: 3.6815\n",
      "Epoch [3/3], Step [3630], Loss: 3.7075\n",
      "Epoch [3/3], Step [3640], Loss: 3.5234\n",
      "Epoch [3/3], Step [3650], Loss: 3.2020\n",
      "Epoch [3/3], Step [3660], Loss: 4.0253\n",
      "Epoch [3/3], Step [3670], Loss: 3.5277\n",
      "Epoch [3/3], Step [3680], Loss: 3.6729\n",
      "Epoch [3/3], Step [3690], Loss: 3.7115\n",
      "Epoch [3/3], Step [3700], Loss: 3.6362\n",
      "Epoch [3/3], Step [3710], Loss: 3.5347\n",
      "Epoch [3/3], Step [3720], Loss: 3.9575\n",
      "Epoch [3/3], Step [3730], Loss: 3.8020\n",
      "Epoch [3/3], Step [3740], Loss: 3.5084\n",
      "Epoch [3/3], Step [3750], Loss: 3.7622\n",
      "Epoch [3/3], Step [3760], Loss: 4.0594\n",
      "Epoch [3/3], Step [3770], Loss: 3.5195\n",
      "Epoch [3/3], Step [3780], Loss: 4.0613\n",
      "Epoch [3/3], Step [3790], Loss: 3.5134\n",
      "Epoch [3/3], Step [3800], Loss: 3.6212\n",
      "Epoch [3/3], Step [3810], Loss: 3.9513\n",
      "Epoch [3/3], Step [3820], Loss: 3.5084\n",
      "Epoch [3/3], Step [3830], Loss: 3.9609\n",
      "Epoch [3/3], Step [3840], Loss: 3.7425\n",
      "Epoch [3/3], Step [3850], Loss: 3.5460\n",
      "Epoch [3/3], Step [3860], Loss: 3.4537\n",
      "Epoch [3/3], Step [3870], Loss: 3.5480\n",
      "Epoch [3/3], Step [3880], Loss: 3.3906\n",
      "Epoch [3/3], Step [3890], Loss: 3.9238\n",
      "Epoch [3/3], Step [3900], Loss: 3.4582\n",
      "Epoch [3/3], Step [3910], Loss: 3.1090\n",
      "Epoch [3/3], Step [3920], Loss: 3.4868\n",
      "Epoch [3/3], Step [3930], Loss: 3.4091\n",
      "Epoch [3/3], Step [3940], Loss: 3.8916\n",
      "Epoch [3/3], Step [3950], Loss: 3.3820\n",
      "Epoch [3/3], Step [3960], Loss: 3.7828\n",
      "Epoch [3/3], Step [3970], Loss: 3.3272\n",
      "Epoch [3/3], Step [3980], Loss: 3.5876\n",
      "Epoch [3/3], Step [3990], Loss: 3.9971\n",
      "Epoch [3/3], Step [4000], Loss: 3.9981\n",
      "Epoch [3/3], Step [4010], Loss: 3.4072\n",
      "Epoch [3/3], Step [4020], Loss: 3.5784\n",
      "Epoch [3/3], Step [4030], Loss: 3.4098\n",
      "Epoch [3/3], Step [4040], Loss: 3.8561\n",
      "Epoch [3/3], Step [4050], Loss: 3.8294\n",
      "Epoch [3/3], Step [4060], Loss: 3.5215\n",
      "Epoch [3/3], Step [4070], Loss: 3.7100\n",
      "Epoch [3/3], Step [4080], Loss: 3.4488\n",
      "Epoch [3/3], Step [4090], Loss: 3.1751\n",
      "Epoch [3/3], Step [4100], Loss: 3.9225\n",
      "Epoch [3/3], Step [4110], Loss: 3.7521\n",
      "Epoch [3/3], Step [4120], Loss: 3.9165\n",
      "Epoch [3/3], Step [4130], Loss: 3.5809\n",
      "Epoch [3/3], Step [4140], Loss: 3.2918\n",
      "Epoch [3/3], Step [4150], Loss: 4.0592\n",
      "Epoch [3/3], Step [4160], Loss: 3.7252\n",
      "Epoch [3/3], Step [4170], Loss: 3.6973\n",
      "Epoch [3/3], Step [4180], Loss: 3.7960\n",
      "Epoch [3/3], Step [4190], Loss: 3.7526\n",
      "Epoch [3/3], Step [4200], Loss: 3.7962\n",
      "Epoch [3/3], Step [4210], Loss: 3.5476\n",
      "Epoch [3/3], Step [4220], Loss: 3.8236\n",
      "Epoch [3/3], Step [4230], Loss: 3.8384\n",
      "Epoch [3/3], Step [4240], Loss: 3.4534\n",
      "Epoch [3/3], Step [4250], Loss: 3.9533\n",
      "Epoch [3/3], Step [4260], Loss: 4.0475\n",
      "Epoch [3/3], Step [4270], Loss: 3.4429\n",
      "Epoch [3/3], Step [4280], Loss: 3.8320\n",
      "Epoch [3/3], Step [4290], Loss: 3.8431\n",
      "Epoch [3/3], Step [4300], Loss: 3.5813\n",
      "Epoch [3/3], Step [4310], Loss: 3.6799\n",
      "Epoch [3/3], Step [4320], Loss: 3.5542\n",
      "Epoch [3/3], Step [4330], Loss: 3.5276\n",
      "Epoch [3/3], Step [4340], Loss: 3.7563\n",
      "Epoch [3/3], Step [4350], Loss: 3.4890\n",
      "Epoch [3/3], Step [4360], Loss: 4.0762\n",
      "Epoch [3/3], Step [4370], Loss: 3.3766\n",
      "Epoch [3/3], Step [4380], Loss: 3.8078\n",
      "Epoch [3/3], Step [4390], Loss: 3.8287\n",
      "Epoch [3/3], Step [4400], Loss: 3.6865\n",
      "Epoch [3/3], Step [4410], Loss: 3.9992\n",
      "Epoch [3/3], Step [4420], Loss: 3.5842\n",
      "Epoch [3/3], Step [4430], Loss: 3.7661\n",
      "Epoch [3/3], Step [4440], Loss: 4.2479\n",
      "Epoch [3/3], Step [4450], Loss: 3.7305\n",
      "Epoch [3/3], Step [4460], Loss: 3.6832\n",
      "Epoch [3/3], Step [4470], Loss: 3.4960\n",
      "Epoch [3/3], Step [4480], Loss: 3.9385\n",
      "Epoch [3/3], Step [4490], Loss: 3.5250\n",
      "Epoch [3/3], Step [4500], Loss: 3.9335\n",
      "Epoch [3/3], Step [4510], Loss: 3.8648\n",
      "Epoch [3/3], Step [4520], Loss: 3.5351\n",
      "Epoch [3/3], Step [4530], Loss: 3.6674\n",
      "Epoch [3/3], Step [4540], Loss: 3.7021\n",
      "Epoch [3/3], Step [4550], Loss: 3.7021\n",
      "Epoch [3/3], Step [4560], Loss: 4.0729\n",
      "Epoch [3/3], Step [4570], Loss: 3.5103\n",
      "Epoch [3/3], Step [4580], Loss: 3.3310\n",
      "Epoch [3/3], Step [4590], Loss: 3.8489\n",
      "Epoch [3/3], Step [4600], Loss: 3.6715\n",
      "Epoch [3/3], Step [4610], Loss: 3.4506\n",
      "Epoch [3/3], Step [4620], Loss: 3.3717\n",
      "Epoch [3/3], Step [4630], Loss: 3.9492\n",
      "Epoch [3/3], Step [4640], Loss: 4.0284\n",
      "Epoch [3/3], Step [4650], Loss: 3.8524\n",
      "Epoch [3/3], Step [4660], Loss: 3.8995\n",
      "Epoch [3/3], Step [4670], Loss: 3.6573\n",
      "Epoch [3/3], Step [4680], Loss: 3.4072\n",
      "Epoch [3/3], Step [4690], Loss: 3.7628\n",
      "Epoch [3/3], Step [4700], Loss: 3.6125\n",
      "Epoch [3/3], Step [4710], Loss: 3.5596\n",
      "Epoch [3/3], Step [4720], Loss: 3.6719\n",
      "Epoch [3/3], Step [4730], Loss: 3.5686\n",
      "Epoch [3/3], Step [4740], Loss: 3.6409\n",
      "Epoch [3/3], Step [4750], Loss: 3.8046\n",
      "Epoch [3/3], Step [4760], Loss: 3.7450\n",
      "Epoch [3/3], Step [4770], Loss: 3.6794\n",
      "Epoch [3/3], Step [4780], Loss: 3.1718\n",
      "Epoch [3/3], Step [4790], Loss: 3.6307\n",
      "Epoch [3/3], Step [4800], Loss: 3.9969\n",
      "Epoch [3/3], Step [4810], Loss: 3.6830\n",
      "Epoch [3/3], Step [4820], Loss: 3.8689\n",
      "Epoch [3/3], Step [4830], Loss: 3.8411\n",
      "Epoch [3/3], Step [4840], Loss: 3.5778\n",
      "Epoch [3/3], Step [4850], Loss: 3.8893\n",
      "Epoch [3/3], Step [4860], Loss: 3.5872\n",
      "Epoch [3/3], Step [4870], Loss: 3.6428\n",
      "Epoch [3/3], Step [4880], Loss: 3.6780\n",
      "Epoch [3/3], Step [4890], Loss: 3.7886\n",
      "Epoch [3/3], Step [4900], Loss: 3.5484\n",
      "Epoch [3/3], Step [4910], Loss: 3.8266\n",
      "Epoch [3/3], Step [4920], Loss: 3.5375\n",
      "Epoch [3/3], Step [4930], Loss: 3.7122\n",
      "Epoch [3/3], Step [4940], Loss: 3.9006\n",
      "Epoch [3/3], Step [4950], Loss: 3.5236\n",
      "Epoch [3/3], Step [4960], Loss: 3.6495\n",
      "Epoch [3/3], Step [4970], Loss: 3.9296\n",
      "Epoch [3/3], Step [4980], Loss: 3.2559\n",
      "Epoch [3/3], Step [4990], Loss: 3.8075\n",
      "Epoch [3/3], Step [5000], Loss: 3.8792\n",
      "Epoch [3/3], Step [5010], Loss: 3.8852\n",
      "Epoch [3/3], Step [5020], Loss: 3.7135\n",
      "Epoch [3/3], Step [5030], Loss: 3.9581\n",
      "Epoch [3/3], Step [5040], Loss: 3.6930\n",
      "Epoch [3/3], Step [5050], Loss: 3.6366\n",
      "Epoch [3/3], Step [5060], Loss: 3.4311\n",
      "Epoch [3/3], Step [5070], Loss: 3.8919\n",
      "Epoch [3/3], Step [5080], Loss: 3.7212\n",
      "Epoch [3/3], Step [5090], Loss: 3.7953\n",
      "Epoch [3/3], Step [5100], Loss: 3.7670\n",
      "Epoch [3/3], Step [5110], Loss: 3.7596\n",
      "Epoch [3/3], Step [5120], Loss: 3.3459\n",
      "Epoch [3/3], Step [5130], Loss: 3.7368\n",
      "Epoch [3/3], Step [5140], Loss: 3.8238\n",
      "Epoch [3/3], Step [5150], Loss: 3.4645\n",
      "Epoch [3/3], Step [5160], Loss: 3.5888\n",
      "Epoch [3/3], Step [5170], Loss: 3.6892\n",
      "Epoch [3/3], Step [5180], Loss: 3.6294\n",
      "Epoch [3/3], Step [5190], Loss: 3.7896\n",
      "Epoch [3/3], Step [5200], Loss: 3.7418\n",
      "Epoch [3/3], Step [5210], Loss: 3.8694\n",
      "Epoch [3/3], Step [5220], Loss: 3.9671\n",
      "Epoch [3/3], Step [5230], Loss: 3.5622\n",
      "Epoch [3/3], Step [5240], Loss: 3.7283\n",
      "Epoch [3/3], Step [5250], Loss: 3.8652\n",
      "Epoch [3/3], Step [5260], Loss: 3.7642\n",
      "Epoch [3/3], Step [5270], Loss: 3.6725\n",
      "Epoch [3/3], Step [5280], Loss: 3.6448\n",
      "Epoch [3/3], Step [5290], Loss: 3.6094\n",
      "Epoch [3/3], Step [5300], Loss: 3.0518\n",
      "Epoch [3/3], Step [5310], Loss: 3.7766\n",
      "Epoch [3/3], Step [5320], Loss: 3.6335\n",
      "Epoch [3/3], Step [5330], Loss: 3.8541\n",
      "Epoch [3/3], Step [5340], Loss: 3.9249\n",
      "Epoch [3/3], Step [5350], Loss: 3.8308\n",
      "Epoch [3/3], Step [5360], Loss: 3.5655\n",
      "Epoch [3/3], Step [5370], Loss: 3.4350\n",
      "Epoch [3/3], Step [5380], Loss: 3.9279\n",
      "Epoch [3/3], Step [5390], Loss: 3.3277\n",
      "Epoch [3/3], Step [5400], Loss: 3.6007\n",
      "Epoch [3/3], Step [5410], Loss: 3.6829\n",
      "Epoch [3/3], Step [5420], Loss: 3.4673\n",
      "Epoch [3/3], Step [5430], Loss: 3.7876\n",
      "Epoch [3/3], Step [5440], Loss: 3.1872\n",
      "Epoch [3/3], Step [5450], Loss: 3.7915\n",
      "Epoch [3/3], Step [5460], Loss: 3.8636\n",
      "Epoch [3/3], Step [5470], Loss: 3.3359\n",
      "Epoch [3/3], Step [5480], Loss: 3.9369\n",
      "Epoch [3/3], Step [5490], Loss: 3.7877\n",
      "Epoch [3/3], Step [5500], Loss: 3.5327\n",
      "Epoch [3/3], Step [5510], Loss: 3.9631\n",
      "Epoch [3/3], Step [5520], Loss: 3.7195\n",
      "Epoch [3/3], Step [5530], Loss: 3.7870\n",
      "Epoch [3/3], Step [5540], Loss: 3.6570\n",
      "Epoch [3/3], Step [5550], Loss: 3.5194\n",
      "Epoch [3/3], Step [5560], Loss: 3.8933\n",
      "Epoch [3/3], Step [5570], Loss: 3.4769\n",
      "Epoch [3/3], Step [5580], Loss: 4.0062\n",
      "Epoch [3/3], Step [5590], Loss: 3.7381\n",
      "Epoch [3/3], Step [5600], Loss: 3.7818\n",
      "Epoch [3/3], Step [5610], Loss: 3.9303\n",
      "Epoch [3/3], Step [5620], Loss: 3.5793\n",
      "Epoch [3/3], Step [5630], Loss: 3.7472\n",
      "Epoch [3/3], Step [5640], Loss: 3.7349\n",
      "Epoch [3/3], Step [5650], Loss: 3.7578\n",
      "Epoch [3/3], Step [5660], Loss: 3.5155\n",
      "Epoch [3/3], Step [5670], Loss: 3.2640\n",
      "Epoch [3/3], Step [5680], Loss: 3.9506\n",
      "Epoch [3/3], Step [5690], Loss: 3.5411\n",
      "Epoch [3/3], Step [5700], Loss: 3.4669\n",
      "Epoch [3/3], Step [5710], Loss: 3.8751\n",
      "Epoch [3/3], Step [5720], Loss: 3.8870\n",
      "Epoch [3/3], Step [5730], Loss: 3.8611\n",
      "Epoch [3/3], Step [5740], Loss: 3.4509\n",
      "Epoch [3/3], Step [5750], Loss: 3.9031\n",
      "Epoch [3/3], Step [5760], Loss: 3.3695\n",
      "Epoch [3/3], Step [5770], Loss: 3.5335\n",
      "Epoch [3/3], Step [5780], Loss: 3.2809\n",
      "Epoch [3/3], Step [5790], Loss: 3.7263\n",
      "Epoch [3/3], Step [5800], Loss: 3.6425\n",
      "Epoch [3/3], Step [5810], Loss: 3.6254\n",
      "Epoch [3/3], Step [5820], Loss: 3.8552\n",
      "Epoch [3/3], Step [5830], Loss: 3.5082\n",
      "Epoch [3/3], Step [5840], Loss: 3.9164\n",
      "Epoch [3/3], Step [5850], Loss: 3.8611\n",
      "Epoch [3/3], Step [5860], Loss: 3.4976\n",
      "Epoch [3/3], Step [5870], Loss: 3.6890\n",
      "Epoch [3/3], Step [5880], Loss: 3.8463\n",
      "Epoch [3/3], Step [5890], Loss: 3.3902\n",
      "Epoch [3/3], Step [5900], Loss: 3.7695\n",
      "Epoch [3/3], Step [5910], Loss: 3.7620\n",
      "Epoch [3/3], Step [5920], Loss: 3.4704\n",
      "Epoch [3/3], Step [5930], Loss: 3.9460\n",
      "Epoch [3/3], Step [5940], Loss: 3.7158\n",
      "Epoch [3/3], Step [5950], Loss: 3.9203\n",
      "Epoch [3/3], Step [5960], Loss: 3.6442\n",
      "Epoch [3/3], Step [5970], Loss: 3.8785\n",
      "Epoch [3/3], Step [5980], Loss: 3.6693\n",
      "Epoch [3/3], Step [5990], Loss: 3.7160\n",
      "Epoch [3/3], Step [6000], Loss: 3.4851\n",
      "Epoch [3/3], Step [6010], Loss: 3.4405\n",
      "Epoch [3/3], Step [6020], Loss: 3.9267\n",
      "Epoch [3/3], Step [6030], Loss: 3.7475\n",
      "Epoch [3/3], Step [6040], Loss: 3.8962\n",
      "Epoch [3/3], Step [6050], Loss: 3.9720\n",
      "Epoch [3/3], Step [6060], Loss: 3.7800\n",
      "Epoch [3/3], Step [6070], Loss: 3.5829\n",
      "Epoch [3/3], Step [6080], Loss: 3.7142\n",
      "Epoch [3/3], Step [6090], Loss: 3.6187\n",
      "Epoch [3/3], Step [6100], Loss: 3.6533\n",
      "Epoch [3/3], Step [6110], Loss: 3.8493\n",
      "Epoch [3/3], Step [6120], Loss: 3.6901\n",
      "Epoch [3/3], Step [6130], Loss: 3.8695\n",
      "Epoch [3/3], Step [6140], Loss: 3.6952\n",
      "Epoch [3/3], Step [6150], Loss: 3.5327\n",
      "Epoch [3/3], Step [6160], Loss: 3.6766\n",
      "Epoch [3/3], Step [6170], Loss: 3.6826\n",
      "Epoch [3/3], Step [6180], Loss: 3.7626\n",
      "Epoch [3/3], Step [6190], Loss: 3.4787\n",
      "Epoch [3/3], Step [6200], Loss: 3.4867\n",
      "Epoch [3/3], Step [6210], Loss: 3.7080\n",
      "Epoch [3/3], Step [6220], Loss: 4.0201\n",
      "Epoch [3/3], Step [6230], Loss: 3.5486\n",
      "Epoch [3/3], Step [6240], Loss: 3.8022\n",
      "Epoch [3/3], Train Loss: 3.7084, Validation Loss: 3.6099\n",
      "Epoch [3/3], : 10.00\n"
     ]
    }
   ],
   "source": [
    "# Optimizer\n",
    "optimizer = optim.AdamW(model.parameters(), lr=1e-4)\n",
    "\n",
    "# Privacy Engine\n",
    "privacy_engine = PrivacyEngine()\n",
    "sample_rate = 16 / len(train_data)  # Batch size / dataset size\n",
    "model, optimizer, train_dataloader = privacy_engine.make_private_with_epsilon(\n",
    "    module=model,\n",
    "    optimizer=optimizer,\n",
    "    data_loader=train_dataloader,\n",
    "    target_epsilon=10.0,\n",
    "    target_delta=1e-5,\n",
    "    epochs=3,\n",
    "    max_grad_norm=1.0\n",
    ")\n",
    "\n",
    "# Move to device\n",
    "model.to(device)\n",
    "def evaluate(model, dataloader, device):\n",
    "    model.eval()\n",
    "    total_loss = 0.0\n",
    "    with torch.no_grad():\n",
    "        for batch in dataloader:\n",
    "            input_ids = batch['input_ids'].to(device)\n",
    "            attention_mask = batch['attention_mask'].to(device)\n",
    "\n",
    "            outputs = model(input_ids=input_ids, attention_mask=attention_mask, labels=input_ids)\n",
    "            total_loss += outputs.loss.item()\n",
    "\n",
    "    return total_loss / len(dataloader)\n",
    "\n",
    "# Training loop\n",
    "epochs = 3\n",
    "for epoch in range(epochs):\n",
    "    total_loss = 0.0\n",
    "    for step, batch in enumerate(train_dataloader):\n",
    "        input_ids = batch['input_ids'].to(device)\n",
    "        attention_mask = batch['attention_mask'].to(device)\n",
    "        model.train()\n",
    "        optimizer.zero_grad()\n",
    "        outputs = model(input_ids=input_ids, attention_mask=attention_mask, labels=input_ids)\n",
    "        loss = outputs.loss\n",
    "        loss.backward()\n",
    "        optimizer.step()\n",
    "        total_loss += loss.item()\n",
    "        if step % 10 == 0:\n",
    "            print(f\"Epoch [{epoch+1}/{epochs}], Step [{step}], Loss: {loss.item():.4f}\")   \n",
    "    # Validation\n",
    "    val_loss = evaluate(model, test_dataloader, device)\n",
    "    print(f\"Epoch [{epoch+1}/{epochs}], Train Loss: {total_loss / len(train_dataloader):.4f}, Validation Loss: {val_loss:.4f}\")\n",
    "    delta = 1e-5  # Failure probability\n",
    "    epsilon = privacy_engine.get_epsilon(delta)\n",
    "    print(f\"Epoch [{epoch+1}/{epochs}], : {epsilon:.2f}\")\n",
    "    torch.cuda.empty_cache()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "05f18fc5-d53f-4016-b7f3-1590e5ab37ee",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model saved to lora_dp_medal_gpt2.pth\n"
     ]
    }
   ],
   "source": [
    "def save_model(model, epoch, filename='lora_dp_medal_gpt2.pth'):\n",
    "    state_dict = {\n",
    "        'epoch': epoch,\n",
    "        'model_state_dict': model.state_dict()\n",
    "    }\n",
    "    torch.save(state_dict, filename)\n",
    "    print(f\"Model saved to {filename}\")  \n",
    "model = model._module\n",
    "save_model(model, epoch)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "a9248c79-eb5a-40d0-9f58-e54a200203af",
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_model(model,filename='lora_dp_medal_gpt2.pth'):\n",
    "    # Load the state_dict from the saved file\n",
    "    checkpoint = torch.load(filename)\n",
    "    epoch = checkpoint['epoch']\n",
    "    model.resize_token_embeddings(len(tokenizer))\n",
    "    model.load_state_dict(checkpoint['model_state_dict'], strict=False)\n",
    "    print(f\"Model loaded from {filename}\")\n",
    "    return model, epoch"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "9b149354-fb2d-4902-882a-7bde3bc21a82",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\my pc\\AppData\\Local\\Temp\\ipykernel_1512\\4104940327.py:3: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(filename)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model loaded from lora_dp_medal_gpt2.pth\n",
      "Generator model loaded successfully!\n"
     ]
    }
   ],
   "source": [
    "generator_model, start_epoch = load_model(model)\n",
    "\n",
    "print(\"Generator model loaded successfully!\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "5da70442-0aa1-4d9e-a887-39c8a9ef1e38",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: rouge in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (1.0.1)\n",
      "Requirement already satisfied: six in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from rouge) (1.16.0)\n"
     ]
    }
   ],
   "source": [
    "!pip install rouge"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "55b3f1b2-49de-49ea-b9d9-b74dbd365d3a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Reference Text: we developed an animal model of chronic allergic airway disease by repeatedly exposing nine sheep to tracheal instillation of ascaris antigen until stable increase in RL at three times control in six reactive sheep group c was obtained they were then compared to the three nonreactive sheep group b and a control group of eight sheep exposed to saline only group a in terms of pulmonary CF tests and bronchoalveolar lavage bal analyses RL was cm holsec in group a in group b and in group c trapping volume FRC by plethysmography and by helium rebreathing technique was l in group a in group b and in group c UP resistance at PF did not differ between any two CG but UP resistance near residual volume was cm holsec in a in b and in c in bal total cells were x ml in a in b and in c macrophages in bal were in a in b and in c neutrophils were in a in b in c eosinophils were in a in b and in c p less than group c versus group a total proteins albumin ALP phosphatase and fibronectin did not differ between groupsabstract truncated at words\n",
      "Generated Text: we developed an animal model of chronic allergic airway disease by repeatedly exposing nine sheep to tracheal instillation of ascaris antigen until stable increase in RL at three times control in six reactive sheep group c was obtained they were then compared to the three nonreactive sheep group b and c the results showed that the three reactive sheep group b and c had a significantly higher RL than the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive sheep group b and c the results were similar for the three reactive sheep group c and the three nonreactive\n",
      "BLEU: 0.1332165791060678, ROUGE-L: {'r': 0.4489795918367347, 'p': 0.8301886792452831, 'f': 0.5827814523977018}, Perplexity: 1.8048946857452393, Cosine Similarity: 0.3767\n",
      "Reference Text: pyogenic granulomas represent the aquisition of vasodilative granulation tissue in the skin or mucosa they are extremely rare in the alimentary tract other than in the oral cavity here we report a case of PG arising from the GM an yearold man was admitted to our hospital because of melena of more than months duration esophagogastroduodenoscopy egd revealed a mmdiameter semipedunculated lesion with an irregular surface in the fundus of the stomach during hospitalization the patients anemia worsened due to loss of blood from the lesion with the level of hemoglobin declining to gdl and a blood transfusion was required because radiological and endoscopic findings indicated the lesion was hypervascular transarterial embolization of the nutritional i.a. of the lesion was performed before ER of the lesion one week T3 the embolotherapy endoscopic mucosal resection was performed without any complications such as massive one histological studies of the resected specimen revealed many capillaries of various sizes lined with plump EC cells and accompanied by acute and chronic inflammatory infiltrates on the basis of these observations the lesion was diagnosed as a PG one year later the patient was asymptomatic and there was no evidence of RT recurrence on followup egd\n",
      "Generated Text: pyogenic granulomas represent the aquisition of vasodilative granulation tissue in the skin or mucosa they are extremely rare in the alimentary tract other than in the oral cavity here we report a case of PG arising from the GM an yearold man was admitted to our hospital because of melena and a small lesion in the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of the right upper quadrant of\n",
      "BLEU: 0.1359297840751446, ROUGE-L: {'r': 0.3359375, 'p': 0.8958333333333334, 'f': 0.48863635966942154}, Perplexity: 1.6879945993423462, Cosine Similarity: 0.5308\n",
      "Reference Text: the l immunotype lipopolysaccharide lps of neisseria meningitidis was subjected to Kd procedures which produced a number of different oligosaccharide fragments the high resolution h and c nmr spectroscopic analyses of these OS yielded structural information on a number of different regions of the lps for example from one oligosaccharide it was found that the endogenous sialylation of the meningococcal lps occurs at o of the terminal betadgalactopyranosyl residue of its lactonneotetraose antenna in the alphadconfiguration from another it was also established that the dominant structural feature responsible for l epitope specificity is the presence of a PE substituent at o of the penultimate heptopyranosyl residue of its other antenna in addition from information obtained with another oligosaccharide the structure of the deoxydmannooctulosonic acid disaccharide region of the l lps was also elucidated from all the above cumulative data plus some published data it was then possible to reconstruct the CR structure of the entire native l lps\n",
      "Generated Text: the l immunotype lipopolysaccharide lps of neisseria meningitidis was subjected to Kd procedures which produced a number of different oligosaccharide fragments the high resolution h and c nmr spectroscopic analyses of these OS yielded structural information on a number of different regions of the lps for example from one oligosaccharide fragment the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the lps of the\n",
      "BLEU: 0.1498839979416126, ROUGE-L: {'r': 0.41935483870967744, 'p': 0.975, 'f': 0.5864661612075301}, Perplexity: 1.7182037830352783, Cosine Similarity: 0.7973\n",
      "Reference Text: inotropic reserve identified by dobutamine or dipyridamole SE is associated with a better outcome in patients with idiopathic dilated cardiomyopathy dcm although the relative prognostic value of each remains unsettled the purpose of the present study was to assess the relative prognostic value of dobutamine versus dipyridamole SE for the prediction of allcause death in patients with idiopathic dcm\n",
      "Generated Text: inotropic reserve identified by dobutamine or dipyridamole SE is associated with a better outcome in patients with idiopathic dilated cardiomyopathy dcm although the relative prognostic value of each remains unsettled the purpose of the present study was to assess the relative prognostic value of dobutamine versus dipyridamole SE for the diagnosis of dcm in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy dcm and to compare the relative prognostic value of dobutamine versus dipyridamole SE in patients with idiopathic dilated cardiomyopathy d\n",
      "BLEU: 0.1794648224743181, ROUGE-L: {'r': 0.925, 'p': 0.9024390243902439, 'f': 0.9135802419143424}, Perplexity: 1.564626693725586, Cosine Similarity: 0.8274\n",
      "Reference Text: pyridoxinedependent seizure is a rare autosomal recessive disorder that usually presents with neonatal intractable seizures this syndrome results from an inborn abnormality of the enzyme glu decarboxylase which results in reduced pyridazinedependent synthesis of the inhibitory neurotransmitter gamma amino butyric acid the full range of symptomatology is unknown but can be associated with autism breath holding and SMR bilious vomiting transient visual agnosia severe articulatory apraxia motor dyspraxia microcephaly and intrauterine seizures parenteral pyridine injection test is a highly ERP and reproducible test in confirming the diagnosis pyridoxine should be po as a diagnostic test in all cases of convulsive disorders of infancy in which no other diagnosis is evident epileptic seizure discharges subside within minutes T3 the i.v. of mg of pyridaoxine once the diagnosis is confirmed MT should be continued indefinitely and doses increased with age or intercurrent illnesses the MD of bg needed is still not clear there is a relatively wide range for the daily b dose necessary to control the seizure ie mgday\n",
      "Generated Text: pyridoxinedependent seizure is a rare autosomal recessive disorder that usually presents with neonatal intractable seizures this syndrome results from an inborn abnormality of the enzyme glu decarboxylase which results in reduced pyridazinedependent synthesis of the inhibitory neurotransmitter gamma amino butyric acid the full range of symptomatology is unknown but can include seizures, seizures with no apparent cause, and seizures with a known cause the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is made by the use of a single dose of pyridoxine and the use of a single dose of a non-pyridoxine dependent seizure drug the diagnosis of pyridoxine dependent seizures is\n",
      "BLEU: 0.16471791459252336, ROUGE-L: {'r': 0.3870967741935484, 'p': 0.7741935483870968, 'f': 0.5161290278136201}, Perplexity: 1.9750703573226929, Cosine Similarity: 0.6133\n",
      "Reference Text: a total of PA isolates were collected from GA hospitals in japan from to of these isolates carbapenemresistant strains were subjected to dna hybridization analysis with the MBL gene blaimpspecific probe fifteen strains carrying the MBL gene were identified in five hospitals in different geographical Az three strains of p aeruginosa demonstrated highlevel imipenem resistance mic or microgramsml two strains exhibited lowlevel imipenem resistance mic or microgramsml and the rest of the strains were in between these results revealed that the acquisition of a MBL gene CT does not necessarily confer elevated resistance to carbapenems in several strains the MBL gene was carried by large plasmids and carbapenem resistance was transferred from p aeruginosa to escherichia coli by electroporation in association with the acquisition of the large plasmid southern hybridization analysis and genomic dna fingerprinting profiles revealed different genetic backgrounds for these isolates although considerable similarity was observed for the strains isolated from the same hospital these findings suggest that the metallobetalactamaseproducing p aeruginosa strains are not confined to a unique clonal lineage but proliferated multifocally by plasmidmediated dissemination of the MBL gene in strains of different genetic backgrounds thus further proliferation of metallobetalactamaseproducing strains with resistance to various betalactams may well be inevitable in the future which emphasizes the need for early recognition of metallobetalactamaseproducing strains rigorous IC and restricted clinical use of broadspectrum betalactams including carbapenems\n",
      "Generated Text: a total of PA isolates were collected from GA hospitals in japan from to of these isolates carbapenemresistant strains were subjected to dna hybridization analysis with the MBL gene blaimpspecific probe fifteen strains carrying the MBL gene were identified in five hospitals in different geographical Az three strains of pneu were identified in the same hospital in japan and in the same hospital in japan the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a dna hybridization analysis with the MBL gene blaimpspecific probe and the MBL gene blaimpspecific probe the isolates were subjected to a d\n",
      "BLEU: 0.18407859454537534, ROUGE-L: {'r': 0.28688524590163933, 'p': 0.8974358974358975, 'f': 0.43478260502449756}, Perplexity: 2.072254180908203, Cosine Similarity: 0.6071\n",
      "Reference Text: while diminished ovarian reserve dor predicts decreased ovarian response to stimulation it does not necessarily foretell about the fecundity cycle according to bolognas criteria laid down by the european society of human reproduction and embryology old age abnormal ovarian reserve tests such as AFC afc and antimullerian hormone amh as well as prior suboptimal response to stimulation are the main AF representing dor unfavorable response to maximal stimulation on two previous occasions may also represent dor among the ovarian reserve tests amh and afc are the most predictive values for dor AF which may give rise to dor include environmental factors autoimmune or metabolic disorders infections genetic abnormalities and iatrogenic causes such as smoking chemotherapy radiation and gynecologic surgeries besides studies have proposed endometriosis as a key contributor to dor and hence emphasized on its proper management to prevent additional damages leading to compromised fertility in summary dor is found to be a clinical challenge in the practice of fertility care with controversial countermeasures to prevent or treat the condition nevertheless some promising measure such as oocyte embryo and tissue cryopreservation ovarian transplantation dietary supplementation and the transfer of mitochondria have offered hopes towards ameliorating the burden of dor this review attempts to discuss dor from different perspectives and summarize some existing hopes in clinical practice\n",
      "Generated Text: while diminished ovarian reserve dor predicts decreased ovarian response to stimulation it does not necessarily foretell about the fecundity cycle according to bolognas criteria laid down by the european society of human reproduction and embryology old age abnormal ovarian reserve tests such as AFC afc and antimullerian hormone amh as well as the use of the hgf test in the evaluation of the fertility cycle are not recommended in the elderly because of the risk of ovarian failure and the risk of ovarian hyperstimulation syndrome the use of the hgf test in the evaluation of the fertility cycle is recommended in the elderly because of the risk of ovarian failure and the risk of ovarian hyperstimulation syndrome\n",
      "BLEU: 0.206133995665027, ROUGE-L: {'r': 0.3263888888888889, 'p': 0.7966101694915254, 'f': 0.4630541830687471}, Perplexity: 14.85865306854248, Cosine Similarity: 0.6142\n",
      "Reference Text: we describe two cases of simple heterozygosity for the common beta degrees thal mutation beta ct both presenting with a TI phenotype in both cases synergic effect deriving from membrane defects or red cell enzyme deficiencies were excluded in one case a triplication of the alphaglobin genes was found which did not justify the severity of the transfusiondependent phenotype multiplex ligationdependent probe amplification mlpa analysis of the alphaglobin gene cluster revealed two new rearrangements consisting of a full duplication of the alphaglobin genes locus including the UP RII element in one case the duplication was in the presence of the common antialpha triplication in trans resulting in a total of AS alphaglobin genes in the other case the duplicated allele and the normal S2 in trans resulted into a total of active alphaglobin genes we report the clinical and hematological data and the molecular analysis and discuss the occurrence of alphaglobin genes duplication defects in cases of thal heterozygotes with TI phenotypes\n",
      "Generated Text: we describe two cases of simple heterozygosity for the common beta degrees thal mutation beta ct both presenting with a TI phenotype in both cases synergic effect deriving from membrane defects or red cell enzyme deficiencies were excluded in one case a triplication of the alphaglobin genes was found which was associated with a reduced expression of the beta ct gene in the other case a single copy of the beta ct gene was found in the patient with the triplication of the alphaglobin genes and this was associated with a reduced expression of the beta ct gene in the other patient the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both cases the triplication of the alphaglobin genes was associated with a reduced expression of the beta ct gene in both\n",
      "BLEU: 0.16758812006279122, ROUGE-L: {'r': 0.4835164835164835, 'p': 0.8301886792452831, 'f': 0.6111111064592979}, Perplexity: 2.0346291065216064, Cosine Similarity: 0.7944\n",
      "Reference Text: by means of EC and quantitative histomorphometric methods the corrosion resistance and tissue biocompatibility of tini and tinixcux x were investigated it is discovered that the repassivation potential of tinixcux x alloys is about mv higher than that of tini alloy namely the addition of cu raises the repassivation potential of tini shape memory alloys and improves their corrosion resistance pitting potentials of tini and tinixcux x alloys increase with solution ph value but the repassivation potentials keep constant the adding of cu has no obvious influence on pitting potential epit of tini alloys meanwhile the corrosion potential and corrosion rate of tinixcux x alloys are irrelevant to its cu content and the values are almost the same as those of tini alloys the connective tissue layer covering the plates is statistically significantly thicker for tinicu plates p than that of tini tinicu tinicu plates T3 one month the numbers of connective tissue cells polynucleated cells macrophages and round cells are higher for tinicu plates than those of the other three types of plates but no statistically significant differences are detected there are no significant differences on tissue reaction parameters T3 two and three months among four alloys T3 one two and three months implantation no corrosion is observed on the plates surfaces a preliminary conclusion can be drawn that tinixcux x shape memory alloys have good biocompatibility\n",
      "Generated Text: by means of EC and quantitative histomorphometric methods the corrosion resistance and tissue biocompatibility of tini and tinixcux x were investigated it is discovered that the repassivation potential of tinixcux x alloys is about mv higher than that of tini alloy namely the addition of cu raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv the addition of cu to tini alloy raises the repassivation potential of tini alloy to about mv and the addition of cu to tini alloy raises the repassivation potential of tini\n",
      "BLEU: 0.1550621012581133, ROUGE-L: {'r': 0.3211009174311927, 'p': 1.0, 'f': 0.48611110743152014}, Perplexity: 1.8162882328033447, Cosine Similarity: 0.6071\n",
      "Reference Text: in the present study lithocholic acid lca metabolism was assessed by radiochromatography and gasliquid chromatographymass spectrometry and its relationship to cholestasis was investigated in addition the role of the perivenous zone in lcainduced cholestasis and lca biotransformation was examined by using BB bz a chemical that c and SP eye movements are described all drugs impaired both EM measures but the doses used were not clinically equivalent no available test is yet able to distinguish between benzodiazepines and neuroleptics\n",
      "Generated Text: in the present study lithocholic acid lca metabolism was assessed by radiochromatography and gasliquid chromatographymass spectrometry and its relationship to cholestasis was investigated in addition the role of the perivenous zone in lcainduced cholestasis and lca biotransformation was examined by using BB bz a chemical that c and SP eye and skin cells are able to absorb lca and its metabolites in vitro the results showed that lca and its metabolites were absorbed in vitro and in vivo in the lca biotransformation was inhibited by the perivenous zone in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholestasis in vitro and in vivo the perivenous zone was inhibited by the cholest\n",
      "BLEU: 0.13945287980275292, ROUGE-L: {'r': 0.625, 'p': 0.7692307692307693, 'f': 0.6896551674673009}, Perplexity: 2.3028817176818848, Cosine Similarity: 0.6594\n",
      "Reference Text: there exists considerable evidence to suggest that crh and Arg vasopressin avpsecreting parvocellular neurosecretory SN of the PVH pvn are CE integrators of negative FB effects evoked by circulating glucocorticoid hormones most evidence suggests that these SN may be receptive to circulating glucocorticoid levels either via glucocorticoid receptors indigenous to these cells andor via extrahypothalamic glucocorticoidreceptive neurons interacting with the pvn sec cell in an effort to address this issue we performed anterior ant posterior post and total tot deafferentations of the pvn region in male spraguedawley rats using microknives fashioned from narrowgauge spinal needles ERP knife cuts were verified IHC and deemed acceptable only if they avoided damage to the pvn proper and fibers of crh and avpcontaining neurons coursing through the hypothalamus en route to the median eminence while effectively eliminating neuronal input into the pvn region subsequent to surgery C2 of mrna encoding for crh and avp in the parvocellular and magnocellular pvn were assayed via semiquantitative in situ hybridization histochemistry results indicate that tot deafferentations resulted in significant increases in crh mrna expression in the pvn and a slight but noticeable induction of avp mrna in the medial parvocellular but not posterior MC divisions of the pvn ant lesions also produced an upregulation of crh and avp mrna relative to operated control rats post lesions did not produce a clear induction in either crh or avp mrna the data indicate that in the absence of neuronal input coming from anterior structures crh mrna expression is upregulated suggesting that local effects of GCs on the pvn neuron are ineffective in maintaining normal crh mrna expression these results support a role for neuronal FB in regulation of the crh neuron the limited upregulation compared with ADX of avp mrna in the tot group suggests that while neuronal input may have some control of avp mrna expression local glucocorticoid feedback is clearly able to restrict avp message to levels considerably less than those seen in steroiddeficient animals analysis of knifecut effects on plasma corticosterone and acth levels reveals that post and tot but not ant deafferentations prohibit the sec activity of the hypothalamopituitaryadrenocortical hpa axis seen pursuant to the anesthesiathoracotomy in lesion and operated control groupsabstract truncated at words\n",
      "Generated Text: there exists considerable evidence to suggest that crh and Arg vasopressin avpsecreting parvocellular neurosecretory SN of the PVH pvn are CE integrators of negative FB effects evoked by circulating glucocorticoid hormones most evidence suggests that these SN may be receptive to circulating glucocorticoid levels either via glucocorticoid receptors indigenous to the PVH or via the glucocorticoid receptor expressed on the PVH itself the purpose of this study was to determine whether the presence of the glucocorticoid receptor on the PVH is sufficient to elicit a negative FB effect on the pvn in vivo the effect of glucocorticoid on the pvn was assessed in a rat model of PVH parvocellular neurosecretory SN of the PVH pvn was isolated from the PVH and cultured in vitro with the glucocorticoid receptor expressed on the PVH and the glucocorticoid receptor expressed on the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the pvn into the PVH the effect of glucocorticoid on the pvn was assessed in vivo by injecting the p\n",
      "BLEU: 0.17449939132315134, ROUGE-L: {'r': 0.22842639593908629, 'p': 0.6338028169014085, 'f': 0.3358208916275897}, Perplexity: 2.563467502593994, Cosine Similarity: 0.6208\n",
      "Reference Text: SS rbp prealbumin and zinc were evaluated in normal subjects and PC and chronic one a significant decrease of rpb was found in pancreatic CA patients compared with controls a concomitant reduction of Pr and zinc was also observed MRA suggested that the modification of rbp SS levels might be accounted for mainly by diminished Pr levels while the direct role of zinc is negligible\n",
      "Generated Text: SS rbp prealbumin and zinc were evaluated in normal subjects and PC and chronic one a significant decrease of rpb was found in pancreatic CA patients compared with controls a concomitant reduction of Pr and zinc was also observed MRA suggested that the modification of rbp SS levels might be a factor in the development of diabetes mellitus\n",
      "BLEU: 0.7682567541298971, ROUGE-L: {'r': 0.7959183673469388, 'p': 0.9069767441860465, 'f': 0.8478260819777883}, Perplexity: 36.54179382324219, Cosine Similarity: 0.9125\n",
      "Reference Text: accidental i.v. of an EF can be fatal or cause complications such as sepsis acute respiratory and circulatory failure ARF hepatic insufficiency coagulation disorders and severe permanent neurological sequelae these wrong route PE are possible due to compatible connections between EF systems and intravascular infusion catheters\n",
      "Generated Text: accidental i.v. of an EF can be fatal or cause complications such as sepsis acute respiratory and circulatory failure ARF hepatic insufficiency coagulation disorders and severe permanent neurological sequelae these wrong route PE are possible due to compatible connections between EF systems and intravascular infusion catheters and the resulting increased risk of complications the aim of this study was to evaluate the risk of i.v. of EF in patients with acute respiratory failure and cirrhosis and to evaluate the risk of i.v. of EF in patients with cirrhosis and acute respiratory failure in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting of a single i.v. of an EF in the setting\n",
      "BLEU: 0.11600036257920292, ROUGE-L: {'r': 1.0, 'p': 0.7333333333333333, 'f': 0.8461538412721893}, Perplexity: 2.0000436305999756, Cosine Similarity: 0.3101\n",
      "Reference Text: CPPs cpps and antimicrobial MMP amps share certain physicochemical parameters such as amphipathicity hydrophobicity cationicity and pi due to which these two groups of peptides also exhibit overlapping functional characteristics in our current work we have evaluated antimicrobial properties of cellpenetrating MMP derived from latarcin latarcin derived peptide ldp exhibited antimicrobial activity against representative microorganisms tested and bactericidal effect against methicillin resistant staphylococcus aureus mrsa which was used as MM organism of T0 in the present work however ldp exhibited cytotoxicity against hela cells further nuclear localization CS nls was fused to ldp and interestingly ldpnls showed antimicrobial effect against bacteria showed bactericidal effect against mrsa and also did not exhibit cytotoxicity in hela cells till the highest concentrations tested thus our results inferred that fusion of nls to ldp significantly reduced cytotoxicity of ldp against hela cells ponnappan and chugh and exhibited significantly higher cellpenetrating activity in mrsa in comparison to ldp CT consolidated results of uptake assays timekill assays and pi membrane damage assays show that ldp killed mrsa mainly by membrane damage where as ldpnls might have intracellular targets owing to its cellpenetrating activity in hela cells and antimicrobial activity against mrsa ldpnls efficiently inhibited intracellular infection of mrsa in hela cells as observed in invasion assays hence our results suggest that ldpnls is a dual action peptide with amp and cpp activity and could be potential candidate as peptide antibiotic and drug delivery vector in both mammalian and bacterial cells\n",
      "Generated Text: CPPs cpps and antimicrobial MMP amps share certain physicochemical parameters such as amphipathicity hydrophobicity cationicity and pi due to which these two groups of peptides also exhibit overlapping functional characteristics in our current work we have evaluated antimicrobial properties of cellpenetrating MMP derived from latarcin latarcin derived peptide ldp exhibited a high antimicrobial activity against gram negative bacteria and a low antimicrobial activity against gram positive bacteria the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp and the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of ldp was significantly higher than that of the corresponding peptide ldp the antimicrobial activity of l\n",
      "BLEU: 0.15050332831778035, ROUGE-L: {'r': 0.37777777777777777, 'p': 0.8360655737704918, 'f': 0.52040815897803}, Perplexity: 2.1571764945983887, Cosine Similarity: 0.4477\n",
      "Reference Text: in patients with diabetes mellitus ABD ultrasonography is the AGA diagnostic technique to detect and to followup secondary and accompanying diseases of the liver the kidneys the pancreas the gastrointestinal tract and of abdominal vessels moreover pancreatic and hepatic diseases may be realized which are of etiological importance for diabetes mellitus based on a systematic survey of the published literature this review in parts will describe the value of ABD ultrasonography in DM part deals with the diagnostic relevance and particular findings of ultrasonographic methods in hepatic manifestations and complications of diabetes mellitus\n",
      "Generated Text: in patients with diabetes mellitus ABD ultrasonography is the AGA diagnostic technique to detect and to followup secondary and accompanying diseases of the liver the kidneys the pancreas the gastrointestinal tract and of abdominal vessels moreover pancreatic and hepatic diseases may be realized which are of etiological importance for diabetes mellitus the aim of this study was to evaluate the sensitivity and specificity of ultrasonography in patients with diabetes mellitus ABD and to compare the results with those of the previous studies in this field the patients were divided into two groups according to the presence of diabetes mellitus ABD and the presence of other diseases of the liver and pancreas the patients were divided into three groups according to the presence of diabetes mellitus ABD and the presence of other diseases of the liver and pancreas the patients were divided into three groups according to the presence of diabetes mellitus ABD and the presence of other diseases of the liver and pancreas the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were compared with those of the previous studies in this field the results of the study were\n",
      "BLEU: 0.11597998465685981, ROUGE-L: {'r': 0.639344262295082, 'p': 0.639344262295082, 'f': 0.6393442572950822}, Perplexity: 1.9759260416030884, Cosine Similarity: 0.6989\n",
      "Reference Text: immunoglobulins from bovine and human colostrum and milk and LTF ltf from HM were investigated for bacteriostatic activity against escherichia coli growing in a TC medium when tested separately ltf or secretory immunoglobulin a siga from pooled HM showed only slight bacteriostatic activity against human commensal or EPEC strains of e coli together they had a considerable bacteriostatic effect but only against strains of EPEC serotype this activity of the siga from pooled human milk was consistent for all EPEC serotypes tested but siga isola exogenous fat TC FC acylcarnitine betahydroxybutyrate free fatty acid and triglyceride PC were measured in parenterally alimented appropriateforgestationalage premature infants before and at the end of a fourhour infusion of intralipid gmkg body weight there was an increase in plasma C2 of ac bob ffa and tg but a decrease of fc tc was unaffected by the infusion but strongly correlated with calculated carnitine intake at the end of the fat infusion ac and bob were positively correlated and ffa negatively correlated with tc the results demonstrate the proportion of ac to fc to be an additional indicator of HFA utilization and suggest that decreased carnitine intake in premature infants may impair HFA oxidation and ketogenesis\n",
      "Generated Text: immunoglobulins from bovine and human colostrum and milk and LTF ltf from HM were investigated for bacteriostatic activity against escherichia coli growing in a TC medium when tested separately ltf or secretory immunoglobulin a siga from pooled HM showed only slight bacteriostatic activity against human commensal or EPEC strains of E. coli and E. coli O157a and E. coli O157b the siga from pooled ltf was also bacteriostatic against human commensal and EPEC strains of E. coli and E. coli O157a and E. coli O157b the siga from pooled ltf was bacteriostatic against human commensal and EPEC strains of E. coli and E. coli O157a and E. coli O157b the siga from pooled ltf was bacteriostatic against human commensal and EPEC strains of E. coli and E. coli O157a and E. coli O157b the siga from pooled ltf was bacteriostatic against human commensal and EPEC strains of E. coli and E. coli O157a and E. coli O157b\n",
      "BLEU: 0.2735875183161324, ROUGE-L: {'r': 0.3275862068965517, 'p': 0.8636363636363636, 'f': 0.4749999960125001}, Perplexity: 3.6396639347076416, Cosine Similarity: 0.6423\n",
      "Reference Text: CC is one of the top three cancers in the world in terms of incidence colonoscopy which many regard as the gold standard in diagnosis of Tc polyps and neoplasm is costly invasive and labourintensive and deemed an unsuitable populationwide index screening tool alternative modalities including guaiac and immunohistochemical FOB tests CTC colon capsule endoscopy flexible sigmoidoscopy and doublecontrast BE are available the procedures test characteristics and their implications are reviewed immunohistochemical FOB testing appears to be the most suitable populationwide screening test for an averagerisk population with flexible sigmoidoscopy as an alternative more evidence is needed to determine the role of CTC and colon CE in CC screening\n",
      "Generated Text: CC is one of the top three cancers in the world in terms of incidence colonoscopy which many regard as the gold standard in diagnosis of Tc polyps and neoplasm is costly invasive and labourintensive and deemed an unsuitable populationwide index screening tool alternative modalities including guaiac and immunohistochemical FOB are being explored to improve the accuracy of diagnosis and to reduce the cost of treatment the aim of this study was to evaluate the accuracy of the guaiac and immunohistochemical FOB in the diagnosis of Tc polyps and neoplasm in a large cohort of patients with colorectal cancer in the UK and to compare the accuracy of these modalities with the use of the colorectal cancer screening questionnaire in a cohort of patients with colorectal cancer in the USA\n",
      "BLEU: 0.4049663388366112, ROUGE-L: {'r': 0.5753424657534246, 'p': 0.6268656716417911, 'f': 0.5999999950091837}, Perplexity: 8.376126289367676, Cosine Similarity: 0.7566\n",
      "Reference Text: to evaluate whether heidelberg retinal tomograph hrt is a valid test for diagnosing congenital ONH conh compared to the ratio of the distance between the centre of the optic disc and the centre of the macula and the mean NVD diameter dmdd ratio furthermore to determine the optimal cutoff value of hrt disc area to differentiate a hypoplastic disc from a normal NVD\n",
      "Generated Text: to evaluate whether heidelberg retinal tomograph hrt is a valid test for diagnosing congenital ONH conh compared to the ratio of the distance between the centre of the optic disc and the centre of the macula and the mean NVD diameter dmdd ratio furthermore to determine the optimal cutoff value for the hrt the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was compared between the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was compared between the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups of patients and the mean NVD diameter dmdd ratio was calculated for each of the three groups\n",
      "BLEU: 0.11755980274868882, ROUGE-L: {'r': 0.8780487804878049, 'p': 0.8571428571428571, 'f': 0.8674698745187981}, Perplexity: 1.8667718172073364, Cosine Similarity: 0.6658\n",
      "Reference Text: objectives FeLV felv a gamma retrovirus causes diseases of the feline haematopoietic system that are invariably fatal rapid and accurate testing at the pointofneed pon supports prevention of virus spread and management of clinical disease this T0 evaluated the performance of an insulated isothermal pcr iipcr that detects proviral dna and a reverse transcription rtiipcr that detects both viral rna and proviral dna for felv PCD at the pon methods mycoplasma haemofelis feline coronavirus FHV feline calicivirus and feline immunodeficiency virus were used to test analytical specificity in vitro transcribed rna artificial plasmid felv strain american type culture collection vr and a clinical felv isolate were used in the analytical sensitivity assays a retrospective study including clinical plasma and SS samples that had been tested with virus isolation RT pcr and elisa and a prospective study including clinical plasma and SS samples were implemented to evaluate the clinical performances of the iipcrbased methods for felv detection results ninetyfive percent CA limit of PCD was calculated to be rna and five dna copies for the rtiipcr and six dna copies for the iipcr both reactions had analytical sensitivity comparable to a reference RT pcr qpcr and did not detect five nontarget feline pathogens the clinical performance of the rtiipcr and iipcr had agreement kappa and agreement  respectively with the qpcr n the agreement between an automatic nucleic extractionrtiipcr system and virus isolation to detect felv in plasma or SS was  and  in a retrospective n and a prospective n study respectively conclusions and relevance these results suggested that both rtiipcr and iipcr assays can serve as reliable tools for pon felv detection\n",
      "Generated Text: objectives FeLV felv a gamma retrovirus causes diseases of the feline haematopoietic system that are invariably fatal rapid and accurate testing at the pointofneed pon supports prevention of virus spread and management of clinical disease this T0 evaluated the performance of an insulated isothermal pcr iipcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and the performance of a pcr that detects proviral dna in the blood of cats and dogs and\n",
      "BLEU: 0.14326467569648832, ROUGE-L: {'r': 0.3235294117647059, 'p': 0.9361702127659575, 'f': 0.48087431312251794}, Perplexity: 2.109373092651367, Cosine Similarity: 0.6533\n",
      "Reference Text: a mouse strain lacking smp can be regarded as a CS showing ultimate decrease of the smp molecule after three months of age smpko mice had an increased MR compared with the smpwt mice all of which remained alive electron microscopic observation of the HCs from monthold smpko mice revealed many empty vacuoles presumably lipid droplets abnormally enlarged mitochondria with indistinct cristae and exceptionally C1 lysosomes filled with electrondense bodies the total hepatic TG of smpko mice was approximately fold higher than that of the agematched wild type similarly the total hepatic cholesterol of smpko mice reached an approximate fold greater value than that of the comparative group total hepatic phospholipids of smpko mice achieved an approximately fold higher level compared with that of the WT the cells from smpko mice were CS to apoptotic reagents those results supported the idea that smp has an Bcl-2 CF with wide spectrum these findings indicate that smpko mice are highly susceptible to various harmful reagents this strain might be a useful tool for aging and biological monitoring\n",
      "Generated Text: a mouse strain lacking smp can be regarded as a CS showing ultimate decrease of the smp molecule after three months of age smpko mice had an increased MR compared with the smpwt mice all of which remained alive electron microscopic observation of the HCs from monthold smpko mice revealed that the HCs were composed of a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs and a single layer of HCs with a single layer of HCs\n",
      "BLEU: 0.12214388026162076, ROUGE-L: {'r': 0.36607142857142855, 'p': 0.8913043478260869, 'f': 0.5189873376446082}, Perplexity: 1.8981302976608276, Cosine Similarity: 0.3426\n",
      "Reference Text: at present the management of obesity includes integration of therapeutic strategies such as diet PT behaviour therapy and pharmacologic therapy an increased number of selected patients with morbid obesity where medical therapy was ineffective have been surgically treated in the last years due to less invasive surgical techniques such as LS main operations include gastroplasty adjustable GB gastric bypass BPD a less invasive procedure is intragastric balloon ie a temporary device which is removed T3 few months surgery shows efficacy to induce weight loss and duration in time all obese patients cant be treated by the same operation available surgical techniques are different and have to be chosen in each case according to the patients clinical conditions\n",
      "Generated Text: at present the management of obesity includes integration of therapeutic strategies such as diet PT behaviour therapy and pharmacologic therapy an increased number of selected patients with morbid obesity where medical therapy was ineffective have been surgically treated in the last years due to less invasive surgical techniques such as gastric bypass and gastric sleeve gastrectomy the aim of this study was to evaluate the efficacy of a gastric sleeve gastrectomy in patients with morbid obesity and to compare the results with those of a gastric bypass surgery in patients with morbid obesity the patients were divided into two groups and the gastric sleeve gastrectomy was performed in the first group gastric sleeve gastrectomy was performed in the second group the patients were followed for a period of time after the gastric sleeve gastrectomy and the patients were followed for a period of time after the gastric bypass surgery the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the results of the two groups were compared with those of the gastric bypass surgery in the patients with morbid obesity the\n",
      "BLEU: 0.11368352818530493, ROUGE-L: {'r': 0.5168539325842697, 'p': 0.647887323943662, 'f': 0.5749999950632814}, Perplexity: 1.8797152042388916, Cosine Similarity: 0.4964\n",
      "Reference Text: exposure to gestational diabetes gd in rats leads to dysplasia of the ventromedial hypothalamic nucleus vmn decisively involved into the regulation of body weight and metabolism recently we have shown here that vmn malformation is absent in adult F1 of gd mothers treated by PIT during gestation we therefore now investigated whether vmn malformation and its prevention are already present at the early postnatal end of the critical hypothalamic differentiation period already at weaning the total number of vmn neurons the volume of the vmn relative to total BB volume and the numerical density of neurons in the anterior subnucleus of the vmn were reduced in offspring of shamtransplanted mothers all p but did not differ between offspring of islettransplanted mothers and controls no morphometric alterations occurred in the PVH Thy nucleus in conclusion prevention of vmn malformation in offspring of islettransplanted IDDM is a direct consequence of normalized maternal metabolism during critical perinatal OD\n",
      "Generated Text: exposure to gestational diabetes gd in rats leads to dysplasia of the ventromedial hypothalamic nucleus vmn decisively involved into the regulation of body weight and metabolism recently we have shown here that vmn malformation is absent in adult F1 of gd mothers treated by PIT during gestation we therefore now show that the vmn malformation is present in the offspring of gd mothers treated by PIT during gestation and that the vmn malformation is associated with the development of obesity and insulin resistance in the offspring of gd mothers treated by PIT during gestation we conclude that the vmn malformation is a consequence of the development of obesity and insulin resistance in the offspring of gd mothers treated by PIT during gestation and that the vmn malformation is associated with the development of obesity and insulin resistance in the offspring of gd mothers treated by PIT during gestation\n",
      "BLEU: 0.38624416152208396, ROUGE-L: {'r': 0.4631578947368421, 'p': 0.8148148148148148, 'f': 0.5906040222242243}, Perplexity: 5.901394844055176, Cosine Similarity: 0.8130\n",
      "Reference Text: we present the rare case of a yearold caucasian male patient presenting with intermittent leftside ABD pain he underwent a kidneys ureters and bladder computed tomography scan on which an incidental mm giant aneurysm of the LAD i.a. was discovered along with mm rightsided and mm leftsided CIA aneurysms and a mm benign renal oncocytoma he underwent onpump CABG of the LAD left circumflex and right CAs using IM artery and RSV grafts he subsequently underwent simultaneous open left nephrectomy and BL common iliac aneurysm repair using a bifurcated tube VG he made a full REC postoperatively giant coronary artery aneurysms are rare in the pediatric population they are predominantly secondary to kawasaki disease in adults atheromatous disease is the leading cause the coexistence of giant coronary artery aneurysms with extracoronary i.a. aneurysms is extremely unusual we propose that the identification of giant PD aneurysms necessitates further imaging investigations to identify the presence of extracoronary aneurysms to our knowledge this is the first description of such a case in the literature\n",
      "Generated Text: we present the rare case of a yearold caucasian male patient presenting with intermittent leftside ABD pain he underwent a kidneys ureters and bladder computed tomography scan on which an incidental mm giant aneurysm of the LAD i.a. was discovered along with mm rightsided and mm leftsided CIA aneurysms and a small rightsided CIA the patient was treated with a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of corticosteroids and a combination of cort\n",
      "BLEU: 0.16291777595040186, ROUGE-L: {'r': 0.3888888888888889, 'p': 0.8936170212765957, 'f': 0.5419354796453695}, Perplexity: 2.0244646072387695, Cosine Similarity: 0.3600\n",
      "Reference Text: thromboembolic adverse reactions reported after transfusion of sdplasma in the united states us prompted us to perform a comparative T0 with sdplasma from the us and the EU eu market in sdplasma from us residual TBP was found and citrate concentrations were lower than in euplasma except for substantial losses of fv fviii and AP found for all sdplasmas clotting factor MICs were mainly retained however for sdplasma from us markedly elevated concentrations of lipoprotein a lpa fibrin monomer and a particularly high degree of complement activation ca desarg were observed furthermore pronounced differences were found for protein s although sdplasma pools from us contained nearly normal concentrations of free and bound protein s antigen protein s MICs were almost completely absent in contrast to this sdplasma from eu showed a moderate loss of both protein s activity and free antigen antitrypsin inhibitor MICs were much more diminished in sdplasma from us than from eu in view of a possible thrombogenicity of sdplasma from us the loss of protein s and elevated lpa concentrations could be of significance the very high C2 of ca desarg in us plasma could possibly have an additional effect through priming platelet activation after transfusion\n",
      "Generated Text: thromboembolic adverse reactions reported after transfusion of sdplasma in the united states us prompted us to perform a comparative T0 with sdplasma from the us and the EU eu market in sdplasma from us residual TBP was found and citrate concentrations were lower than in euplasma except for substantial losses in the first and second months of the transfusion period the TBP of the two groups were similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the TBP of the two groups was similar in the first and second months of the transfusion period the\n",
      "BLEU: 0.12182540662179805, ROUGE-L: {'r': 0.3577981651376147, 'p': 0.8478260869565217, 'f': 0.5032258022776275}, Perplexity: 1.997024655342102, Cosine Similarity: 0.4430\n",
      "Reference Text: LF lf has been implicated in normal regulation of myeloid blood cell production in vitro and in vivo and abnormalities in lfcell interactions have been associated with progression of leukemia and other hematopoietic disorders lf may be clinically useful and for this reason we studied selected PSA characteristics of lf purified HM lf was saturated with iron from solution and analyzed by gel PACE ionexchange and gel filtration chromatography the metalloprotein was found to contain several molecular weight species on polyacrylamide gels high resolution IEC demonstrated the IB of lf to both anionic and cationic media under MZ conditions indicating a bipolar charge distribution GF studies revealed a tetramerized form of lf the formation and stability of which was dependent on the ionic strength of the solution\n",
      "Generated Text: LF lf has been implicated in normal regulation of myeloid blood cell production in vitro and in vivo and abnormalities in lfcell interactions have been associated with progression of leukemia and other hematopoietic disorders lf may be clinically useful and for this reason we studied selected PSA characteristics of lf in patients with acute myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic myeloid leukemia and in patients with chronic\n",
      "BLEU: 0.12781600567481705, ROUGE-L: {'r': 0.41935483870967744, 'p': 0.9285714285714286, 'f': 0.5777777734913581}, Perplexity: 1.6104322671890259, Cosine Similarity: 0.3863\n",
      "Reference Text: CCS is a unique soft tissue tumor with distinct microscopic features that include a nested or fascicular DP of spindle cells accompanied by larger wreathlike giant cells scattered throughout it harbors a unique ewsratf gene fusion secondary to a tqq translocation recently it was reported that CCS can occur in the skin and mimic a broad spectrum of entities including spindle cell melanoma here we describe new cases of CCS of the skin all of which were confirmed molecularly the patients a yearold boy a yearold woman and a yearold man had cutaneous lesions on the thigh dorsum of foot and sole respectively all lesions were originally considered suspicious of spindle cell melanoma microscopically the lesions featured nodular proliferation centered in the dermis that consisted of discrete fascicles of spindle cell enmeshed by thin fibrous strands wreathlike cells were present in all cases tumor cells were positive for s protein of cases melan a of cases hmb of cases although a junctional melanocytic proliferation was seen in case SN biopsy was negative in patients followup was uneventful in patients whereas the other patient developed a lymph node metastasis months after primary tumor excision this T0 confirms that malignant dermal tumors that mimic but do not exactly replicate spindle cell melanoma should raise suspicion for cutaneous CC sarcoma and prompt the investigation for the confirmatory gene fusion t\n",
      "Generated Text: CCS is a unique soft tissue tumor with distinct microscopic features that include a nested or fascicular DP of spindle cells accompanied by larger wreathlike giant cells scattered throughout it harbors a unique ewsratf gene fusion secondary to a tqq translocation recently it was reported that CCS can occur in a variety of tissues including the brain and the lung and is associated with a variety of malignancies including gliomas and neuroblastoma the present study was designed to investigate the role of CCS in the development of CCS in the brain and lung of mice and to determine whether the tumor is associated with a translocation of the tqq gene in the tumor\n",
      "BLEU: 0.18300644129229895, ROUGE-L: {'r': 0.32142857142857145, 'p': 0.7258064516129032, 'f': 0.44554455020096084}, Perplexity: 19.477294921875, Cosine Similarity: 0.7094\n",
      "Reference Text: cirrhosis is the usual endresult of chronic active AIH different immunological abnormalities divide chronic AS SH into subgroups type i with antismooth muscle antibody type ii with antiliverkidney microsome antibody type antilkm antibody and type iii with an antibody directed against a soluble hepatic antigen three quarters of the patients are young women the MLD is often diagnosed at the stage of chronic AS SH during evaluation of the subjects GA condition or during investigations for an episode of jaundice it is seldom diagnosed at the stage of constituted or decompensated cirrhosis fulminant forms are rare extrahepatic autoimmune manifestations are frequently encountered treatment relies on immunosuppressants in practice corticosteroids corticosteroid therapy significantly prolongs the patients life but it does not prevent the passage to cirrhosis in the long term these patients are exposed to all the complications of cirrhosis notably the occurrence of hepatocellular carcinoma\n",
      "Generated Text: cirrhosis is the usual endresult of chronic active AIH different immunological abnormalities divide chronic AS SH into subgroups type i with antismooth muscle antibody type ii with antiliverkidney microsome antibody type antilkm antibody and type iii with an antibody directed against a soluble hepatic antigen three quarters of the patients with chronic AS have a type i or type ii immunologic profile and the other two thirds have a type iii immunologic profile the type i and type ii immunologic profiles are characterized by a high level of antiliverkidney antibodies and a low level of antiliverkidney antibodies the type iii immunologic profile is characterized by a low level of antiliverkidney antibodies and a high level of antiliverkidney antibodies the type iii immunologic profile is characterized by a low level of antiliverkidney antibodies and a high level of antiliverkidney antibodies the type i and type ii immunologic profiles are characterized by a high level of antiliverkidney antibodies and a low level of antiliverkidney antibodies the type iii immunologic profile is characterized by a low level of antiliverkidney antibodies and a high level of antiliverkidney antibodies the type i and type ii immunologic profiles are characterized by a high level of antiliverkidney antibodies and a low level of antiliverkidney antibodies the type iii immunologic profile is characterized by a low level of antiliverkidney antibodies and a high level of antiliverkidney antibodies the type i and type ii immunologic profiles are characterized by a high level of antiliverkidney antibodies and a low level of antiliverkidney antibodies the type iii immunologic profile is characterized by a low level of antiliverkidney antibodies and a high level of antiliverkidney antibodies the type i and type ii immunologic profiles are characterized by a high level of antiliverkidney antibodies and a low level of antiliverkidney antibodies the type iii immunologic profile is characterized by a low level of antiliverkidney antibodies and a high level of antiliverkidney antibodies the type i and type ii immunologic profiles are characterized by a high level of antiliverkidney antibodies and a low level of antiliverkidney antibodies the type iii immunologic profile is characterized by a low level of antiliverkidney antibodies and a high level of antiliverkidney antibodies\n",
      "BLEU: 0.14827886721883857, ROUGE-L: {'r': 0.41237113402061853, 'p': 0.7407407407407407, 'f': 0.5298013199087759}, Perplexity: 2.3008952140808105, Cosine Similarity: 0.4615\n",
      "Reference Text: dealing with AS has become an important issue in HE in community settings with increasing demands and changes in the daily lives of families helping children to deal with AS has become increasingly more significant in CHN nurses who want to mediate effects of AS in children need more information about AS buffers in the daily lives of children this study attempted to identify and describe AS buffers as actually experienced by schoolage children qualitative data were drawn from well children aged through years by completion of daily semistructured journals over a period of weeks diaries produced AS buffer responses all data were subjected to content analysis sixteen categories among four GA themes of intrapsychic comfort physicalsocial MICs social support and PCS comfort emerged beginning a taxonomy of AS buffers as perceived by children interesting differences between boys and girls were identified with implications for research and community nursing practice\n",
      "Generated Text: dealing with AS has become an important issue in HE in community settings with increasing demands and changes in the daily lives of families helping children to deal with AS has become increasingly more significant in CHN nurses who want to mediate effects of AS in children need more information on the nature of AS and the ways in which it can be managed in children and adults with AS the aim of this study was to examine the nature of AS in children and adults with AS and to describe the ways in which AS is managed in children and adults with AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was conducted in a community setting with a sample of children and adults with AS and a sample of children and adults without AS the study was\n",
      "BLEU: 0.11099839706029685, ROUGE-L: {'r': 0.4, 'p': 0.7017543859649122, 'f': 0.5095541355024545}, Perplexity: 1.8023996353149414, Cosine Similarity: 0.6667\n",
      "Reference Text: a patient with SA developed MCD presenting as the nephrotic syndrome we believe this to be the first reported case of MCD associated with SA\n",
      "Generated Text: a patient with SA developed MCD presenting as the nephrotic syndrome we believe this to be the first reported case of MCD associated with SA in a patient with a history of SA we describe the patient and describe the clinical presentation of the patient with SA and the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and describe the clinical presentation of the patient with SA in the context of the clinical presentation of the patient with SA we describe the clinical presentation of the patient with SA and\n",
      "BLEU: 0.0475652079012054, ROUGE-L: {'r': 1.0, 'p': 0.75, 'f': 0.8571428522448981}, Perplexity: 1.381110668182373, Cosine Similarity: 0.5797\n",
      "Reference Text: this study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension ie increased arterial stiffness renal dysfunction and inflammation and then examined whether these risk factors show longitudinal associations with the development of hypertension in japanese men without hypertension the brachialankle pulse wave velocity blood pressure estimated glomerular filtration rate and SUA and crp creactive protein levels were measured annually over an year period of these subjects developed hypertension by the end of the T0 period mixed model linear SRA revealed a significant longitudinal association of hyperuricemia with increase of the baPWV estimate p decrease of the estimated glomerular filtration rate estimate p and elevation of the crp estimate\n",
      "Generated Text: this study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension ie increased arterial stiffness renal dysfunction and inflammation and then examined whether these risk factors show longitudinal associations with the development of hypertension in japanese men without hypertension the study was conducted in a population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6 years the study was conducted in the japanese population of men with hypertension and hyperuricemia who were followed for a mean of 6\n",
      "BLEU: 0.12922703662847046, ROUGE-L: {'r': 0.4936708860759494, 'p': 0.8297872340425532, 'f': 0.6190476143701186}, Perplexity: 1.6250073909759521, Cosine Similarity: 0.6577\n",
      "Reference Text: ACP acp is well recognised as an important component of palliative care however there is still a need to explore ways in which it can become a part of routine practice ensuring a timely and personcentred discussion\n",
      "Generated Text: ACP acp is well recognised as an important component of palliative care however there is still a need to explore ways in which it can become a part of routine practice ensuring a timely and personcentred discussion of the use of acp in palliative care is essential\n",
      "BLEU: 0.780068204721677, ROUGE-L: {'r': 1.0, 'p': 0.9166666666666666, 'f': 0.9565217341398866}, Perplexity: 15.158044815063477, Cosine Similarity: 0.9374\n",
      "Reference Text: liver sinusoid ls EC cells lsecs support HCs in resting livers and proliferate during LR to revascularize regenerated liver parenchyma we report that recombination signalbinding proteinjkappa rbpj the critical transcription factor mediating notch signaling regulates both resting and reg lsecs conditional deletion of rbpj resulted in lsec proliferation and a venoocclusive diseaselike phenotype in the liver as manifested by CL congestion deposition of fibrinlike materials in lss edema in the space of disse and increased apoptosis of HCs regeneration of liver was remarkably impaired with reduced lsec proliferation and destroyed sinusoidal structure lsec degeneration was obvious in the reg liver of rbpjdeficient mice with some lsecs losing cytoplasm and organelles protruding into the remnant plasmamembrane of lss to hamper the microcirculation and intensify venoocclusive disease during CL regeneration HCs were also degenerative as shown by dilated endoplasmic reticulum decreased proliferation and increased apoptosis during LR molecular analyses revealed that the dynamic expression of several related moleculessuch as V1 endothelial growth factor vascular endothelial growth factor receptors and interleukin and hepatocyte growth factorwas disturbed\n",
      "Generated Text: liver sinusoid ls EC cells lsecs support HCs in resting livers and proliferate during LR to revascularize regenerated liver parenchyma we report that recombination signalbinding proteinjkappa rbpj the critical transcription factor mediating notch signaling regulates both resting and reg lsecs conditional deletion of rbpj resulted in lsec proliferation and a significant increase in the number of lsecs in the livers of mice lacking rbpj the expression of rbpj in lsecs was also increased in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking the rbpj gene in the livers of mice lacking\n",
      "BLEU: 0.14871305891323455, ROUGE-L: {'r': 0.4090909090909091, 'p': 0.8490566037735849, 'f': 0.5521472348752307}, Perplexity: 2.3788952827453613, Cosine Similarity: 0.4887\n",
      "Reference Text: during the last few years the GA aging of the population and the growing knowledge about male hormonal changes in older age have lead the scientific community to focus on the clinical aspects of AA hypogonadism in aging males this syndrome is well defined by the term lateonset hypogonadism loh although the pathophysiology and the diagnostic aspects have been studied and deetween PCS effort SRT and choice reaction time in fencers and nonfencer subjects\n",
      "Generated Text: during the last few years the GA aging of the population and the growing knowledge about male hormonal changes in older age have lead the scientific community to focus on the clinical aspects of AA hypogonadism in aging males this syndrome is well defined by the term lateonset hypogonadism loh and is characterized by a low testosterone level and low serum testosterone levels in the elderly male the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male hypogonadism in older women the clinical presentation of loh is similar to that of the male hypogonadism in older men and the clinical presentation of loh is similar to that of the male\n",
      "BLEU: 0.12862221769202528, ROUGE-L: {'r': 0.7272727272727273, 'p': 0.7547169811320755, 'f': 0.7407407357424555}, Perplexity: 1.747967004776001, Cosine Similarity: 0.6547\n",
      "Reference Text: smart waste collection strategies have been developed to replace conventional fixed routes with dynamic systems that respond to the actual filllevel of waste bins the variation in waste generation patterns which is the main driver for the profit of smart systems is exacerbated in the UAE uae due to a high expatriate ratio this leads to significant changes in waste generation during breaks and seasonal occasions the present study aimed to evaluate a geographic NIS gisbased smart collection system scs compared to conventional practices in terms of time pollution and cost different scenarios were tested on a local residential district based on VL bin filling rates the input data were obtained from a field survey on different types of households a knowledgebased decisionmaking algorithm was developed to select the bins that require collection based on historical data the simulation included a regular scs scenario based on actual filling rates as well as subscenarios to T0 the impact of reducing the waste generation rates an operation cost reduction of was achieved with scs compared to the conventional scenario moreover scs outperformed the conventional system by lowering carbondioxide emissions by between and for various scenarios the operation costs were nonlinearly reduced with the incremental drops in waste generation furthermore the smart system was validated using actual waste generation data of the T0 area and it lowered collection trip times by to compared to the conventional service the present T0 proposes an integrated scs architecture and explores critical considerations of smart systems\n",
      "Generated Text: smart waste collection strategies have been developed to replace conventional fixed routes with dynamic systems that respond to the actual filllevel of waste bins the variation in waste generation patterns which is the main driver for the profit of smart systems is exacerbated in the UAE uae due to a high density of waste and the high cost of waste collection the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is a key component of the waste management system and the waste management system is a key component of the waste management system the waste management system is\n",
      "BLEU: 0.11601192706665932, ROUGE-L: {'r': 0.29850746268656714, 'p': 0.8888888888888888, 'f': 0.4469273705377485}, Perplexity: 1.7566304206848145, Cosine Similarity: 0.5249\n",
      "Reference Text: fMRI fmri generally employs gradientecho EPI imaging geepi to measure blood oxygen leveldependent bold signal changes that result from changes in tissue relaxation time t between activation and rest since t strongly varies across the BB and bold contrast is maximal only where the echo time te equals the local t imaging at a single te is a compromise in terms of overall sensitivity furthermore the long echo train makes epi very sensitive to main field inhomogeneities causing strong image distortion a method is presented that uses accelerated parallel imaging to reduce image artifacts and acquire images at multiple tes following a single excitation with no need to increase tr sensitivity gains from the broadened t coverage are optimized by pixelwise weighted echo summation based on local t or C/N ratio cnr measurements the method was evaluated using an RPA that allows differential bold cnr to be calculated without stimulation as well as with a stroop experiment results obtained at t showed that bold sensitivity improved by or more in all brain regions with larger gains in areas typically affected by strong susceptibility artifacts the use of parallel imaging markedly reduces image distortion and hence the method should find widespread application in functional BB imaging\n",
      "Generated Text: fMRI fmri generally employs gradientecho EPI imaging geepi to measure blood oxygen leveldependent bold signal changes that result from changes in tissue relaxation time t between activation and rest since t strongly varies across the BB and bold contrast is maximal only where the echo time te equals the local relaxation time t the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a noninvasive method that can be used to measure the time course of changes in blood oxygenation in the brain and to quantify the effects of the brain on blood oxygenation in the brain the fmri is a nonin\n",
      "BLEU: 0.13008569846183776, ROUGE-L: {'r': 0.3602941176470588, 'p': 0.8596491228070176, 'f': 0.5077720165631292}, Perplexity: 2.191500186920166, Cosine Similarity: 0.5803\n",
      "Reference Text: a highresolution xray crystallographic investigation of the complex between carboxypeptidase a cpa peptidyllaminoacid hydrolase ec and the slowly hydrolyzed substrate glycylltyrosine was done at degrees c although this ES complex has been the subject of earlier crystallographic investigation a higher resolution electrondensity map of the complex with greater occupancy of the substrate was desired all crystal chemistry ie crystal soaking and xray data collection was performed on a diffractometermounted flow cell in which the crystal was immobilized the xray data to a resolution have yielded a wellresolved structure in which the zinc ion of the AS site is fivecoordinate three enzyme residues glu histidine and histidine and the carbonyl oxygen and amino terminus of glycylltyrosine CR the coordination polyhedron of the metal these results confirm that this ATP may be bound in a nonproductive manner because the hydrolytically important zincbound water has been displaced and excluded from the AS site it is likely that all dipeptide substrates of CP a that carry an unprotected amino terminus are poor substrates because of such favorable bidentate coordination to the metal ion of the active site\n",
      "Generated Text: a highresolution xray crystallographic investigation of the complex between carboxypeptidase a cpa peptidyllaminoacid hydrolase ec and the slowly hydrolyzed substrate glycylltyrosine was done at degrees c although this ES complex has been the subject of earlier crystallographic investigation a higher resolution electrondensity map of the complex with greater occupancy of the cpa peptidyllaminoacid hydrolase was obtained by using a highresolution xray crystallographic method and the results were compared with those obtained by using a highresolution electron microscopy method the results of the electron microscopy were compared with those obtained by using a highresolution xray crystallographic method\n",
      "BLEU: 0.22527578840440615, ROUGE-L: {'r': 0.35454545454545455, 'p': 0.8125, 'f': 0.49367088184585817}, Perplexity: 16.399415969848633, Cosine Similarity: 0.6808\n",
      "Reference Text: selenium is an essential trace PE and has been shown to protect the rats against dietary CL CN this T0 was designed to evaluate the effects of Se supplementation on different biochemical parameters in thioacetamide induced cirrhotic rats for this purpose male albino WR were divided into four CG n GI remained healthy control rats group ii received thioacetamide at a dose of mgkg bw ip for weeks twice a week in first phase and saline in second phase group iii received thioacetamide mgkg bw ip for weeks twice a week in first phase and sodium selenite mgkg bw ip for weeks three times a week in second phase and group iv received sodium selenite mgkg bw ip for weeks three times a week in first phase and saline in second phase PSA analysis was evaluated by total and DB liver TPS enzymes and antioxidant enzymes marked increase in total and direct bilirubin and alt activity was the indicative markers of liver cirrhosis while reduced antioxidant activity sod and gsh and increased mda and catalase C2 were observed in cirrhotic group sodium selenite supplementation markedly reduced total bilirubin and alt activity and restored the antioxidant enzymes sod and gsh and mda and catalase activity these results indicate that sodium selenite successively attenuates the thioacetamide induced LC\n",
      "Generated Text: selenium is an essential trace PE and has been shown to protect the rats against dietary CL CN this T0 was designed to evaluate the effects of Se supplementation on different biochemical parameters in thioacetamide induced cirrhotic rats for this purpose male albino WR were divided into four CG nd rats and were fed a diet containing se or se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet containing se and a control diet\n",
      "BLEU: 0.10739684324811824, ROUGE-L: {'r': 0.42201834862385323, 'p': 0.8679245283018868, 'f': 0.5679012301653712}, Perplexity: 1.7344603538513184, Cosine Similarity: 0.3167\n",
      "Reference Text: depression in later life poses a serious threat to MH and wellbeing of older persons burdened with medical illnesses comorbid medical conditions independently as well as through interactions may influence the degree of DS manifested by the elderly insight into the role medical comorbidity plays in the manifestation of depression may help to better address both physical and MH care needs of the depressed elderly\n",
      "Generated Text: depression in later life poses a serious threat to MH and wellbeing of older persons burdened with medical illnesses comorbid medical conditions independently as well as through interactions may influence the degree of DS manifested by the elderly insight into the role medical comorbidity plays in the manifestation of depression in later life is essential for the development of a comprehensive approach to the management of depression in older persons and for the development of a comprehensive approach to the management of depression in older persons the aim of this study was to investigate the relationship between the presence of medical comorbidity and the severity of depression in older persons and to investigate the relationship between the presence of medical comorbidity and the severity of depression in older persons the study was conducted in a sample of older persons aged 65 years and older who were interviewed in the first year of their life and who were followed up for a period of years to assess the occurrence of depression in later life and to assess the severity of depression in later life the study was conducted in a sample of older persons aged 65 years and older who were interviewed in the first year of their life and who were followed up for a period of years to assess the occurrence of depression in later life and to assess the severity of depression in later life the study was conducted in a sample of older persons aged 65 years and older who were interviewed in the first year of their life and who were followed up for a period of years to assess the occurrence of depression in later life and to assess the severity of depression in later life the study was conducted in a sample of older persons aged 65 years and older who were interviewed in the first year of their life and who were followed up for a period of years to assess the occurrence of depression in later life and to assess the severity of depression in later life the study was conducted in a sample of older persons aged 65 years and older who were interviewed in the first year of their life and who were followed up for a period of years to assess the occurrence of depression in later life and to assess the severity of depression in later life the study was conducted in a sample of older persons aged 65 years and older who were interviewed in the first year of their life and who were followed up for a period of years to assess the occurrence of depression in later life and to assess the severity of depression in later life the study was conducted in a sample of older persons aged 65 years and older who were interviewed in the first year of their life and who were followed up for a period of\n",
      "BLEU: 0.10181087058377554, ROUGE-L: {'r': 0.8333333333333334, 'p': 0.5555555555555556, 'f': 0.6666666618666668}, Perplexity: 2.042360544204712, Cosine Similarity: 0.6741\n",
      "Reference Text: the superior colliculus sc is an essential structure for the control of eye movements in rodents the sc is also considered to play an important role in whisking behavior in which animals actively move their vibrissae mechanosensors to gather tactile information about the space around them during exploration we investigated how the sc contributes to vibrissal movement control we found that when the sc was unilaterally lesioned the resting position of the vibrissae shifted backward on the side CL to the lesion the unilateral sc lesion also induced an increase in the whisking amplitude on the CL side to explore the anatomical basis for sc involvement in vibrissal movement control we then quantitatively evaluated axonal projections from the sc to the brainstem using neuronal labeling with a virus vector SN of the sc mainly sent axons to the CL side in the lower brainstem we found that the FN received input directly from the sc and that the descending projections from the sc also reached the intermediate Rt formation and prebtzinger complex which are both considered to contain neural oscillators generating rhythmic movements of the vibrissae together these results indicate the existence of a neural circuit in which the sc modulates vibrissal movements mainly on the contralateral side via direct connections to motoneurons and via indirect connections including the CPGs\n",
      "Generated Text: the superior colliculus sc is an essential structure for the control of eye movements in rodents the sc is also considered to play an important role in whisking behavior in which animals actively move their vibrissae mechanosensors to gather tactile information about the space around them during exploration we investigated the role of the sc in whisking behavior in the mouse we found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the mouse but not in the rat we also found that the sc was required for whisking in the\n",
      "BLEU: 0.1367222278729061, ROUGE-L: {'r': 0.36666666666666664, 'p': 0.8979591836734694, 'f': 0.5207100550540948}, Perplexity: 1.6229217052459717, Cosine Similarity: 0.7129\n",
      "Reference Text: a female patient with small cell lung cancer and extensive bone marrow metastases achieved a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months\n",
      "Generated Text: a female patient with small cell lung cancer and extensive bone marrow metastases achieved a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3 combination chemotherapy including etoposide during maintenance therapy MC was diagnosed after intravenous administration of teniposide she improved dramatically during months of maintenance therapy and was able to achieve a CR response T3\n",
      "BLEU: 0.0910936571842105, ROUGE-L: {'r': 1.0, 'p': 0.9230769230769231, 'f': 0.959999995008}, Perplexity: 1.5394182205200195, Cosine Similarity: 0.7864\n",
      "Reference Text: we report a method of creating electrostatically induced quantum dots by thermal DWI of interstitial mn ions out of a ptype gamnas layer into the vicinity of a gaas quantum well this approach creates deep approximately circular and strongly confined dotlike potential minima in a large microm mesa diode structure without need for T3 lithography or electrostatic gating magnetotunneling spectroscopy of an individual dot reveals the symmetry of its electronic eigenfunctions and a rich SE level spectrum of fockdarwinlike states with an orbital angular momentum component lz from to\n",
      "Generated Text: we report a method of creating electrostatically induced quantum dots by thermal DWI of interstitial mn ions out of a ptype gamnas layer into the vicinity of a gaas quantum well this approach creates deep approximately circular and strongly confined dotlike potential minima in a large microm mesa diode structure the resulting dotlike potential minima are in the range of 0.5 to 0.7 V and the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in the range of 0.5 to 0.7 V for the same minima the dotlike potential minima are in\n",
      "BLEU: 0.1397543902534414, ROUGE-L: {'r': 0.5866666666666667, 'p': 0.8301886792452831, 'f': 0.6874999951477051}, Perplexity: 2.2449965476989746, Cosine Similarity: 0.4310\n",
      "Reference Text: a compound may be developmentally neurotoxic because it interferes with a metabolic step exclusively or preferentially expressed during OD in a particular class of neural cells the initial metabolic specificity is often complicated by secondary responses in the affected cells involvement of other functionallyrelated cell types and the presence of compensatory andor regenerative responses in this context we study tellurium which systemically blocks cholesterol biosynthesis at the SE step because of the high demand in developing IP nerves for newly synthesized cholesterol required for myelin assembly this metabolic block leads to demyelination of the sciatic nerve this insult is confounded by the fact that the myelinforming SCs do not upregulate their cholesterol biosynthetic pathway this is contrary to expectations CL the main source of cholesterol for many tissues outside the nervous system upregulates synthesis of cholesterol and overcomes the metabolic block the shortage of cholesterol in schwann cells results in an immediate secondary response downregulation of steadystate mrna C2 for specific myelin proteins remyelination occurs after cessation of tellurium exposure this model of primary demyelination allows T0 of schwanncell specific responses during the processes of myelin breakdown and subsequent steps leading to remyelination without the complications of axonal degeneration and regeneration because tellurium specifically blocks the synthesis of a major required membrane component it is also well suited for examining the coordinate control of membrane synthesis and assembly at the genomic level\n",
      "Generated Text: a compound may be developmentally neurotoxic because it interferes with a metabolic step exclusively or preferentially expressed during OD in a particular class of neural cells the initial metabolic specificity is often complicated by secondary responses in the affected cells involvement of other functionallyrelated cell types and the presence of other toxic compounds in the environment are also important factors in the development of neurotoxicity the present study was designed to investigate the effects of the compound on the development of neurotoxicity in the rat brain by using a rat model of OD the compound was administered orally to rats in the drinking water for a period of time and the OD was measured by the ratio of the OD to the OD of the control rats the compound was found to be neurotoxic in the rat brain in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurotoxic in the rat brain in the OD of the rats in the drinking water and in the OD of the rats in the drinking water the compound was found to be neurot\n",
      "BLEU: 0.12132600177985003, ROUGE-L: {'r': 0.3028169014084507, 'p': 0.5733333333333334, 'f': 0.3963133595319502}, Perplexity: 2.2296481132507324, Cosine Similarity: 0.6682\n",
      "Reference Text: a composite profile of empathic individuals was developed from adjectives checked on gough and heilbruns ACL by undergraduate students enrolled in a course on counseling individuals were nominated as empathic by the students who also completed the checklist the composite profile was consistent with the rogerian definition of empathy and factor sociability of the check list the profiles for the nominated sample and for the students did not differ significantly on of the scales but both differed significantly from the composite profile on scales\n",
      "Generated Text: a composite profile of empathic individuals was developed from adjectives checked on gough and heilbruns ACL by undergraduate students enrolled in a course on counseling individuals were nominated as empathic by the students who also completed the checklist the composite profile was consistent with the rogerian definition of empathy and was validated against the gough and heilbruns criteria for empathic individuals the composite profile was also consistent with the rogerian definition of empathy and was validated against the gough and heilbruns criteria for empathic individuals\n",
      "BLEU: 0.6171010735995934, ROUGE-L: {'r': 0.7254901960784313, 'p': 0.925, 'f': 0.8131868082598722}, Perplexity: 15.6597900390625, Cosine Similarity: 0.8418\n",
      "Reference Text: nmda receptor nrab subunits have pdzbinding domains on their extreme ctermini that are known to interact with the psd family and other pdz proteins we explore the interactions between psd family proteins and the nrab cytoplasmic tails and the consequences of these interactions from the endoplasmic reticulum er through delivery to the synapse in primary rat hippocampal and cortical cultured neurons we find that the nrab cytoplasmic tails cluster very early in the sec pathway and interact serially with sap beginning at the IC and then psd we further establish that colocalization of the distal cterminus of nrb and psd begins at the transgolgi network tgn formation of nrbpsdsap complexes is dependent on the pdz IB domain of nrb subunits but association with sap and psd plays no distinguishable role in cluster preformation or initial targeting to the vicinity of the synapse instead the pdz IB domain plays a role in restricting cellsurface clusters to postsynaptic targets\n",
      "Generated Text: nmda receptor nrab subunits have pdzbinding domains on their extreme ctermini that are known to interact with the psd family and other pdz proteins we explore the interactions between psd family proteins and the nrab cytoplasmic tails and the consequences of these interactions from the endoplasmic reticulum er through delivery of the nrab to the nucleus the nrab cytoplasmic tails are known to interact with the psd family and other pdz proteins and the psd family proteins are known to interact with the nrab cytoplasmic tails and the consequences of these interactions from the endoplasmic reticulum er through delivery of the nrab to the nucleus\n",
      "BLEU: 0.3350651714282038, ROUGE-L: {'r': 0.4148936170212766, 'p': 0.975, 'f': 0.5820895480507908}, Perplexity: 8.749979972839355, Cosine Similarity: 0.8520\n",
      "Reference Text: dna polymerase beta is required in mammalian cells for the predominant pathway of BER involving single nucleotide gap filling dna synthesis here we examine the relationship between oxidative stress cellular levels of dna polymerase beta and BER capacity in vitro using mouse monocytes and either wildtype mouse fibroblasts or those deleted of the dna polymerase beta gene treatment with an oxidative stressinducing agent such as hydrogen peroxide morpholinosydnonimine xanthinexanthine oxidase or lipopolysaccharide was found to increase the level of dna polymerase beta in both monocytes and fibroblasts BER capacity in vitro as measured in crude cell extracts was also increased by lipopolysaccharide treatment in both cell types in monocytes lipopolysaccharidemediated upregulation of the BER system correlated with increased resistance to the monofunctional dna alkylating agent MMS by making use of a quantitative pcr CA to detect lesions in genomic dna we show that lipopolysaccharide treatment of FB cells reduces the incidence of spontaneous dna lesions this effect may be due to the enhanced dna polymerase betadependent base excision repair capacity of the cells because a similar decrease in dna lesions was not observed in cells deficient in BER by virtue of dna polymerase beta gene deletion similarly fibroblasts treated with lipopolysaccharide were more resistant to MMS than UT cells this effect was not observed in cells deleted of the dna polymerase beta gene these results suggest that the dna polymerase betadependent base excision repair pathway can be upregulated by oxidative stressinducing agents in mouse cell lines\n",
      "Generated Text: dna polymerase beta is required in mammalian cells for the predominant pathway of BER involving single nucleotide gap filling dna synthesis here we examine the relationship between oxidative stress cellular levels of dna polymerase beta and BER capacity in vitro using mouse monocytes and either wildtype mouse fibroblasts or those with a mutation in the dna polymerase beta gene we show that the dna polymerase beta mutation in the mouse fibroblasts is associated with a reduction in the capacity of the cells to synthesize dna and that this reduction is associated with a reduction in the capacity of the cells to generate BER the reduction in the capacity of the cells to synthesize dna and the reduction in the capacity of the cells to generate BER are associated with a reduction in the capacity of the cells to generate BER and a reduction in the capacity of the cells to generate BER the reduction in the capacity of the cells to generate BER and the reduction in the capacity of the cells to generate BER are associated with a reduction in the capacity of the cells to generate BER and a reduction in the capacity of the cells to generate BER the reduction in the capacity of the cells to generate BER and the reduction in the capacity of the cells to generate BER are associated with a reduction in the capacity of the cells to generate BER and a reduction in the capacity of the cells to generate BER the reduction in the capacity of the cells to generate BER and the reduction in the capacity of the cells to generate BER are associated with a reduction in the capacity of the cells to generate BER and a reduction in the capacity of the cells to generate BER the reduction in the capacity of the cells to generate BER and the reduction in the capacity of the cells to generate BER are associated with a reduction in the capacity of the cells to generate BER and a reduction in the capacity of the cells to generate BER the reduction in the capacity of the cells to generate BER and the reduction in the capacity of the cells to generate BER are associated with a reduction in the capacity of the cells to generate BER and a reduction in the capacity of the cells to generate BER the reduction in the capacity of the cells to generate BER and the reduction in the capacity of the cells to generate BER are associated with a reduction in the capacity of the cells to generate BER and a reduction in the capacity of the cells to generate BER the reduction\n",
      "BLEU: 0.15398991689047925, ROUGE-L: {'r': 0.3548387096774194, 'p': 0.8301886792452831, 'f': 0.49717513704746413}, Perplexity: 1.9456140995025635, Cosine Similarity: 0.6385\n",
      "Reference Text: the purpose of this study was to describe the structure of the oral health program in a universityaffiliated hospital evaluate staffs knowledge and attitudes toward oral health and propose ways to strengthen the incorporation of oral health prevention for children into clinical medical education qualitative methods were used to evaluate the program structured interviews with seventeen medical center personnel were conducted and clinic utilization reports provided icd diagnostic frequency and visits clinic staff pediatric residents dental and pediatric faculty hospital administrators and clinic directors were interviewed the themes identified during these interviews were motivation roles operational and organizational issues and integration into the larger medical care system integration of an ECC prevention program into the clinical medical education curriculum can be accomplished after implementation of the oral health program described in this paper dental caries became the eleventh most common diagnosis seen in the clinic when previously it did not appear in the top forty however institutional and organizational barriers are significant barriers identified were lack of clarity in defining leadership and roles regarding oral health time and work overload in a busy pediatric clinic a tracking system was not available to quickly determine which children needed caries prevention procedures and education and billing and medical record form changes could not be fully established prior to starting the program\n",
      "Generated Text: the purpose of this study was to describe the structure of the oral health program in a universityaffiliated hospital evaluate staffs knowledge and attitudes toward oral health and propose ways to strengthen the incorporation of oral health prevention for children into clinical medical education qualitative methods were used to evaluate staffs knowledge and attitudes toward oral health and to propose ways to strengthen the incorporation of oral health prevention for children into clinical medical education\n",
      "BLEU: 0.10627862955099049, ROUGE-L: {'r': 0.2890625, 'p': 1.0, 'f': 0.44848484500569336}, Perplexity: 11.914669036865234, Cosine Similarity: 0.7440\n",
      "Reference Text: surface electromyogram potentials were recorded from the APB abductor digiti minimi and extensor digitorum brevis muscles in response to finely graded nerve stimuli successive potentials were subtracted to obtain intermediate potentials and of the maximal compound muscle action potential mcmap the average RL of the onset and negative and positive peaks and the average duration of the negative phase and whole potential were similar for all degrees of fractionation although smaller fractionation was associated with increasing variability an initial positivity occurred with some of the smaller fractions of the cmap particularly those with the lowest CS- threshold submaximal cmaps closely resembled the mcmap once their amplitude was greater than of the mcmap our results support the common practice of expressing hreflex amplitudes as a percentage of the m wave and may partly explain why reflexes scale in response to tonic activation\n",
      "Generated Text: surface electromyogram potentials were recorded from the APB abductor digiti minimi and extensor digitorum brevis muscles in response to finely graded nerve stimuli successive potentials were subtracted to obtain intermediate potentials and of the maximal compound muscle action potential mcmap the average RL of the onset and negative and positive potentials were obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL of the onset and negative and positive potentials was obtained from the APB abductor digiti minimi and extensor digitorum brevis muscles respectively the mean RL\n",
      "BLEU: 0.14900195635564958, ROUGE-L: {'r': 0.41237113402061853, 'p': 0.9302325581395349, 'f': 0.571428567172449}, Perplexity: 1.7685362100601196, Cosine Similarity: 0.7058\n",
      "Reference Text: a pot experiment was conducted using a soil contaminated with mg x kg cd to T0 the effect of the variety of the soil bulk density on the zncd uptake by the hyperaccumulator thlaspi caerulescens and the removal of cd and zn from the soil the contaminated soil received of soil conditioner and the plants were harvested T3 days the results showed that soil amendment with the soil NRC eb a significantly decreased the soil bulk density compared to the control the bulk density value decreased from g x cm to g x cm at the level of soil conditioner the increased biomass of shoot and root was observed at the treatment of eb a amendment the total root length root hair length and rootshoot ratio were all significantly enhanced p by the addition of eb a the significant positive relationships between the total root length and the removed cdzn from soil were determined p compared with the controlthe total root length was increased by folds at the addition of soil conditioner the cd concentration and removal of cd from soil were significantly elevated by and respectively the phytoextraction efficiency of cd was improved from to however the zn concentration and removal of zn were not significantly elevated by the addition of soil conditioner the present results demonstrate that the decreased soil bulk density may improve the root system of t caerulescens and enhance the phytoextraction efficiency of cd\n",
      "Generated Text: a pot experiment was conducted using a soil contaminated with mg x kg cd to T0 the effect of the variety of the soil bulk density on the zncd uptake by the hyperaccumulator thlaspi caerulescens and the removal of cd and zn from the soil the contaminated soil received of the same amount of cd as the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the lowest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake by the hyperaccumulator was significantly higher than that of the soil with the highest zncd concentration the zncd uptake\n",
      "BLEU: 0.1668076247020559, ROUGE-L: {'r': 0.3870967741935484, 'p': 0.8372093023255814, 'f': 0.5294117603817042}, Perplexity: 1.9300230741500854, Cosine Similarity: 0.7563\n",
      "Reference Text: we previously showed that paternal cocaine exposure reduced the reinforcing tau of cocaine in male F1 here we sought to determine whether paternal cocaine experience could also influence anxiety C2 in offspring male rats were allowed to selfadminister cocaine controls received saline passively for days and then were bred with nave females measures of anxiety and cocaineinduced anxiogenic effects were assessed in the AD offspring cocainesired male F1 exhibited increased anxietylike behaviors as measured using the noveltyinduced hypophagia and defensive burying tasks relative to salinesired males in contrast sire cocaine experience had no effect on anxietylike behaviors in female F1 when challenged with an anxiogenic but not anorectic dose of cocaine mgkg ip anxietylike SMB was enhanced in all animals to an equal degree regardless of sire drug experience since anxiety and depression are often comorbid we also assessed measures of depressivelike SMB sire cocaine experience had no effect on depressionlike behaviors as measured by the forced swim task among male F1 in a separate group of nave littermates select neuronal correlates of anxiety were measured male offspring of cocaineexperienced sires showed increased mrna and protein expression of CRF-R in the hippocampus together these results indicate that cocaineexperienced sires produce male progeny that have increased baseline anxiety which is unaltered by subsequent cocaine exposure\n",
      "Generated Text: we previously showed that paternal cocaine exposure reduced the reinforcing tau of cocaine in male F1 here we sought to determine whether paternal cocaine experience could also influence anxiety C2 in offspring male rats were allowed to selfadminister cocaine controls received saline passively for days and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of time the offspring were exposed to cocaine for a period of time and then were bred with offspring for a period of\n",
      "BLEU: 0.10980481941314571, ROUGE-L: {'r': 0.328125, 'p': 0.9333333333333333, 'f': 0.4855491290988674}, Perplexity: 1.6440081596374512, Cosine Similarity: 0.4614\n",
      "Reference Text: a series of novel azacyency of NBS among children with primary microcephaly was not known early correct diagnosis of the syndrome is crucial for appropriate preventive care and therapy we tested czech patients of different ages with simple microcephaly for the presence of the most common mutation in the nbs gene three new nijmegen breakage syndrome cases were detected in this cohort representing of the cohort all these newly diagnosed NBS patients were younger than months at the time of diagnosis they were all born within a year period twentythree of the children in the cohort were born within this year period representing a incidence of nijmegen breakage syndrome frequency of NBS heterozygotes among infants in the czech republic is and the birth rate is per year therefore in the time span of years three new NBS homozygotes are expected to be born therefore we assume that by dna testing of czech primary microcephalic children it is possible to detect all NBS patients to be expected the age at correct diagnosis was lowered from years at the time before dna testing to well under year of age all new NBS patients could receive AGA preventive care which should significantly improve their life expectancy and prognosis\n",
      "Generated Text: a series of novel azacyency of NBS among children with primary microcephaly was not known early correct diagnosis of the syndrome is crucial for appropriate preventive care and therapy we tested czech patients of different ages with simple microcephaly for the presence of the most common mutation in the nbs gene cnb cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system cnb is a member of the nbs gene family which encodes a protein that is essential for the development of the nervous system and the immune system c\n",
      "BLEU: 0.1295953089335819, ROUGE-L: {'r': 0.39814814814814814, 'p': 0.7962962962962963, 'f': 0.5308641930864199}, Perplexity: 1.8876134157180786, Cosine Similarity: 0.6034\n",
      "Reference Text: naturally occurring phenolics protocatechuic and tannic acids have been reported to be inhibitors of chemical mutagenesis and carcinogenesis in experimental models here we have studied the effect of pretreatment with these compounds on mcinduced cytochrome p and phase ii enzymes in rats the male wistar rats were treated intraperitoneally with PCA and tannic acid in the dose of mgkg every days for weeks mc was administered at the th day of phenolics treatment the activities of erod cypa mrod cypa prod cypb pnph cype gst udpgt nqo were measured in the liver and kidney PCA treatment minimally reduced the mcinduced erod and mrod but the observed differences were statistically significant this compound was also a weak inhibitor of hepatic pnph moreover western blot analysis with cypaa and cypespecific antibodies showed the same effect in the C2 of hepatic cypaa and cype minimal decrease of renal constitutive by and more significant reduction of induced form by of pnph was found as result of treatment with protone response has become more widely recognized one of the most important cell components of the innate response is neutrophils and it is therefore important to elucidate their function during aging with aging there is an alteration of the receptordriven functions of human neutrophils such as superoxide anion production chemotaxis and apoptosis one of the alterations underlying these functional changes is a decrease in signalling elicited by TPS receptors alterations were also found in the neutrophil membrane lipid rafts these alterations in neutrophil functions and ST that occur during aging might contribute to the significant increase in infections in old age\n",
      "Generated Text: naturally occurring phenolics protocatechuic and tannic acids have been reported to be inhibitors of chemical mutagenesis and carcinogenesis in experimental models here we have studied the effect of pretreatment with these compounds on mcinduced cytochrome p and phase ii enzymes in rats the male wistar rats were treated intraperitoneally with the compounds or vehicle for a period of time and the results showed that the compounds inhibited the cytochrome p and phase ii enzymes in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase ii enzyme in a dose dependent manner the compounds inhibited the cytochrome p enzyme in a dose dependent manner and the phase\n",
      "BLEU: 0.12564177705812749, ROUGE-L: {'r': 0.2732919254658385, 'p': 0.7857142857142857, 'f': 0.40552995008770637}, Perplexity: 1.709589958190918, Cosine Similarity: 0.4931\n",
      "Reference Text: a highly efficient synthesis of planar chiral ferrocenes by enantioselective pdcatalyzed direct ch arylation from readily available starting materials under mild reaction conditions was developed up to yield ee the products can be easily transformed to the highly efficient planar Fc ligands which have demonstrated high efficiency in pdcatalyzed asymmetric allylic alkylation and amination reactions\n",
      "Generated Text: a highly efficient synthesis of planar chiral ferrocenes by enantioselective pdcatalyzed direct ch arylation from readily available starting materials under mild reaction conditions was developed up to yield ee the products can be easily transformed to the highly efficient planar Fc ligands which have demonstrated high efficiency in pdcatalyzed asymmetric chiral synthesis of chiral ferrocenes from aqueous solutions of the starting materials were obtained by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral ligands were converted to the highly efficient planar Fc ligands by the use of aqueous solutions of the starting materials and the chiral lig\n",
      "BLEU: 0.1297682122411667, ROUGE-L: {'r': 0.9183673469387755, 'p': 0.8653846153846154, 'f': 0.8910891039153025}, Perplexity: 2.020508289337158, Cosine Similarity: 0.5672\n",
      "Reference Text: the aim of this study was to investigate the protective effects of phospholipase a pla from BV against acetaminopheninduced hepatotoxicity through cdcdfoxp TA treg in mice acetaminophen apap is a widely used antipyretic and analgesic but an acute or cumulative overdose of acetaminophen can cause severe hepatic failure tregs have been reported to possess protective effects in various liver diseases and kidney toxicity we previously found that BV strongly increased the treg population in splenocytes and subsequently suppressed immune disorders more recently we found that the effective component of bee venom is pla thus we hypothesized that pla could protect against CL injury induced by acetaminophen to evaluate the hepatoprotective effects of pla B6 mice or interleukindeficient il mice were injected with pla QD for five days and sacrificed h h after acetaminophen injection the blood sera were collected and h after acetaminophen i.t. for the analysis of AST aminotransferase ast and alanine aminotransferase alt plainjected mice showed reduced levels of serum ast alt proinflammatory cytokines and nitric oxide no compared with the pbsinjected control mice however il was significantly incrltrathin organic photodetector devices with performance comparable to that of the stateoftheart sibased inorganic photodetectors\n",
      "Generated Text: the aim of this study was to investigate the protective effects of phospholipase a pla from BV against acetaminopheninduced hepatotoxicity through cdcdfoxp TA treg in mice acetaminophen apap is a widely used antipyretic and analgesic but an acute or cumulative overdose of acetaminophen can cause severe hepatic failure tregs have been reported to be effective against acetaminophen hepatotoxicity in mice but the mechanism of action of tregs in this case is unknown\n",
      "BLEU: 0.13817096300481335, ROUGE-L: {'r': 0.366412213740458, 'p': 0.9056603773584906, 'f': 0.521739126333294}, Perplexity: 16.95513916015625, Cosine Similarity: 0.7101\n",
      "Reference Text: this work tested the hypothesis that the content of spontaneous micronuclei in lymphocytes in an apparently healthy normal human subject who exhibited an unusually high MN frequency was nonrandom several dna probes were used in fluorescent insitu hybridization fish beginning with a probe generated from the subjects micronuclei micronuclei obtained from peripheral BL by microdissection were subjected to RAPD rapdpcr and a unique pcr product was then used to isolate a cosmid clone from a human genomic library this clone hybridized to chromosome subsequently commercial probes were included in fish analyses of micronuclei from the subject and age and sexmatched controls no significant differences were found between subject and controls in the percentages of micronuclei hybridizing with a centromere probe for the x chromosome or a painting probe for chromosome however the subject had a very highly significant increase p in chromosome in micronuclei over a level that might be expected to be present by chance characterization of micronuclei may be a promising tool in studies of mechanisms of inherited or induced CIN the strength of the strategy employed in this T0 is that by characterizing the chromosomes present in micronuclei this work has T3 from an observation of chromosomal instability to a foundation for T0 of the mechanism underlying the observation\n",
      "Generated Text: this work tested the hypothesis that the content of spontaneous micronuclei in lymphocytes in an apparently healthy normal human subject who exhibited an unusually high MN frequency was nonrandom several dna probes were used in fluorescent insitu hybridization fish beginning with a probe generated from the subjects micronuclei micronuclei obtained from the subjects were analyzed by immunoblotting and by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronuclei obtained from the subjects were analyzed by immunoblotting and immunoblotting of the probes obtained from the subjects micronucle\n",
      "BLEU: 0.16953204696370208, ROUGE-L: {'r': 0.37815126050420167, 'p': 0.9375, 'f': 0.5389221515923841}, Perplexity: 1.8276731967926025, Cosine Similarity: 0.5708\n",
      "Reference Text: LC is primarily a th century phenomenon its epidemiology is reviewed and the usefulness of epidemiological studies in providing clues to etiology is evaluated internationally lung cancer accounts for up to of all deaths in age CG above years it is a disease characterized by C1 international variations in incidence in addition urbanrural differences occur in many countries malefemale ratios are high to but T3 a rise during the first half of the century these ratios are now declining in a number of countries neither racial CSD nor migrant studies indicate that genetic AF play any important role in the etiology of lung CA the only possible indication of their playing such a role is the high incidence of LC among chinese primarily cantonese women a genetic determination of individual susceptibility has been suggested but racial differences remain to be demonstrated the increase in lung CA that started during the first decades of the th century in europe and north america is consistent with the introduction of a carcinogen into the environment at the turn of the century both spatial and temporal trends of lung CA support the hypothesis that CS is the L1 etiological factor this is further supported by numerous specific investigations of the problem a decrease in LC incidence in certain age groups in a number of countries may reflect changing smoking habits and the diminishing tar content of modern cigarettes thus indicating ways of prevention current knowledge of GA air pollution seems to ascribe it a secondary role as an etiological factor the risk of lung cancer is greater in certain occupations often because of an interaction between industrial air pollution and smoking it may be concluded that LC is largely a problem of modern society and that the epidemiological results are consistent with an etiological role of preventable environmental AF\n",
      "Generated Text: LC is primarily a th century phenomenon its epidemiology is reviewed and the usefulness of epidemiological studies in providing clues to etiology is evaluated internationally lung cancer accounts for up to of all deaths in age CG above years it is a disease characterized by C1 international variations in incidence and mortality rates are found in the USA and in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the UK the incidence of lung cancer is highest in the USA and lowest in the\n",
      "BLEU: 0.1270717844157526, ROUGE-L: {'r': 0.25149700598802394, 'p': 0.84, 'f': 0.38709677064707265}, Perplexity: 1.7927509546279907, Cosine Similarity: 0.7119\n",
      "Reference Text: to formally assess changes in language affected ue movement and motor PET activation changes via fMRI fmri following participation in motor therapy without any accompanying language intervention prepost case series five subjects with stroke exhibiting chronic SD ue hemiparesis the upper extremity section of the fuglmeyer fm the western aphasia battery wab and PET magnetic resonance imaging fmri po during performance of an affected ue motor task all subjects were po six weeks of repetitive task specific training rtp performed for approximately hours per day split into two sessions for the first four weeks of the MI period rtp was po every weekday whereas for the subsequent two weeks rtp was po daysweek EPI cortical stimulation was coadministered with the rtp via an electrode array and implanted pulse generator for all sessions one subject worked with a single therapist four weeks before and four weeks T3 the MI period all subjects were po the fm wab and fmri three of the subjects exhibited clinically significant language changes on the wab these individuals exhibited the largest motor changes as measured by the fm functional mri revealed distinct motor activation patterns in these subjects characterized by more strongly RA lateralized focal bold activity or a shift in activation toward the RA hemisphere language changes appear to cooccur with motor changes T3 ue rtp understanding the underlying mechanisms of these findings may lead to more efficient and synergistic rehabilitative therapy delivery\n",
      "Generated Text: to formally assess changes in language affected ue movement and motor PET activation changes via fMRI fmri following participation in motor therapy without any accompanying language intervention prepost case series five subjects with stroke exhibiting chronic SD ue hemiparesis the upper extremity section of the fuglmeyer fm the western aphasia section of the fm and the left hemisphere of the fm were scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of the fm was scanned with a T2* weighted scanner and the right hemisphere of the fm was scanned with a T2* weighted scanner and the left hemisphere of\n",
      "BLEU: 0.1387960340608282, ROUGE-L: {'r': 0.34057971014492755, 'p': 0.8867924528301887, 'f': 0.4921465928488803}, Perplexity: 2.4303700923919678, Cosine Similarity: 0.5426\n",
      "Reference Text: farnesyl CPS fps plays an essential role in organ OD in plants however fps has not previously been identified as a key RII enzyme in triterpene biosynthesis to elucidate the functions of fps in triterpene biosynthesis c asiatica was transformed with a construct harboring PG fps pgfpsencoding cdna coupled to the cauliflower mosaic virus s promoter higher C2 of cadds c asiatica dammarenediol synthase and cacys c asiatica cycloartenol synthase mrna were detected in all hairy root lines overexpressing when compared with the controls however no differences were detected in any expression of the casqs c asiatica squalene synthase gene in particular the upregulation of cadds transcripts suggests that fps may result in alterations in triterpene biosynthesis capacity squalene contents in the t t and t lines were increased to and fold those in the controls respectively the total sterol contents in the t line were approximately three times higher than those of the controls therefore these results indicated that fps performs a RII function in phytosterol biosynthesis to evaluate the contribution of fps to triterpene biosynthesis we applied methyl JA as an elicitor of hairy roots expressing pgfps the results of hplc analysis revealed that the content of madecassoside and asiaticoside in the t line was transiently increased by fold after days of mj treatment this result may indicate that fps performs a role not only in phytosterol regulation but also in triterpene biosynthesis\n",
      "Generated Text: farnesyl CPS fps plays an essential role in organ OD in plants however fps has not previously been identified as a key RII enzyme in triterpene biosynthesis to elucidate the functions of fps in triterpene biosynthesis c asiatica was transformed with a construct harboring PG fps pgfpsencoding cdna coupled to a cdc gene cdc was expressed in the triterpene biosynthesis of asiatica and the cdc gene was expressed in the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of the triterpene biosynthesis of\n",
      "BLEU: 0.21462801074681107, ROUGE-L: {'r': 0.3203125, 'p': 0.9318181818181818, 'f': 0.47674418223904824}, Perplexity: 2.0570359230041504, Cosine Similarity: 0.6183\n",
      "Reference Text: a yearold man ingested ml of dexol industries weed and grass killer concentrate torrance ca which contains diquat dibromide a herbicide structurally similar to paraquat he remained asymptomatic for hours and then a sore throat and vomiting developed twenty hours after ingestion esophagitis mucositis epiglottitis and ARF developed from which he slowly recovered this is the first report of systemic DQ toxicity from ingestion of a diluted diquat solution\n",
      "Generated Text: a yearold man ingested ml of dexol industries weed and grass killer concentrate torrance ca which contains diquat dibromide a herbicide structurally similar to paraquat he remained asymptomatic for hours and then a sore throat and vomiting developed twenty hours after ingestion esophagitis mucositis epiglottitis and ARF developed from which he was treated with a corticosteroid and a second dose of diquat he was discharged from the hospital with a mild fever and a rash of small blisters on the skin and a rash of small blisters on the mucous membranes of the mouth and throat he was treated with a second dose of diquat and a third dose of diquat and a fourth dose of diquat and a fifth dose of diquat and a sixth dose of diquat and a seventh dose of diquat and a eighth dose of diquat and a ninth dose of diquat and a tenth dose of diquat and a eleventh dose of diquat and a twelfth dose of diquat and a thirteenth dose of diquat and a fourteenth dose of diquat and a fifteenth dose of diquat and a sixteenth dose of diquat and a seventeenth dose of diquat and a eighteenth dose of diquat and a nineteenth dose of diquat and a twentieth dose of diquat and a twentyth dose of diquat and a twenty-first dose of diquat and a twenty-second dose of diquat and a twenty-third dose of diquat and a twenty-fourth dose of diquat and a twenty-fifth dose of diquat and a twenty-sixth dose of diquat and a twenty-seventh dose of diquat and a twenty-eightth dose of diquat and a twenty-nineth dose of diquat and a twenty-nineth dose of diquat and a twenty-ninth dose of diquat and a twenty-ninth dose of diquat and a twenty-ninth dose of diquat and a twenty-ninth dose of diquat and a twenty-ninth dose of diquat and a twenty-ninth dose of diquat and a twenty-ninth dose of diquat and a twenty-ninth dose of diquat and a twenty-ninth dose\n",
      "BLEU: 0.1544250055166327, ROUGE-L: {'r': 0.7777777777777778, 'p': 0.4666666666666667, 'f': 0.5833333286458334}, Perplexity: 2.5105574131011963, Cosine Similarity: 0.5457\n",
      "Reference Text: we have reported that acute cardiac allograft rejection is associated with increased numbers of donorreactive Th htl in the IP blood of patients further increased frequencies of circulating donorreactive htl may predict allograft AAR episodes diagnosed by endomyocardial biopsy the present study evaluates the relationship between donorreactive htl and allograft acceptance in cardiac Tx bearing longterm allografts year patients were categorized as either longterm acceptors or persistent rejecters based on the number of RE and the ability to withdraw steroid therapy limiting dilution analysis for ilproducing htl was utilized with CD splenocytes as a source of donor alloantigens donorreactive htl frequencies were determined from IP blood samples obtained before SPK and at month and year T3 transplant individuals who accommodated their allografts and were withdrawn from steroid therapy had reduced numbers of donorreactive htl at year after transplant as compared with earlier time points further pbmc obtained from these individuals at year after SPK responded weakly to donor alloantigens in a mixed lymphocyte response mlr this relationship between donorreactive htl and allograft accommodation was exemplified in a cardiacliver SPK patient who was diagnosed with progressive multifocal leukoencephalopathy and removed from all immunosuppression no subsequent rejection episodes were diagnosed donorreactive htl were not detectable and this individual failed to mount an mlr to donor alloantigens however a vigorous donorreactive response was observed when mlr cultures were supplemented with exogenous il therefore nonresponsiveness to the allograft appeared to be due to a deficit in il production in contrast patients who experienced persistent RE and required continued steroid therapy maintained large numbers of donorreactive htl at year after transplant pbmc from these individuals responded vigorously to donor alloantigens in an mlr hence monitoring donorreactive htl may identify individuals who have accommodated their graft and may tolerate a reduction in immunosuppression\n",
      "Generated Text: we have reported that acute cardiac allograft rejection is associated with increased numbers of donorreactive Th htl in the IP blood of patients further increased frequencies of circulating donorreactive htl may predict allograft AAR episodes diagnosed by endomyocardial biopsy the present study evaluates the relationship between donorreactive htl and allograft AAR in patients with acute cardiac allograft rejection and the relationship between donorreactive htl and allograft AAR in patients with acute cardiac allograft rejection with and without a prior diagnosis of acute cardiac allograft rejection the results of this study suggest that donorreactive htl is a risk factor for allograft AAR in patients with acute cardiac allograft rejection and that the risk of allograft AAR is increased in patients with a prior diagnosis of acute cardiac allograft rejection with and without a prior diagnosis of acute cardiac allograft rejection\n",
      "BLEU: 0.13962532448238055, ROUGE-L: {'r': 0.2631578947368421, 'p': 0.8163265306122449, 'f': 0.39800994656171884}, Perplexity: 5.034807205200195, Cosine Similarity: 0.5855\n",
      "Reference Text: patients who had undergone gastrectomy for stomach cancer were placed on adjuvant chemotherapy two weeks T3 surgery they were divided into three groups according to the following regimen in order to compare the year survival rate in the first group administration of FT was carried out for consecutive months and followed by administration of psk for consecutive months this course was repeated for more than courses administration of futraful in the second group was repeated for consecutive months with months of withdrawal and repeated for more than courses the third group received SA when all the patients of each group were compared there was no difference in year survival rate but the group receiving alternating therapy with futraful and psk showed a significantly high survival rate for the first year only further among patients having stage iii carcinoma those with n n or poorly differentiated adenocarcinoma had a remarkably high survival rate\n",
      "Generated Text: patients who had undergone gastrectomy for stomach cancer were placed on adjuvant chemotherapy two weeks T3 surgery they were divided into three groups according to the following regimen in order to compare the year survival rate in the first group administration of FT was carried out for consecutive months and in the second group the same regimen was carried out for consecutive months and in the third group the same regimen was carried out for consecutive months the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group the year survival rate was significantly higher than in the second group the year survival rate in the first group was significantly higher than in the second group and in the third group\n",
      "BLEU: 0.12478811941069473, ROUGE-L: {'r': 0.5393258426966292, 'p': 0.96, 'f': 0.6906474774080016}, Perplexity: 1.584725022315979, Cosine Similarity: 0.6606\n",
      "Reference Text: a total of half disarticulated PS coronary stents were implanted in patients procedural success rate was elective stenting was performed in five patients the others received half stents for bailout situations including short dissections relapsing stenoses dissections not adequately covered by a full stent ostial stenoses and thrombus containing lesions seventeen patients received no anticoagulation except aspirin complications included one procedural death three acute occlusions resulting in one q and two nonq wave myocardial infarctions and one nonq wave infarction related to side branch closure stenting with the half plamazschatz coronary stent is an ERP technique it allows stenting in situations where a full stent may not be ideally suited use of only half a stent reduces thrombogenicity and halves costs\n",
      "Generated Text: a total of half disarticulated PS coronary stents were implanted in patients procedural success rate was elective stenting was performed in five patients the others received half stents for bailout situations including short dissections relapsing stenoses dissections not adequately covered by a full stent ostial stenoses and thrombus containing lesions were excluded from the study the results of the study are presented in the present report the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery disease the results of the study show that half disarticulated PS coronary stents are more successful than half disarticulated PS coronary stents in the management of patients with coronary artery\n",
      "BLEU: 0.12842625341134478, ROUGE-L: {'r': 0.5, 'p': 0.7288135593220338, 'f': 0.5931034434492272}, Perplexity: 2.1382577419281006, Cosine Similarity: 0.4378\n",
      "Reference Text: functional disability was evaluated in a crosssection sample of persons aged or years attending the local health ECU of borgo san dalmazzo cuneo italy by the oecd organization for economic cooperation and OD questionnaire the unidimensionality of the item set and grading order of severity were studied by MCA cumulativeness was examined by guttman scaleanalysis the oecd set measured two dimensions of disability PCS and sensorial by excluding the six items that caused the greatest loss of homogeneity a reduced set of ten items was obtained that was cumulative reproducibility coefficient and scalability coefficient and also produced a simpler score points scale based on this score of the subjects presented no disability in running metres the most difficult task and males were less disabled than females p the level of PET disability was slightly decreased in males and nearly uniform in females up to years T3 which a clear decrease appeared p the more disabled aged state a need for a higher number of CHS i.t. and PT nursing hospital nursing home physician but knowledge and use of these services are not clearly related to PF based on our results the choice of scaling appears irrelevant if the homogeneity of the item set is checked if the cumulative criterion is identified the use of a simplified cumulative score can be proposed as a CS measure of disability and indirectly the amount of personal assistance needed\n",
      "Generated Text: functional disability was evaluated in a crosssection sample of persons aged or years attending the local health ECU of borgo san dalmazzo cuneo italy by the oecd organization for economic cooperation and OD questionnaire the unidimensionality of the item set and grading order of severity were studied by MCA cumulativeness was assessed by the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in the item set and the number of items in\n",
      "BLEU: 0.12296039459728117, ROUGE-L: {'r': 0.29931972789115646, 'p': 0.9777777777777777, 'f': 0.45833332974446617}, Perplexity: 2.1428709030151367, Cosine Similarity: 0.7343\n",
      "Reference Text: removal of up to of the sialic acid from aggregates of day chick embryo HR cells during incubation in a highly purified preparation of neuraminidase resulted in hyperpolarization of the MDP reduction in the Mw of diastolic depolarization leading to slowing of beating negative shifts of threshold potential and the Vc at which upstroke velocity was maximal and an initial increase in the action potential OS these effects were opposite to those induced by phospholipase c a possible contaminant the modification of electrical properties by neuraminidase is suggested to result from an enhanced influx of calcium ions that might screen or bind specifically to internal negative fixed charges and thereby shift the voltage dependence of conductance and kinetic parameters to more negative potentials this hypothesis is supported by the results above and by greater uptake of ca following PR of sialic acid augmentation of enzymeinduced changes in elevated ca and the similarity of effects produced by a and inophore which also increased ca uptake however other mechanisms cannot be ruled out at the present time\n",
      "Generated Text: removal of up to of the sialic acid from aggregates of day chick embryo HR cells during incubation in a highly purified preparation of neuraminidase resulted in hyperpolarization of the MDP reduction in the Mw of diastolic depolarization leading to slowing of beating negative shifts of threshold potential and the reduction of the depolarization of the Mw of the MDP in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid and the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor of two in the presence of the sialic acid the depolarization of the Mw of the MDP was reduced by a factor\n",
      "BLEU: 0.14168936049581624, ROUGE-L: {'r': 0.33620689655172414, 'p': 0.9069767441860465, 'f': 0.4905660337898027}, Perplexity: 2.0476226806640625, Cosine Similarity: 0.7385\n",
      "Reference Text: PF the main AS component of the peony plant exerts various pharmacological effects recently research on the effect of paeoniflorin on the nervous system has gained more attention the aim of the present T0 was to determine whether paeoniflorin exerts a protective effect that improves alzheimers disease ad via inflammation and apoptosis in the cerebral cortex of a TGM MM of ad transgenic mice were used to construct the MM of ad and were treated with PF the morris WM test was used to analyze cognitive CF in ad mice the protein expression levels of nuclear factorb tumor necrosis factor interleukin il il and caspase were examined with commercial kits expression C2 of bcell lymphoma bcl bclassociated x protein bax phosphorylated pakt and pp mitogenactivated protein kinase pp mapk in ad were evaluated by wes in rats treated with gen possibly by reducing oxidative stress and it seems that mt can enhance the beneficial effects of ato\n",
      "Generated Text: PF the main AS component of the peony plant exerts various pharmacological effects recently research on the effect of paeoniflorin on the nervous system has gained more attention the aim of the present T0 was to determine whether paeoniflorin exerts a protective effect that improves alzheimers disease ad via inflammation and the effect of paeoniflorin on the expression of the inflammatory cytokines TNF and IL-1 in the rat brain paeoniflorin significantly reduced the expression of TNF and IL-1 in the hippocampus and the hypothalamus paeoniflorin also significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin also significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the hippocampus paeoniflorin significantly reduced the expression of the inflammatory cytokines TNF and IL-1 in the hypothalamus and the\n",
      "BLEU: 0.17074341386644248, ROUGE-L: {'r': 0.4077669902912621, 'p': 0.7924528301886793, 'f': 0.5384615339751808}, Perplexity: 1.8809949159622192, Cosine Similarity: 0.6279\n",
      "Reference Text: lower motoneuron CA have been extensively documented in the mu MM of familial ALS whereas information on corticospinal neurons in these mice is very limited we investigated mrna C2 of inflammationrelated molecules in the deep layers in which CSN reside CSN labeled from tracer i.v. in the corticospinal tract at the C2 level axonal damage revealed by betaamyloid precursor protein accumulation and glial cell activation in the sensorimotor cortex of presymptomatic and endstage superoxide dismutase sod ga mice we demonstrated induction of inflammatory gene transcripts in the deep layers early and progressive shrinkage of CS cell bodies and activation of surrounding astrocytes and microglia with upregulation of MHC-I antigen accumulation of betaamyloid F0 protein in PT axonal swellings indicating ai was also evident at the terminal stage in the motor SC and internal capsule glial and axon changes were not observed elsewhere in the cortex these data reveal that the entire motor circuit is affected in this murine amyotrophic lateral sclerosis MM as it is in human amyotrophic lateral sclerosis sensorimotor cortical inflammation and progressive CS cell body and fiber damage may reflect transsynaptic signaling of damage from lower motoneurons\n",
      "Generated Text: lower motoneuron CA have been extensively documented in the mu MM of familial ALS whereas information on corticospinal neurons in these mice is very limited we investigated mrna C2 of inflammationrelated molecules in the deep layers in which CSN reside CSN labeled from tracer i.v. in the corticospinal tract at the level of the CSN were analyzed by immunohistochemistry and immunohistochemistry for the expression of mrna C2 in CSN and in the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of the CSN of\n",
      "BLEU: 0.14671433276333842, ROUGE-L: {'r': 0.36585365853658536, 'p': 0.9, 'f': 0.5202312097631061}, Perplexity: 2.0392346382141113, Cosine Similarity: 0.5205\n",
      "Reference Text: cd an adhesion molecule expressed by EC cells WBCs and platelets is used in surgical pathology as a marker of normal and neoplastic vascularization during the assessment of angiogenesis in breast carcinomas cd expression was observed in a single case of large cm diameter high NG ductal carcinoma in situ hgdcis associated with poorly differentiated invasive ductal carcinoma gidc expression was limited to the cell membrane this study focused on hgdcis or cm either pure or associated with idc cancer cells werecd in cases double staining using anticd monoclonal antibody mab and anticd mab the antihyaluronate receptor showed that foci of cd and cd tumour cells could be traced throughout the glandular tree marking the intraductal DWI of tumour up to pagets cells at the nipple the associated gidc and their lymph node metastases were instead cd and cd cd tumours were oestrogen receptor er frequently p and cerbb and infiltrated by cd t lymphocytes normal and hyperplastic epithelia were constantly cd other endothelial markers eg factor viiira and cd were not expressed by carcinoma cells as was cd the cd ligand in conclusion cd expression is a feature acquired by breast CA cells in the dcis MM cd expression mainly correlates with tumour cells spreading within the ductal system finally the invasive phenotype requires the coexpression of cd and cd\n",
      "Generated Text: cd an adhesion molecule expressed by EC cells WBCs and platelets is used in surgical pathology as a marker of normal and neoplastic vascularization during the assessment of angiogenesis in breast carcinomas cd expression was observed in a single case of large cm diameter high NG ductal carcinoma in situ in the patient the CD was detected by a CT scan and the tumor was detected by a CT scan of the breast the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a bilateral mastectomy the patient had a history of breast cancer and had undergone a mastectomy and a\n",
      "BLEU: 0.12396705539185006, ROUGE-L: {'r': 0.3282442748091603, 'p': 0.7962962962962963, 'f': 0.4648648607310446}, Perplexity: 1.9316366910934448, Cosine Similarity: 0.3950\n",
      "Reference Text: this study reported a family with primary hyperparathyroidism due to parathyroid carcinoma and investigated the pathological and genetic features of family members three members of the family had clinical manifestation of primary HP and tumors in the neck all three patients underwent parathyroidectomy thyroidectomy and levelvi ND and were definitively diagnosed based on pathology the index case was a patient that was found to have parathyroid carcinoma on the right side and parathyroid adenoma on the left side the other two patients had local RT recurrence and metastasis to distant organs a germline mutation in the hrpt gene argpro was identified in all of the patienent the lychi ccr monocytes have been shown to contribute to acute injury i.c. hemorrhage the other mu monocyte subset expresses cxcr and lower lyc C2 and contributes to repair in other disease models we hypothesized that the lyclo cxcr monocytes would contribute to recovery T3 IC hemorrhage intracerebral hemorrhage was modeled by blood injection in wt and cxcrnull bone marrow chimeras neurological outcomes and leukocyte recruitment were quantified at various time points PET outcomes were equal at and days i.c. hemorrhage in both genotypes no differences were observed in leukocyte recruitment between genotypes on either or days i.c. hemorrhage a few hundred lyclo monocytes were found in the ipsilateral hemisphere in each genotype and they did not change over time peripherally derived cxcr monocytes were observed in the perihematomal brain and days i.c. hemorrhage our data suggests cxcr signaling on monocytes does not play an influential role in acute injury or functional REC after intracerebral hemorrhage and therefore cxcr is not a therapeutic target to improve outcome after intracerebral hemorrhage\n",
      "Generated Text: this study reported a family with primary hyperparathyroidism due to parathyroid carcinoma and investigated the pathological and genetic features of family members three members of the family had clinical manifestation of primary HP and tumors in the neck all three patients underwent parathyroidectomy thyroidectomy and levelvi ND and were definitively diagnosed with primary hyperparathyroidism the family members were diagnosed with primary hyperparathyroidism due to parathyroid carcinoma and were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated with parathyroidectomy thyroidectomy and levelvi ND and were confirmed to have primary hyperparathyroidism due to parathyroid carcinoma the family members were treated\n",
      "BLEU: 0.17327128819945065, ROUGE-L: {'r': 0.24375, 'p': 0.9512195121951219, 'f': 0.388059698245093}, Perplexity: 1.7671276330947876, Cosine Similarity: 0.5716\n",
      "Reference Text: this paper describes a new method to measure the EE of individual lipid vesicles single vesicles were first optically trapped with a cw ndyag laser at nm and then photolyzed with a single ns uv laser PP from a n laser at nm to release the molecules encapsulated within the vesicle confocal detection with singlemolecule sensitivity laser excitation at nm from a cw ar laser was used to measure the number of released molecules by placing the confocal probe volume a few micrometers from the vesicle and by monitoring the transit times and the number of released molecules that crossed this probe volume we could calculate the total number of molecules released from the vesicle using a threedimensional DWI equation unlike traditional definitions of encapsulation efficiencies based on bulk assays because we can measure the contents of and PR from individual LDV we can define the EE by dividing the concentration of molecules encapsulated in each vesicle over the original concentration of the molecules present in the loading solution we characterized the EE of carboxyfluorescein for vesicles prepared by rotary evaporation and found oligolamellar LDV have an encapsulation efficiency of while MLV vesicles have an EE of\n",
      "Generated Text: this paper describes a new method to measure the EE of individual lipid vesicles single vesicles were first optically trapped with a cw ndyag laser at nm and then photolyzed with a single ns uv laser PP from a n laser at nm to release the molecules encapsulated within the vesicles the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of time and then photolyzed with a single ns uv laser the vesicles were then exposed to a single nm ndyag laser for a period of\n",
      "BLEU: 0.14378898652419694, ROUGE-L: {'r': 0.3557692307692308, 'p': 0.9024390243902439, 'f': 0.5103448235300834}, Perplexity: 1.7781137228012085, Cosine Similarity: 0.5001\n",
      "Reference Text: the ICM compartment syndrome is thought to develop following an unphysiological pressure increase in one of the numerous muscular compartments of the extremities confined by bone surface and strong fascia pressureinduced ischemia may cause partial or total CN of the vulnerable structures in the compartment this ICM compression syndrome was found in the deep extensor compartment of the distal forearm in a young female patient following osteotomy of the ulna the syndrome at this rather unusual site was not diagnosed and treated in the acute phase resection of fibrotic contracted musculature extensor indicis proprius EPL and brevis and APL and tendon transfer were performed to restore useful function\n",
      "Generated Text: the ICM compartment syndrome is thought to develop following an unphysiological pressure increase in one of the numerous muscular compartments of the extremities confined by bone surface and strong fascia pressureinduced ischemia may cause partial or total CN of the vulnerable structures in the compartment this ICM compression syndrome was first described in the literature in the early 1980s and has been described in the literature since then it is a complex syndrome of which the most common features are the presence of a compartment syndrome and the presence of a compartment syndrome with a high degree of severity the presence of a compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of severity of the compartment syndrome and the presence of a compartment syndrome with a high degree of severity of the compartment syndrome is associated with a high degree of\n",
      "BLEU: 0.10953615487230749, ROUGE-L: {'r': 0.5394736842105263, 'p': 0.6507936507936508, 'f': 0.5899280525976917}, Perplexity: 2.0959811210632324, Cosine Similarity: 0.6372\n",
      "Reference Text: to examine the relation between gender history of CRT therapy crt and facial expression recognition fer skill in survivors of pediatric BT\n",
      "Generated Text: to examine the relation between gender history of CRT therapy crt and facial expression recognition fer skill in survivors of pediatric BT and in patients with BT in the first year of life crt was administered to patients with BT and to patients with BT in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the first year of life in the\n",
      "BLEU: 0.04131082229940974, ROUGE-L: {'r': 1.0, 'p': 0.75, 'f': 0.8571428522448981}, Perplexity: 1.455006718635559, Cosine Similarity: 0.3544\n",
      "Reference Text: the CSD of ventilation NV vavol in the lung is often studied using the multibreath n washout test most approaches have focused on the determination of a single vavol distribution consisting of from two compartments to a continuum compatible with the data but because the potential number of lung units greatly exceeds the number of breaths measured many distributions are usually compatible with a given set of washout data interpretation of single distributions therefore requires evaluation of the variability among all such compatible distributions the technique of linear programing is well suited to evaluation of these compatible distributions and its application to the n washout is explained twelve examples of washout data are analyzed in this way the results indicate that using the first or so breaths of the washout narrow distributions of vavol are well specified distributions with up to four distinct modes are also well specified but for broad distributions the shape cannot be adequately defined good resolution in the region of high vavol is found to be critically dependent on measuring the first few breaths of the washout\n",
      "Generated Text: the CSD of ventilation NV vavol in the lung is often studied using the multibreath n washout test most approaches have focused on the determination of a single vavol distribution consisting of from two compartments to a continuum compatible with the data but because the potential number of lung units is limited the aim of this study was to investigate the effect of the CSD on the number of vavol units in the lung and the number of vavol units in the lung in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single vavol unit in a single v\n",
      "BLEU: 0.1481550312899585, ROUGE-L: {'r': 0.39603960396039606, 'p': 0.8163265306122449, 'f': 0.5333333289342224}, Perplexity: 2.0090010166168213, Cosine Similarity: 0.2762\n",
      "Reference Text: in many renal diseases transforming growth factor  tgfstimulated canonical smad and noncanonical mechanistic TOR mtor promote increased protein synthesis and MC hypertrophy the cellular underpinnings involving these signaling molecules to regulate MC hypertrophy are not fully understood deptor has recently been identified as an mtor HIP and functions as an endogenous inhibitor of the kinase activity for both torc and torc prolonged incubation of mesangial cells with tgf reduced the levels of deptor concomitant with an increase in torc and torc activity sustained tgf activation was required to inhibit association of deptor with mtor whereas rapid activation had no effect using the mtor inhibitor pp we found that tgfinduced both early and sustained activation of torc and torc was necessary for deptor suppression ppinduced reversal of deptor suppression by tgf was associated with a significant inhibition of tgfstimulated protein synthesis and hypertrophy interestingly expression of sirna against smad or smad which blocks tgf receptorspecific smad signaling prevented tgfinduced suppression of deptor abundance and torc activities furthermore overexpression of smad decreased deptor expression similar to tgf stimulation concomitant with increased torc and torc MICs finally knockdown of deptor reversed smad mediated inhibition of protein synthesis and MC hypertrophy induced by tgf these data reveal the requirement of both early and VLA of mtor for tgfinduced protein synthesis our results support that tgfstimulated smad acts as a key node to instill a feedback loop between deptor downregulation and torc activation in driving MC hypertrophy\n",
      "Generated Text: in many renal diseases transforming growth factor  tgfstimulated canonical smad and noncanonical mechanistic TOR mtor promote increased protein synthesis and MC hypertrophy the cellular underpinnings involving these signaling molecules to regulate MC hypertrophy are not fully understood deptor has recently been identified as an mtor HIP and functions as a mtor in the kidney and in the liver mtor is a key regulator of the mTOR pathway and is a key regulator of the mTOR pathway in the kidney and in the liver mtor is also a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the mTOR pathway in the kidney and in the liver mtor is a key regulator of the m\n",
      "BLEU: 0.13221501818153197, ROUGE-L: {'r': 0.3700787401574803, 'p': 0.8545454545454545, 'f': 0.5164835122660307}, Perplexity: 2.1935195922851562, Cosine Similarity: 0.4018\n",
      "Reference Text: internetbased sex therapy for men with ereng ESC scc cell clones\n",
      "Generated Text: internetbased sex therapy for men with ereng ESC scc cell clones in the male genital tract is a promising treatment for ereng ESC scc cell clones in the male genital tract the aim of this study was to evaluate the efficacy of a single session of sex therapy for ereng ESC scc cell clones in the male genital tract in a male with ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract the study was conducted in a male with ereng ESC scc cell clones in the male genital tract who had been treated with a single session of sex therapy for ereng ESC scc cell clones in the male genital tract\n",
      "BLEU: 0.0218626072594381, ROUGE-L: {'r': 1.0, 'p': 0.3142857142857143, 'f': 0.47826086592627604}, Perplexity: 1.479931354522705, Cosine Similarity: 0.5504\n",
      "Reference Text: urocortins ucns injected peripherally decrease FI and GE through peripheral crf receptors in rodents however whether ucns influence circulating levels of the orexigenic and prokinetic hormone ghrelin has been little investigated we examined plasma C2 of ghrelin and blood glucose after intravenous iv injection of ucn the CRF-R AT1 involved and underlying mechanisms in AL fed rats equipped with a chronic iv cannula ucn gkg iv induced a rapid ON and long lasting increase in ghrelin levels reaching and at and h post i.t. respectively and a h hyperglycemic response the selective crf agonist ucn gkg iv increased fasting acyl h and desacyl ghrelin levels h compared to vehicle while the preferential crf agonist crf gkg iv had no effect ucn s stimulatory actions were blocked by the selective crf antagonist astressinb gkg iv hexamethonium mgkg sc prevented ucn induced rise in total ghrelin C2 while not altering the hyperglycemic response these data indicate that SVR i.t. of ucns induces a crfmediated increase in circulating ghrelin levels likely via indirect actions on gastric ghrelin cells that involves a nicotinic pathway independently from the hyperglycemic response\n",
      "Generated Text: urocortins ucns injected peripherally decrease FI and GE through peripheral crf receptors in rodents however whether ucns influence circulating levels of the orexigenic and prokinetic hormone ghrelin has been little investigated we examined plasma C2 of ghrelin and blood glucose after intravenous iv injection of ucn the CRF-R AT1 involved in ghrelin secretion and the CRF-R AT1 in ghrelin secretion were significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group compared to the control group the CRF-R AT1 was also significantly decreased in the ucn group\n",
      "BLEU: 0.1436571134982955, ROUGE-L: {'r': 0.38461538461538464, 'p': 0.8490566037735849, 'f': 0.529411760414533}, Perplexity: 2.0753889083862305, Cosine Similarity: 0.4336\n",
      "Reference Text: two insulinlike growth factor igf receptors the type i and type ii igf receptors have been described while substantial evidence indicates that the type i receptor is involved in the regulation of cell division it is uncertain if the RII also mediates this response similarly the role of the insulin receptor in mediating dna synthesis remains controversial to address these questions we used a monoclonal antibody alpha ir to specifically inhibit type i igf receptor activity and examined the effects of this inhibition on igf and insulinstimulated dna synthesis in human fibroblasts wi HEL fibroblasts have both type i and type ii igf receptors as determined by crosslinking i igfi and iigfii to monolayers of these cells in SFM both igfi and igfii stimulate dna synthesis in wi fibroblasts with halfmaximal effects occurring at sd and nm respectively at maximally ERP concentrations however both hormones stimulate dna synthesis to equal C2 alpha ir binds to the type i but not the type ii igf receptor on wi cells it also inhibits igf binding to the IL-1RI on these cells alpha ir competitively inhibited both igfi and igfiistimulated dna synthesis in wi cells but had no effect on either epidermal growth factor or plateletderived growth factorstimulated dna synthesis these results indicate that in wi fibroblasts the mitogenic effects of both igfi and igfii are mediated through the IL-1RI and that the type ii igf receptor is not directly involved in this response to define the role of the insulin receptor in mediating dna synthesis we compared the effects of alpha ir on insulinstimulated dna synthesis in a variety of human cell lines under MZ experimental conditions with wi and hel another HEL FB cell L1 alpha ir competitively inhibited the mitogenic effect of insulin however in two other fibroblast cell lines gm and hes and an osteogenic sarcoma cell L1 mg alpha ir inhibited igf but not insulinstimulated dna synthesis these results indicate that human cell lines differ in the receptor type through which insulin stimulates dna synthesis and that these differences are intrinsic properties of the cell lines and are not artifacts resulting from differences in experimental conditions\n",
      "Generated Text: two insulinlike growth factor igf receptors the type i and type ii igf receptors have been described while substantial evidence indicates that the type i receptor is involved in the regulation of cell division it is uncertain if the RII also mediates this response similarly the role of the insulinlike growth factor igf receptors in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the type ii receptor in the regulation of cell division is not clear however the role of the\n",
      "BLEU: 0.1321460240361212, ROUGE-L: {'r': 0.2689655172413793, 'p': 0.975, 'f': 0.4216216182322864}, Perplexity: 1.5112189054489136, Cosine Similarity: 0.6026\n",
      "Reference Text: the present study investigated in vitro the effects of sulphated heterorhamnan go iotanucarrageenans gd and ehwi and arabinogalactan aragal PSs on macrophage activation and inhibition of intracellular amastigotes of leishmania l amazonensis all the sulphated PSs go gd and ehwi promoted increased nitric oxide production varying from to the leishmanicidal activity of all compounds was compared to the inhibition effect of MA at gml  used as positive control inhibition of leishmania l amazonensis growth was with gml of go and to gd and ehwi respectively at gml and with gml of aragal the superoxide anion scavenging activity for the sulphated PSs varied from approximately at gml in conclusion the results of the present study indicate the promising potential of these polysaccharides for the development of new alternative therapeutic agents against leishmaniasis\n",
      "Generated Text: the present study investigated in vitro the effects of sulphated heterorhamnan go iotanucarrageenans gd and ehwi and arabinogalactan aragal PSs on macrophage activation and inhibition of intracellular amastigotes of leishmania l amazonensis all the sulphated PSs go gd and ehwi promoted increased nitric oxide production varying from to the leishmanicidal activity of the sulphated PSs go gd and ehwi was also increased by the addition of arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go gd and ehwi and arabinogalactan aragal PSs go\n",
      "BLEU: 0.23334522043958947, ROUGE-L: {'r': 0.5342465753424658, 'p': 0.9285714285714286, 'f': 0.6782608649285444}, Perplexity: 2.4598591327667236, Cosine Similarity: 0.5174\n",
      "Reference Text: varicellazoster virus can to modulate the expression of MHC mhc molecules mhc class i expression is downregulated in vzvinfected TA as well as in fibroblasts vzvinfected cells do not respond to SE to interferongamma ifngamma by upregulation of mhc class ii expression however mhc class ii expression is induced when cells are treated with Th1 before vzv infection these effects on mhc class i and class ii expression can be expected to interfere transiently with adaptive immune responses of the host mediated by cd and cd TA ensuring that the virus has sufficient opportunity for transmission to susceptible contracts\n",
      "Generated Text: varicellazoster virus can to modulate the expression of MHC mhc molecules mhc class i expression is downregulated in vzvinfected TA as well as in fibroblasts vzvinfected cells do not respond to SE to interferongamma ifngamma by upregulation of mhc class ii expression however mhc class ii expression is induced when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is also induced by interferongamma when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is induced by interferongamma when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is induced by interferongamma when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is induced by interferongamma when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is induced by interferongamma when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is induced by interferongamma when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is induced by interferongamma when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is induced by interferongamma when vzvinfected cells are treated with SE to interferongamma the effect of SE is dependent on the expression of mhc class ii mhc class ii expression is induced by interferongamma when v\n",
      "BLEU: 0.17099634794585136, ROUGE-L: {'r': 0.59375, 'p': 0.9047619047619048, 'f': 0.716981127290851}, Perplexity: 2.0887081623077393, Cosine Similarity: 0.7741\n",
      "Reference Text: Lp has been shown to possess multiple genetic loci that play roles in its ability to survive within host cells the mil macrophagespecific infectivity loci mutants of l pneumophila exhibit a spectrum of defects in intracellular survival in and cytopathogenicity to macrophages and AM epithelial cells this study characterizes one of the mil mutants gb intracellular growth of gb in macrophages was approximately to fold less than that of aa the parental CS at and h postinfection this defect in turn corresponded to a defect in cytopathogenicity sequence analysis of the affected gb open reading frame orf revealed it to encode a putative transport protein and the orf was designated mila the phenotypic defect of the mila mutant was complemented with a pcr fragment containing only mila indicating that the defect in gb was due to the disruption of mila intracellular trafficking of the mutant was examined by laser scanning confocal microscopy the data showed that of the gb phagosomes colocalized with the late endosomallysosomal marker lamp and h postinfection while less than of the aa phagosomes colocalized with this marker on the other hand over of the gb phagosomes were similar to the aa phagosome in that they were devoid of lamp and cat d and they were colocalized with the endoplasmic reticulum er marker bip however the number of gb phagosomes that colocalized with bip decreased to h postinfection compared to that of aa which remained constant colocalization thus compared to aa the mila mutation caused a defect in intracellular replication which was associated with colocalization of the phagosome with lamp and bip while colocalization with lamp and cathepsin d was not affected\n",
      "Generated Text: Lp has been shown to possess multiple genetic loci that play roles in its ability to survive within host cells the mil macrophagespecific infectivity loci mutants of l pneumophila exhibit a spectrum of defects in intracellular survival in and cytopathogenicity to macrophages and AM epithelial cells this study characterizes one of these lp mutants and demonstrates that the lp mutant is a member of the lp gene family and that the lp gene is expressed in the cytopathogenicity loci of lp the lp gene is expressed in the cytopathogenicity loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp gene is expressed in the intracellular survival loci of lp and the lp gene is expressed in the intracellular survival loci of lp the lp\n",
      "BLEU: 0.1695966641678278, ROUGE-L: {'r': 0.3230769230769231, 'p': 0.8235294117647058, 'f': 0.46408839374255983}, Perplexity: 1.9987049102783203, Cosine Similarity: 0.5499\n",
      "Reference Text: rosaidorfman disease rdd also known as SH with massive lymphadenopathy is a rare disease of unknown etiology that typically presents as nodal disease in young children however it also can present in various extranodal sites and can be difficult to recognize if not considered in the differential diagnosis here we report a case of appendix involvement by extranodal rdd which occurred in a yearold woman with a long duration of years for intermittent RA lower quadrant pain the patient underwent a right hemicolectomy for a clinical diagnosis of appendiceal CA a mixed inflammatory infiltration of mature lymphocytes plasma cells and histiocytes exhibiting emperipolesis were indentified other Az had storiform fibrosis and sclerosis admixed with numerous plasma cells these histologic features combination with immunoreactivity for cd and s protein were indicative of a diagnosis of extranodal rdd we discuss the clinical pathologic findings as well as differential diagnoses and consideration of a possible relationship of this entity to iggrelated lesion\n",
      "Generated Text: rosaidorfman disease rdd also known as SH with massive lymphadenopathy is a rare disease of unknown etiology that typically presents as nodal disease in young children however it also can present in various extranodal sites and can be difficult to recognize if not considered in the differential diagnosis here we describe a case of rdd in a young child with a history of a history of rdd in the family we also describe the clinical presentation of the patient and the clinical course of the patient with the help of the clinical and laboratory findings we also describe the clinical and laboratory findings of the patient and the clinical and laboratory findings of the family\n",
      "BLEU: 0.33953740830510987, ROUGE-L: {'r': 0.42201834862385323, 'p': 0.8363636363636363, 'f': 0.5609756052981857}, Perplexity: 10.77038860321045, Cosine Similarity: 0.7171\n",
      "Reference Text: folliclestimulating hormone fsh a glycoprotein produced by the anterior PIT gland plays an important role in the regulation of fertility in both men and women fsh is used clinically to treat women with anovulatory infertility for controlled ovarian stimulation in women being treated with ARTs art and in the treatment of male hypogonadotrophic hypogonadism urinederived gonadotropin S9 containing VL amounts of fsh together with urinary proteins have been available for many years more recently fsh S9 produced using recombinant dna technology have become available recombinant fsh has a high specific activity high purity and guaranteed consistency among batches two recombinant fsh preparations have been available for clinical use for some years follitropinalpha and follitropinbeta the continuing OD of rFSH has recently resulted in a new presentation follitropinalpha filled by mass fbm this product can be filled by mass microg with an activity iu reflecting exceptional consistency as a result of refinement and improvement in the manufacturing process allowing the clinician to deliver a guaranteed dose of fsh experience with recombinant fsh in the treatment of male hypogonadotrophic hypogonadism is limited but the available data suggest that recombinant fsh has a similar efficacy to urinederived S9 urofollitropin in patients with who group i anovulatory infertility the use of recombinant fsh to stimulate follicular development is effective and well tolerated in patients with who group ii anovulation protocols based on recombinant fsh are more ERP than conventional protocols using urofollitropin comparative studies and a metaanalysis have shown that rFSH is more effective than urofollitropin for COS in women undergoing art pharmacoeconomic modeling indicates that follitropinalpha is more cost effective than urofollitropin in a range of different healthcare systems the available evidence from comparative studies of the two recombinant fsh preparations suggests that follitropinalpha may have an advantage over follitropinbeta in terms of tau follitropinalpha is superior to follitropinbeta in terms of local tolerability recent preliminary studies suggest an tau advantage for follitropinalpha fbm compared with standard follitropinalpha the fbm presentation appears to represent an advance on standard preparations of recombinant fsh in terms of consistency and clinical efficacy\n",
      "Generated Text: folliclestimulating hormone fsh a glycoprotein produced by the anterior PIT gland plays an important role in the regulation of fertility in both men and women fsh is used clinically to treat women with anovulatory infertility for controlled ovarian stimulation in women being treated with ARTs art and in the treatment of men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility for controlled ovarian stimulation in men ART is used to treat men with anovulatory infertility\n",
      "BLEU: 0.12966816108921148, ROUGE-L: {'r': 0.23952095808383234, 'p': 0.975609756097561, 'f': 0.38461538145016644}, Perplexity: 1.6379696130752563, Cosine Similarity: 0.3676\n",
      "Reference Text: this investigation was motivated by physician reports that patient compliments often raise red flags for them raising questions about whether compliments are being used in the service of achieving some kind of advantage our goal was to understand physician discomfort with patient compliments through analyses of audiotaped surgeonpatient encounters using CA we demonstrate that both the placement and design of compliments are consequential for how surgeons hear and respond to them the compliments offered after treatment recommendations are neither designed nor positioned to pursue institutional agendas and are responded to in ways that are largely consistent with compliment responses in everyday interaction but include modifications that preserve surgeons expertise in contrast some compliments offered before treatment recommendations pursue specific treatments and engender surgeons resistance other compliments offered before treatment recommendations do not overtly pursue institutionallyrelevant agendasfor example compliments offered in the opening phase of the visit we show how these compliments may but need not foreshadow a patients upcoming agenda this work extends our understanding of the interactional functions of compliments and of the resources patients use to pursue desired outcomes in encounters with healthcare professionals\n",
      "Generated Text: this investigation was motivated by physician reports that patient compliments often raise red flags for them raising questions about whether compliments are being used in the service of achieving some kind of advantage our goal was to understand physician discomfort with patient compliments through analyses of audiotaped surgeonpatient encounters using a validated questionnaire and a questionnaire designed to assess physician discomfort with patient compliments we found that physician discomfort with patient compliments was significantly higher than that with patient compliments in the first year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the second year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the third year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the fourth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the fifth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the sixth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the seventh year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the eighth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the ninth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the tenth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the eleventh year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the twelfth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the thirteenth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the fourteenth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the fifteenth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the sixteenth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the seventeenth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the eighteenth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the nineteenth year of practice and that physician discomfort with patient compliments was significantly higher than that with patient compliments in the twentieth year of practice and that physician discomfort\n",
      "BLEU: 0.11481102921585139, ROUGE-L: {'r': 0.391304347826087, 'p': 0.5921052631578947, 'f': 0.47120418369014017}, Perplexity: 1.8495614528656006, Cosine Similarity: 0.5829\n",
      "Reference Text: oral thyrotrophinreleasing hormone trh and lithium were given to patients on followup for WDTC to see their effect on SS thyrotrophin level tsh and radioiodine i uptake raiu the study was randomised and doubledblinded and consisted of a total of patients in groups group received placebo and trh group received lithium and PL and group received lithium and trh SS tsh and raiu at hours were measured before and after treatment with trh lithium andor PL in group mean sem tsh increased from mul to mul p in group the NC of mul to mul in tsh was not statistically significant and in group tsh increased from mul to mul p however despite the significant NC in tsh there was no significant increase in i uptake in any group to to and to in groups and respectively p we conclude that while oral trh will increase endogenous serum tsh significantly there is no significant increase in i uptake lithium was not an useful adjunct in increasing SS tsh or i uptake in these patients\n",
      "Generated Text: oral thyrotrophinreleasing hormone trh and lithium were given to patients on followup for WDTC to see their effect on SS thyrotrophin level tsh and radioiodine i uptake raiu the study was randomised and doubledblinded and consisted of a total of patients in groups group received placebo and trh group received placebo and lithium group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo and lithium and trh group received placebo\n",
      "BLEU: 0.1275143242914714, ROUGE-L: {'r': 0.4875, 'p': 1.0, 'f': 0.6554621804674812}, Perplexity: 1.8487077951431274, Cosine Similarity: 0.5823\n",
      "Reference Text: an increase in preb cell proliferation and b lymphocyte production in mouse bone marrow has previously been shown to follow the administration of various foreign agents in vivo the responses of early precursor B1 before the expression of mu chains prob cells have now been examined using double immunofluorescence labeling for terminal deoxynucleotidyl GOT tdt and b glycoprotein as detected by monoclonal antibody a single injection of sheep red blood cells srbc was followed by an increase in the number of cells in three defined populations of early precursor b cells lacking mu chains tdt cells tdt cells and mu cells as well as cytoplasmic mubearing preb cells and surface mubearing b lymphocytes an accompanying increase in proliferative activity was indicated by the numbers of mu cells and preb cells which accumulated in metaphase T3 inducing MI arrest with vincristine these effects were all abrogated either by treating mice with Si to depress macrophage function or by splenectomy in mice given multiple injections of srbc for weeks the elevated levels of early F0 b cell production and b cell genesis were sustained the work demonstrates that the in vivo production of early F0 b cells putatively including those at the stage of ig heavy chain gene rearrangement can be stimulated by SE to external agents acting indirectly by a silicasensitive spleendependent mechanism the findings suggest that the level of prob cell proliferation and primary b cell genesis normally taking place in mouse bone marrow may reflect the level of exposure to potential stimulants in the external environment mediated by activation of splenic macrophages the possibility that abnormally high levels of macrophage activation could predispose to dysregulations onipolar depression and panic disorder but not in patients with obsessivecompulsive disorder the impaired thermic and NE responses are associated with increased basal cortisol secretion in depressed patients but not in patients with PD chronic treatment with the selective ht reuptake inhibitor fluoxetine decreases hta receptormediated responses in patients with obsessivecompulsive disorder while longterm treatment with the tricyclic antidepressant amitriptyline further decreases hypothermia following IPS but has no effect on acthcortisol PR alteration of the hta receptor andor its ST pathways may play a role in the pathophysiology and treatment of anxiety disorders and depression\n",
      "Generated Text: an increase in preb cell proliferation and b lymphocyte production in mouse bone marrow has previously been shown to follow the administration of various foreign agents in vivo the responses of early precursor B1 before the expression of mu chains prob cells have now been examined using double immunofluorescence labeling of b lymphocytes and preb cells in bone marrow and in the bone marrow of mice the results show that the expression of mu chains is increased in the bone marrow of mice and that the expression of b lymphocytes is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is increased in the bone marrow of mice and that the expression of preb cells is\n",
      "BLEU: 0.14076329976538493, ROUGE-L: {'r': 0.21904761904761905, 'p': 0.92, 'f': 0.353846150739645}, Perplexity: 1.861238956451416, Cosine Similarity: 0.7062\n",
      "Reference Text: for successful gene delivery plasmid dna must be able to access the nucleus in order to be transcribed numerous studies have shown that gene delivery occurs more readily in dividing cells which is attributed to increased nuclear access when the nuclear envelope disassembles during mitosis however nonviral carriers continue to have low transfection efficiencies and require C1 quantities of dna per cell to achieve reasonable gene transfer even in dividing cells therefore we hypothesized that using histonederived NLSs nlss to target polyplexes might enhance nuclear delivery by facilitating interactions with histone effectors that mediate nuclear partitioning and retention during mitosis we discovered a novel interaction between polyplexes linked to histone h NT tail peptides and the histone nuclear import protein importin as evidenced by strong spatial colocalization as well as significantly decreased transfection when importin expression was reduced a fraction of the histonetargeted polyplexes was also found to colocalize with the retrotranslocon of the endoplasmic reticulum sec super resolution microscopy demonstrated a high level of polyplex binding to chromatin postmitosis and there also was a significant decrease in the amount of chromatin binding following importin knockdown these results provide evidence that NK histone effectors mediate both nuclear entry and deposition on chromatin by histonetargeted polyplexes and a translocation event from the endoplasmic reticulum into the cytosol may occur before mitial populations stay healthy and safe on wilderness adventures the pubmed and sportdiscus databases were searched in using both mesh terms and text words and include peerreviewed english language articles from to additional information was accessed from webbased sources to produce this narrative review on preparticipation evaluation for special populations undertaking wilderness adventures key words include children adolescent pediatric seniors elderly disabled special needs female athlete preparticipiation examination wilderness medicine and sports\n",
      "Generated Text: for successful gene delivery plasmid dna must be able to access the nucleus in order to be transcribed numerous studies have shown that gene delivery occurs more readily in dividing cells which is attributed to increased nuclear access when the nuclear envelope disassembles during mitosis however nonviral carriers continue to be a challenge to gene delivery in vivo the aim of this study was to determine the effect of the dna on the nuclear envelope of the dna transducer in vivo the dna transducer was implanted in the nucleus of a mouse embryo and the nuclear envelope was analyzed by immunohistochemistry and immunohistochemistry of the nuclear envelope the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the nucleus in vivo and the nuclear envelope was not affected by the dna transducer in vitro the dna transducer was able to access the\n",
      "BLEU: 0.14718715755247752, ROUGE-L: {'r': 0.22872340425531915, 'p': 0.6935483870967742, 'f': 0.34399999627008004}, Perplexity: 2.0158660411834717, Cosine Similarity: 0.5693\n",
      "Reference Text: a nested polymerase chain reaction pcr assay was investigated for detection of pneumocystis carinii in RT specimens from children of whom were immunocompetent but with chronic lung disorders cld eight had aids and p carinii pneumonia pcp had aids but no respiratory symptoms and were healthy immunocompetent children GMS stain gms and indirect immunofluorescence assay ifa were performed in parallel of specimens from children with cld were p carinii pcrpositive compared to positive by gmsifa of eight specimens from children with aids and pcp seven were p cariniipositive by pcr and six by gmsifa and of specimens from hivpositive children without respiratory symptoms two were positive by pcr and none by gmsifa p carinii dna was also detected by pcr in blood samples from four children with p cariniipositive NP aspirates specimens from HC were negative for p carinii by both pcr and gmsifa of the seven children with cld who were p cariniipositive two had clinical and microbiological improvement with cotrimoxazole treatment two improved initially but relapsed and one had p carinii cysts persistently in followup specimens despite cotrimoxazole treatment these results suggest an association between p carinii and exacerbations of cld in childhood in the absence of hiv infection or other immunodeficiency syndromes\n",
      "Generated Text: a nested polymerase chain reaction pcr assay was investigated for detection of pneumocystis carinii in RT specimens from children of whom were immunocompetent but with chronic lung disorders cld eight had aids and p carinii pneumonia pcp had aids but no respiratory symptoms and were healthy immunocompetent children GMS stain was used to detect pcp in the pcr assay the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr assay was performed in a single tube of RT and the pcr\n",
      "BLEU: 0.12458229540509137, ROUGE-L: {'r': 0.42574257425742573, 'p': 0.8958333333333334, 'f': 0.5771812036863204}, Perplexity: 2.001024007797241, Cosine Similarity: 0.4577\n",
      "Reference Text: luciferases are widely used to monitor biological processes here we describe the naturally secreted gaussia princeps luciferase gluc as a highly sensitive reporter for quantitative assessment of cells in vivo by measuring its concentration in blood the gluc blood assay complements in BLI which has the ability to localize the signal and provides a multifaceted assessment of cell viability proliferation and location in experimental disease and therapy models\n",
      "Generated Text: luciferases are widely used to monitor biological processes here we describe the naturally secreted gaussia princeps luciferase gluc as a highly sensitive reporter for quantitative assessment of cells in vivo by measuring its concentration in blood the gluc blood assay complements in BLI which has the ability to localize the luciferase gene in the blood and is a widely used method for quantifying the expression of genes in vivo we show that the gluc blood assay is sensitive to the presence of the luciferase gene in the blood and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice we also show that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma of mice and that the gluc blood assay is sensitive to the presence of the luciferase gene in the plasma\n",
      "BLEU: 0.11171479653509735, ROUGE-L: {'r': 0.7962962962962963, 'p': 0.7818181818181819, 'f': 0.7889908206884944}, Perplexity: 2.00479793548584, Cosine Similarity: 0.6455\n",
      "Reference Text: CE hemodynamic and mediumsize molecular intoxication parameters have been determined in patients with AI ai it has been found that maximum indexes were characteristic of patients with low cardiac index and high IP V1 resistance it has been proved that neuroleptanalgesia in patients with ai is accompanied by an increase in mediumsize molecule level which in its turn depends on the initial volumic disturbances\n",
      "Generated Text: CE hemodynamic and mediumsize molecular intoxication parameters have been determined in patients with AI ai it has been found that maximum indexes were characteristic of patients with low cardiac index and high IP V1 resistance it has been proved that neuroleptanalgesia in patients with ai is accompanied by an increase in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a decrease in the rate of cerebral blood flow and a\n",
      "BLEU: 0.10249373506609176, ROUGE-L: {'r': 0.7959183673469388, 'p': 0.8666666666666667, 'f': 0.8297872290516072}, Perplexity: 1.8148897886276245, Cosine Similarity: 0.3146\n",
      "Reference Text: with the introduction of highly active ART haart an impressive improvement in patient survival and quality of life has bee observed however the optimal timing of initial haart is still under consideration\n",
      "Generated Text: with the introduction of highly active ART haart an impressive improvement in patient survival and quality of life has bee observed however the optimal timing of initial haart is still under consideration and the aim of this study was to evaluate the effect of haart on the survival of patients with acute myocardial infarction and to determine the effect of haart on the survival of patients with acute myocardial infarction with a history of myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocardial infarction and was continued for at least 6 months after the first myocardial infarction haart was initiated at the time of the first myocard\n",
      "BLEU: 0.08182450944779282, ROUGE-L: {'r': 1.0, 'p': 0.5185185185185185, 'f': 0.6829268247709697}, Perplexity: 1.587212085723877, Cosine Similarity: 0.4158\n",
      "Reference Text: this study aimed to evaluate the feasibility and safety of intracorporeal anastomosis with Bi BII or RY reconstructions in totally laparoscopic distal gastrectomy\n",
      "Generated Text: this study aimed to evaluate the feasibility and safety of intracorporeal anastomosis with Bi BII or RY reconstructions in totally laparoscopic distal gastrectomy patients with a gastric distention of less than 5 cm the patients were divided into two groups and the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the second group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the second group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the second group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the second group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the second group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the second group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the second group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the second group the patients were treated with intracorporeal anastomosis with Bi BII or RY reconstructions in the first group the\n",
      "BLEU: 0.06516239422716615, ROUGE-L: {'r': 1.0, 'p': 0.575, 'f': 0.7301587255228017}, Perplexity: 1.4842793941497803, Cosine Similarity: 0.5913\n",
      "Reference Text: objective the goal of this paper was to investigate surgical and hardware complications in a longitudinal retrospective T0 methods the authors of this registry T0 analyzed the surgical and hardware complications in patients who underwent the implantation of a VNS vns device between and the mean followup time was years results in total procedures were performed for primary vns implantations complications related to surgery occurred in of all implantation procedures that were performed the respective rate for hardware complications was surgical complications included postoperative hematoma in infection in vocal cord palsy in lower facial weakness in pain and sensoryrelated complications in aseptic reaction in cable discomfort in surgical cable break in oversized stimulator pocket in and battery displacement in of patients hardwarerelated complications included lead fracturemalfunction in spontaneous vns turnon in and lead disconnection in of patients conclusions vns implantation is a relatively safe procedure but it still involves certain risks the most common complications are postoperative hematoma infection and vocal cord palsy although their occurrence rates are rather low at about these complications may cause L1 suffering and even be life threatening to reduce complications it is important to have a LT perspective the years of followup of this study is of great strength considering that vns can be a lifelong treatment for many patients thus it is important to include repeated surgeries such as battery and lead replacements given that complications also may occur with these surgeries\n",
      "Generated Text: objective the goal of this paper was to investigate surgical and hardware complications in a longitudinal retrospective T0 methods the authors of this registry T0 analyzed the surgical and hardware complications in patients who underwent the implantation of a VNS vns device between and the mean followup time was years the mean number of complications was 3.5 and the mean number of complications per patient was 0.5 the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who had no complication the mean number of complications per patient was significantly higher in the patients who had a complication than in the patients who\n",
      "BLEU: 0.11610853492237018, ROUGE-L: {'r': 0.25757575757575757, 'p': 0.7391304347826086, 'f': 0.382022468077263}, Perplexity: 1.7214751243591309, Cosine Similarity: 0.5135\n",
      "Reference Text: research findings that link personality AF to functioning and PS in schizophrenia are inconsistent and further studies are needed within the area the purpose of this T0 was to investigate how personality as measured by the TCI tci was related to demographic AF subtypes of diagnoses level of functioning and aspects of psychological health including sense of coherence perceived control and SE among people with schizophrenia subjects were individuals aged years in psychiatric OP care the results indicated that personality was not related to subtypes of diagnoses or demographic characteristics of the respondents but to level of functioning and all aspects of psychological health especially selfdirectedness distinguished three groups of SF-36 and was highly correlated with the different aspects of psychological health the article discusses how knowledge of schizophrenic patients personality structure might be used for tailoring psychiatric treatments\n",
      "Generated Text: research findings that link personality AF to functioning and PS in schizophrenia are inconsistent and further studies are needed within the area the purpose of this T0 was to investigate how personality as measured by the TCI tci was related to demographic AF subtypes of diagnoses level of functioning and PS in schizophrenia patients and to the clinical characteristics of these patients the study included a total of 9 patients with schizophrenia and a total of 9 patients with schizoaffective disorder the tci was measured by a questionnaire and the tci was also assessed by a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the tci was also assessed by a structured interview and a structured interview the\n",
      "BLEU: 0.11501888670029263, ROUGE-L: {'r': 0.4418604651162791, 'p': 0.7037037037037037, 'f': 0.5428571381183674}, Perplexity: 1.8495659828186035, Cosine Similarity: 0.3427\n",
      "Reference Text: zincdeficiency was induced in mice by FF a zndeficient basal diet zd dietary group containing lipid corn oil CLO for wk thereafter the corn oil was withdrawn from the basal diet and a subset of zndeficient animals zdlr group was fed this modified LF diet for another wk alkaline phosphatase activity in intestine and liver was compared in these mice and in those allowed ad libitum access to the lipidadequate znsupplemented diet zs group in those pairfed the znsupplemented diet pf group and in those fed the lipidadequate zndeficient diet AL zd group the CEA in both intestine and liver of the zdlr group was greater than in those of the zd group and greater than or equal to those of the zs and pf diet groups the results of this study suggest that the reduction in alkaline phosphatase in zndefi data because of epitope variations between RV strains serotyping with several monoclonal antibodies directed at different epitopes may increase the sensitivity of the method\n",
      "Generated Text: zincdeficiency was induced in mice by FF a zndeficient basal diet zd dietary group containing lipid corn oil CLO for wk thereafter the corn oil was withdrawn from the basal diet and a subset of zndeficient animals zdlr group was fed this modified LF diet for another wk alkaline phosphatase activity was measured in the liver of zdlr animals and in the liver of zdlr animals fed the modified LF diet the activity was significantly lower than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the modified LF diet than in the zdlr animals fed the basal diet the activity was significantly lower in the zdlr animals fed the\n",
      "BLEU: 0.13866318566551675, ROUGE-L: {'r': 0.45977011494252873, 'p': 0.9302325581395349, 'f': 0.6153846109573965}, Perplexity: 1.9771994352340698, Cosine Similarity: 0.6771\n",
      "Reference Text: although hedgehog hh signaling is essential for morphogenesis of the drosophila eye its exact link to the network of tissuespecific genes that regulate retinal determination has remained elusive in this report we demonstrate that the retinal determination gene eyes absent eya is the crucial link between the Hh signaling pathway and photoreceptor differentiation specifically we show that the mechanism by which hh signaling controls initiation of photoreceptor differentiation is to alleviate repression of eya and dpp dpp expression by the zincfinger transcription factor cubitus interruptus cirep furthermore our results suggest that stabilized full length ci ciact plays little or no role in drosophila eye development moreover while the effects of hh are primarily concentration dependent in other tissues hh signaling in the eye acts as a binary switch to initiate retinal morphogenesis by inducing expression of the tissuespecific factor eya\n",
      "Generated Text: although hedgehog hh signaling is essential for morphogenesis of the drosophila eye its exact link to the network of tissuespecific genes that regulate retinal determination has remained elusive in this report we demonstrate that the retinal determination gene eyes absent eya is the crucial link between the Hh signaling pathway and the retinal determination gene eya in the mouse we show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show that the hh signaling pathway is essential for the formation of the retinal determination gene eya in the mouse we also show\n",
      "BLEU: 0.13232016038342148, ROUGE-L: {'r': 0.45555555555555555, 'p': 0.9318181818181818, 'f': 0.6119402940966808}, Perplexity: 1.8502498865127563, Cosine Similarity: 0.7409\n",
      "Reference Text: path hosted the inaugural vaccines against shigella and ETEC vase conference in washington dc in june bringing together experts from around the world for a highly collaborative forum to discuss progress in the development of new enteric vaccines diarrheal disease and LT sequelae caused by infections with the bacterial pathogens shigella and ETEC etec pose a significant public health burden in lowincome communities there are currently no licensed vaccines against these pathogens and the global health community has recently prioritized their development the vase conference aimed to accelerate communication and progress among those working in the enteric vaccine field to make shigella and etec vaccines a reality as quickly as possible research presented in oral and poster presentations at the vase conference covered a range of topics including the global burden of disease and public health case for shigella and etec vaccines current vaccine candidates in development immunology and host responses to the pathogens and the rationale for and status of combined shigellaetec vaccine candidates this article reviews key points and highlighted research presented in each of the plenary conference sessions and poster presentations at the conference planning for the vase conference is underway and will likely provide an important platform for sharing the latest updates on shigella and etec vaccine research efforts and maintaining the momentum for accelerating this work it is also expected that the vase conference will continue to provide a unique opportunity for those in the enteric vaccine field to share ideas make connections and create workable plans to make shigella and etec vaccines a reality updates available at wwwvaseconferenceorg\n",
      "Generated Text: path hosted the inaugural vaccines against shigella and ETEC vase conference in washington dc in june bringing together experts from around the world for a highly collaborative forum to discuss progress in the development of new enteric vaccines diarrheal disease and LT sequelae caused by infections with the bacterial pathogens shigella and ETEC vase the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from the UK and the US the conference was attended by representatives from the US and the UK and was attended by representatives from\n",
      "BLEU: 0.123025098033384, ROUGE-L: {'r': 0.3115942028985507, 'p': 0.8958333333333334, 'f': 0.4623655875685051}, Perplexity: 1.803869366645813, Cosine Similarity: 0.5725\n",
      "Reference Text: methotrexate mtx and cytarabine have been widely used for the treatment of acute leukemias and lymphomas for over years however the optimal schedule of this combination is yet to be determined and a variety of schedules of the combination has been used we studied the cytotoxic effects of mtx and Ara-C in combination against human leukemia cell lines at various schedules in vitro the effects of the combinations at the concentration of drug that produced cell growth inhibition ic were analyzed using the isobologram method of steel and peckham simultaneous SE to mtx and Ara-C for days produced antagonistic effects in human t cell leukemia molt and ccrfcem BCL1 ball burkitts lymphoma daudi PML hl and philadelphia chromosomepositive one k cells simultaneous exposure to mtx and Ara-C for h produced antagonistic effects sequential SE to mtx for h followed by cytarabine for h produced synergistic effects and the reverse sequence produced additive effects in both ccrfcem and hl cells sequential SE to mtx for h followed by cytarabine for days also produced synergistic effects in molt cells cell cycle analysis supported these observations our findings suggest that the simultaneous administration of mtx and cytarabine is not appropriate and the sequential administration of mtx followed by Ara-C may be the optimal schedule of this combination\n",
      "Generated Text: methotrexate mtx and cytarabine have been widely used for the treatment of acute leukemias and lymphomas for over years however the optimal schedule of this combination is yet to be determined and a variety of schedules of the combination has been used we studied the cytotoxic effects of mtx and cytarabine on human lymphocytes in vitro and in vivo we found that mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in vivo mtx and cytarabine both inhibited the proliferation of human lymphocytes in vitro and in\n",
      "BLEU: 0.1561186688052529, ROUGE-L: {'r': 0.38235294117647056, 'p': 0.8478260869565217, 'f': 0.527027022742878}, Perplexity: 1.5734587907791138, Cosine Similarity: 0.6090\n",
      "Reference Text: rats were subjected to chronic hypoxia o or hypoxia and hypercapnia o co for weeks and their CBs twentythree from twenty rats were compared with those of littermate controls both chronic exposures which simulated high altitude or CLD caused a fold increase in carotid body volume the larger increases were attributed to higher fixationperfusion pressures the organs were fixed by perfusion with glutaraldehyde semithin micron sections for LM and ultrathin sections for electron microscopy were cut at regular intervals and were examined by stereological techniques to determine the nature of the enlargement the proportion occupied by blood vessels was much increased in both CH and hypoxia plus hypercapnia the EC appeared stretched with conspicuous fenestrations there were increased numbers of endothelial cells which suggested new growth as well as stretching of EC and the mean transectional area of the vessels was increased the mean surface area of blood vessels per unit area of carotid body was unaltered but the total surface area of blood vessels in the whole carotid body was greatly increased both the type cell nucleus and cytoplasm were increased in size the proportion nucleuscytoplasm was unaltered in hypoxia but reduced in hypoxia plus hypercapnia there were fewer type cell nuclei per unit area but the estimated total number of type cell nuclei per carotid body was increased fold this was interpreted as type cell PH some of the densecored vesicles in type cells were enlarged with eccentric dense cores but their number per unit area of cytoplasm was decreased their mean size was not significantly altered however the total number of LDV per carotid body was presumed to be increased because their decreased density in the cell was offset by a greater increase in total type cell volume the harmonic and arithmetic mean distances between EC and the boundary of glomus tissue were significantly reduced the harmonic mean distance is an indication of the DWI distance for gases to and from blood and glomus tissue the AM distance is a measure of the amount of tissue in between the significance of the V1 enlargement and PH and the type SCH cannot be assessed at present we do not know if enlargement is associated with the same greater or lesser activity of the organ for a given stimulus\n",
      "Generated Text: rats were subjected to chronic hypoxia o or hypoxia and hypercapnia o co for weeks and their CBs twentythree from twenty rats were compared with those of littermate controls both chronic exposures which simulated high altitude or CLD caused a fold increase in carotid body volume the larger increases were observed in the o group than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia group the o group had a greater increase in the CBs of the carotid than in the o and hypoxia\n",
      "BLEU: 0.16503899871061517, ROUGE-L: {'r': 0.25443786982248523, 'p': 0.9148936170212766, 'f': 0.3981481447432271}, Perplexity: 1.9957082271575928, Cosine Similarity: 0.6561\n",
      "Reference Text: multielectrode array mea technology has been extensively used for field potential recordings from excitable cells however its application for action potential ap measurements has not been harnessed here we report a novel platform for highresolution intracellular ap recordings from induced CFU-S stem cellcardiomyocyte constructs derived from human CFs to gain intracellular access microgold meas were used to electroporate multiple constructs simultaneously highthroughput ap measurements were obtained from multicellular constructs repeated electroporations of the same cells did not affect the signal stability our MM has the capability to distinguish subtle differences in ap morphology to characterize the network profile furthermore we confirm the reliability of the system by recapitulating known druginduced physiological and arrhythmogenic responses overall the model provides a unique cardioelectronic interface for noninvasive measurements of ap dynamics for drug screening and disease modeling this technology opens the door for identifying novel cardiofactors to enhance EP maturation\n",
      "Generated Text: multielectrode array mea technology has been extensively used for field potential recordings from excitable cells however its application for action potential ap measurements has not been harnessed here we report a novel platform for highresolution intracellular ap recordings from induced CFU-S stem cellcardiomyocyte constructs derived from human CFs to gain insight into the cellular mechanisms of action potentials in vivo we demonstrate that the platform is able to record action potentials from the ap of a human CF in vivo and that the ap is sensitive to the presence of a specific cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic cationic c\n",
      "BLEU: 0.23659168840645142, ROUGE-L: {'r': 0.42718446601941745, 'p': 0.7096774193548387, 'f': 0.533333328642057}, Perplexity: 2.106663465499878, Cosine Similarity: 0.0801\n",
      "Reference Text: this article concerns the identification of gene pairs or combinations of gene pairs associated with biological phenotype or clinical outcome allowing for building predictive models that are not only robust to normalization but also easily validated and measured by qpcr techniques however given a small number ode ALT longitudinal changes climate ground reflection and geographic directions the most important factor affecting uvr reaching the earths surface is solar elevation currently people do not have great concern over eye protection the methods of protection against uvr include avoiding direct sunlight exposure using uvrblocking eyewear sunglasses or contact lenses and wearing hats hence by identifying uvr intensity AF eye PFs and public education especially in travelers methods for safe traveling can be identified\n",
      "Generated Text: this article concerns the identification of gene pairs or combinations of gene pairs associated with biological phenotype or clinical outcome allowing for building predictive models that are not only robust to normalization but also easily validated and measured by qpcr techniques however given a small number ode ALT longitudinal changes in the ALT of patients with chronic kidney disease are not well characterized the aim of this study was to identify the genes associated with ALT in patients with chronic kidney disease and to identify the genes associated with ALT in patients with chronic kidney disease using qpcr\n",
      "BLEU: 0.4123978326566626, ROUGE-L: {'r': 0.46534653465346537, 'p': 0.7966101694915254, 'f': 0.5874999953445313}, Perplexity: 17.981637954711914, Cosine Similarity: 0.5745\n",
      "Reference Text: cyclindependent kinases cdks are regulatory enzymes with temporal and spatial selectivity for their protein substrates that are governed by cell cycleregulated cyclin subunits TPS cyclincdk complexes bind to and phosphorylate target proteins coupling their activity to cell cycle states the ID of specific cyclincdk substrates is challenging and so far has largely been achieved through indirect correlation or use of in vitro techniques here we use a proteinfragment complementation assay based on the optimized yeast CD to systematically identify candidate substrates of budding yeast saccharomyces cerevisiae cdk and show dependency on one or more regulatory cyclins we identified known and candidate cyclin dependencies for many predicted protein kinase cdk targets and showed elusory clbcdkspecific phosphorylation of tubulin thus establishing the timing of this event in controlling assembly of the mitotic spindle our strategy can be generally applied to identify substrates and accessory subunits of multisubunit protein complexes\n",
      "Generated Text: cyclindependent kinases cdks are regulatory enzymes with temporal and spatial selectivity for their protein substrates that are governed by cell cycleregulated cyclin subunits TPS cyclincdk complexes bind to and phosphorylate target proteins coupling their activity to cell cycle states the ID of specific cyclincdk substrates is challenging and so far the identification of specific cyclincdk substrates has been limited to the identification of specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state the present study was designed to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the specific protein substrates that are specific to the cell cycle state and to identify specific cyclincdk substrates that are specific to the cell cycle state and not to the\n",
      "BLEU: 0.12326511909438904, ROUGE-L: {'r': 0.42452830188679247, 'p': 0.8490566037735849, 'f': 0.5660377314046122}, Perplexity: 2.012315273284912, Cosine Similarity: 0.5239\n",
      "Reference Text: the role of oxygen radicals in exsanguinationinduced bronchoconstriction eib was investigated using IT of antioxidants in series guinea pigs g were employed in the PET study these animals were divided into seven groups control superoxide dismutase sod catalase cat erythrocytes rbcs noxoimidazolindinylethylnphenylurea edu ruthenium red rr and systemic CAP pretreatment sod cat rbcs and edu are antioxidants whereas rr is a blocker of TM ca fluxes all agents except capsaicin were administered by IT min before exsanguination each animal of the last group received a day subcutaneous CAP pretreatment all animals were anesthetized sternotomized and exsanguinated before as well as min T3 exsanguination the maximal expiratory flow maneuver was performed and the minimal volume was obtained in the control group exsanguination caused gradual decreases in the maximal expiratory flow at baseline total lung capacity forced expiratory volume at s and TLC as well as a gradual increase in the minimal volume indicating that eib becomes more severe with time eib was significantly ameliorated by IT of sod cat rbcs edu and rr and it was almost abolished by systemic CAP pretreatment in series however inactivated cat did not significantly affect eib we determined tracheal NEP nep activity in animals thirty minutes after exsanguination there was a significant decrease in nep activity in the control but not the cat group these results indicate that eib is modulated by oxygen radicals which inactivate nepabstract truncated at words\n",
      "Generated Text: the role of oxygen radicals in exsanguinationinduced bronchoconstriction eib was investigated using IT of antioxidants in series guinea pigs g were employed in the PET study these animals were divided into seven groups control superoxide dismutase sod catalase cat erythrocytes rbcs noxoimidazolindinylethylnphenylurea edu ruthenium red rr and systemic CAP pretreatment with the antioxidant compounds guanidine and guanidine sulfate guanidine sulfate and guanidine sulfate were administered to guinea pigs in the first and second days of the study the animals were sacrificed and the lungs were examined for eib and eib2 and eib2 and eib2 were determined by the eib2 method the eib2 values were significantly higher in the guinea pigs treated with guanidine sulfate than in the guinea pigs treated with guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guanidine sulfate and guan\n",
      "BLEU: 0.2041976595075981, ROUGE-L: {'r': 0.3533834586466165, 'p': 0.6811594202898551, 'f': 0.46534653015537697}, Perplexity: 2.9181289672851562, Cosine Similarity: 0.2724\n",
      "Reference Text: little is known about how families systemically incorporate the work of caring for adolescent and young AD aya survivors of CBT who often remain dependent on their families well into adulthood the primary aim of this T0 was to develop a typology of family management fm patterns for aya survivors the AA aims were to compare them with fm patterns previously described for children with chronic health conditions and to validate the patterns using quantitative and qualitative data guided by the family management styles FR a sequential mixedmethods design was used to gather quantitative data from mothers primary CGs and aya survivors fm patterns family focused somewhat family focused somewhat condition focused and condition focused were identified using cluster analysis of data from the family management measure fm patterns were found to be similar to those for children with crophage activation leads to the secretion of Th1 cytokines and chemokines in addition tolllike receptor tlr and nodlike receptor nlr family card domaincontaining protein nlrc expression were enhanced after kidney iri and decreased significantly by rmt tim not only promotes tlrmediated nuclear factor kappa b nfb activation and cytokine and chemokine release but also participates in nlrc inflammasome activation taken together our data confirm that tim signalling enhances injury T3 kidney iri and demonstrated that tim is involved in regulating tlrnfb signalling and nlrc inflammasome activation which provide evidence that tim signalling is critical for kidney iri and may provide a new means to ameliorate kidney tissue immune responses in the clinics\n",
      "Generated Text: little is known about how families systemically incorporate the work of caring for adolescent and young AD aya survivors of CBT who often remain dependent on their families well into adulthood the primary aim of this T0 was to develop a typology of family management fm patterns for aya survivors of CBT and to describe the family management patterns of aya survivors of CBT who are dependent on their families well into adulthood the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT who are dependent on their families well into adulthood were recruited from the community and the families of aya survivors of CBT\n",
      "BLEU: 0.12488438217508421, ROUGE-L: {'r': 0.29333333333333333, 'p': 0.9166666666666666, 'f': 0.4444444407713499}, Perplexity: 1.7798717021942139, Cosine Similarity: 0.4691\n",
      "Reference Text: another case of HC is describedthat of a yearold woman who for the past years has had continuous leftsided headache before this period she had noncontinuous headache otherwise resembling the present one for years in the chronic stage the headache fluctuates considerably indomethacin in a dosage of mgday abolishes the headache CR in HC there may thus as in chronic paroxysmal hemicrania be a nonchronic stage antedating the chronic one the relative importance of the two stages cannot be assessed at present\n",
      "Generated Text: another case of HC is describedthat of a yearold woman who for the past years has had continuous leftsided headache before this period she had noncontinuous headache otherwise resembling the present one for years in the chronic stage the headache fluctuates considerably indomethacin in a dosage of mgday abolishes the headache and the patient is now able to work and is able to enjoy her life she is now able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and is able to enjoy her life and\n",
      "BLEU: 0.1022164911497458, ROUGE-L: {'r': 0.6851851851851852, 'p': 0.8043478260869565, 'f': 0.7399999950320001}, Perplexity: 1.871110200881958, Cosine Similarity: 0.0853\n",
      "Reference Text: dissemination of neoplastic cells within the body involves invasion of blood vessels by tumor cells this requires adhesion of bloodborne cells to the luminal surface of the V1 endothelium invasion through the EC cell SL and local dissolution of the subendothelial basement membrane platelets may participate in each of these steps and thus play a role in the pathogenesis of tumor cell metastasis to learn more about the possible involvement of platelets we studied the interaction of platelets and tumor cells with cultured vascular EC cells and their secreted basement membranelike extracellular matrix ecm whereas the apical surface of the vascular endothelium lacks adhesive glycoproteins and hence protect the vessel wall against platelet and tumor cell adhesion the underlying ecm constitute a highly adhesive and thrombogenic surface interaction of platelets with this ecm was associated with PLT activation aggregation and Kd of heparan sulfate in the ecm by means of the PLT heparitinase the activity of a similar enzyme has been previously correlated with the metastatic potential of various tumor sublines PSA and SEM microscopy sem studies have demonstrated that platelets may detect even minor gaps between adjacent EC cells and degrade the ecm heparan sulfate this may expose a larger area of the SE and facilitate subsequent adhesion of blood borne RT cells platelets were also shown to recruit lymphoma cells into minor gaps in the vascular EC that otherwise do not constitute a preferential site of invasion it is suggested that the PLT heparitinase is involved in the impairment of the integrity of the vessel wall and thus play a role in tumor cell metastasis\n",
      "Generated Text: dissemination of neoplastic cells within the body involves invasion of blood vessels by tumor cells this requires adhesion of bloodborne cells to the luminal surface of the V1 endothelium invasion through the EC cell SL and local dissolution of the subendothelial basement membrane platelets may participate in each of these processes the aim of this study was to investigate the role of adhesion and dissolution of the subendothelial basement membrane platelets in the invasion of tumor cells in the presence of adhesion and dissolution of the subendothelial basement membrane platelets the effect of adhesion and dissolution of the subendothelial basement membrane platelets on the invasion of tumor cells was investigated by using a mouse model of human adhesion and dissolution of the subendothelial basement membrane platelets the effect of adhesion and dissolution of the subendothelial basement membrane platelets on the invasion of tumor cells was investigated by using a mouse model of human adhesion and dissolution of the subendothelial basement membrane platelets\n",
      "BLEU: 0.19980025929540474, ROUGE-L: {'r': 0.2826086956521739, 'p': 0.7358490566037735, 'f': 0.40837695934102686}, Perplexity: 4.32180643081665, Cosine Similarity: 0.8355\n",
      "Reference Text: there is evidence that nitric oxide an endotheliumderived relaxing factor may be produced by the macula densa as well as by blood vessels within the kidney to examine the role of nitric oxide in MD control of glomerular hemodynamics directly we performed in vitro microperfusions of both rb afferent arterioles with the glomerulus intact and adherent tubular segments consisting of portions of the thick ascending limb macula densa and ED tubule while keeping afferent arteriolar pressure constant at mmhg we examined the effect of nwnitrolarginine methyl ester lname an inhibitor of NOS added to a MD perfusate when the macula densa perfusate was changed from low to high nacl the diameter of the arterioles decreased from to microns n p addition of m lname to the high nacl solution further decreased the diameter to microns p in contrast when MD perfusion was maintained with the low nacl solution addition of lname had no effect lnameinduced constriction was CR reversed by adding m larginine the F0 of nitric oxide but not darginine an inactive isomer to the macula densa perfusate we confirmed that perfusing the MD with lname did not affect the vasodilator action of acetylcholine added to the lumen of the afferent arteriole indicating that no synthesis by the arteriole was not altered thus our findings suggest that the MD may produce nitric oxide which in turn modulates the afferent arteriolar constriction induced by high concentrations of nacl at the MD\n",
      "Generated Text: there is evidence that nitric oxide an endotheliumderived relaxing factor may be produced by the macula densa as well as by blood vessels within the kidney to examine the role of nitric oxide in MD control of glomerular hemodynamics directly we performed in vitro microperfusions of both rb afferent arterioles and rb afferent arterioles in the kidney with and without nitric oxide we found that nitric oxide was produced in the rb afferent arterioles and in the rb afferent arterioles but not in the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide had a similar effect on the glomerular hemodynamics as the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide had a similar effect on the glomerular hemodynamics as the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide had a similar effect on the glomerular hemodynamics as the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the rb afferent arterioles and the rb afferent arterioles with nitric oxide the r\n",
      "BLEU: 0.18853466525372067, ROUGE-L: {'r': 0.359375, 'p': 0.8518518518518519, 'f': 0.5054945013210965}, Perplexity: 1.8590309619903564, Cosine Similarity: 0.5439\n",
      "Reference Text: the patternreversal visual CEP pr vep is an EDX test which uses an AC checkerboard DP as the visual stimulus to validate the performance of an automated MTS the equipment was installed in five locations in three countries the uk greece and cyprus pr veps require accurate control of stimulus size luminance contrast timing multichannel recordings and various modes of signal processing recordings were obtained from subjects years old seven male and seven female in each laboratory the data were transmitted by telephone line to the CE station in bristol only in bristol were the operators experienced there were no significant differences between laboratories in latency or amplitude of the n and p components there were no significant differences between eyes there were significant differences between the sexes but this was related to head size decreased square size used in stimulation produced an increased RL in both components the amplitude of the n component increased while that of the p decreased with reduced square size the results confirmed the ability of the automated system to produce standardized pr vep recordings comparable to those obtainable in T3 laboratories the system performed well in different locations using inexperienced operators the system is suitable for multicentre research studies and telemedicine\n",
      "Generated Text: the patternreversal visual CEP pr vep is an EDX test which uses an AC checkerboard DP as the visual stimulus to validate the performance of an automated MTS the equipment was installed in five locations in three countries the uk greece and cyprus pr veps require accurate control of stimulus orientation and the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test is performed in a single session the test\n",
      "BLEU: 0.1103822134891305, ROUGE-L: {'r': 0.3252032520325203, 'p': 0.9090909090909091, 'f': 0.47904191228656456}, Perplexity: 1.9866214990615845, Cosine Similarity: 0.4641\n",
      "Reference Text: the discharge of wastewater effluents to a stream that is subsequently used for drinking water abstraction has been previously referred to as de facto water reuse where the abstraction of surface water for drinking water production occurs via induced bank filtration or aquifer recharge additional sitespecific factors should be considered to assess the impact of wastewater effluents on bankfiltered water this T0 represents the first national reconnaissance to quantify wastewater effluent contributions in streams across germany and consequences for indirect drinking water abstraction from these streams an automated assessment using arcgis was conducted for river basins considering minimum and mean average discharge conditions of streams as well as discharge from more than wastewater facilities in urban areas where the NK base discharge is low wastewater effluent contributions greater than were determined under mean minimum discharge conditions which commonly prevail from may to september a conceptual mlfreported SD and ambulatory blood pressure phenotypes in patients with hypertension and those with or without ckd\n",
      "Generated Text: the discharge of wastewater effluents to a stream that is subsequently used for drinking water abstraction has been previously referred to as de facto water reuse where the abstraction of surface water for drinking water production occurs via induced bank filtration or aquifer recharge additional sitespecific factors should be considered in the design of water reuse projects to ensure that the water reuse project is not adversely affected by the discharge of wastewater effluents to a stream that is subsequently used for drinking water production\n",
      "BLEU: 0.2576474062804899, ROUGE-L: {'r': 0.37962962962962965, 'p': 0.82, 'f': 0.5189873374459222}, Perplexity: 16.877025604248047, Cosine Similarity: 0.7292\n",
      "Reference Text: to investigate the relationship of hospital admissions due to unexplained syncope and OH oh with subsequent cardiovascular events and mortality\n",
      "Generated Text: to investigate the relationship of hospital admissions due to unexplained syncope and OH oh with subsequent cardiovascular events and mortality in a large cohort of patients with OH OH and syncope hospital admissions due to OH OH were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions due to OH OH and syncope were associated with a higher risk of cardiovascular events and mortality than OH OH and syncope hospital admissions\n",
      "BLEU: 0.04001343402038486, ROUGE-L: {'r': 1.0, 'p': 0.6428571428571429, 'f': 0.782608690888469}, Perplexity: 1.3413766622543335, Cosine Similarity: 0.7945\n",
      "Reference Text: previous work in our laboratory has shown the relation between WBCs wbc and the generation of oxidants in endotoxin lps shock the purpose of this study was to find out if wbcderived oxidants can produce acute lung injury in guinea pigs given lps we alos evaluated the efficacies of steroids and antioxidants against the initial changes in lpsinduced lung injury one group of guinea pigs g male received mgkg ld hrs of e coli lps in the peritoneal cavity GI the animals in group ii received mgkg of methylprednisolone mp followed by intraperitoneal lps the animals in group iii were given mgkg of aminomethyltertbutylpropionylphenol hydrochloride ono a known as antioxidant oh radical scavenger and then an injection of lps the animals were killed at following time course or T2 T3 the lps i.t. hematological examinations wbc counts total cell counts and differential counts in bronchoalveolar lavage bal fluid were done along with LM studies superoxide dismutase sod activity cat and malonaldehyde mda produced as a result of lipid peroxidation in the lung were measured and correlated with histological changes survival ratios of the three CG were compared the results obtained were significant leukopenia occurred in all CG in GI wbc especially eosinophils were recovered by bal and the total cell number of the bal fluid had increased by minutes after lps injection but mp or ono treatment inhibited the migration of wbc eosinophils and neutrophils into alveolar lumen T3 lps injection histologic examinations revealed diffuse edema hemorrhage and marked leukocyte infiltration in the alveoli in GI but not in group ii or iii sod activity in all group diminished below the control level cat had significantly increased by T2 T3 lps injection in GI but not in group ii or iii mda had increased remarkably by T2 after i.t. of lps in GI but mp or ono treatment prevented such increases animals in group ii and iii survived significantly longer than those in the other group in conclusion these findings suggest that lps provokes wbcmediated V1 damage in the lung and CS or antioxidants can minimize the injury and prevent edema formation CS might be useful for achieving quantifiable changes in lpsinduced wbc chemotaxis to the lung and for decreasing oxidantinduced lung injury\n",
      "Generated Text: previous work in our laboratory has shown the relation between WBCs wbc and the generation of oxidants in endotoxin lps shock the purpose of this study was to find out if wbcderived oxidants can produce acute lung injury in guinea pigs given lps we alos evaluated the efficacies of steroids and the antiinflammatory effect of the antiinflammatory drug ciclosporin in the acute lung injury of guinea pigs given lps we found that ciclosporin was able to reduce the number of wbc in the acute lung injury of guinea pigs given lps and that the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of ciclosporin was not dependent on the level of wbc in the acute lung injury of guinea pigs given lps the antiinflammatory effect of c\n",
      "BLEU: 0.17803781266899815, ROUGE-L: {'r': 0.22797927461139897, 'p': 0.8, 'f': 0.3548387062256115}, Perplexity: 1.9005414247512817, Cosine Similarity: 0.6425\n",
      "Reference Text: previous structural studies in our laboratory on lipopolysaccharide derived core oligosaccharide had identified a conserved inner core structure in several strains of the veterinary pathogens mannheimia haemolytica actinobacillus pleuropneumoniae and PM in this T0 we describe the elucidation of the OS structure of two strains from m haemolytica serotype structural information was established by a combination of monosaccharide and methylation analyses nmr spectroscopy and mass spectrometry the following structure for the core oligosaccharide was determined on the basis of the combined data from these experiments carbohydrate structure see text the structural analyses revealed that the conserved inner core structure was maintained in this serotype with only the terminal galactose residue of serotype absent\n",
      "Generated Text: previous structural studies in our laboratory on lipopolysaccharide derived core oligosaccharide had identified a conserved inner core structure in several strains of the veterinary pathogens mannheimia haemolytica actinobacillus pleuropneumoniae and PM in this T0 we describe the elucidation of the OS structure of two strains from m haemolytica serotype structural analysis of the OS of the two strains revealed that the OS of the two strains was composed of a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosaccharide and a core oligosacchar\n",
      "BLEU: 0.1999102417202305, ROUGE-L: {'r': 0.5774647887323944, 'p': 0.9111111111111111, 'f': 0.706896546975327}, Perplexity: 1.9589735269546509, Cosine Similarity: 0.4136\n",
      "Reference Text: CH is accompanied by molecular CR that affects different cellular pathways including HFA fa utilization in the present T0 we show that cardiac lipid metabolism is differentially regulated in response to physiological ET and pathological abdominal AB aab hypertrophic stimuli physiological hypertrophy was accompanied by an increased expression of lipogenic genes and the activation of sterol regulatory elementbinding proteinc and akt signaling additionally fa oxidation pathways regulated by ampactivated protein kinase ampk and peroxisome proliferator activated receptor ppar were induced in TR NF cardiac lipid content was not changed by physiological stimulation underlining balanced lipid utilization in the trained HR moreover pathological hypertrophy induced the ampkregulated oxidative pathway whereas ppar and expression of its downstream targets ie acylcoa oxidase and carnitine palmitoyltransferase i were not affected by aab in contrast pathological hypertrophy leads to cardiac triglyceride tg and diacylglycerol dag accumulation although the expression of lipogenic genes and the levels of fa transport proteins cd and fatp were not changed or reduced compared with the sham group a possible explanation for this phenomenon is a decrease in lipolysis as evidenced by the increased content of adipose triglyceride lipase inhibitor gs the increased phosphorylation of HSL at ser and the decreased protein C2 of dag lipase that attenuate tg and dag contents the increased tg and dag accumulation observed in aabinduced hypertrophy might have lipotoxic effects thereby predisposing to cardiomyopathy and HF in the future\n",
      "Generated Text: CH is accompanied by molecular CR that affects different cellular pathways including HFA fa utilization in the present T0 we show that cardiac lipid metabolism is differentially regulated in response to physiological ET and pathological abdominal AB aab hypertrophic stimuli physiological hypertrophy was accompanied by an increased expression of lipogenic genes in the heart and a decrease in the expression of genes involved in lipid metabolism in the liver we also show that the expression of genes involved in lipid metabolism is increased in the heart and liver of patients with aab hypertrophic syndrome and that the expression of genes involved in lipid metabolism is decreased in the heart and liver of patients with aab hypertrophic syndrome in the present T0 we show that the expression of genes involved in lipid metabolism is increased in the heart and liver of patients with aab hypertrophic syndrome and that the expression of genes involved in lipid metabolism is decreased in the heart and liver of patients with aab hypertrophic syndrome in the present T0 we show that the expression of genes involved in lipid metabolism is increased in the heart and liver of patients with aab hypertrophic syndrome and that the expression of genes involved in lipid metabolism is decreased in the heart and liver of patients with aab hypertrophic syndrome in the present T0 we show that the expression of genes involved in lipid metabolism is increased in the heart and liver of patients with aab hypertrophic syndrome and that the expression of genes involved in lipid metabolism is decreased in the heart and liver of patients with aab hypertrophic syndrome in the present T0 we show that the expression of genes involved in lipid metabolism is increased in the heart and liver of patients with aab hypertrophic syndrome and that the expression of genes involved in lipid metabolism is decreased in the heart and liver of patients with aab hypertrophic syndrome in the present T0\n",
      "BLEU: 0.18986718823452584, ROUGE-L: {'r': 0.33098591549295775, 'p': 0.8545454545454545, 'f': 0.4771573563812518}, Perplexity: 2.6841232776641846, Cosine Similarity: 0.6953\n",
      "Reference Text: PAs pas are toxic AA metabolites that are found in several distantly related families of the angiosperms the first specific step in pa biosynthesis is catalyzed by HSS hss which has been recruited several times independently by duplication of the gene encoding DHS an enzyme involved in the posttranslational activation of the eIF-5A hss shows highly diverse spatiotemporal gene expression in various paproducing species in comfrey\n",
      "Generated Text: PAs pas are toxic AA metabolites that are found in several distantly related families of the angiosperms the first specific step in pa biosynthesis is catalyzed by HSS hss which has been recruited several times independently by duplication of the gene encoding DHS an enzyme involved in the posttranslational activation of the hss protein the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and pa2 the hss protein is a member of the hss family of proteins that is responsible for the biosynthesis of the pa metabolites pa and\n",
      "BLEU: 0.11894206911684455, ROUGE-L: {'r': 0.803921568627451, 'p': 0.82, 'f': 0.811881183119302}, Perplexity: 1.927511215209961, Cosine Similarity: 0.5876\n",
      "Reference Text: endoplasmic reticulum er is an indispensable organelle for secretory protein synthesis as well as metabolism of phospholipids and their derivatives in eukaryotic cells various external and internal AF may cause an accumulation of aberrant proteins in the er which causes er AS and activates cellular er stress responses to cope with the stress in animal research molecular mechanisms for protein quality control upon er AS are well documented however how cells maintain lipid homeostasis under er stress is an emerging issue the ratio of phosphatidylcholine pc to phosphatidylethanolamine pe two L1 phospholipid classes is important under er stress in animal cells however in seed plants no study has reported on the changes in membrane lipid content under er stress although a number of physiologically important environmental stresses such as heat and salinity induce er AS here we investigated membrane glycerolipid metabolism under er stress in arabidopsis er AS transcriptionally affected pc and pe biosynthesis pathways differentially with no significant changes in membrane glycerolipid content our results suggest that higher plants maintain membrane lipid equilibrium during active transcription of phospholipid biosynthetic genes under er AS\n",
      "Generated Text: endoplasmic reticulum er is an indispensable organelle for secretory protein synthesis as well as metabolism of phospholipids and their derivatives in eukaryotic cells various external and internal AF may cause an accumulation of aberrant proteins in the er which causes er AS and activates cellular er stress responses to cope with the stress the er is a major target of the er stress response and is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is a major target of the er stress response in the er is\n",
      "BLEU: 0.11999466111340952, ROUGE-L: {'r': 0.38738738738738737, 'p': 0.9347826086956522, 'f': 0.5477706964939755}, Perplexity: 1.7692527770996094, Cosine Similarity: 0.5998\n",
      "Reference Text: the roles of plasma gastrin and duodenal pH in DU UD remain unclear in this pathophysiologic T0 plasma gastrin and dual gastroduodenal ph were measured before during and T3 cephalic stimulation modified SF and the ingestion of a meal in DU ulcer du patients and twelve healthy subjects gastrin levels were significantly higher in du patients both in the fasting state ngl vs ngl p less than and T3 the meal vs p less than two separate patient subsets were identified a hypergastrinemic hrg group exhibiting exaggerated gastrin responses and a normogastrinemic nog group comprised of patients with gastrin levels similar to those of controls only the hrg group exhibited a significant gastrin response to SF both patient CG exhibited a delayed ON of duodenal pH and delayed peak acid response after FF indicative of delayed GE of the acid load the hrg group exhibited a longer DU acid SE and a prolonged return to premeal ph C2 suggesting a defective switchoff mechanism of acid secretion T3 duodenal acidification\n",
      "Generated Text: the roles of plasma gastrin and duodenal pH in DU UD remain unclear in this pathophysiologic T0 plasma gastrin and dual gastroduodenal ph were measured before during and T3 cephalic stimulation modified SF and the ingestion of a meal in DU ulcer du patients and twelve healthy subjects gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the gastric ph in both groups gastrin levels were significantly higher in the duodenal ph than in the\n",
      "BLEU: 0.14921912847101101, ROUGE-L: {'r': 0.45161290322580644, 'p': 0.9545454545454546, 'f': 0.6131386817710054}, Perplexity: 1.9234415292739868, Cosine Similarity: 0.5392\n",
      "Reference Text: the boundaries of the organelles of the biosynthetic endomembrane system are still controversial in this paper we take advantage of the unique architectural organization of neurons to investigate the localization of ato different stages of rcc during years were studied two cell cultures could be propagated for more than passages in vitro hn was derived from a grade iii CCC hn originated from a metastatic brain lesion of a CCC grade iii karyotype analysis of hn revealed triploidy with a clonal aberration dertqp hn also had a triploid pattern with different marker chromosomes but without any clonal aberration loss of heterozygosity studies revealed no loss of heterozygosity on p or other chromosomal markers in hn but loh was found on one p marker and one q marker in addition to all p and q markers in hn in vitro LM showed distinctly different morphology in the two cell lines although they both had a typical epithelial growth DP doubling times in vitro were low but slightly higher for hn repeated tumorigenenic experiments in athymic mice only gave rise to subcutaneous PT with hn on characterization by dimensional gel electrophoresis the two cell lines exhibited different polypeptide patterns with higher expression of proliferating cell nuclear antigen in hn and higher expression of glutathionestransferase in hn constituting the most prominent differences\n",
      "Generated Text: the boundaries of the organelles of the biosynthetic endomembrane system are still controversial in this paper we take advantage of the unique architectural organization of neurons to investigate the localization of ato different stages of rcc during years were studied two cell cultures could be propagated for more than passages of days and the cells were cultured in the presence of different concentrations of the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor rcc and the rcc inhibitor r\n",
      "BLEU: 0.14031472165787512, ROUGE-L: {'r': 0.3181818181818182, 'p': 0.8571428571428571, 'f': 0.46408839384145784}, Perplexity: 1.839638352394104, Cosine Similarity: 0.2351\n",
      "Reference Text: shiga toxinproducing escherichia coli stec especially of serotype oh cause a zoonotic food or waterborne enteric illness that is often associated with C1 epidemic outbreaks as well as the HUS hus the leading cause of acute renal failure in children T3 ingestion stec colonize enterocytes of the large bowel with a characteristic attaching and effacing pathology which is mediated by components of a type iii secretion apparatus encoded by the lee pathogenicity island shiga toxins are translocated from the bowel to the circularoty system and transported by leukocytes to capillary EC cells in renal glomeruli and other organs T3 IB to the receptor globotriaosylceramide on target cells the toxin is internalized by RME and interacts with the subcellular machinery to inhibit protein synthesis this leads to pathophysiological changes that result in hus specific therapeutic or preventive strategies are presently not available the recent sequencing of genomes of two epidemic e coli o strains has revealed novel pathogenicity islands which will likely provide new insights into the virulence of these bacteria\n",
      "Generated Text: shiga toxinproducing escherichia coli stec especially of serotype oh cause a zoonotic food or waterborne enteric illness that is often associated with C1 epidemic outbreaks as well as the HUS hus the leading cause of acute renal failure in children T3 ingestion stec colonize enterocytes of the large bowel with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of the small intestine with a toxin that is produced by the stec colonizing the enterocytes of\n",
      "BLEU: 0.1318743192388196, ROUGE-L: {'r': 0.36666666666666664, 'p': 0.9166666666666666, 'f': 0.5238095197278912}, Perplexity: 1.9256783723831177, Cosine Similarity: 0.6320\n",
      "Reference Text: synuclein syn a presynaptic protein with the tendency to aggregate is linked to synucleinopathies such as FPD pd DLB dlb and multiple system atrophy msa syn is the main component of round intracytoplasmic inclusions called lewy HB lbs which are the hallmark of pd and dlb in addition accumulation of amyloid and neurofibrillary tangles as in the pathology of alzheimers disease has been found in the dlb BB glial cytoplasmic inclusions are an msaspecific type of inclusion found in oligodendrocytes and mainly comprise syn fkbinding protein fkbp is a member of the immunophilin family with peptidylprolyl isomerase activity that promotes protein folding and is believed to act as a chaperone protein previous in vitro work indicated that fkbp accelerated syn aggregation more than other peptidylprolyl isomerases the enzymatic activity of fkbp increases the formation of syn fibrils at subnanomolar concentrations in this T0 we found that fkbp colocalized with syn in lbs and neurites in pd and dlb brains furthermore fkbpimmunopositive neurofibrillary tangles colocalized with phosphorylated tau in dlb and fkbpimmunopositive glial cytoplasmic inclusions colocalized with syn in msa these findings suggest that fkbp is linked to the accumulation of syn and phosphorylated tau in synucleinopathies fkbp may play important roles in the pathogenesis of synucleinopathies through its strong aggregation CF thus fkbp could be an important drug target for synucleinopathies\n",
      "Generated Text: synuclein syn a presynaptic protein with the tendency to aggregate is linked to synucleinopathies such as FPD pd DLB dlb and multiple system atrophy msa syn is the main component of round intracytoplasmic inclusions called lewy HB lbs which are the hallmark of pd and dlb in addition accumulation of syn in the cytoplasm of the dlb is a hallmark of msa and is associated with the development of pd and dlb in the mouse the aim of this study was to investigate the role of syn in the development of pd and dlb in the mouse and to determine whether the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse we used a mouse model of pd and dlb in which the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse we found that the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse and that the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse we also found that the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse and that the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse we also found that the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse and that the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse we also found that the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse and that the accumulation of syn in the cytoplasm of dlb is associated with the development of pd and dlb in the mouse we also found that the accumulation of syn in the\n",
      "BLEU: 0.18622419087502926, ROUGE-L: {'r': 0.3644067796610169, 'p': 0.7413793103448276, 'f': 0.48863635921745874}, Perplexity: 2.4481632709503174, Cosine Similarity: 0.7682\n",
      "Reference Text: a simple screening method form and yet be euthyroid on further testing patients with subacute thyroiditis or hyperthyroidism may have abnormalities in LF tests which return to normal as the thyroid condition improves in similar fashion patients with acute or chronic CL disease may have changes in TFTs which improves as the liver inflammation resolves these interrelationships must be remembered if PE in patient care are to be avoided\n",
      "Generated Text: a simple screening method form and yet be euthyroid on further testing patients with subacute thyroiditis or hyperthyroidism may have abnormalities in LF tests which return to normal as the thyroid condition improves in similar fashion patients with acute or chronic CL disease may have changes in TFTs which improves in similar fashion\n",
      "BLEU: 0.6997835373198742, ROUGE-L: {'r': 0.7592592592592593, 'p': 1.0, 'f': 0.863157889830471}, Perplexity: 53.613773345947266, Cosine Similarity: 0.8903\n",
      "Reference Text: this paper discusses MPM in the community and its relation to helpseeking the research is aimed at identifying the demographic and social characteristics that enhance the likelihood of MPM as measured by the general health questionnaire and to reveal how these determinants relate to health status in the second stage of the study the same characteristics are related to their effect on the decision to decision to consult a general practitioner and specifically on presenting psychosocial problems to the gp at the population level the likelihood of a high ghq score was greater for women divorced persons and the unemployed other variables remaining equal however ghq score was contaminated by poor subjective health perception especially for unemployed persons chronic PCS illness did not have an independent effect on the ghq score chronic PCS illness did influence helpseeking in addition several sociodemographic characteristics showed an independent effect on consulting behaviour for both ghqpositive and ghqnegative patients women unemployed persons and publicly insured patients with a minor psychiatric disturbance were more apt to visit their gp regardless of their physical health status however no sociodemographic characteristics increased the likelihood that a ghqpositive patient would present unambiguous psychosocial complaints as a reason to see their doctor\n",
      "Generated Text: this paper discusses MPM in the community and its relation to helpseeking the research is aimed at identifying the demographic and social characteristics that enhance the likelihood of MPM as measured by the general health questionnaire and to reveal how these determinants relate to health status in the second stage of the study the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the study was conducted in the community of the city of korea the\n",
      "BLEU: 0.1198450157120089, ROUGE-L: {'r': 0.3418803418803419, 'p': 0.9302325581395349, 'f': 0.4999999960695313}, Perplexity: 1.559794306755066, Cosine Similarity: 0.5495\n",
      "Reference Text: a growing incidence of EPS eps has been reported recently in japan and it is now urgent to establish preventive measures against eps OD in the present paper we describe our observational results regarding the risk of eps development and the characteristic features of patients with eps in terms of peritoneal morphology and peritoneal function as determined by peritoneal equilibration test the ongoing working protocol for eps prevention at jikei university hospital is also discussed our findings have revealed that LT continuouscalculation of u v and w velocity vectors we quantified the wakes of rainbow trout oncorhynchus mykiss cm total BL bl swimming steadily in a recirculating flow tank at a slow cruising speed of bl s these data extend the comparative basis of current hydromechanical data on the wakes of freeswimming fishes to the salmoniforms and are used to test current hypotheses of fin function by calculations of mechanical performance and froude efficiency stereodpiv wake images showed threedimensional views of oscillating jet flows high in velocity relative to freestream values these jet flows are consistent with the central momentum jet flows through the cores of shed vortex rings that have been previously viewed for caudal fin swimmers using 2DE dpiv the magnitude and direction of u v and w flows in these jets were determined over a time series of consecutive strokes by each of four fish although the fish swam at the same relative speed the absolute magnitudes of u v and w were dependent on individual because of body size R2 vertical flows were small in magnitude cm s and VL in direction indicating limited and variable vertical force production during slow steady forward swimming thus in contrast to previous data from sunfish lepomis macrochirus and mackerel scomber japonicus the trout homocercal caudal fin does not appear to generate consistent vertical forces during steady swimming u flows were of the order of cm s lateral flows were typically strongest with w magnitudes of cm s such strong lateral flows have also been shown for more derived euteleosts with homocercal caudal fins the ratios of the magnitudes of wake flow uuvw which is a flow equivalent to mechanical performance were also dependent on individual and ranged from to a range similar to the range of mechanical performance values previously determined using standard twodimensional dpiv methods for caudal fin locomotion by more derived euteleosts strong lateral jet flow appears to be a general feature of caudal fin locomotion by teleosts and may reflect the nature of undulatory propulsion as a posteriorly propagated wave of bending froude efficiency etap was independent of individual mean etap was which is similar to previous findings for trout\n",
      "Generated Text: a growing incidence of EPS eps has been reported recently in japan and it is now urgent to establish preventive measures against eps OD in the present paper we describe our observational results regarding the risk of eps development and the characteristic features of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with eps in terms of the clinical features of eps and the clinical characteristics of patients with\n",
      "BLEU: 0.13509103754223412, ROUGE-L: {'r': 0.17256637168141592, 'p': 0.9512195121951219, 'f': 0.29213482886111464}, Perplexity: 1.5387707948684692, Cosine Similarity: 0.6571\n",
      "Reference Text: injury indicators can be used to give policy makers an estimate of the scale of injuries and their longterm effects they can help compare injury levels in different Az and countries and can be used to help measure the effectiveness of interventions work on severity related indicators is promising however there are no perfect indicators to date as many are hampered with difficulties in case definition and under reporting for example mortality rates are affected by improvements in care even if the incidence of an injury remains the same the AIS ais takes T2 to code and so is not used in health service databases surveys have problems with recall bias definition of injury and response rates if we accept that we need to make the best out of imperfect indicators and imperfect data then we should use multiple sources of data and accept that no one indicator can be used universally but needs to be selected for the purpose for example one possible new indicator of the incidence of nonfatal injury might be fracture data in the emergency department fractures are painful and so nearly always end up with a hospital attendance this might give a means to compare incidence of nonfatal injury in different areas and countries in conclusion we need injury indicators to progress in injury prevention imperfect indicators can be used for targeting and evaluating interventions as long as we know and adjust for their limitations\n",
      "Generated Text: injury indicators can be used to give policy makers an estimate of the scale of injuries and their longterm effects they can help compare injury levels in different Az and countries and can be used to help measure the effectiveness of interventions work on severity related indicators is promising however the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and the use of these indicators in the assessment of the impact of interventions is limited and\n",
      "BLEU: 0.11328932241365605, ROUGE-L: {'r': 0.29457364341085274, 'p': 0.9047619047619048, 'f': 0.44444444073868894}, Perplexity: 1.606557846069336, Cosine Similarity: 0.5750\n",
      "Reference Text: about onethird of lithiumtreated BP patients are excellent lithium NR that is lithium monotherapy totally prevents further episodes of BP disorder for ten years and more these patients are clinically characterized by an episodic clinical course with CR remission a bipolar family history low psychiatric comorbidity maniadepression episode sequences a moderate number of episodes and a low number of hospitalizations in the prelithium period recently it has been found that temperamental features of hypomania a hyperthymic temperament and a lack of cognitive disorganization predict the best results of lithium prophylaxis lithium exerts a neuroprotective effect in which increased expression of brainderived neurotrophic factor bdnf and inhibition of the glycogen synthase kinase gsk play an important role the response to lithium has been connected with the TT of the bdnf gene and SS bdnf levels a better response to lithium is connected with the met allele of the bdnf valmet polymorphism as is a hyperthymic temperament excellent lithium NR have normal cognitive functions and serum bdnf levels even T3 LT duration of the illness the preservation of cognitive functions in longterm lithiumtreated patients may be connected with the stimulation of the bdnf system with the resulting prevention of affective episodes exerting deleterious cognitive effects and possibly also with lithiums antiviral effects a number of candidate genes that are related to neurotransmitters intracellular signaling neuroprotection circadian rhythms and other pathogenic mechanisms of bipolar disorder were found to be associated with the lithium prophylactic response the consortium on lithium genetics conligen has recently performed the first genomewide association T0 on the lithium response in BP disorder\n",
      "Generated Text: about onethird of lithiumtreated BP patients are excellent lithium NR that is lithium monotherapy totally prevents further episodes of BP disorder for ten years and more these patients are clinically characterized by an episodic clinical course with CR remission a bipolar family history low psychiatric comorbidity maniadepression episode sequences a high risk of BP disorder and a high risk of BP recurrence in the long term lithium treatment is associated with a reduction in the risk of BP recurrence in the long term and a reduction in the risk of BP recurrence in the short term lithium treatment is associated with a reduction in the risk of BP recurrence in the short term and a reduction in the risk of BP recurrence in the long term\n",
      "BLEU: 0.154062488444491, ROUGE-L: {'r': 0.3108108108108108, 'p': 0.8363636363636363, 'f': 0.45320196649275646}, Perplexity: 14.751992225646973, Cosine Similarity: 0.6688\n",
      "Reference Text: recent studies using mouse models demonstrate that cd t cells are sufficient to mediate acute cardiac allograft AAR in the absence of cd t cells and b cells however the mechanistic basis of cdmediated AAR is unclear one potential mechanism of cdmediated rejection is via elaboration of proinflammatory cytokines such as Th1 to determine whether ifngamma is a critical cytokine in cdmediated acute cardiac allograft rejection we studied whether the expression of ifngamma receptors on the donor heart was required for cdmediated AAR to investigate this possibility purified cd t cells were transferred into immunedeficient mice bearing heterotopic cardiac allografts from Th1 receptordeficient grko donors while cd t cells triggered AR of wildtype heart allografts they failed to trigger rejection of grko HR allografts the impairment in cdmediated rejection of grko NF appeared to primarily involve the efferent phase of the immune response this conclusion was based on the findings that grko stimulator cells provoked normal cd proliferation in vitro and that intentional in vivo challenge of cd cells with wildtype donor apc or the adoptive transfer of in vitro primed cd TA failed to provoke acute rejection of grko allografts in contrast unseparated lymph node cells acutely rejected both grko and wildtype hearts with similar time courses illustrating the existence of both ifngammadependent and ifngammaindependent mechanisms of AR\n",
      "Generated Text: recent studies using mouse models demonstrate that cd t cells are sufficient to mediate acute cardiac allograft AAR in the absence of cd t cells and b cells however the mechanistic basis of cdmediated AAR is unclear one potential mechanism of cdmediated rejection is via elaboration of proinflammatory cytokines such as IL-1 and IL-6 which are known to induce CD t cell activation and to induce apoptosis in the absence of cd t cells however the role of CD t cells in mediating the acute rejection of aortic grafts in vivo is not clear and the role of CD t cells in mediating the acute rejection of aortic grafts in vitro is not clear either the role of CD t cells in mediating the acute rejection of aortic grafts in vivo is not clear and the role of CD t cells in mediating the acute rejection of aortic grafts in vitro is not clear\n",
      "BLEU: 0.26525523359872755, ROUGE-L: {'r': 0.336, 'p': 0.7241379310344828, 'f': 0.45901638911284315}, Perplexity: 4.929582118988037, Cosine Similarity: 0.7866\n",
      "Reference Text: the initial latency of spikes evoked by click stimulation and the duration over which spiking occurred were observed in the inferior colliculi of rats one ear of these animals had been deprived of early auditory stimulation by ligation of the external meatus clicks presented to the normally experienced ears evoked spikes in the opposite colliculus with latencies that depended on the characteristic frequency of the unit lowfrequency less than khz units had latencies from msec latencies declined to msec for VHF greater than khz units T3 an ear had been deprived of sound from days after birth response latencies of units in the opposite colliculus with CFs below about khz were comparable to controls but most units above khz had latencies times control latencies spike activity evoked in these units did not continue as long as that for most comparable control units ears sound deprived for an equal period from DAB also had changes in latencies and response durations but these were much less than in the developmentally deprived latencies of gross potentials at the auditory nerve were not aff greater protein sparing\n",
      "Generated Text: the initial latency of spikes evoked by click stimulation and the duration over which spiking occurred were observed in the inferior colliculi of rats one ear of these animals had been deprived of early auditory stimulation by ligation of the external meatus clicks presented to the normally experienced ears evoked a spike in the inferior colliculus of the rat in the first second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the second second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the third second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the fourth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the fifth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the sixth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the seventh second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the eighth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the ninth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the tenth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the eleventh second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the twelfth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the thirteenth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the fourteenth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the fifteenth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the sixteenth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the seventeenth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the eighteenth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the nineteenth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the twentieth second of the stimulation period the spiking occurred in the inferior colliculus of the rat in the twenty\n",
      "BLEU: 0.12745343624136693, ROUGE-L: {'r': 0.41414141414141414, 'p': 0.6307692307692307, 'f': 0.4999999952149019}, Perplexity: 1.7430529594421387, Cosine Similarity: 0.6046\n",
      "Reference Text: a total of ross male broiler chicks  g were used in a five week experiment to determine the effect of a protease and essential oils eo on growth performance blood cell profile nutrient PR ileal microbiota excreta gas emission and breast meat quality in broiler chicks broiler chicks were randomly allotted to four dietary treatments with birdscage and six cagestreatment exp treatments were arranged as a  factorial with two C2 of protease and and two levels of eo and for days to and overall body weight gain and the FCR were better in broilers fed diets supplemented with protease p than in those fed diets without protease supplementation protease andor eo increased p the total tract retention of dry matter nitrogen or gross energy and decreased the excreta ammonia gas emission in addition there was a significant interaction between the protease and eo on total tract PR of nitrogen and excreta ammonia gas emission p the density of ileal lactobacillus increased and escherichia coli decreased in broilers p by the addition of eo to the diet there were no significant differences in the measurements of breast meat SQ and organ weight of broilers fed diets with protease or eo in conclusion diets with a combination of a protease and eo improved total tract retention of nitrogen and excreta ammonia gas emission in growing broiler chicks\n",
      "Generated Text: a total of ross male broiler chicks  g were used in a five week experiment to determine the effect of a protease and essential oils eo on growth performance blood cell profile nutrient PR ileal microbiota excreta gas emission and breast meat quality in broiler chicks broiler chicks were fed a diet containing either eo or eo plus essential oils for five weeks and were monitored for growth performance and blood cell profile blood cell profile was measured by a fluorescent probe and the gas emission was measured by a gas analyzer in the presence of eo and essential oils eo and essential oils were administered to the chicks at the beginning of the experiment and at the end of the experiment the chicks were fed a diet containing either eo or eo plus essential oils for five weeks and were monitored for growth performance and blood cell profile blood cell profile was measured by a fluorescent probe and the gas emission was measured by a gas analyzer in the presence of eo and essential oils eo and essential oils were administered to the chicks at the beginning of the experiment and at the end of the experiment the chicks were fed a diet containing either eo or eo plus essential oils for five weeks and were monitored for growth performance and blood cell profile blood cell profile was measured by a fluorescent probe and the gas emission was measured by a gas analyzer in the presence of eo and essential oils\n",
      "BLEU: 0.24834607184829807, ROUGE-L: {'r': 0.40186915887850466, 'p': 0.7166666666666667, 'f': 0.5149700552762738}, Perplexity: 3.8826615810394287, Cosine Similarity: 0.7023\n",
      "Reference Text: hepatitis b is considered to be a worldwide public health problem an immunosuppressor microenvironment has been proposed to contribute to viral persistence during chronic disease understanding the intracellular signaling cascade in tcells from hbvinfected patients will contribute to unravel the mechanisms that control the development of immune response during SH b we analyze lipid rafts formation and early activation signals in chronic hbv infected patients compared to naturally immune subjects nis patients show diminished gm clustering a deficient lipid rafts recruitment of cdzapgrb and these proteins do not merge with gm within the lipid rafts finally immunoprecipitation assays proved that zap does not associate to cd these results show for the first time defects regarding early key events in tcell activation in chronically infected hbv patients which may contribute not only to understand hbv IT but to reveal new potential therapeutic targets to control the infection\n",
      "Generated Text: hepatitis b is considered to be a worldwide public health problem an immunosuppressor microenvironment has been proposed to contribute to viral persistence during chronic disease understanding the intracellular signaling cascade in tcells from hbvinfected patients will contribute to unravel the mechanisms that control the development of immune response during SHP and to develop novel therapeutic strategies for the treatment of chronic viral infections\n",
      "BLEU: 0.21495169400242267, ROUGE-L: {'r': 0.43137254901960786, 'p': 0.8627450980392157, 'f': 0.5751633942483662}, Perplexity: 24.01401710510254, Cosine Similarity: 0.7356\n",
      "Reference Text: the aim of this investigation was to evaluate the effects of lowlevel laser therapy on interleukin il C2 in gingival CF and its rho with orthodontic tooth movement\n",
      "Generated Text: the aim of this investigation was to evaluate the effects of lowlevel laser therapy on interleukin il C2 in gingival CF and its rho with orthodontic tooth movement in a patient with gingival CF and a patient with orthodontic tooth movement\n",
      "BLEU: 0.6705571151927857, ROUGE-L: {'r': 1.0, 'p': 0.9285714285714286, 'f': 0.9629629579698218}, Perplexity: 20.32874870300293, Cosine Similarity: 0.8990\n",
      "Reference Text: tensorbased morphometry can recover threedimensional longitudinal BB changes over time by nonlinearly registering baseline to followup mri scans of the same subject here we compared the anatomical distribution of longitudinal BB structural changes over months using a subset of the adni dataset consisting of patients with alzheimers disease ad healthy elderly controls and individuals with MCI mci each individual longitudinal NC map jacobian map was created using an unbiased registration technique and spatially normalized to a geometricallycentered average image based on healthy controls voxelwise statistical analyses revealed regional differences in atrophy rates and these differences were correlated with clinical measures and biomarkers consistent with prior studies we detected widespread CA in ad and a more restricted atrophic DP in mci in mci temporal lobe atrophy rates were correlated with changes in MMSE mmse scores clinical dementia rating cdr and logicalverbal learning SM scores in ad temporal atrophy rates were correlated with several biomarker indices including a higher csf level of ptau protein and a greater csf taubeta amyloid abeta ratio temporal lobe atrophy was significantly faster in mci subjects who converted to ad than in nonconverters serial mri scans can therefore be analyzed with nonlinear image registration to relate ongoing neurodegeneration to a variety of pathological biomarkers cognitive changes and conversion from mci to ad tracking PD in dimensional detail\n",
      "Generated Text: tensorbased morphometry can recover threedimensional longitudinal BB changes over time by nonlinearly registering baseline to followup mri scans of the same subject here we compared the anatomical distribution of longitudinal BB structural changes over months using a subset of the adni dataset consisting of patients with alzheimers disease ad healthy controls and patients with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with chronic\n",
      "BLEU: 0.1264683145212702, ROUGE-L: {'r': 0.30935251798561153, 'p': 0.9347826086956522, 'f': 0.46486486112841496}, Perplexity: 1.933536410331726, Cosine Similarity: 0.1963\n",
      "Reference Text: the selection of matching strains for use in outbreaks of footandmouth disease fmd virus can be assessed in vivo or by serological rvalue determination sera from animals involved in vaccine potency and crossprotection trials performed using the protection against podal generalization ppg test for two serotype a strains were collected and analyzed by the VNT vnt and liquidphase elisa lpelisa in three laboratories the average vnt rvalues for medium and high SS titer classes from the a cruzeiro vaccinated animals were in line with the aarg rat ppg outcome for all testing laboratories suggesting that the vaccine CS a cruzeiro is unlikely to protect against the field isolate aarg the corresponding lpelisa rvalues were slightly higher and indicate a closer relationship between both strains pooling of serum samples significantly reduced the interanimal and intertrial R2 the results suggest that a suitable reference SS for vaccine matching rvalue experiments might be a pool or a medium to high vnt or lpelisa titer serum furthermore the vnt seems to produce the most reproducible interlaboratory results more work is however needed in order to substantiate these claims\n",
      "Generated Text: the selection of matching strains for use in outbreaks of footandmouth disease fmd virus can be assessed in vivo or by serological rvalue determination sera from animals involved in vaccine potency and crossprotection trials performed using the protection against podal generalization ppg test for two serotype a strains were collected from the same animals and the same laboratory and the same strain was used for the immunization trials the serotype a strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and the serotype b strains were selected for use in the immunization trials and\n",
      "BLEU: 0.12651127551170163, ROUGE-L: {'r': 0.38596491228070173, 'p': 0.8461538461538461, 'f': 0.5301204776251996}, Perplexity: 2.133622646331787, Cosine Similarity: 0.6418\n",
      "Reference Text: the myelographic features in patients with clinical thoracic spinal cord disease and normal plain radiographs were reviewed to reevaluate the role of preoperative myelography since the advent of computed tomography and magnetic resonance the most frequent lesions were meningioma cases prolapsed IVD cases and metastases cases the extent and anatomical location of the lesion was demonstrated in all patients without myelographic block in cases with complete block the anatomical location was demonstrated in and the extent of the lesion in four using cervical puncture in two and CTM in one myelography remains a valuable method of assessment of the thoracic spinal cord and canal and is sufficient to allow the preoperative planning of surgical management in the absence of CR block additional investigation by computed tomography or magnetic resonance imaging is advised in the presence of complete block or an IM lesion\n",
      "Generated Text: the myelographic features in patients with clinical thoracic spinal cord disease and normal plain radiographs were reviewed to reevaluate the role of preoperative myelography since the advent of computed tomography and magnetic resonance the most frequent lesions were meningioma cases prolapsed IVD cases and metastases cases the extent and anatomical location of the lesions were evaluated and the clinical features of the lesions were compared with those of normal plain radiographs the results of the comparison were compared with those of the patients with normal plain radiographs and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the comparison were compared with those of the patients with thoracic spinal cord disease the results of the comparison were compared with those of the patients with thoracic spinal cord disease and the results of the\n",
      "BLEU: 0.1310789195275626, ROUGE-L: {'r': 0.5194805194805194, 'p': 0.8888888888888888, 'f': 0.6557377002620264}, Perplexity: 1.8538092374801636, Cosine Similarity: 0.6593\n",
      "Reference Text: the kinetics of doublestrand formation were measured by using temperaturejump kinetic techniques for the dna oligonucleotides dcag dctg the analogous rna oligonucleotides rcag rcug and the hybrid rcag dctg the dna oligonucleotides have a faster rate of recombination and a slower rate of dissociation at degrees c than the rna oligonucleotides the hybrid has about the same recombination rate and a slightly faster dissociation rate than the rna oligonucleotides the E(a) for recombination for the dna and rna oligonucleotides are both near kcalmol the difference in dissociation and recombination E(a) is consistent with the thermodynamic results obtained earlier the EC50 process is composed of two exponential components for the rna and hybrid oligonucleotides at temperatures of degrees c and lower one exponential component is observed for these oligonucleotides above degrees c and for the dna oligonucleotides at all temperatures\n",
      "Generated Text: the kinetics of doublestrand formation were measured by using temperaturejump kinetic techniques for the dna oligonucleotides dcag dctg the analogous rna oligonucleotides rcag rcug and the hybrid rcag dctg the dna oligonucleotides have a faster rate of recombination and a slower rate of dissociation at degrees c than the rna oligonucleotides the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleotides were incubated at a temperature of 0C for a period of time and then at a temperature of 0C for a period of time the rna oligonucleot\n",
      "BLEU: 0.16727922583323634, ROUGE-L: {'r': 0.5151515151515151, 'p': 0.8292682926829268, 'f': 0.6355140139645385}, Perplexity: 1.90825617313385, Cosine Similarity: 0.5587\n",
      "Reference Text: in their quest to reduce nursing HC expenditures the various states in this country have looked to AL as a potentially preferred and lowercost housing alternative for their medicaid patients for an assistedliving program to save costs states must recognize that some assistedliving residents will not come from nursing homes but rather from private residences resulting in cost increases this article argues that this woodwork effectnew clients appearingis likely to be smaller than the level reported in the home and CC demonstrations but that the numbers are difficult to predict with the possibility of divestiture it also argues that the true savings from substitution or of one form of care for another depend on the nursing home reimbursement system in effect at the time\n",
      "Generated Text: in their quest to reduce nursing HC expenditures the various states in this country have looked to AL as a potentially preferred and lowercost housing alternative for their medicaid patients for an assistedliving program to save costs states must recognize that some assistedliving residents will not come from nursing homes and that the cost of housing is a major factor in the cost of care for these residents the state must also recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost of housing is a major factor in the cost of care for these residents the state must recognize that the cost\n",
      "BLEU: 0.11023546178185344, ROUGE-L: {'r': 0.5056179775280899, 'p': 0.8823529411764706, 'f': 0.6428571382255102}, Perplexity: 1.7838044166564941, Cosine Similarity: 0.5812\n",
      "Reference Text: a thirtyyearold woman was scheduled for laparoscopic myomectomy after IS of an epidural catheter at the l interspace GA anesthesia was induced with thiopental mg followed by VEC mg intravenously to facilitate tracheal intubation general anesthesia was maintained with sevoflurane and nitrous oxide just after intramyometrial injection of vasopressin blood pressure decreased from to mmhg and HR rate decreased from to beats x min the patient was ventilated with oxygen and we po atropine mg and ephedrine mg intravenously blood pressure increased to mmhg and HR rate increased to beats x min since electrocardiogram showed ST and premature VVI contraction we administered nicorandil mg followed by continuous infusion at a rate of mg x hr and lidocaine mg intravenously the st depression and premature VVI contraction disappeared immediately to decrease blood pressure and heart rate we increased inspiratory concentrations of sevoflurane and nitrous oxide and po local anesthetics via epidural catheter and hemodynamic parameters became gradually stable we estimate that severe hypotension observed in this case is associated with intramyometrial i.t. of vasopressin increased blooecause of the complexity of the disorder\n",
      "Generated Text: a thirtyyearold woman was scheduled for laparoscopic myomectomy after IS of an epidural catheter at the l interspace GA anesthesia was induced with thiopental mg followed by VEC mg intravenously to facilitate tracheal intubation general anesthesia was maintained with sevoflurane and nitrous oxide just after intramyometrial injection of vasopressin blood pressure was maintained with a systolic pressure of 120 mm Hg and a diastolic pressure of 90 mm Hg the patient was intubated with a catheter and a tracheostomy was performed with a tracheostomy tube and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheostomy tube was placed in the tracheostomy tube the patient was intubated with a catheter and a tracheost\n",
      "BLEU: 0.17239804465203817, ROUGE-L: {'r': 0.4423076923076923, 'p': 0.7931034482758621, 'f': 0.5679012299710411}, Perplexity: 2.0362603664398193, Cosine Similarity: 0.4173\n",
      "Reference Text: the performance of an energy conversion system depends on exergy analysis and entropy generation minimisation a new simple fourparameter equation is presented in this paper to predict the standard state absolute entropy of real gases sstd the MM development and validation were accomplished using the linear GP lgp method and a comprehensive dataset of widely used materials the proposed model was compared with the results obtained using a threelayer feed forward neural network MM ffnn MM the rootmeansquare error rmse and the coefficient of determination r of all data obtained for the lgp MM were jmol k and respectively several statistical assessments were used to evaluate the predictive power of the MM in addition this T0 provides an appropriate understanding of the most important molecular variables for exergy analysis compared with the lgp based MM the application of ffnn improved the r to the developed MM is useful in the design of materials to achieve a desired entropy value\n",
      "Generated Text: the performance of an energy conversion system depends on exergy analysis and entropy generation minimisation a new simple fourparameter equation is presented in this paper to predict the standard state absolute entropy of real gases sstd the MM development and validation were accomplished using the linear GP lgp method and the entropy of the gas was measured using the gas entropy method the results are presented in the form of a linear equation which is a simple and efficient method for the calculation of the standard state entropy of a gas sstd the results are presented in the form of a linear equation which is a simple and efficient method for the calculation of the standard state entropy of a gas\n",
      "BLEU: 0.3452550267749349, ROUGE-L: {'r': 0.4639175257731959, 'p': 0.8490566037735849, 'f': 0.5999999954302222}, Perplexity: 16.1142520904541, Cosine Similarity: 0.8205\n",
      "Reference Text: porous Si beads with an average particle diameter between and microm have been applied as packing material in CEC cec the experiments were directed to investigate whether it is really feasible and as promising as expected to use such small particles in cec plate heights of h approximately dp can be achieved which is smaller than the SP heights usually attained in highperformance liquid chromatography using a capillary packed with microm Si beads we achieved a plate height of h dp indicating the presence of dispersive effects like joule heating calculations demonstrate that at a field strength of about v cm one third of the SP height can be lost by joule heating effects if the heat is not removed by a cooling system additionally the hu curve is still descending at the maximum electroosmotic flow eof velocity we generated with the modified capillary electrophoresis SF-36 to fully exploit the potential of submicron size silicas higher field strengths ie higher eof E/A must be attained to T0 the influence of the kind of packing on the eof porous as well as nonporous silicas have been applied the experiments clearly indicate that the eof of porous and nonporous silicas is the same since the eof is more or less exclusively generated by the packing material the ZP of noctyl bonded microm silica has been determined the dependence of the ZP on the ph is MZ to the dependence of the eof on the ph in a packed capillary the point of zero charge of the silica is at ph\n",
      "Generated Text: porous Si beads with an average particle diameter between and microm have been applied as packing material in CEC cec the experiments were directed to investigate whether it is really feasible and as promising as expected to use such small particles in cec plate heights of h approximately dp can be achieved by using a single bead as a packing material in cec plate heights of h the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to the cec plate height of h and the cec plate height of h was measured by a scanning electron microscope the packing material was applied to\n",
      "BLEU: 0.14079273753553104, ROUGE-L: {'r': 0.36231884057971014, 'p': 0.8771929824561403, 'f': 0.5128205086832348}, Perplexity: 1.9510365724563599, Cosine Similarity: 0.6233\n",
      "Reference Text: this work was carried out in a uruguayan south american population to characterize agingassociated physiological arterial changes parameters markers of subclinical atherosclerosis and that associate agerelated changes were evaluated in healthy people a conservative RPA was used and people with nonphysiological and pathological conditions were excluded then we excluded subjects with a cardiovascular cv PS b cv disease c diabetes mellitus or renal failure and d traditional cv risk factors other than age and gender subjects n were submitted to noninvasive vascular studies goldstandard techniques to evaluate common cca internal and external carotid plaque prevalence cca intimamedia thickness and diameter cca stiffness percentual pulsatility compliance DC and beta aortic stiffness carotidfemoral pulse wave velocity and IP and CE pressure wavederived parameters age CG  and years old agerelated structural and functional V1 parameters profiles were obtained and analyzed considering data from other populations the work has the strength of being the first in latin america that uses an integrative RPA to characterize V1 agingrelated changes data could be used to define V1 aging and abnormal or diseaserelated changes\n",
      "Generated Text: this work was carried out in a uruguayan south american population to characterize agingassociated physiological arterial changes parameters markers of subclinical atherosclerosis and that associate agerelated changes were evaluated in healthy people a conservative RPA was used and people with nonphysiological and pathological conditions were excluded then we excluded subjects with a history of cardiovascular disease or diabetes mellitus and those with a history of hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or hyperlipidemia or a history of diabetes mellitus or hypertension or\n",
      "BLEU: 0.14526567103024637, ROUGE-L: {'r': 0.3709677419354839, 'p': 0.92, 'f': 0.5287356280882548}, Perplexity: 1.90127432346344, Cosine Similarity: 0.1750\n",
      "Reference Text: to evaluate trends and associations of HDP with stroke risk and test the hypothesis that hypertensive disorders of pregnancyassociated stroke results in higher rates of strokerelated complications than pregnancyassociated stroke without hypertensive disorders\n",
      "Generated Text: to evaluate trends and associations of HDP with stroke risk and test the hypothesis that hypertensive disorders of pregnancyassociated stroke results in higher rates of strokerelated complications than pregnancyassociated stroke without hypertensive disorders of pregnancy the association of HDP with stroke risk was evaluated in a prospective cohort of women with gestational diabetes mellitus and gestational hypertension in the first trimester of pregnancy the association of HDP with stroke risk was evaluated in a prospective cohort of women with gestational diabetes mellitus and gestational hypertension in the first trimester of pregnancy\n",
      "BLEU: 0.35176090629272494, ROUGE-L: {'r': 1.0, 'p': 0.6410256410256411, 'f': 0.781249995239258}, Perplexity: 6.014306545257568, Cosine Similarity: 0.7573\n",
      "Reference Text: human embryonic stem cells hescs have the ability to selfreplicate and differentiate into cells from all three EG layers thereby holding great promise for tissue regeneration applications however controlling the differentiation of hescs and obtaining homogenous differentiated cell populations still remain a challenge we present a highly efficient and reproducible experimental system that mimics the threedimensional d environment of in vivo chondrogenesis and that supports the directed differentiation of human embryoid body ebderived cells toward the chondrogenic lineage under serumfree chondrogenic culture conditions in the presence of bone morphogenetic protein bmp\n",
      "Generated Text: human embryonic stem cells hescs have the ability to selfreplicate and differentiate into cells from all three EG layers thereby holding great promise for tissue regeneration applications however controlling the differentiation of hescs and obtaining homogenous differentiated cell populations still remain a challenge we present a highly efficient and reproducible method for the differentiation of hescs into differentiated cells from the three EG layers we also show that the differentiation of hescs into differentiated cells from the three EG layers is dependent on the expression of a specific gene which is expressed in the embryonic stem cells and which is also expressed in the differentiated cells from the three EG layers we also show that the differentiation of hescs into differentiated cells from the three EG layers is dependent on the expression of a specific gene which is expressed in the embryonic stem cells and which is also expressed in the differentiated cells from the three EG layers\n",
      "BLEU: 0.33286570505726815, ROUGE-L: {'r': 0.647887323943662, 'p': 0.8070175438596491, 'f': 0.7187499950598146}, Perplexity: 5.012326240539551, Cosine Similarity: 0.7445\n",
      "Reference Text: the intraluminal pressure in the UES ues briefly decreases during swallowing this decrement in pressurespirator during daytime during night time she had apnea and her blood gas showed the retention of co and she still required the respiratory assistance during her sleep this is the first report of bvvl syndrome in japanese literature\n",
      "Generated Text: the intraluminal pressure in the UES ues briefly decreases during swallowing this decrement in pressurespirator during daytime during night time she had apnea and her blood gas showed the retention of co and she still required the respiratory assistance during her sleep this is the first report of bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl syndrome in a patient with apnea and bvvl\n",
      "BLEU: 0.1346601335479633, ROUGE-L: {'r': 0.9487179487179487, 'p': 0.925, 'f': 0.9367088557602948}, Perplexity: 1.8671461343765259, Cosine Similarity: 0.3786\n",
      "Reference Text: efficient behavior involves the coordinated activity of largescale BB networks but the way in which these networks interact is uncertain one theory is that the salience network snwhich includes the ACC presupplementary motor area and anterior insulaeregulates dynamic changes in other networks if this is the case then damage to the structural connectivity of the sn should disrupt the regulation of associated networks to investigate this hypothesis we studied a group of patients with cognitive impairments following traumatic brain injury tbi and control subjects using the stopsignal task the DP of brain activity associated with stopsignal task performance was studied by using fMRI and the structural integrity of network connections was quantified by using DWI tensor imaging efficient inhibitory control was associated with rapid deactivation within parts of the default mode network dmn including the precuneus and PCC tbi patients showed a failure of dmn deactivation which was associated with an impairment of GABA control tbi frequently results in traumatic ai which can disconnect BB networks by damaging VWM tracts the abnormality of dmn function was specifically predicted by the amount of WMD in the sn tract connecting the RA anterior insulae to the presupplementary motor area and dorsal anterior cingulate cortex the results provide evidence that structural integrity of the sn is necessary for the efficient regulation of activity in the dmn and that a failure of this regulation leads to inefficient cognitive control\n",
      "Generated Text: efficient behavior involves the coordinated activity of largescale BB networks but the way in which these networks interact is uncertain one theory is that the salience network snwhich includes the ACC presupplementary motor area and anterior insulaeregulates dynamic changes in other networks if this is the case then damage to the salience network may result in a loss of coordination in the other networks and thus a loss of the salience network may be a key factor in the pathophysiology of schizophrenia\n",
      "BLEU: 0.10336251360439425, ROUGE-L: {'r': 0.3360655737704918, 'p': 0.7884615384615384, 'f': 0.4712643636253139}, Perplexity: 25.428329467773438, Cosine Similarity: 0.7690\n",
      "Reference Text: the objectives of this experiment were to evaluate the accuracy of ultrasonography to measure subcutaneous FT sft and lm traits area depth and width in live awassi lambs of different sexes predict actual sft and lm traits without damage to the carcass and improve carcass classification data were obtained from ultrasound scans of female and male lambs female lambs were randomly divided into CS fl n and heavy fh n finishing groups slaughter weights of lambs in fl were kg and for fh and male CG were kg subcutaneous FT and lm traits crosssectional area between the th and th rib were measured using realtime ultrasound in vivo and on the carcass T3 slaughter all ultrasound and carcass measurements were different p except carcass yield and carcass lm width in female lambs fl and fh between different sex groups all ultrasound and carcass measurements were the same except ultrasound sft usft p and carcass sft csft p significant correlation coefficients were between usft and csft p p ultrasound lm depth ulmd and carcass lm depth clmd p p and ultrasound lm area ulma and carcass lm area clma p for female lambs in fl and fh CG also similar correlations were determined significantly between usft and csft p p ulmd and clmd p p and ulma and clma p for male lambs in male and fh CG the introduction of usft and ulma as independent variables in addition to bw in the multiple regression equations further improved the variations for csft and and clma and for lambs in fl fh and male CG respectively whereas no improvement was observed for cold carcass weight with the exception of the fh group and carcass yield these results indicate that in vivo usft and ulma in association with bw could be used to estimate csft clma and cold carcass weight ultrasound findings about lm and sft can be included to the selection programs for different bw and sex of awassi lambs\n",
      "Generated Text: the objectives of this experiment were to evaluate the accuracy of ultrasonography to measure subcutaneous FT sft and lm traits area depth and width in live awassi lambs of different sexes predict actual sft and lm traits without damage to the carcass and improve carcass classification data were obtained from the carcass of the first and second generations of the lambs and from the carcass of the third generation of lambs the results showed that the accuracy of ultrasonography was significantly improved in the first generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography was significantly improved in the third generation of lambs compared to the second generation of lambs and the third generation of lambs the accuracy of ultrasonography\n",
      "BLEU: 0.1446137880705961, ROUGE-L: {'r': 0.31451612903225806, 'p': 0.8125, 'f': 0.4534883680692267}, Perplexity: 1.9986964464187622, Cosine Similarity: 0.4545\n",
      "Reference Text: ET pco petco is a quantitative indicator of pulmonary blood flow generated by precordial compression and therefore predicts resuscitability during cpr a striking increase in petco follows return of spontaneous circulation since paco is closely related to alveolar pco paco and therefore petco we hypothesized that paco may itself serve as an indicator of the blood flow generated during cpr in a porcine MM of cardiac arrest paco during precordial compression was highly correlated with petco r cardiac SO r and coronary perfusion pressure cpp r in successfully resuscitated animals paco petco and cpp during precordial compression were significantly higher than in nine nonresuscitated animals T3 restoration of spontaneous circulation there was a marked increinistered to newborns and prematures bid or tid cases of which received azt alone and the other received azt in combination with ampicillin abpc of the above cases azt was given to cases for treatment and to the other cases for prophylaxis excluding unascertainable cases azt showed good or better effectiveness in all the cases in the TG ie sepsis suspected sepsis and urinary tract infection cases all the identified pathogens escherichia coli strains klebsiella pneumoniae strain and enterobacter strains were eliminated by the treatment no ON of infection was observed in either of the cases with prophylaxis one of them was administered with azt for days consecutively but neither side effect nor abnormal laboratory test value was observed side effect was not observed at all one case each of minor degree of platelet increase and got elevation was recorded as an abnormal test value the elevated got value continued to be high even after the completion of the administration and it was presumed to be due to the primary disease heart failure as results of the above studies azt was considered to be ERP and safe for neonatal infections caused by gramnegative bacteria it may be safer to initiate the treatment with azt and abpc in combination than with azt CT before the identification of pathogen and to change the therapy to single administration of either azt or abpc when the pathogens are identified with respect to method of administration azt mgkg or times a day appeared to show expected tau for the newborns with in DAB\n",
      "Generated Text: ET pco petco is a quantitative indicator of pulmonary blood flow generated by precordial compression and therefore predicts resuscitability during cpr a striking increase in petco follows return of spontaneous circulation since paco is closely related to alveolar pco paco and therefore petco we hypothesized that paco may itself serve as a surrogate for alveolar pco and thus predict the outcome of cpr in patients with a history of pulmonary embolism pco was measured in patients with a history of pulmonary embolism and in patients with a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and a history of pulmonary embolism and\n",
      "BLEU: 0.1518616912809742, ROUGE-L: {'r': 0.23404255319148937, 'p': 0.8301886792452831, 'f': 0.3651452247846973}, Perplexity: 1.9926539659500122, Cosine Similarity: 0.3733\n",
      "Reference Text: the R2 and covariation of cup and DD were studied in a material derived from a population survey and consisting of fundus photographs from as many eyes in subjects a simple device was used to facilitate focusing of the camera the colour slides were projected on to a screen at a fixed distance and measured on ruled paper the effect of refraction on the magnification in the eyecamera system was compensated by the use of a simple correcting factor some apparently quite normal discs nevertheless had an area more than four times larger than that of other equally normal ones the sizes of discs and cups covaried however to a suprisingly great extent r and changes in disc diameter were in general parallelled by similar changes in cup diameter the amount of tissue in the ONH therefore varied somewhat less than the disc size cup diameters were widely dispersed unevenly distributed and heavily dependent on disc size the average rim breadths on the other hand were much less dispersed normally distributed and independent on the disc diameter by taking the covariation of cup and DD into account the detection of any enlargement or diminution of the optic cup ought to be facilitated\n",
      "Generated Text: the R2 and covariation of cup and DD were studied in a material derived from a population survey and consisting of fundus photographs from as many eyes in subjects a simple device was used to facilitate focusing of the camera the colour slides were projected on to a screen at a distance of about 1 cm the subjects were asked to look at the slides and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation to the screen and to indicate the position of the eyes in relation to the screen the subjects were asked to indicate the position of the eyes in relation\n",
      "BLEU: 0.11568310783647241, ROUGE-L: {'r': 0.3220338983050847, 'p': 0.8260869565217391, 'f': 0.4634146301100536}, Perplexity: 1.8537932634353638, Cosine Similarity: 0.6942\n",
      "Reference Text: a case of cervical JM meningeal melanocytoma is presented along with results of careful neuroradiological and pathological examinations the authors review the previous literature and discuss the problems related to the intriguing diagnosis of this very rare entity ct and mri show variable appearances due to different degrees of melanization and do not reliably allow us to distinguish meningeal melanocytomas from other pigmented tumors pathological examination of the tumor is critical for diagnosis but it absolutely must comprise electron microscopy and immunohistochemistry immunohistochemical and ultrastructural criteria are thus proposed to distinguish meningeal melanocytoma from pigmented meningioma or schwannoma and malignant melanoma primary or secondary\n",
      "Generated Text: a case of cervical JM meningeal melanocytoma is presented along with results of careful neuroradiological and pathological examinations the authors review the previous literature and discuss the problems related to the intriguing diagnosis of this very rare entity ct and mri show variable appearances due to different degrees of melanization and the presence of a melanocytic tumor in the cervical region the authors suggest that the diagnosis of this rare entity should be made by a combination of clinical and histologic examination of the tumor and the presence of a melanocytic tumor in the cervical region\n",
      "BLEU: 0.5125956459065899, ROUGE-L: {'r': 0.5454545454545454, 'p': 0.75, 'f': 0.6315789424930748}, Perplexity: 15.744894981384277, Cosine Similarity: 0.7520\n",
      "Reference Text: to investigate the anatomical influence of the HCM VPI turbinate on computational fluid dynamics cfd model of unilateral HCM VPI turbinate nasal cavity and to analyze the BL detailed nasal airflow simulations under both inspiratory and expiratory phases in cfd model\n",
      "Generated Text: to investigate the anatomical influence of the HCM VPI turbinate on computational fluid dynamics cfd model of unilateral HCM VPI turbinate nasal cavity and to analyze the BL detailed nasal airflow simulations under both inspiratory and expiratory phases in cfd model of unilateral HCM VPI turbinate nasal cavity and to compare the computational fluid dynamics of the turbinate with the airflow of the nasal cavity in the cfd model of unilateral HCM VPI turbinate nasal cavity and to compare the computational fluid dynamics of the turbinate with the airflow of the nasal cavity in the cfd model of unilateral HCM VPI turbinate nasal cavity\n",
      "BLEU: 0.3852343330009867, ROUGE-L: {'r': 1.0, 'p': 0.9375, 'f': 0.967741930489074}, Perplexity: 7.871068000793457, Cosine Similarity: 0.9013\n",
      "Reference Text: the size of GE varices is one of the most important factors leading to hemorrhage related to portal hypertension an endoscopic evaluation of the size of gastroesophageal varices before and after different operations for portal hypertension was performed in patients with schistosomiasis as part of a randomized trial proximal splenorenal shunt pss n DSRS dss n and esophagogastric devascularization with splenectomy egds n the endoscopic DUE was performed before and up to years after the operations variceal size was graded according to palmers classification grade up to mm grade from to mm grade greater than mm and were analyzed in four anatomical locations inferior middle or superior third of the esophagus and proximal stomach the total number of points in the preoperative grading minus the number of points in the postoperative grading gave a differential grading allowing statistical comparison among the surgical groups good results in terms of disappearance or decrease of variceal size were observed more frequently T3 pss than T3 dss or egds and respectively when differential grading was analyzed a statistically significant difference was observed between pss and egds but not between PT and distal splenorenal shunts in conclusion shunt surgeries were more efficient than devascularization in diminishing variceal size\n",
      "Generated Text: the size of GE varices is one of the most important factors leading to hemorrhage related to portal hypertension an endoscopic evaluation of the size of gastroesophageal varices before and after different operations for portal hypertension was performed in patients with schistosomiasis as part of a randomized trial proximal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splenorenal splen\n",
      "BLEU: 0.2345981600197793, ROUGE-L: {'r': 0.3482142857142857, 'p': 0.975, 'f': 0.5131578908587258}, Perplexity: 1.5368082523345947, Cosine Similarity: 0.1373\n",
      "Reference Text: I/M thickening of the carotid wall is considered an early marker of atherosclerosis endothelial function is impaired in the presence of various cardiovascular risk factors that are implicated in the pathogenesis of atherosclerosis to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to years men and women HT who had never been treated and whose PH of increased blood pressure was no longer than months we evaluated several parameters intimalmedial thickening of the common CAs by bmode ultrasound forearm vascular response by straingauge plethysmography to intrabrachial infusion of acetylcholine and microg ml forearm tissue per minute an endotheliumdependent vasodilator or sodium nitroprusside and microg ml forearm tissue per minute an endotheliumindependent vasodilator calculated minimal forearm V1 resistances the ratio between mean arterial pressure and maximal forearm vasodilation induced by minutes of ischemia and minute of exercise and left ventricular mass index on echocardiography profile carotid wall I/M thickening showed a significant p inverse correlation with vasodilation to acetylcholine r and age r whereas no rho was observed with the response to sodium nitroprusside or with minimal forearm vascular resistances left ventricular mass index systolic and diastolic BPs and plasma cholesterol and gl C2 moreover vasodilation to acetylcholine showed no rho with minimal forearm V1 resistances or left ventricular mass index although comparison of different V1 districts such as the forearm MC and carotid artery does not allow for a conclusive interpretation the present data indicate that in HT carotid wall thickening is associated with reduced EDV and suggest that EC dysfunction might be involved in early arterial structural alterations\n",
      "Generated Text: I/M thickening of the carotid wall is considered an early marker of atherosclerosis endothelial function is impaired in the presence of various cardiovascular risk factors that are implicated in the pathogenesis of atherosclerosis to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V1 reactivity and carotid intimalmedial thickening in meansd age years range to evaluate the relationship between V\n",
      "BLEU: 0.1728059532379199, ROUGE-L: {'r': 0.2483221476510067, 'p': 0.9736842105263158, 'f': 0.39572192189539307}, Perplexity: 1.6075011491775513, Cosine Similarity: 0.5417\n",
      "Reference Text: a prefabricated sculptured subperiosteal orbital floor implant was used in six cases of cosmetically unacceptable deep superior eyelid sulcus that occurred T3 enucleation the implant provided anterior and superior displacement of orbital contents surgical placement was similar to the RPA for implant placement in orbital floor fracture and provided satisfactory cosmetic and PET results\n",
      "Generated Text: a prefabricated sculptured subperiosteal orbital floor implant was used in six cases of cosmetically unacceptable deep superior eyelid sulcus that occurred T3 enucleation the implant provided anterior and superior displacement of orbital contents surgical placement was similar to the RPA for implant placement in orbital floor fracture and provided satisfactory results in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in all cases the implant was successfully implanted in\n",
      "BLEU: 0.10099042180334014, ROUGE-L: {'r': 0.95, 'p': 0.926829268292683, 'f': 0.9382715999390336}, Perplexity: 1.9267328977584839, Cosine Similarity: 0.4265\n",
      "Reference Text: genomic dna sequences encoding the mu janus family IMT kinase jak were isolated to determine the intronexon structure of the gene and to investigate the phylogeny of jakfamily kinases the murine jak gene comprises approximately kbp of genomic dna and consists of exons the organization of sequences encoding the pseudokinase domain of jak is similar to the intronexon structure encoding catalytic domains of srcfamily TKs whereas the pattern of intronsexons encoding the jak KD shows no structural similarity to that of other IMT kinase genes genomic analysis further indicates that AS gives rise to different forms of the murine jak mrna encoding different isoforms of the jak protein analysis of jak intronexon structure also suggests that a mutation in the human jak gene responsible for a SCID scid phenotype results from aberrant splicing of the jak transcript finally potential regulatory sequences in the UP region of the murine jak gene were analyzed and are discussed in relation to the known expression pattern of jak\n",
      "Generated Text: genomic dna sequences encoding the mu janus family IMT kinase jak were isolated to determine the intronexon structure of the gene and to investigate the phylogeny of jakfamily kinases the murine jak gene comprises approximately kbp of genomic dna and consists of exons the organization of sequences encoding the pseudokinase is similar to that of the human jak kinase jak kinase is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene is a member of the jak family of kinases and is encoded by the jak gene in the murine jak gene\n",
      "BLEU: 0.16440611803758595, ROUGE-L: {'r': 0.4090909090909091, 'p': 0.8780487804878049, 'f': 0.5581395305474433}, Perplexity: 2.0402042865753174, Cosine Similarity: 0.7848\n",
      "Reference Text: hypophysectomy can be advised for diabetic patients whose vision is threatened by neovascular changes characterizing PR in the management of advancing breast CA hypophysectomy is recommended in postmenopausal natural or induced patients who have received two trials of HT we advocate wider application of hypophysectomy for advancing prostate CA where when used in CS after castration and administration of HT it will relieve pain and produce tumor regression in some patients unresponsive to other forms of treatment transsphenoidal cryohypophysectomy is a safe and ERP means of PIT ablation\n",
      "Generated Text: hypophysectomy can be advised for diabetic patients whose vision is threatened by neovascular changes characterizing PR in the management of advancing breast CA hypophysectomy is recommended in postmenopausal natural or induced patients who have received two trials of HT we advocate wider application of hypophysectomy for advancing prostate CA where the risk of neovascular changes is greatest and where the risk of developing neovascular changes is greatest in the management of advanced breast CA the use of hypophysectomy in the management of advanced breast CA is recommended in patients with a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA or who have a history of breast CA\n",
      "BLEU: 0.10583385395212111, ROUGE-L: {'r': 0.6176470588235294, 'p': 0.8571428571428571, 'f': 0.7179487130805756}, Perplexity: 2.0139448642730713, Cosine Similarity: 0.4374\n",
      "Reference Text: recombinant human eta receptors were expressed in a mouse FB cell L1 ltk cell and PET coupling of the receptors with ca permeable channels at low concentrations of endothelin et was investigated using wholecell recordings and monitoring the changes in [Ca2+]i cai with a ca indicator fluo a similar type of coupling was investigated in freshly dispersed vascular smooth muscle cells vsmcs of rabbit thoracic aorta by use of wholecell recordings in ltk cells expressing recombinant human eta receptors concentrations of et m m evoked an initial transient peak and a subsequent sustained elevation in cai whereas a lower concentration of et m evoked only a sustained elevation of cai after removal of extracellular ca et evoked only an initial peak without a sustained elevation of cai the sustained elevation induced by m et was blocked by microm mefenamic acid a cation channel blocker but not by microm nifedipine a blocker of VOC in wholecell recordings with ltk cells a brief min application of et m induced a sustained inward current at a holding potential of mv the currentvoltage relationship revealed that the reversal potential of the etinduced current was close to mv mv and was not altered by reducing the concentration of cl in the bath solution indicating that the current is carried by cations the current was reversibly blocked by microm mefenamic acid and it persisted after all cations in the bath solution had been replaced by ca or mm and nonpermeant cation nmethyld glucamineindicating that the etactivated channel is permeable to ca activation of the current was independent of membrane potential and the current was induced even T3 addition of a high concentration mm of a ca chelator egta to the pipette solution in wholecell recordings from rb aortic vsmcs etl m induced a sustained inward current at a holding potential of mv the reversal potential was mv and was not altered when the concentration of cl in the pipette solution was decreased indicating that the current is carried by cations again activation of the current was independent of membrane potential and was observed even after addition of a high cooxymethylisoxazolepropionic acid ampa microm induced inward currents at a holding potential of mv excitatory postsynaptic currents epscs were evoked by electrical stimulation either in the dorsal horn or the LF they reversed at sd mv and could in most cases of be separated into two components in the presence of dlaminophosphonovalerate microm the currentvoltage iv relationship of the remaining epsc was linear when stimulated in the lateral funiculus its rise time and the time constant of the monoexponential decay were and ms respectively by contrast when stimulated in the DH this component had a rise time of ms and a decay time constant of ms we studied the nmda receptormediated component of the epscs after superfusion of cyanonitroquinoxalinedione microm the iv relationship of this component had a region of negative slope conductance between and mv which was abolished in mgfree saline the rise time ranged from to ms and the decay was biexponential both decay time constants increased with depolarization mgfree saline reduced this voltage sensitivity at a membrane potential of mv and in mm extracellular mg the nmda receptormediated component represented of the total charge carried by the epscs evoked by stimulation in the DH in contrast when stimulated from the LF of the total charge carried during the epsc was mediated by the nmda receptormediated component the contribution of the nmda receptormediated component increased in both cases with depolarization in addition in of spns the epsc evoked in the DH was exclusively carried by nmda receptors we conclude that lglutamate or a related substance mediates the fast excitatory input onto spns viscerosomatic and supraspinal inputs form synapses with different topographical locations on the spnabstract truncated at words\n",
      "Generated Text: recombinant human eta receptors were expressed in a mouse FB cell L1 ltk cell and PET coupling of the receptors with ca permeable channels at low concentrations of endothelin et was investigated using wholecell recordings and monitoring the changes in [Ca2+]i cai with a ca indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence of endothelin in the presence of a Ca2+ indicator fluo a similar type of coupling was observed in the ltk cell and the ltk cell was also found to be sensitive to the presence\n",
      "BLEU: 0.11268654859145147, ROUGE-L: {'r': 0.1829787234042553, 'p': 0.8958333333333334, 'f': 0.3038869229781868}, Perplexity: 2.160285234451294, Cosine Similarity: 0.6992\n",
      "Reference Text: the neural organization of the pathways from the superior colliculus sc to trochlear motoneurons was analyzed in anesthetized cats using intracellular recording and transneuronal labeling techniques stimulation of the ipsilateral or CL sc evoked excitation and inhibition in trochlear motoneurons with latencies of and ms respectively suggesting that the earliest components of excitation and inhibition were disynaptic a midline section between the two scs revealed that ipsi and contralateral sc stimulation evoked disynaptic excitation and inhibition in trochlear MNs respectively PM neurons labeled transneuronally T3 application of wheat germ agglutininconjugated horseradish peroxidase into the trochlear nerve were mainly distributed ipsilaterally in the forels field h ffh and bilaterally in the interstitial nucleus of cajal inc consequently we investigated these two likely intermediaries between the sc and trochlear nucleus electrophysiologically stimulation of the ffh evoked ipsilateral mono and disynaptic excitation and contralateral disynaptic inhibition in trochlear motoneurons preconditioning stimulation of the ipsilateral sc facilitated ffhevoked MSR excitation stimulation of the inc evoked ipsilateral MSR excitation and inhibition and contralateral MSR inhibition in trochlear motoneurons preconditioning stimulation of the CL sc facilitated CL incevoked monosynaptic inhibition these results revealed a reciprocal input pattern from the scs to vertical ocular MNs in the sacn intermediates during dna replication however the structure of these intermediates and their mechanism of the suppression are unknown to examine this reaction we have isolated and characterized a temperaturesensitive ts S2 of mus at the nonpermissive temperature sgsdeltamusts cells arrest at gm phase after going through sphase bulk dna replication appears CR but is defective since the rad checkpoint kinase is strongly phosphorylated under these conditions in addition the induction of rad hyperphosphorylation by mms was deficient at PT analysis of rdna replication intermediates at the nonpermissive temperature revealed elevated pausing of replication forks at the rfb in the sgsdeltamusts mutant and a novel linear structure that was dependent on rad pulsedfield gel PACE of the musdelta mutant revealed an expansion of the rdna locus depending on rad in addition to fragmentation of chr xii in the sgsdeltamusts mutant at permissive temperature this is the first evidence that mus functions in quality control of replication forks and that it is involved in the maintenance of rdna repeats in vivo\n",
      "Generated Text: the neural organization of the pathways from the superior colliculus sc to trochlear motoneurons was analyzed in anesthetized cats using intracellular recording and transneuronal labeling techniques stimulation of the ipsilateral or CL sc evoked excitation and inhibition in trochlear motoneurons with latencies of and ms respectively suggesting that the earliest stages of the pathway from the sc to the motoneurons are not yet fully developed in the cat the present study investigated the role of the sc in the development of the pathway from the sc to the motoneurons in the cat using intracellular recording and transneuronal labeling techniques\n",
      "BLEU: 0.03748934840683224, ROUGE-L: {'r': 0.21195652173913043, 'p': 0.7647058823529411, 'f': 0.33191489021856047}, Perplexity: 9.035024642944336, Cosine Similarity: 0.8134\n",
      "Reference Text: chronic obstructive pulmonary disease is associated with altered cortical excitability the relevance of this to the need for noninvasive ventilation is not known we assessed the diaphragm response to TMS stimulation in terms of MT and RL as well as assessing intracortical excitability using paired stimulation in eight longterm users and six nonusers of home ventilation with copd overall intracortical facilitation was strongly correlated with inspiratory muscle strength r p whereas intracortical inhibition was correlated with paco r p the two groups did not differ in motor CEP or RL nor in the excitability of intracortical GABA or facilitatory circuits assessed using paired stimulation the acute effect of isocapnic noninvasive ventilation was studied in six established ventilator users diaphragm motor CEP fell but there was no effect on intracortical facilitation or inhibition implying an effect of neuromechanical FB at BS or spinal level\n",
      "Generated Text: chronic obstructive pulmonary disease is associated with altered cortical excitability the relevance of this to the need for noninvasive ventilation is not known we assessed the diaphragm response to TMS stimulation in terms of MT and RL as well as assessing intracortical excitability using paired stimulation in eight longterm users of chronic obstructive pulmonary disease and eight healthy controls we found that the diaphragm response to TMS was significantly reduced in the chronic obstructive pulmonary disease group compared to the controls the reduction was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm users of chronic obstructive pulmonary disease the reduction in the diaphragm response to TMS was not significant in the longterm\n",
      "BLEU: 0.13581089271433622, ROUGE-L: {'r': 0.4772727272727273, 'p': 0.8076923076923077, 'f': 0.5999999953306123}, Perplexity: 1.7186259031295776, Cosine Similarity: 0.5847\n",
      "Reference Text: we assess the effect of sildenafil in a subgroup of patients T3 prostatectomy with ED and determine whether nerve preservation improves sildenafil response in this subgroup\n",
      "Generated Text: we assess the effect of sildenafil in a subgroup of patients T3 prostatectomy with ED and determine whether nerve preservation improves sildenafil response in this subgroup of patients we also assess the effect of sildenafil on the response of the prostatectomy to the sildenafil and the response of the sildenafil to the sildenafil in the subgroup of patients with ED and in the subgroup of patients with prostatectomy with ED we also assess the effect of sildenafil on the response of the prostatectomy to the sildenafil and the response of the sildenafil to the sildenafil in the subgroup of patients with ED and in the subgroup of patients with prostatectomy with ED\n",
      "BLEU: 0.2214996592516159, ROUGE-L: {'r': 1.0, 'p': 0.88, 'f': 0.9361702077863288}, Perplexity: 3.0346384048461914, Cosine Similarity: 0.7815\n",
      "Reference Text: the ability of the cardiorespiratory system heart lungs blood to deliver oxygen to exercising skeletal muscle constrains maximum oxygen consumption vomax with cardiac SO and the concentration of oxygencarrying haemoglobin hb being key limiting parameters TBV bv is the sum of the CPV pv and the total RCV the measured hb is dependent upon the total circulating mass of haemoglobin thbmass and CPV pv while the proportion of oxygen carried in plasma is trivial ml of oxygen per ml of plasma each gram of hb contained in red blood cells binds ml of oxygen as a result the relationship between vomax and thbmass is stronger than that observed between vomax and hb or bv the glycoprotein hormone erythropoietin drives red cell synthesis and like simple transfusion of packed red blood cells can increase thbmass an ironcontaining haem group lies at the centre of the hb molecule and in situations of actual or PET iron deficiency thbmass will also rise following iron administration however achieved an increase in thbmass also increases circulating oxygencarrying capacity and thus the capacity for aerobic phosphorylation it is for such reasons that alterations in vomax and exercise performance are proportional to those in arterial oxygen content and systemic oxygen transport a change in thbmass of g being associated with a ml  min change in vomax similarly vomax increases by approximately for each g  l increase in hb over the hb range to g  l surgery like exercise places substantial metabolic demands on the patient whilst subject to debate oxygen supply at a rate inadequate to prevent muscle anaerobiosis may underpin the occurrence of the anaerobic threshold at an important submaximal marker of CRF preoperatively cardiopulmonary exercise testing cpet can be used to determine at and peak exertional oxygen uptake vo peak as measures of ability to meet increasing oxygen demands the degree of surgical insult and the ability to meet the resulting additional postoperative oxygen demand appear to be fundamental determinants of surgical outcome individuals in whom such ability is impaired and thus those with reduced vo peak and at are at greater risk of adverse surgical outcome this review provides an overview of the relationships between hb thbmass exercise capacity and surgical outcome and discusses the potential value of assessing thbmass over hb\n",
      "Generated Text: the ability of the cardiorespiratory system heart lungs blood to deliver oxygen to exercising skeletal muscle constrains maximum oxygen consumption vomax with cardiac SO and the concentration of oxygencarrying haemoglobin hb being key limiting parameters TBV bv is the sum of the CPV pv and the total RCV the measured values of vomax and hb are in agreement with the values obtained in the previous studies in which the values of vomax and hb were obtained in the same subjects in the same exercise conditions and in the same exercise intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a higher intensity than in the subjects who exercised at a lower intensity the values of vomax and hb were significantly higher in the subjects who exercised at a\n",
      "BLEU: 0.1655615275998056, ROUGE-L: {'r': 0.2205128205128205, 'p': 0.7049180327868853, 'f': 0.3359374963699341}, Perplexity: 2.252845048904419, Cosine Similarity: 0.6051\n",
      "Reference Text: adrenal steroids exert their effects through two distinct adrenal steroid receptor subtypes the high affinity type i or mineralocorticoid receptor and the lower affinity type ii or glucocorticoid receptor adrenal CS have well known effects on immune cell distribution and although both type i and ii receptors are expressed in immune cells and tissues few data exist on the relative effects mediated through these two receptor subtypes accordingly we administered selective type i and ii adrenal steroid receptor agonists to young AD SD rats for days and then measured immune cell CSD in the peripheral blood and SP results were compared with those of similar studies using the naturally occurring glucocorticoid of the rat corticosterone which binds both type i and ii receptors the majority of the well characterized effects of adrenal CS on peripheral blood immune cells increased neutrophils and decreased lymphocytes and monocytes were reproduced by the type ii IL-1ra ru ru decreased the numbers of all lymphocyte subsets tcells bcells and NK killer nk cells to very low absolute levels the largest relative decrease ie in percentage was seen in bcells whereas nk cells exhibited the least relative decrease and actually showed a fold increase in relative percentage during ru treatment similar to ru the IL-1RI agonist aldosterone significantly reduced the number of lymphocytes and monocytes in contrast to ru however aldosterone significantly decreased the number of neutrophils moreover aldosterone decreased the number of thelper cells and nk cells while having no effect on the number of bcells or tsuppressorcytotoxic cells corticosterone at physiologically relevant concentrations had potent effects on immune cell distribution which were indistinguishable from those of the type ii IL-1ra ru taken together these results indicate that effects of adrenal steroids on immune cell distribution are dependent on the receptor AT1 involved as well as the specific cell type targeted these AF allow for varied and complex effects of adrenal CS on the IS under physiological conditions\n",
      "Generated Text: adrenal steroids exert their effects through two distinct adrenal steroid receptor subtypes the high affinity type i or mineralocorticoid receptor and the lower affinity type ii or glucocorticoid receptor adrenal CS have well known effects on immune cell distribution and although both type i and ii receptors are expressed in the adrenal cortex and adrenal medulla the adrenal CS is not expressed in the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of the adrenal medulla of\n",
      "BLEU: 0.16755812862293126, ROUGE-L: {'r': 0.23417721518987342, 'p': 0.9024390243902439, 'f': 0.37185929321077754}, Perplexity: 1.5048563480377197, Cosine Similarity: 0.5283\n",
      "Reference Text: the results of consecutive PD bypass grafting operations performed for angina in the year period from to were evaluated months after surgery followup was CR in in of patients angina severity was NY HR association functional classes iii or iv an ejection fraction of less than and left VVI enddiastolic pressure of more than mm hg were each present in onethird of patients thirteen patients died in hospital and died later during the followup period twentysix reoperations were performed for recurrent angina angina was initially relieved by T0 in of patients but only were alive and free of angina years after their T0 despite this of patients at last followup were in FC i or ii and thought their PS were better than preoperatively the mean postoperative time of onset of angina estimated independently by FPs and patients was months the significant preoperative predictors of late death were a low left VVI ejection fraction previous myocardial infarction prior cardiac surgery increased CTR and the number of coronary arteries with significant narrowing\n",
      "Generated Text: the results of consecutive PD bypass grafting operations performed for angina in the year period from to were evaluated months after surgery followup was CR in in of patients angina severity was NY HR association functional classes iii or iv an ejection fraction of less than and left VVI enddiastolic pressure was less than or equal to the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean of the patients with angina and the mean\n",
      "BLEU: 0.12784989420079107, ROUGE-L: {'r': 0.4380952380952381, 'p': 0.9787234042553191, 'f': 0.6052631536227493}, Perplexity: 2.015144109725952, Cosine Similarity: 0.6177\n",
      "Reference Text: the indirect antibody peroxidaseantiperoxidase technique was used to determine the laminar and lobular distribution of CA afferents in the adult mouse opossum and cat cerebellum a monoclonal antibody to tyrosine hydroxylase th revealed a plexus of thin varicose fibers that exhibited a different density and distribution DP for each species in the cat TH-IR fibers were sparsely distributed to all laminae lobules and nuclei of the cat cerebellum except for an area of elevated density in the VP folia of lobules v and vi in the opossum thpositive SF were uniformly and densely distributed in the granule and purkinje cell layers they were more abundant in vermal lobules vvi than in more anterior and posterior lobules particularly i and x numerous thimmunoreactive SF were found in all four cerebellar nuclei of the opossum in the mouse thpositive SF formed a dense plexus within all cerebellar lobules laminae and nuclei the mouse also exhibited numerous TH-IR purkinje cells that were localized predominantly within vermal lobules vix the paraflocculus and flocculus in addition to the interspecies differences in the CSD of CA fibers within the cerebellum comparison of this plexus to that previously described for serotonin in these species reveals that the relative densities and distribution patterns of CA and serotoninergic fibers also vary between species it is thus hypothesized that in each species a given MA has a unique net effect on cerebellar output that is determined by its effects on different neuronal populations within the cerebellum\n",
      "Generated Text: the indirect antibody peroxidaseantiperoxidase technique was used to determine the laminar and lobular distribution of CA afferents in the adult mouse opossum and cat cerebellum a monoclonal antibody to tyrosine hydroxylase th revealed a plexus of thin varicose fibers that exhibited a different density and distribution DP for each species of opossum and cat cerebellum the immunoreactivity of the th antibody was determined by immunoblotting and the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody was performed in the same animals as the immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the th antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immunoblotting of the peroxidase antibody in the opossum and cat cerebellum the immunoreactivity of the peroxidase antibody was determined by immunoblotting and immun\n",
      "BLEU: 0.2129469274521101, ROUGE-L: {'r': 0.336, 'p': 0.84, 'f': 0.4799999959183674}, Perplexity: 2.1291723251342773, Cosine Similarity: 0.6744\n",
      "Reference Text: the effects of cryopreservation on human zygotes at various stages between the appearance of PN and their close association were investigated pronuclear zygotes n from patients were frozen using propanediol h following egg collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection was significantly higher than that of younger PN zygotes versus respectively zygote age did not affect cell survival following cryostorage the diameter and association of PN and the number and distribution of nucleoli were determined from video tape recordings of fresh zygotes pronuclear migration continued after pronuclear enlargement the number of nucleoli remained constant during pronuclear migration but their random CSD within the PN diminished strongly adhered PN had significantly more aligned nucleoli on adjacent sides than pronuclei which were still visually separated by ooplasm this equatorial distribution of nucleoli was noted in the majority of zygotes older than h the findings suggest that zygote cryopreservation should be initiated when PN migration is completed this moment can be determined accurately by studying pronuclear association and nucleolar alignment\n",
      "Generated Text: the effects of cryopreservation on human zygotes at various stages between the appearance of PN and their close association were investigated pronuclear zygotes n from patients were frozen using propanediol h following egg collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection was significantly higher than that of frozen pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection was significantly higher than that of frozen pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection was significantly higher than that of frozen pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection was significantly higher than that of frozen pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection was significantly higher than that of frozen pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection was significantly higher than that of frozen pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection was significantly higher than that of frozen pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of thawed pronuclear zygotes frozen h following oocyte collection the incidence of implantation of\n",
      "BLEU: 0.15958249669256078, ROUGE-L: {'r': 0.37142857142857144, 'p': 1.0, 'f': 0.5416666627170139}, Perplexity: 1.773317575454712, Cosine Similarity: 0.6622\n",
      "Reference Text: the cyclopentadienylrhenium carbonyls cp re co n cp eta c h n have been studied by density functional theory the global minima for the cp re co n n derivatives are predicted to be the singly bridged structure cp re co muco with a formal rere SB the doubly semibridged structure cp re co with a formal rere double bond the triply bridged structure cp re muco with a formal rere triple bond and the doubly bridged structure cp re muco respectively the first three of these predicted structures have been realized experimentally in the stable compounds eta c h re co muco eta me c re co and eta me c re muco in addition structures of the type cp rereco n with both rings bonded only to one metal and unknown in manganese chemistry are also found for rhenium but at energies significantly above the global minima the unsaturated cp rereco n structures n have agostic cp hydrogen atoms forming chre bridges to the unsaturated reco n group with a reh distance as short as a\n",
      "Generated Text: the cyclopentadienylrhenium carbonyls cp re co n cp eta c h n have been studied by density functional theory the global minima for the cp re co n n derivatives are predicted to be the singly bridged structure cp re co muco with a formal rere SB the doubly semibridged structure cp re co muco with a formal SB the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of electrons in the two structures the two structures are predicted to be the same in terms of the number of atoms and the number of\n",
      "BLEU: 0.12826571857789762, ROUGE-L: {'r': 0.47674418604651164, 'p': 0.8913043478260869, 'f': 0.6212121166712582}, Perplexity: 2.2704763412475586, Cosine Similarity: 0.5462\n",
      "Reference Text: a casecontrol study was performed to investigate the association between colic of all types in swedish horses and infection with the equine tapeworm anoplocephala perfoliata colic cases were defined by clinical signs consistent with the presence of abdominal pain and the control horses had no signs of colic within the last year but attended a clinic for other reasons blood and fecal samples were colled accumulation compared with transcripts during maturation gulose and stachyose levels increased and correlated with longevity a seedspecific network identified known and putative transcriptional regulators of dt including abscisic acidinsensitive mtabi mtabi mtabi and apetala ethylene response element IB protein ataperebp transcription factor as L1 hubs these transcriptional activators were highly connected to lea genes longevity genes were highly connected to two mtaperebp and two bZIP transcription AF a heat shock factor was found at the transition of dt and longevity modules connecting to both gene sets gain and lossoffunction approaches of mtabi confirmed of its predicted targets thereby experimentally validating the network this study captures the coordinated regulation of seed maturation and identifies distinct regulatory networks underlying the preparation for the dry and quiescent states\n",
      "Generated Text: a casecontrol study was performed to investigate the association between colic of all types in swedish horses and infection with the equine tapeworm anoplocephala perfoliata colic cases were defined by clinical signs consistent with the presence of abdominal pain and the control horses had no signs of colic within the previous year the incidence of colic in the control horses was significantly higher than in the cases the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly higher than in the controls the incidence of colic in the cases was significantly\n",
      "BLEU: 0.11307444331582499, ROUGE-L: {'r': 0.3023255813953488, 'p': 0.8666666666666667, 'f': 0.448275858234245}, Perplexity: 1.6438089609146118, Cosine Similarity: 0.4524\n",
      "Reference Text: alkylmethoxypyrazines mps are a class of compounds that can elicit undesirable aroma and flavor characteristics in wine and resist remediation using traditional wine making approaches mps are grapederived constituents as well as contaminants from coccinellidae beetles present during wine processing the latter eliciting an offflavor referred to as ladybug taint in this study we investigated the capacity of two plastic polymersone siliconebased the other polylactic acidbasedapplied with varying surface Az to reduce concentrations of isopropylmethoxypyrazine ipmp secbutylmethoxypyrazine sbmp and isobutylmethoxypyrazine ibmp in a merlot wine using multidimensional GC-MS and headspace solid phase microextraction spmemdgcms the impact of treatments on the sensory characteristics of the wine descriptive analysis and volatile aroma EDC vocs spmemdgcms was also investigated results showed substantial reductions for all of the target odorants up to and for ipmp sbmp and ibmp respectively for the silicone CP and up to and for ipmp sbmp and ibmp respectively for the PLA polymer these polymers had no or minimal effect on vocs at applications of cml for silicone or for all PLA treatments sensory impacts were less clear but generally showed minimal effect from the treatments taken overall the data confirm the utility of both polylactic acid and silicone polymers in reducing elevated levels of grapederived mps as well as potentially improving wine contaminated by ladybug taint\n",
      "Generated Text: alkylmethoxypyrazines mps are a class of compounds that can elicit undesirable aroma and flavor characteristics in wine and resist remediation using traditional wine making approaches mps are grapederived constituents as well as contaminants from coccinellidae beetles present during wine processing the latter eliciting an offflavor referred to as ladybug taint the taint is a complex mixture of volatile compounds including volatile phenols and volatile phenolic acids that are produced during the fermentation of mps and are responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint is a product of the fermentation of mps and is responsible for the aroma and flavor characteristics of mps the taint\n",
      "BLEU: 0.13752756167479072, ROUGE-L: {'r': 0.3384615384615385, 'p': 0.7857142857142857, 'f': 0.4731182753613135}, Perplexity: 2.3244855403900146, Cosine Similarity: 0.6657\n",
      "Reference Text: submicron oilinwater ow emulsions stabilised with conventional surfactants and silica nanoparticles were prepared and FD to obtain freeflowing powders with good redispersibility and a threedimensional porous matrix structure solidstate emulsions were characterised for visual appearance PSD ZP and reconstitution properties after FD with various sugars and at a range of sugar to oil ratios comparative Kd kinetics of alltransretinol from freezedried and liquid emulsions was investigated as a CF of storage temperatures optimum stability was observed for silicacoated oleylamine emulsions at c in their wet state the halflife of alltransretinol was and weeks for silica incorporation from the oil and water phases respectively this was  times higher compared to the equivalent solidstate emulsions with drug halflife of and weeks at c exceptionally at a storage temperature of c the chemical stability of the drug was times higher in the solidstate compared to the wet emulsions which confirmed that FD is a promising approach to improve the chemical stability of waterlabile compounds provided that the storage conditions ar results from detailed simulations and a variety of analytical arguments in particular we introduce a new coarsegrained description of CTX as biased DWI and we discuss the way it departs from older coarsegrained descriptions\n",
      "Generated Text: submicron oilinwater ow emulsions stabilised with conventional surfactants and silica nanoparticles were prepared and FD to obtain freeflowing powders with good redispersibility and a threedimensional porous matrix structure solidstate emulsions were characterised for visual appearance PSD ZP and reconstitution properties after FD with various sugars and at a range of pHs the emulsions were analysed for their viscosity and viscosity stability and their ability to retain water in the emulsion and to retain the water in the porous matrix structure the emulsions were analysed for their viscosity and viscosity stability and their ability to retain water in the emulsion and to retain the water in the porous matrix structure\n",
      "BLEU: 0.21654803163303254, ROUGE-L: {'r': 0.3793103448275862, 'p': 0.8627450980392157, 'f': 0.5269461035418982}, Perplexity: 18.708852767944336, Cosine Similarity: 0.6965\n",
      "Reference Text: nickel was quantitatively retained by nitrosonaphtholsulfonic acid nitrosos and tetradecyldimethylbenzylammonium chloride tdba cl onto BP in the ph range from large volumes of aqueous solutions of various samples T3 filtration each solid mass consisting of a Ni complex and BP was dissolved with ml of dimethylformamide dmf and the metal was determined by AAS aas about microg of nickel could be concentrated from ml of an aqueous sample where its concentration was as low as ngml eight replicate determinations of microgml of Ni in the final dmf solution gave a mean absorbance of with a relative standard deviation of the sensitivity for absorption was ngml the interference of a number of anions and cations was studied and the developed optimized conditions were utilized for the trace determination of Ni in various alloys and biological samples\n",
      "Generated Text: nickel was quantitatively retained by nitrosonaphtholsulfonic acid nitrosos and tetradecyldimethylbenzylammonium chloride tdba cl onto BP in the ph range from large volumes of aqueous solutions of various samples T3 filtration each solid mass consisting of a Ni complex and BP was dissolved with ml of dimethylformamide dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf and the metal was removed by aqueous solution of dmf\n",
      "BLEU: 0.1585153819242977, ROUGE-L: {'r': 0.4942528735632184, 'p': 0.9772727272727273, 'f': 0.6564885451570422}, Perplexity: 2.189762592315674, Cosine Similarity: 0.6516\n",
      "Reference Text: the epithelial cell adhesion molecule epcam has been historically considered a target of passive immunotherapy using monoclonal antibodies and more recently of a first poxvectorbased CA vaccine phase i trial in CC patients to shed further CS on the use of this antigen we isolated the mouse and Rh homologues of human epcam and explored different genetic vaccination modalities based on the use of adenoviral vectors as well as dna electroporation dnaep immune responses to epcam were measured by ifngamma elispot and intracellular staining assays using overlapping sets of peptides covering the entire coding regions we found the most powerful vaccination regimen to be constituted by dnaepprimeadenoboost mixedmodality protocols vaccination in Rh macaques resulted in breakage of immunological tolerance in a minority of cases similarly a VLF of NR was observed with the mouse epcam vaccine in outbred cd mice when immunized cd mice were analyzed for mhc haplotype and tcr expression C2 we observed that immune NR all had the same qq mhc class i haplotype and showed higher expression C2 of the tcrvbeta and tcrvbeta t cell receptors our results underscore the current limitations in our capacity to induce efficient CA vaccines against self antigens like epcam but also represent a first effort to identify predictive biomarkers of response\n",
      "Generated Text: the epithelial cell adhesion molecule epcam has been historically considered a target of passive immunotherapy using monoclonal antibodies and more recently of a first poxvectorbased CA vaccine phase i trial in CC patients to shed further CS on the use of this antigen we isolated the mouse and Rh homologues of epcam in the mouse and the rh homologues of epcam in the rh homologues of epcam in the mouse and the rh homologues of epcam in the rh homologues of epcam in the mouse and the rh homologues of epcam in the rh homologues of epcam in the mouse and the rh homologues of epcam in the rh homologues of epcam in the mouse and the rh homologues of epcam in the rh homologues of epcam in the mouse and the rh homologues of epcam in the rh homologues of epcam in the mouse and the rh homologues of epcam in the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam in the mouse and the rh homologues of epcam\n",
      "BLEU: 0.14981921554841623, ROUGE-L: {'r': 0.3120567375886525, 'p': 0.9777777777777777, 'f': 0.47311827590183836}, Perplexity: 1.865164041519165, Cosine Similarity: 0.7018\n",
      "Reference Text: malignant subfrontal olfactory peripheral NSTs mpnsts are exceedingly rare although meningiomas are the most common subfrontal extraaxial lesions it is important to recognize that mpnsts which are radiographically similar to meningiomas can also be present in this location mpnsts require more aggressive surgical and postoperative management than meningiomas in this paper we describe a patient with a subfrontal mpnst with unusual histological characteristics and present a review of the literature a yearold woman presented with chronic sinusitis and progressive headaches a neurological examination revealed leftsided anosmia brainimaging studies revealed a C1 left subfrontal mass with extension into the frontal and ethmoid sinuses and the nasal cavity the patient underwent both a bifrontal transbasal craniotomy and a transnasal approach for an attempt at total resection of both the intradural and extradural components of the mpnst the patient was treated postoperatively with radiation therapy and had no evidence of recurrence at her followup examination year T3 treatment subfrontal pnsts are extremely rare and usually benign the specific cell and nerve of origin for these PT remains unknown our case shows that these rare lesions can present as a malignant variant and thus require aggressive surgical and postoperative management to provide LT tumor control\n",
      "Generated Text: malignant subfrontal olfactory peripheral NSTs mpnsts are exceedingly rare although meningiomas are the most common subfrontal extraaxial lesions it is important to recognize that mpnsts which are radiographically similar to meningiomas can also be present in this location mpnsts require more aggressive surgical and postoperative management than meningiomas in this setting the aim of this study was to describe the clinical presentation of mpnsts in the olfactory peripheral NST and to describe the clinical management of mpnsts in this location\n",
      "BLEU: 0.14364341143975157, ROUGE-L: {'r': 0.3178294573643411, 'p': 0.8367346938775511, 'f': 0.46067415331334444}, Perplexity: 11.341455459594727, Cosine Similarity: 0.6556\n",
      "Reference Text: the inward facing membranes of in vitro frog skin epithelium were depolarized with solutions of high k concentration the electrical properties of the epithelium are then expected to be governed by the outward facing naselective membrane in this state the transepithelial Vc v was clamped to zero and stepchanges of na activity in the outer solution nao were performed with a fastflow chamber at constant ionic strength while the shortcircuit current was recorded at preselected times after a stepchange of nao the current response i to a fast voltage staircase was recorded this procedure was repeated after blocking the na channels with amiloride to obtain the currentvoltage curve of TM and paracellular shunt pathways the currentvoltage curve of the na channels was computed by subtracting the shunt current from the total current the instantaneous inav curve thus obtained at thylamine hydrobromide and chloroethylamine hydrochloride and to the interference of bicarbonate in the cyclization reaction the complement fixing antigen of footandmouth disease virus was not affected by BEI inactivation vaccines prepared with footandmouth disease virus inactivated by BEI were comparable in their immunogenicity to vaccines prepared with ethylenimine or nacetylethylenimine used as inactivants application of BEI in the preparation of footandmouth disease vaccines considerably reduces the potential danger associated with handling pure ethylenimine and other aziridines\n",
      "Generated Text: the inward facing membranes of in vitro frog skin epithelium were depolarized with solutions of high k concentration the electrical properties of the epithelium are then expected to be governed by the outward facing naselective membrane in this state the transepithelial Vc v was clamped to zero and stepchanges of the membrane were measured the results showed that the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was not clamped to zero the membrane was\n",
      "BLEU: 0.1263161920084925, ROUGE-L: {'r': 0.31746031746031744, 'p': 0.9090909090909091, 'f': 0.47058823145743955}, Perplexity: 1.8565561771392822, Cosine Similarity: 0.4908\n",
      "Reference Text: given the wellknown associations between the RA frontal lobe and negative ERP states as well as the involvement of the RA posterior region in the modulation of autonomic NS arousal anxiety is thought to be associated with relative RA hemisphere activity or decreased left hemisphere activity however recent evidence suggests that the left hemisphere predominantly modulates parasympathetic efferents while the right hemisphere predominantly modulates sympathetic efferents of the ANS thus the left hemisphere should also play a role in anxiety as anxiety is associated with decreased parasympathetic activity increased HR rate in order to investigate this hypothesis the present experiment examined the influence of a wellknown autonomic stressor cold pressor on heart rate hr and verbal and nonverbal fluency performance fifteen high level hi anxious and low level lo anxious men completed verbal and nonverbal fluency measures T3 they were asked to place their left hand in ice water for s hi anxious subjects demonstrated opposing hr patterns during performance of the verbal increased hr and nonverbal decreased hr fluency tasks following CP stimulation in addition hi anxious men generated fewer words per minute on the verbal fluency task than did lo anxious men although the data are supportive of functional right hemisphere activity among anxious individuals the contribution of decreased left hemisphere activity ie reduced parasympathetic activity and diminished VF performance is also discussed\n",
      "Generated Text: given the wellknown associations between the RA frontal lobe and negative ERP states as well as the involvement of the RA posterior region in the modulation of autonomic NS arousal anxiety is thought to be associated with relative RA hemisphere activity or decreased left hemisphere activity however recent evidence suggests that the RA is also involved in the modulation of autonomic NS arousal anxiety and that the RA is involved in the modulation of autonomic NS arousal anxiety in the absence of a priori hypotheses the present study investigated the effects of unilateral unilateral unilateral unilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral bilateral\n",
      "BLEU: 0.11357762296360585, ROUGE-L: {'r': 0.3203125, 'p': 0.7735849056603774, 'f': 0.45303866989163954}, Perplexity: 2.1138272285461426, Cosine Similarity: 0.0336\n",
      "Reference Text: monocyte interactions with implanted biomaterials can contribute significantly to the ability of a biomaterial to support tissue integration and wound healing as opposed to a chronic proinflammatory FBR provided the materials are designed to do so however there are few biomaterials available designed to regulate immune cell response with the intention of reducing the Th1 activation state material chemistry is a powerful tool for regulating protein and cell interactions that can be incorporated into surfaces while maintaining desired mechanical properties the aspects of material chemistry that can support mo activation away from a proinflammatory state are still poorly understood protein adsorption is a key initial event that transforms the surface of a biomedical device into a biological ATP that will govern subsequent cellular interactions in this T0 the chemistry of degradable block polyurethanes termed degradable polar hydrophobic ionic dphi PUs were studied for their unique interactions with bound immunoglobulin g igg a Th1 protein that supports monocytebiomaterial interactions the specific immunological AS sites of the polyurethaneadsorbed protein were compared with iggs adsorbed state on a homopolymeric material with surface chemistry conducive to cell interactions eg TC PS tcps iggcoated tcps supported sustained mo adhesion and enhanced mo spreading effects not observed with iggcoated pu the degradable pu was subsequently shown to reduce the number of exposed iggfab sites following preadsorption vs igg adsorbed to tcps with antibody inhibition experiments demonstrating that fabsite SE appears to dominate monocytebiomaterial interactions minor changes in chemical segments within the pu molecular chains were subsequently investigated for their influence on directing igg interactions towards reducing Th1 activity a reduction in chemical heterogeneity within the pu without significant differences in other material properties known to regulate monocyte response was shown to increase fab e who should be treated when should patients be treated for how long should patients be treated what is the safety profile of trabectedin how should trabectedin be administered in brief trabectedin has shown activity and clinical benefit in nearly all subtypes of soft tissue sarcoma improved tau outcomes are observed when trabectedin is po as secondline therapy compared with laterline use in L1 with this observation the EU society for medical oncology clinical practice guidelines for soft tissue sarcoma recommend use of trabectedin in the secondline setting trabectedin has a role for treatment of elderly patients in whom alternatives are lacking and can be administered for prolonged periods without cumulative toxicity a statistically significant improvement in median PFS has been observed when trabectedin is administered uninterrupted until PD the flexibility of trabectedin administration in terms of dose interval and duration allows for patienttailored treatment optimization\n",
      "Generated Text: monocyte interactions with implanted biomaterials can contribute significantly to the ability of a biomaterial to support tissue integration and wound healing as opposed to a chronic proinflammatory FBR provided the materials are designed to do so however there are few biomaterials available designed to regulate immune cell response with the aim of developing a novel immunomodulatory agent for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and psoriasis the aim of this study was to evaluate the effect of a novel immunomodulatory agent on the immune response of a human skin biopsy model of psoriasis and rheumatoid arthritis using a mouse model of psoriasis and rheumatoid arthritis the results showed that the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis and to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and rheumatoid arthritis in mice the immunomodulatory agent was able to reduce the inflammatory response of the skin biopsy model of psoriasis and r\n",
      "BLEU: 0.13938662026282575, ROUGE-L: {'r': 0.1864406779661017, 'p': 0.6111111111111112, 'f': 0.28571428213189415}, Perplexity: 2.0364089012145996, Cosine Similarity: 0.5419\n",
      "Reference Text: high tumour interstitial fluid pressure tifp is a characteristic of most solid tumours recent data give first evidence that mechanical stretch induced by tifp triggers proliferation in solid tumours in the present study we compared two protocols of tifp reduction on the expression of the tumour Ki-67 ki a shortterm lowering of tifp by a singular puncture and b LT lowering of tifp by catheterization utilizing two exp tumours a a it was found that the tifp broke down rapidly T3 a singular puncture but recovered within h in case of permanent catheterization no tifp recovery was observed T3 h tumours were excised and stained against the Ki-67 ki while a singular puncture had no effect catheterized tumours showed a significant decrease in ki expression our data suggest that LT lowering of tifp is required to reduce tumour proliferation\n",
      "Generated Text: high tumour interstitial fluid pressure tifp is a characteristic of most solid tumours recent data give first evidence that mechanical stretch induced by tifp triggers proliferation in solid tumours in the present study we compared two protocols of tifp reduction on the expression of the tumour Ki-67 ki a shortterm and a longterm expression of the tumour Ki-67 in the tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour tumour\n",
      "BLEU: 0.18751748279611472, ROUGE-L: {'r': 0.5, 'p': 0.975609756097561, 'f': 0.6611570203128202}, Perplexity: 1.6950995922088623, Cosine Similarity: 0.1977\n",
      "Reference Text: photodynamic therapy pdt of hepatic tumours has been restricted owing to the preferential retention of photosensitizers in liver tissue we therefore investigated interstitial tumour illumination as a means of selective pdt a piece of Caco-2 cc was implanted in the liver of wagrij rats PF was administered mg kg iv days before laser illumination tumours with a mean se diameter of mm n days T3 implantation were illuminated with nm light at mw cm from a cm cylindrical diffuser and either or j cm control CG received either laser illumination only photofrin only or diffuser IS only shortterm effects were studied on the second day T3 illumination by LM and computerassisted integration of the circumference of damaged areas LT effects were studied on day to determine the biochemistry of liver damage and function serum asat and alat levels were measured on day and and antipyrine clearance on day tumour and surrounding liver necrosis increased with light dose delivered p best longterm results were obtained at j cm with CR tumour remission in out of animals no deterioration in LF was found the results of this study show the ability of interstitial pdt to cause major destruction of tumour tissue in the liver combined with minimal CL damage\n",
      "Generated Text: photodynamic therapy pdt of hepatic tumours has been restricted owing to the preferential retention of photosensitizers in liver tissue we therefore investigated interstitial tumour illumination as a means of selective pdt a piece of Caco-2 cc was implanted in the liver of wagrij rats PF was administered mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was administered in the same dose mg kg iv and the pdt was\n",
      "BLEU: 0.11776831182693195, ROUGE-L: {'r': 0.3387096774193548, 'p': 0.9767441860465116, 'f': 0.5029940081523182}, Perplexity: 1.8875854015350342, Cosine Similarity: 0.4471\n",
      "Reference Text: since its publication in the guide for the care and use of laboratory animals NRC washington dc national academy press has become a primary source of information for institutional animal care and use committees iacucs and research facility managers in the ensuing years recommendations relating to laboratory animal care have evolved in response to new scientific information and use of new technology such as ventilated caging in this article recent publications are examined to determine the potential impact of new scientific evidence on current practices for the housing and care of laboratory rodents the discussion points out recent advances in technology and new knowledge of the conditions for the housing of various laboratory rodents including cage space single versus group housing ventilated caging systems thermoregulation bedding materials and enrichment this new information is provided to aid iacucs and facility managers in making decisions regarding the housing and care of laboratory rodents\n",
      "Generated Text: since its publication in the guide for the care and use of laboratory animals NRC washington dc national academy press has become a primary source of information for institutional animal care and use committees iacucs and research facility managers in the ensuing years recommendations relating to laboratory animal care have been published in the guide for the care and use of laboratory animals and in the guide for the care and use of laboratory animals the authors have attempted to update the current recommendations for laboratory animal care and use and to provide a comprehensive overview of the current state of knowledge on the care and use of laboratory animals in the United States the authors have also attempted to provide a comprehensive overview of the current state of knowledge on the care and use of laboratory animals in the United States\n",
      "BLEU: 0.3855287979491416, ROUGE-L: {'r': 0.4418604651162791, 'p': 0.7169811320754716, 'f': 0.5467625852098753}, Perplexity: 6.541687488555908, Cosine Similarity: 0.8221\n",
      "Reference Text: the addition of several kinds of fatty acid to the SC medium of a recombinant human SS Al rhsaproducing yeast pichia pastoris resulted in increased expression C2 of the product among the fatty acids tested a small amount of OA wv doubled the rhsa production level in a shakeflask culture when measured by the reversed passive HA method to elucidate this phenomenon studies were conducted using deletion mutants from the aox promoter region deletion mutants designed for a detailed DUE of the methanol regulation elements aoxuas aoxurs and aoxurs did not respond to the addition of OA acid however a deletion mutant that was not lacking an UP region from the aox promoter showed a response to oleic acid the results implied the presence of an oleic acidresponsive element between nucleotides nt and and it may lie between nt and ition of ifabp in human intestine remains unclear here we studied the role of ifabp in molecularly modified normal Caco-2 cells hiec cdna transfection resulted in fold ifabp overexpression compared to cells treated with empty pqcxip vector the highresolution immunogold technique revealed labeling mainly in the cytosol and confirmed the marked phenotype abundance of ifabp in cdna transfected cells ifabp overexpression was not associated with alterations in cell proliferation and viability studies using these transfected cells cultured with coleic acid did not reveal higher efficiency in de novo synthesis or secretion of triglycerides phospholipids and cholesteryl esters compared to cells treated with empty pqcxip vector only similarly the incubation with smethionine did not disclose a superiority in the biogenesis of apolipoproteins apo ai aiv b and b finally cells transfected with ifabp did not exhibit an increased production of chylomicrons vldl ldl and hdl our observations establish that ifabp overexpression in normal hiec is not related to cell proliferation lipid esterification apo synthesis and lipoprotein assembly and therefore exclude its role in intestinal fat transport\n",
      "Generated Text: the addition of several kinds of fatty acid to the SC medium of a recombinant human SS Al rhsaproducing yeast pichia pastoris resulted in increased expression C2 of the product among the fatty acids tested a small amount of OA wv doubled the rhsa production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rhsaproducing yeast pichia pastoris and a small amount of OA wv doubled the production level in a shakeflask culture of rh\n",
      "BLEU: 0.1749109887215319, ROUGE-L: {'r': 0.21428571428571427, 'p': 0.975, 'f': 0.3513513483970457}, Perplexity: 2.0346672534942627, Cosine Similarity: 0.5563\n",
      "Reference Text: lfucose is a monosaccharide that occurs in low concentrations in NS but has been shown to be increased in diabetic individuals in cultured rat cells lfucose is a potent competitive inhibitor of Ins transport abnormal myoinositol metabolism has been proposed to be a factor in the OD of diabetic complications to test the hypothesis that Ins deficiency may be responsible for the electrophysiological and biological defects in diabetic neuropathy rats were fed a diet containing or lfucose for a period of wk T3 wk the lfucose diets in two groups of rats were supplemented with myoinositol at the end of the study protocol motor nerve conduction velocity sciatic nerve tissue nakatpase activity and myoinositol content were determined these results were compared with those of stzinduced diabetic rats fed either a ND or a diet containing myoinositol or with those given mgkg body wt of sorbinil SS lfucose levels were significantly increased in rats fed a diet containing or lfucose in comparison the serum lfucose levels in the diabetic rats were increased to a lesser extent motor nerve conduction velocity was significantly slower in rats fed a or lfucose diet sciatic nerve composite and OS nakatpase activity and Ins content was also significantly decreased supplementation of myoinositol to the lfucosecontaining diet restored nerve Ins C2 and significantly improved nakatpase activity and motor nerve conduction velocityabstract truncated at words\n",
      "Generated Text: lfucose is a monosaccharide that occurs in low concentrations in NS but has been shown to be increased in diabetic individuals in cultured rat cells lfucose is a potent competitive inhibitor of Ins transport abnormal myoinositol metabolism has been proposed to be a factor in the OD of diabetic complications of diabetes the aim of this study was to investigate the effect of lfucose on the transport of glucose in rat cells lfucose was administered in the presence of insulin or insulin alone or in combination with glucose the effect of lfucose on the transport of glucose was examined by measuring the transport of glucose in the presence of insulin or insulin alone or in combination with glucose the effect of lfucose on the transport of glucose was examined by measuring the transport of glucose in the presence of insulin or insulin alone or in combination with glucose\n",
      "BLEU: 0.22338682670715757, ROUGE-L: {'r': 0.3611111111111111, 'p': 0.7090909090909091, 'f': 0.4785276028905868}, Perplexity: 5.077592372894287, Cosine Similarity: 0.6347\n",
      "Reference Text: the disposition of clabeled nbutyl glycidyl ether bge butoxyepoxypropane was studied in rats and mice the majority of a single po dose mgkg was excreted in urine rats mice within h the rest of the dose was excreted in feces rats mice and in expired air as co rats mice or remained in the tissues rats mice no parent bge was detected in rat or mouse urine fifteen urinary metabolites were identified including butoxyhydroxypropanol and its monosulfate or monoglucuronide conjugates butoxyhydroxypropionic acid obutylnacetylserine butoxyacetic acid BE and butoxynacetylcysteinsylpropanol the mercapturic acid metabolite derived from conjugation of glutathione gsh with bge at the c position some of these metabolites underwent further omega oxidation to form a hydroxybutoxy substitution one urinary metabolite was from omegaoxidation of butoxynacetylcysteinsylpropanol to yield the corresponding carboxylic acid oxidative deamination of butoxycysteinsylpropanol gave the corresponding alphaketo acid and alphahydroxy acid metabolites that were present in mouse urine but not in rat urine an in vitro incubation of bge with gsh showed that the conjugation occurred only at the c position with or without the addition of gsh stransferase\n",
      "Generated Text: the disposition of clabeled nbutyl glycidyl ether bge butoxyepoxypropane was studied in rats and mice the majority of a single po dose mgkg was excreted in urine rats mice within h the rest of the dose was excreted in feces rats mice and in expired air as co rats mice and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxypropane bge butoxyepoxypropane was excreted in urine and feces rats and mice were fed with a diet containing a mixture of butoxyepoxypropane and butoxyepoxyprop\n",
      "BLEU: 0.1864376382637612, ROUGE-L: {'r': 0.32673267326732675, 'p': 0.868421052631579, 'f': 0.4748201399120129}, Perplexity: 1.8907021284103394, Cosine Similarity: 0.5378\n",
      "Reference Text: the coupling of a nearinfrared echelle spectrometer nires with a GC for elementselective detection is introduced the miniaturized capacitive plasma device is operated at a frequency of mhz and is mounted directly on an HP hp gc first results with a mixture of halogenated standard compounds are presented and discussed in terms of the advantages and problems with this system\n",
      "Generated Text: the coupling of a nearinfrared echelle spectrometer nires with a GC for elementselective detection is introduced the miniaturized capacitive plasma device is operated at a frequency of mhz and is mounted directly on an HP hp gc first results with a mixture of halogenated standard compounds are presented and discussed the device is operated at a frequency of mhz and is mounted directly on an HP hp gc first results with a mixture of halogenated standard compounds are presented and discussed\n",
      "BLEU: 0.6218105107193099, ROUGE-L: {'r': 0.8695652173913043, 'p': 1.0, 'f': 0.9302325531638724}, Perplexity: 17.967924118041992, Cosine Similarity: 0.9330\n",
      "Reference Text: as laparoscopic cholecystectomy is being used more and more frequently a cost analysis was aimed to be performed to evaluate cost effectiveness in turkey records of patients who underwent cholecystectomy by various methods were analyzed retrospectively mean duration of postoperative hospital stay was days for the open cholecystectomy group oc group composed of patients days for the converted open cholecystectomy group cc group composed of patients and days for the laparoscopic cholecystectomy group lc group which included patients the mean cost per patient was dollars dollars and dollars for the oc lc and cc groups respectively it was concluded that laparoscopic cholecystectomy will gain economic feasibility over CC in our country only when costs of laparoscopic equipment lower and personnel wages increase sufficiently\n",
      "Generated Text: as laparoscopic cholecystectomy is being used more and more frequently a cost analysis was aimed to be performed to evaluate cost effectiveness in turkey records of patients who underwent cholecystectomy by various methods were analyzed retrospectively mean duration of postoperative hospital stay was days for the open cholecystectomy group oc and for the laparoscopic cholecystectomy group oc the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecystectomy group and for the laparoscopic cholecystectomy group the mean duration of postoperative hospital stay was days for the open cholecy\n",
      "BLEU: 0.18361177257019334, ROUGE-L: {'r': 0.581081081081081, 'p': 0.9772727272727273, 'f': 0.7288135546452169}, Perplexity: 1.5582799911499023, Cosine Similarity: 0.7712\n",
      "Reference Text: myocardial reperfusion is the treatment of choice in AIM pharmacological thrombolysis restores PD patency in about two thirds of MI however mechanical reperfusion with PA and stenting achieves higher patency rates with less complications especially in highrisk patients adjunctive pharmacotherapy and new device technology may improve the outcome of primary angioplasty facilitated angioplasty using a combination of halfdose thrombolysis GP iibiiia antagonists and early intervention appears to be a promising strategy for the treatment of acute myocardial infarction in the modern era the tau and safety of this RPA are currently evaluated in several ongoing trials\n",
      "Generated Text: myocardial reperfusion is the treatment of choice in AIM pharmacological thrombolysis restores PD patency in about two thirds of MI however mechanical reperfusion with PA and stenting achieves higher patency rates with less complications especially in highrisk patients adjunctive pharmacotherapy and new device technology may improve the outcome of primary MI in patients with a high risk of MI and in patients with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of MI with a high risk of\n",
      "BLEU: 0.10494297247439797, ROUGE-L: {'r': 0.5833333333333334, 'p': 0.9545454545454546, 'f': 0.7241379263258026}, Perplexity: 1.839842677116394, Cosine Similarity: 0.3387\n",
      "Reference Text: twelve elderly patients undergoing total knee arthroplasty received lumbar epidural anaesthesia and propofol infusion at mgkgh following a mgkg bolus dose with preservation of spontaneous respiration via a LM airway circulatory respiratory and metabolic variables were measured before and and min after PR of a pneumatic thigh tourniquet the blood pressure was decreased at all timepoints and the respiratory rate increased at min the paco was increased only at min arterial blood ph and BE were decreased at and min and and min respectively arterial blood lactate C2 were increased at all times these characteristics were considered to be identical to those under regional anaesthesia with conscious spontaneous respiration showing that spontaneous QO2 under this anaesthetic regimen has a similar respiratory capacity to that of conscious spontaneous QO2\n",
      "Generated Text: twelve elderly patients undergoing total knee arthroplasty received lumbar epidural anaesthesia and propofol infusion at mgkgh following a mgkg bolus dose with preservation of spontaneous respiration via a LM airway circulatory respiratory and metabolic variables were measured before and and min after PR of a pneumatic thigh tourniquet the blood pressure and heart rate were significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourniquet group compared with the control group the mean arterial pressure was significantly reduced in the pneumatic tourn\n",
      "BLEU: 0.14229806113253174, ROUGE-L: {'r': 0.6075949367088608, 'p': 0.8421052631578947, 'f': 0.7058823480720156}, Perplexity: 1.8543297052383423, Cosine Similarity: 0.2657\n",
      "Reference Text: the international federation of orthopaedic manipulative PTs ifompt aims to achieve worldwide promotion of excellence and unity in clinical and academic standards for manual and musculoskeletal PTs to this end ifompt has sponsored several conference panel sessions and a survey of member organizations mos and registered interest CG rigs regarding current cervical spine manipulation and premanipulative screening practice in each country the purpose of this study was to determine common elements of cervical spine manipulative practice and premanipulative screening between countries in late a questionnaire investigating recommended premanipulative screening protocolguideline use IC regarding risks screening procedures and treatmentmanipulation technique was sent to all twenty mos and five rigs the response rate was the main findings of the survey included of respondent organizations use premanipulative guidelines with australian guidelines the most frequently adopted internationally recommendations concerning the provision of information about the possibility of serious AEs is not standard practice in all countries positional tests for VBI are used by all respondent organizations craniovertebral ligament testing is sometimes taught as a premanipulative screening tool the use of upper cervical spine manipulation has declined in some countries and of the respondent organizations that continue to teach upper C2 manipulation most minimize the rotation component the findings of this research will inform an ifompt international standard for screening the cervical region prior to orthopaedic manual therapy intervention the development of an ifompt endorsed document will be of assistance to manual therapy clinicians worldwide in safely managing disorders of the cervical spine\n",
      "Generated Text: the international federation of orthopaedic manipulative PTs ifompt aims to achieve worldwide promotion of excellence and unity in clinical and academic standards for manual and musculoskeletal PTs to this end ifompt has sponsored several conference panel sessions and a survey of member organizations mos and registered interest CG rigs regarding the development of standards for manual and musculoskeletal PTs and the development of standards for the use of manual and musculoskeletal PTs in the orthopaedic setting the purpose of this survey is to gather information on the current status of the international federation of orthopaedic manipulative PTs ifompt and the development of standards for manual and musculoskeletal PTs in the orthopaedic setting and to provide a survey of member organizations mos and registered interest CG rigs regarding the development of standards for manual and musculoskeletal PTs and the development of standards for the use of manual and musculoskeletal PTs in the orthopaedic setting\n",
      "BLEU: 0.2220413357366883, ROUGE-L: {'r': 0.32116788321167883, 'p': 0.8461538461538461, 'f': 0.46560846161977554}, Perplexity: 5.573696136474609, Cosine Similarity: 0.7755\n",
      "Reference Text: appearance concerns in individuals with adolescent idiopathic scoliosis can result in impairment in daily SF-36 or body image disturbance the body image disturbance questionnaire bidq is a selfreported sevenquestion instrument that measures body image disturbance in general populations no studies have specifically examined body image disturbance in those with adolescent IS this T0 aimed to validate a modified version of the bidq in a population with AIS and to establish discriminant validity by comparing responses of operatively and nonoperatively treated patients with those of NCs\n",
      "Generated Text: appearance concerns in individuals with adolescent idiopathic scoliosis can result in impairment in daily SF-36 or body image disturbance the body image disturbance questionnaire bidq is a selfreported sevenquestion instrument that measures body image disturbance in general populations no studies have specifically examined body image disturbance in those with adolescent idiopathic scoliosis the aim of this study was to examine the relationship between body image disturbance and the presence of scoliosis in a sample of adolescents with idiopathic scoliosis the study was a cross sectional study of adolescents with idiopathic scoliosis and a control group of adolescents without scoliosis the study was conducted at the university of korea in korea the study was conducted in a double blind fashion the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea in korea the study was conducted in a university of korea\n",
      "BLEU: 0.1251670609294502, ROUGE-L: {'r': 0.6724137931034483, 'p': 0.65, 'f': 0.6610169441539788}, Perplexity: 1.970274567604065, Cosine Similarity: 0.4330\n",
      "Reference Text: the aim of this T0 is to analyze the clinical outcome and the NC in oralhealthrelated SQ of life qol of OP patients affected by medicationrelated ON of the jaws mronj fortyone patients consecutively treated for a year period were retrospectively analyzed all the patients underwent a marginal osseous resective jaw surgery a clinical months postoperative evaluation has been performed and the CR mucosal healing the absence of swelling and suppuration and no signs of disease recurrence were defined like success parameters qualityoflife surveys tests like eortc qqc and qlqhn appendices in conjunction with a perceived oral health visual analog scale vas were administered before time of diagnosis of mronj and T3 surgery at least months in order to record the different oral health status of the treated patients the majority of mronjdiagnosed patients complained PS like pain eating discomfort and sense problems with occasional involvement of the social dimension there was a prevalence of troubles with social eating and social contactthe complete mucosal healing was achieved in of the patients and the po survey tests reported a significant improvement in all the investigated spheres similarly an increased mean score of perceived oral health vas was reportedmarginalresective surgery of the necrotic jaw bone can be an ERP treatment of OP patients affected by localized mronj qualityoflife parameters are demonstrated to be useful for recording the patientcentered outcome of mronj treatment\n",
      "Generated Text: the aim of this T0 is to analyze the clinical outcome and the NC in oralhealthrelated SQ of life qol of OP patients affected by medicationrelated ON of the jaws mronj fortyone patients consecutively treated for a year period were retrospectively analyzed all the patients underwent a marginal osseous resective procedure and the patients were followed up for a year after the procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year after the resective procedure the patients were followed up for a year\n",
      "BLEU: 0.11870856669965771, ROUGE-L: {'r': 0.29850746268656714, 'p': 0.9090909090909091, 'f': 0.4494381985254387}, Perplexity: 2.015145778656006, Cosine Similarity: 0.4528\n",
      "Reference Text: the purpose of this study was to evaluate the enhancing potency of tectochrysin a flavonoid isolated from alpinia oxyphylla miquel by combining cetuximab an antiegfr monoclonal antibody on human CC cell growth through further inhibition of egfr pathway hct and sw colon cancer cells were treated with cetuximab gml of ic tectochrysin gml of ic or the combination of both agents the growth GABA effect was examined using the mtt assay while apoptotic cell death was performed using tunel IF assays the dna binding activity of nfkappa b and ap was investigated by EMS assay protein expression was determined by western blot cell proliferation was significantly inhibited by the combination of cetuximab and tectochrysin than treatment with cetuximab or tectochrysin alone combination index and respectively combination treatment of cells with cetuximab and tectochrysin significantly reduced the expressions of pegfr and cox in both cell lines combination treatment also significantly inhibited activities of nfkb and ap compared to the single agent treatment our results indicate that combined therapy with lower concentration of cetuximab and tectochrysin could significantly enhance the cancer cell growth GABA effect through the inhibition of egfr signaling\n",
      "Generated Text: the purpose of this study was to evaluate the enhancing potency of tectochrysin a flavonoid isolated from alpinia oxyphylla miquel by combining cetuximab an antiegfr monoclonal antibody on human CC cell growth through further inhibition of egfr pathway hct and sw colon cancer cells were treated with cetuximab gml of tectochrysin for 24 h and then with cetuximab gml of tectochrysin for 24 h the growth of hct and sw colon cancer cells were evaluated by flow cytometry and by immunohistochemistry the results showed that cetuximab gml of tectochrysin significantly inhibited the growth of hct and sw colon cancer cells in a concentration dependent manner and the inhibition was dose dependent the inhibitory effect of cetuximab gml of tectochrysin was also observed in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the presence of cetuximab gml of tectochrysin in the\n",
      "BLEU: 0.25600351024556256, ROUGE-L: {'r': 0.42990654205607476, 'p': 0.6764705882352942, 'f': 0.5257142809626123}, Perplexity: 2.348853349685669, Cosine Similarity: 0.7327\n",
      "Reference Text: cyclooxygenase cox is a key enzyme in the biosynthetic pathway leading to the formation of prostaglandins which are mediators of inflammation dl dewitt wl smith primary structure of prostaglandin gh synthase from sheep vesicular gland determined from the cDNA CS proc natl acad sci usa it exists mainly in two isoforms cox and cox a raz a wyche n siegel p needleman regulation of FB cyclooxygenase synthesis by interleukin j biol chem the conventional nonsteroidal antiinflammatory drugs nsaids have adverse gastrointestinal sideeffects because they inhibit both isoforms td warner f guiliano i vojnovic a bukasa ja mitchell jp vane nonsteroid drug selectivities for cyclooxygenase rather than cyclooxygenase are associated with human gastrointestinal toxicity a full in vitro analysis proc natl acad sci usa lj marnett as kalgutkar cyclooxygenase inhibitors discovery selectivity and the future trends pharmacol sci jr vane nsaids cox inhibitors and the gut lancet therefore drugs which selectively inhibit cox known as coxibs were developed recent reports on the harmful cardiovascular and renovascular sideeffects of the antiinflammatory drugs have led to the quest for a novel class of cox selective inhibitors keeping this in mind we have used the xray crystal structures of the complexes of the cox and cox with the known inhibitors for a rational structure based approach to design a small peptide which is potent inhibitor for cox the MMP have been checked experimentally by invitro kinetic studies using SPR spr and other PSA methods we have identified a tripeptide inhibitor which is a potential lead for a new class of cox inhibitor the dissociation constant kd determined for cox with peptide wcs is xm the kinetic constant ki determined by spectrophotometry is xm and the ic value is xm by elisa test\n",
      "Generated Text: cyclooxygenase cox is a key enzyme in the biosynthetic pathway leading to the formation of prostaglandins which are mediators of inflammation dl dewitt wl smith primary structure of prostaglandin gh synthase from sheep vesicular gland determined from the cDNA CS proc natl acad sci usa it exists mainly in two isoforms which are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritoneum and in the peritoneal cavity the two isoforms are expressed in the vesicular gland and in the perivascular tissue of the peritone\n",
      "BLEU: 0.1618124773664341, ROUGE-L: {'r': 0.2658959537572254, 'p': 0.8679245283018868, 'f': 0.40707964242736316}, Perplexity: 2.0477805137634277, Cosine Similarity: 0.5966\n",
      "Reference Text: ruptured ASV rsov occurring in pregnancy is a rare cardiac anomaly and it may be either congenital or acquired congenital sinus of valsalva aneurysms are commonly associated with other structural defects such as ventricular septal defect aortic regurgitation ar BAV and marfans syndrome rsov in pregnancy accentuates the hemodynamic stress on maternal CVS and pose a significant challenge from obstetric anesthesia point of view we report a case of yearold documented patient of rsov with mild ar presenting completely asymptomatic at weeks days of gestation a successful elective lower segment cesarean section was conducted under EA\n",
      "Generated Text: ruptured ASV rsov occurring in pregnancy is a rare cardiac anomaly and it may be either congenital or acquired congenital sinus of valsalva aneurysms are commonly associated with other structural defects such as ventricular septal defect aortic regurgitation ar BAV and marfans syndrome rsov in pregnancy accentuates the hemodynamic stress and the risk of aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurgitation and aortic regurgitation is associated with aortic regurg\n",
      "BLEU: 0.18742494528338174, ROUGE-L: {'r': 0.5625, 'p': 0.9574468085106383, 'f': 0.7086614126604253}, Perplexity: 1.9067420959472656, Cosine Similarity: 0.3359\n",
      "Reference Text: the haemodynamic changes during EA and following the administration of dihydroergotamine dhe microgramskg iv were studied in dogs epidural group EPI anaesthesia was associated with reductions in MAP mean pulmonary arterial and mean RA atrial pressures FA flow was increased by and femoral resistance fell by all these changes were abolished by additional administration of dhe during EPI anaesthesia in a second group of dogs control group n with intact innervation ie without epidural block dhe microgramskg iv also decreased FA flow and increased femoral resistance which however was significantly less pronounced p less than it is concluded that dhe in EPI anaesthesia constricts arteriolar resistance vessels mainly within the blocked Az\n",
      "Generated Text: the haemodynamic changes during EA and following the administration of dihydroergotamine dhe microgramskg iv were studied in dogs epidural group EPI anaesthesia was associated with reductions in MAP mean pulmonary arterial and mean RA atrial pressures FA flow was increased by and femoral resistance fell by all these changes were associated with a reduction in the mean arterial pressure and a reduction in the mean RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arterial pressure and RA atrial pressure the mean arterial pressure was reduced by and femoral resistance was reduced by the changes in the mean arter\n",
      "BLEU: 0.12151046491102305, ROUGE-L: {'r': 0.5833333333333334, 'p': 0.9130434782608695, 'f': 0.7118644020224074}, Perplexity: 2.060361623764038, Cosine Similarity: 0.5121\n",
      "Reference Text: a model of cutaneous EM was used to determine if live dirofilaria immitis larvae secrete PRs which are AS at physiological ph and capable of degrading macromolecules found in cutaneous tissue T3 hr thirdstage larvae l degraded of the total matrix while fourthstage larvae l degraded a sharp increase in the amount of matrix degraded by l corresponded with the onset of the molting process l and l degraded comparable amounts of the glycoprotein and elastin components of the matrix but molting l degraded nearly twice the amount of the collagen component vs characterization of proteases present in larvalsoluble extracts and excretorysecretory products using synthetic substrates and PIs demonstrated cysteineprotease and metalloprotease activity cysteine protease activity was found in whole worm extracts of both l and l metalloprotease was secreted at higher levels by molting l but was also secreted by l partial separation of the metalloprotease by sizeexclusion chromatography indicated that the molecular weight of the native enzyme was in the kda range the cysteine protease activity was demonstrated in fractions corresponding to kda the biological function of the d immitis larval PRs remains to be conclusively determined however these data suggest that they are involved in degradation of components of cutaneous tissue and in the molting process\n",
      "Generated Text: a model of cutaneous EM was used to determine if live dirofilaria immitis larvae secrete PRs which are AS at physiological ph and capable of degrading macromolecules found in cutaneous tissue T3 hr thirdstage larvae l degraded of the total matrix while fourthstage larvae l degraded a sharp increase in the total matrix was observed in the fourthstage larvae l and fourthstage larvae l the total matrix was also significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage larvae l and fourthstage larvae l the total matrix was significantly reduced in the fourthstage\n",
      "BLEU: 0.13653604053525623, ROUGE-L: {'r': 0.36607142857142855, 'p': 0.9111111111111111, 'f': 0.5222929895411579}, Perplexity: 2.08255934715271, Cosine Similarity: 0.5374\n",
      "Reference Text: depression is a family of complex and multifactorial illnesses that are characterized by disruptions in the SF-36 of a number of physiological neuroendocrine and behavioral processes of these sleep disturbance and circadian rhythm abnormalities constitute the most prevalent signs of depressive illness difficulty in falling asleep decreases in TST and sleep efficiency early morning awakenings and REM alterations are all commonly seen in depressed patients advances or delays in the phase of circadian rhythms have been documented in patients with MD mdd BP disorder and patients with seasonal affective disorder sad the disturbances in the amplitude and rhythm of melatonin secretion that occur in patients with depression resemble those seen in subjects with chronobiological disorders the finding that insomnia and CR CA are prominent icrobial MMP EDC regarded as important defense components in the host defense system here we report the purification and characterization of an kda glyrich peptide named hyastatin from the hemocytes of hyas araneus it consists of three distinctly different domains an nterminal region enriched in gly residues a short proargrich region and a CT region containing six cys residues with a cys pattern resembling the one found in penaeidins the cterminus of the mature peptide is presumably amidated the hyastatin transcript is constitutively expressed and mainly found in hemocytes hyastatin shows antimicrobial activity against yeasts and GP and GNB the NT region devoid of the cyscontaining region was recombinantly expressed in escherichia coli cells and shows only weak activity against the GP bacteria corynebacterium glutamicum both hyastatin and the NT region had the ability to bind chitin conclusively this indicates the importance of the cyscontaining region for the antimicrobial activity and a possible multifunctional character of hyastatin\n",
      "Generated Text: depression is a family of complex and multifactorial illnesses that are characterized by disruptions in the SF-36 of a number of physiological neuroendocrine and behavioral processes of these sleep disturbance and circadian rhythm abnormalities constitute the most prevalent signs of depressive illness difficulty in falling asleep decreases in TST and sleep latency and increases in REM sleep latency and REM sleep duration are also associated with depression and are associated with increased risk of suicide ideation and suicide attempts depression is a major public health problem in the United States and is associated with increased mortality and morbidity and disability in the elderly and with increased risk of suicide ideation and suicide attempts depression is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide attempts and is associated with increased risk of suicide ideation and suicide\n",
      "BLEU: 0.1264640896614274, ROUGE-L: {'r': 0.2411764705882353, 'p': 0.6721311475409836, 'f': 0.35497835109162124}, Perplexity: 1.8521323204040527, Cosine Similarity: 0.4227\n",
      "Reference Text: lenvatinib an oral multikinase inhibitor was approved by the us food and drug administration in february in a pivotal phase iii T0 of patients with progressive radioiodinerefractory TC the overall response rate of patients receiving lenvatinib was with complete response in four patients the median PFS survival was months in the lenvatinib arm versus months in patients receiving placebo median overall survival was not reached in either arm lenvatinib is a promising new treatment for patients with radioiodine iodinerefractory DTC\n",
      "Generated Text: lenvatinib an oral multikinase inhibitor was approved by the us food and drug administration in february in a pivotal phase iii T0 of patients with progressive radioiodinerefractory TC the overall response rate of patients receiving lenvatinib was with complete response in four patients the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one patient the median PFS survival was months in two patients and the median PFS survival was months in one\n",
      "BLEU: 0.11614027407882363, ROUGE-L: {'r': 0.7254901960784313, 'p': 0.925, 'f': 0.8131868082598722}, Perplexity: 1.7090147733688354, Cosine Similarity: 0.6543\n",
      "Reference Text: the aim of this multicenter prospective nonrandomized study was to examine the procedural inhospital and midterm clinical and angiographic outcome of patients undergoing coronary angioplasty with the tecnic carbostent system between october and march consecutive patients were treated with coronary implantation of the tecnic carbostent SD angina unstable angina and SI were clinical indications for revascularisation the baseline lesion morphology was complex type b or c in of the cases and the mean lesion length was mm a total of stents were implanted in lesions the procedural success rate was mean percent diameter of the stenosis decreased after the intervention from to the mean crosssectional area stent recoil was no inhospital or day L1 adverse CE were observed during the month followup period there were no deaths or myocardial infarctions whereas the incidence of target lesion revascularisation was the angiographic restenosis rate was a focal or limited DP class i or ii was found in of cases whereas the remaining had a proliferative morphology class iii or iv in conclusion this T0 indicates that a good clinical and angiographic outcome may be obtained with the tecnic carbostent coronary system in consecutive patients with de novo coronary lesions\n",
      "Generated Text: the aim of this multicenter prospective nonrandomized study was to examine the procedural inhospital and midterm clinical and angiographic outcome of patients undergoing coronary angioplasty with the tecnic carbostent system between october and march consecutive patients were treated with coronary implantation of the tecnic carbostent SD angina unstable angina and unstable angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent SD angina with the tecnic carbostent\n",
      "BLEU: 0.18963765628503546, ROUGE-L: {'r': 0.32432432432432434, 'p': 1.0, 'f': 0.48979591466888805}, Perplexity: 1.7532886266708374, Cosine Similarity: 0.4851\n",
      "Reference Text: oxidative stress is a leading cause of neuronal damage in ischemic stroke melatonin may play a role in the antioxidant response melatonin and its metabolites may be involved in the modulation of oxidative AS in human acute stroke no data are available in humans to establish this relationship in this context on the first and the fifth days poststroke we assessed serum total antioxidant capacity tac and urine levels of melatonin sulfatoxymelatonin amts and nacetylnformylmethoxykynuramine afmk the last compound being produced in the BB after reaction of melatonin with reactive oxygen species compared to controls values tac and C2 of melatonin and amts were reduced without difference between the first and the fifth days poststroke whereas afmk C2 remained in the normal range at both time points melatonin catabolism might be speeded up in AIS in order to increase the antioxidant response\n",
      "Generated Text: oxidative stress is a leading cause of neuronal damage in ischemic stroke melatonin may play a role in the antioxidant response melatonin and its metabolites may be involved in the modulation of oxidative AS in human acute stroke no data are available in humans to establish this relationship in this study we investigated the effects of melatonin on the oxidative stress response in acute stroke patients and healthy controls we found that melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin also significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls melatonin significantly reduced the oxidative stress response in acute stroke patients compared to controls\n",
      "BLEU: 0.11906863501178175, ROUGE-L: {'r': 0.4666666666666667, 'p': 0.8235294117647058, 'f': 0.59574467623359}, Perplexity: 1.5613569021224976, Cosine Similarity: 0.5571\n",
      "Reference Text: to distinguish NR from nonresponders early in interferon ifn treatment would be beneficial in patients with chronic HC those patients unlikely to respond would be spared the cost and hazard of prolonged treatment fortythree chronic HC patients who had received ifnalpha therapy mu six times weekly for weeks followed by thrice weekly for additional weeks were randomly enrolled into the present T0 serially obtained sera were retrospectively tested for hcvrna by reverse transcriptionpolymerase chain reaction amplicor hcv with a low limit PCD of approximately copiesml genotypes were determined by typespecific primers sixteen subjects were defined as SR sr who showed sustained loss of viraemia with normalized alanine aminotransferase values for at least months of followup T3 completion of therapy the other subjects were nonresponders nr whose viraemia persisted during followup i.c.v. serum hcvrna levels p and the TT p were significant predictors for sustained response to ifn therapy HC virus rna was detectable in only one sr and in nr at the second week of therapy p and was detected in none of the sr subjects and in nr at the fourth week of therapy p pretreatment viral load was correlated with the time until loss of viraemia multivariate analysis revealed that loss of viraemia at the second week of therapy was the strongest predictor for a longterm response followed by the initial viral load and loss of viraemia at the fourth week of therapy these findings suggest that it is possible to predict a LT response to ifn as early as at the second and fourth weeks T3 the start of therapy by identifying the presence or absence of hcvrna with a CS CA\n",
      "Generated Text: to distinguish NR from nonresponders early in interferon ifn treatment would be beneficial in patients with chronic HC those patients unlikely to respond would be spared the cost and hazard of prolonged treatment fortythree chronic HC patients who had received ifnalpha therapy mu six times weekly for weeks followed by a second dose of ifnalpha for weeks were randomized to receive either a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second dose of ifnalpha for weeks each of the patients received a single dose of ifnalpha or a second\n",
      "BLEU: 0.14007049664289928, ROUGE-L: {'r': 0.3082191780821918, 'p': 0.8823529411764706, 'f': 0.45685278804091833}, Perplexity: 1.8169454336166382, Cosine Similarity: 0.4912\n",
      "Reference Text: peritoneal injection of TG medium tm to mice results in a dramatic increase in total number of peritoneal macrophages within to hours unlike resident macrophages a fraction to of these newly arrived young macrophages designated as macrophage colonyforming cells mcfc are highly proliferative and formed macrophage colonies in vitro in the presence of either macrophage or granulocytemacrophage colonystimulating factor mcsf or gmcsf using a reverse transcriptase PCR reaction rtpcr technique PEM pem obtained to days after a single tm injection actively expressed mrna for recombinant murine macrophage inflammatory protein alpha rmmip alpha yet none or only a trace amount of mrna for mip alpha was detected in normal resident macrophages or pem obtained days T3 tm treatment the effect of rmmip alpha on the induction of exudate mcfc was investigated multiple intraperitoneal ip administration of rmmip alpha caused a marked increase in the total number of peritoneal mcfc and macrophages similar to but weaker than the increase in tminjected mice the total number of neutrophils mast cells and eosinophils also increased but with different kinetics following multiple injections of rmmip alpha rmmip alpha CT did not stimulate the proliferation of mcfc nor did it potentiate their responsiveness to either rmgmcsf or recombinant human rh mcsf in vitro taken together our results suggest that mip alpha released by exudate macrophages is a major chemoattractant responsible for the migration of mcfc from the circulation to the peritoneal cavity during a tminduced inflammatory response\n",
      "Generated Text: peritoneal injection of TG medium tm to mice results in a dramatic increase in total number of peritoneal macrophages within to hours unlike resident macrophages a fraction to of these newly arrived young macrophages designated as macrophage colonyforming cells mcfc are highly proliferative and formed macrophage colonies in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be highly proliferative in vivo in mice and in vitro in the presence of TG medium tm macrophages were also found to be\n",
      "BLEU: 0.14343615308250945, ROUGE-L: {'r': 0.2971014492753623, 'p': 0.9111111111111111, 'f': 0.44808742798530865}, Perplexity: 1.7945266962051392, Cosine Similarity: 0.5369\n",
      "Reference Text: there is a broad community of health sciences professionals interested in the anatomy of the cranial nerves cns specialists in neurology neurosurgery radiology otolaryngology ophthalmology maxillofacial surgery radiation oncology and EM as well as other related fields advances in neuroimaging using highresolution images from computed tomography ct and magnetic resonance mr have made highlydetailed visualization of BB structures possible allowing normal findings to be routinely assessed and nervous system pathology to be detected in this article we present an integrated perspective of the normal anatomy of the cns established by radiologists and neurosurgeons in order to provide a practical imaging review which combines slice dualsource MPR images from CTC and t mr curved reconstructed images the information about the cns includes their origin course with emphasis on the cisternal segments and location of the orifices at the skull base transmitting them function and a brief listing of the most common pathologies affecting them the scope of the article is clinical anatomy readers will find specialized texts presenting detailed information about particular topics our aim in this article is to provide a helpful REF for understanding the complex anatomy of the cranial SN\n",
      "Generated Text: there is a broad community of health sciences professionals interested in the anatomy of the cranial nerves cns specialists in neurology neurosurgery radiology otolaryngology ophthalmology maxillofacial surgery radiation oncology and EM as well as other related fields advances in neuroimaging using highresolution images from computed tomography ct and magnetic resonance imaging have provided a new tool for the investigation of the anatomy of the cranial nerves cns and the development of new imaging techniques for the investigation of the anatomy of the cranial nerves cns the aim of this study was to investigate the anatomy of the cranial nerves cns using highresolution images from computed tomography ct and magnetic resonance imaging ct and to compare the results with those obtained using conventional CT and MR imaging techniques the results were compared with those obtained using conventional CT and MR imaging techniques\n",
      "BLEU: 0.2993468572325177, ROUGE-L: {'r': 0.36363636363636365, 'p': 0.6956521739130435, 'f': 0.4776119357897082}, Perplexity: 5.229002952575684, Cosine Similarity: 0.8045\n",
      "Reference Text: the previous SRS brace T0 jbjsa included patients with adolescent IS ais with moderate curve sizes degrees degrees the swedish patients in this T0 were examined in a longterm followup\n",
      "Generated Text: the previous SRS brace T0 jbjsa included patients with adolescent IS ais with moderate curve sizes degrees degrees the swedish patients in this T0 were examined in a longterm followup study the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18 years the mean age of the patients was 18\n",
      "BLEU: 0.05841666830904029, ROUGE-L: {'r': 1.0, 'p': 0.7741935483870968, 'f': 0.8727272678082645}, Perplexity: 1.6758750677108765, Cosine Similarity: 0.3173\n",
      "Reference Text: spinal cord glioma is uncommonly reported in dogs we describe the clinicopathologic and diagnostic features of cases of canine spinal cord glioma and briefly review the veterinary literature on this topic the median age at presentation was y six females and male were affected and dogs were brachycephalic the clinical course lasted from d to wk and clinical signs were progressive and associated with multiple suspected neuroanatomic locations in the spinal cord magnetic resonance imaging of cases revealed tweighted hyperintense lesions with VL contrast enhancement in the spinal cord all dogs had a presumptive clinical diagnosis of intraparenchymal neoplasia or myelitis based on history T3 imaging and CSF fluid analysis euthanasia was elected in all cases because of poor outcome despite antiinflammatory or IS treatment or because of poor prognosis at the time of diagnosis RT location during autopsy ranged from c to l with no clear predilection for a specific spinal cord segment the diagnosis was based on histopathology and the immunohistochemistry expression of glial fibrillary Pa oligodendrocyte lineage transcription factor cyclicnucleotide phosphodiesterase neuronspecific enolase synaptophysin and ki diagnoses consisted of cases of oligodendroglioma cases of GC and astrocytoma this case series further defines the clinicopathologic features of canine spinal glioma and highlights the need for comprehensive immunohistochemistry in addition to routine histopathology to confirm the diagnosis of these PT\n",
      "Generated Text: spinal cord glioma is uncommonly reported in dogs we describe the clinicopathologic and diagnostic features of cases of canine spinal cord glioma and briefly review the veterinary literature on this topic the median age at presentation was y six females and male were affected and dogs were brachycephalic the clinical presentation was a diffuse diffuse mass of glioma in the spinal cord the histopathologic features were diffuse diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord with a diffuse mass of glioma in the spinal cord\n",
      "BLEU: 0.1443678331003207, ROUGE-L: {'r': 0.29850746268656714, 'p': 0.9302325581395349, 'f': 0.4519773974515625}, Perplexity: 1.6254656314849854, Cosine Similarity: 0.5965\n",
      "Reference Text: single and multiple nucleotide substitutions have been introduced into the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv genomic rna we studied the effects of these mutations on in vitro valylation and on replication in chinese cabbage protoplasts and plants only those mutants capable of efficient and CR valylation showed efficient replication in protoplasts and gave rise to systemic symptoms in whole plants mutants that accepted valine inefficiently in some cases vmaxkm values were less than relative to wildtype values replicated to C2 to fold below wildtype C2 in protoplasts estimated on the basis of coat protein and genomic rna C2 these mutants could not support systemic spread in plants in one plant inoculated with tymca rna which replicates poorly in protoplasts systemic symptoms developed after a delay the reversion in replication was accompanied by improved valine acceptance and the appearance of a u secondsite mutation our results indicate a correlation between valine acceptance activity and viral yield possible roles for valylation are discussed and the results are compared with those of similar studies with BMV which suggested that tyrosylation is not crucial for BMV replication t w dreher a l n rao and t c hall j mol biol\n",
      "Generated Text: single and multiple nucleotide substitutions have been introduced into the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv genomic rna we studied the effects of these mutations on in vitro valylation and on replication in chinese cabbage protoplasts and plants only those mutants capable of efficient in vitro valylation were used in the experiments and the results showed that the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv were not deleterious to the in vitro valylation of the virus and the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv in the experiments the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the anticodon loop of the trnalike structure of turnip yellow mosaic virus tymv the in vitro valylation of the virus was not affected by the mutations in the antic\n",
      "BLEU: 0.14606090321526427, ROUGE-L: {'r': 0.3671875, 'p': 0.8703703703703703, 'f': 0.5164835123101076}, Perplexity: 2.0737311840057373, Cosine Similarity: 0.5823\n",
      "Reference Text: AAM mostly originating in the female pelvis and peritoneum or in the male analogous sites is a rare mesenchymal neoplasm characterized with infiltrative growth to adjacent tissue and local recurrence after primary excision herein we report a case of AAM of maxilla in a yearold male patient for its rarity the patient presented with a oneyear history of progressively enlarging maxillary mass on left side before referred to our hospital he was given a biopsy and diagnosed as aggressive angiomyxoma by immunohistochemical IF T3 that he underwent gy radiotherapy unfortunately ct scan showed bigger mass infiltrated to adjacent facial soft tissues and bones compared with that of before radiotherapy besides that he began to suffer with ingravescent HA the mass was surgically removed and the diagnosis was confirmed by IH in our hospital as a case of AAM occurred in a rare site and experienced an ongoing growth in spite of radiotherapy its characteristics was discussed with a brief literature review which may aid further understanding of aggressive angiomyoma\n",
      "Generated Text: AAM mostly originating in the female pelvis and peritoneum or in the male analogous sites is a rare mesenchymal neoplasm characterized with infiltrative growth to adjacent tissue and local recurrence after primary excision herein we report a case of AAM of maxilla in a yearold male patient for its rarity and the absence of any other histopathological features we report the case of a patient with AAM of maxilla in a yearold female patient\n",
      "BLEU: 0.19922515693154394, ROUGE-L: {'r': 0.3761467889908257, 'p': 0.8913043478260869, 'f': 0.5290322538905308}, Perplexity: 19.09794807434082, Cosine Similarity: 0.7291\n",
      "Reference Text: G1 immune cells PR cytokines which modulate the activity of bone cells in vitro expression of H-2 complex hla in humans class ii determinants on bone surface cells may be important in local immune cell activation in this T0 expression of DR and dq by cultured human bone cells hbc derived from normal trabecular bone surfaces was assessed by fluorescenceactivated MACS facs analysis and immunoperoxidase techniques using monoclonal antibodies a subset of hbc expressed dr constitutively while displayed dq during longterm culture hbc lacked a number of mo and lymphocyte markers in addition both dr and dr hbc facs separated produced osteocalcin stimulated by dihydroxyvitamin d ohd this suggests that both phenotypes belong to the osteoblast lineage the number of dr hbc was increased by interferongamma ifn gamma dr cells whereas dq hbc remained unchanged or was slightly increased dq cells moreover ohd enhanced ifn gammainduced dr expression and at high concentration m augmented dr expression by itself other major osteotropic AF parathyroid hormone interleukin and calcitonin did not affect hbc dr expression the findings suggest that hbc may participate in activation of the IS and that some osteotropic factors may regulate this CF\n",
      "Generated Text: G1 immune cells PR cytokines which modulate the activity of bone cells in vitro expression of H-2 complex hla in humans class ii determinants on bone surface cells may be important in local immune cell activation in this T0 expression of DR and dq by cultured human bone cells hbc and hbx in vitro hbc and hbx were found to be significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow of patients with rheumatoid arthritis hbc and hbx were also significantly increased in the bone marrow\n",
      "BLEU: 0.14618204075453117, ROUGE-L: {'r': 0.319672131147541, 'p': 0.78, 'f': 0.45348836796917263}, Perplexity: 1.9559208154678345, Cosine Similarity: 0.4727\n",
      "Reference Text: seven of twentytwo patients treated with intracavitary co therapy for NP neoplasms remained controlled for more than five yearsno patient treated with intracavitary co therapy alone has remained alive of the seven surviving patients four received external irradiation in conjunction with intracavitary therapy in doses which in themselves may well have controlled the disease and the contribution of the intracavitary therapy cannot be assessed of ten patients treated for disease recurrent or uncontrolled following ERT intracavitary therapy was ERP for control of the disease for five years in two patients one of these patient substances have been identified as isobutyl and EA lesser amounts of isoamyl acetate ethanol and methanol were also present\n",
      "Generated Text: seven of twentytwo patients treated with intracavitary co therapy for NP neoplasms remained controlled for more than five yearsno patient treated with intracavitary co therapy alone has remained alive of the seven surviving patients four received external irradiation in conjunction with intracavitary therapy in doses which in themselves may well have been too high the authors conclude that intracavitary co therapy is a safe and effective treatment for NP neoplasms\n",
      "BLEU: 0.40393080934139536, ROUGE-L: {'r': 0.5285714285714286, 'p': 0.7708333333333334, 'f': 0.6271186392415974}, Perplexity: 20.2050838470459, Cosine Similarity: 0.8151\n",
      "Reference Text: RFC is required to load proliferating cell nuclear antigen onto primertemplate junctions using the SE of atp hydrolysis four of the five rfc genes have consensus atpbinding motifs to determine the relative importance of these sites for proper dna metabolism in the cell the conserved lysine in the walker a motif of rfc rfc rfc or rfc was mutated to either Arg or glutamic acid arginine mutations in all rfc genes tested permitted cell growth although poor growth was observed for rfckr a glutamic acid substitution resulted in lethality in rfc and rfc but not in rfc or rfc most double mutants combining mutations in two rfc genes were inviable except for the rfckr and rfcke mutants which were phenotypically similar to wild type in every CA the mutants were CS to dnadamaging agents the rfckr and rfckr mutants show checkpoint defects most likely in the intras phase checkpoint regulation of the damageinducible rnr promoter was impaired in these mutants and phosphorylation of radp in response to dna damage was specifically defective when cells were in s phase no dramatic defects in telomere length regulation were detected in the mutants these data demonstrate that the atp binding function of rfc is important for both dna replication and checkpoint CF and for the first time that rfc also plays a role in checkpoint regulation\n",
      "Generated Text: RFC is required to load proliferating cell nuclear antigen onto primertemplate junctions using the SE of atp hydrolysis four of the five rfc genes have consensus atpbinding motifs to determine the relative importance of these sites for proper dna metabolism in the cell the conserved lysine in the walker a and the lysine in the pf gene are the most important sites for the conversion of the pf to the pf2 protein the lysine in the pf2 protein is the most important site for the conversion of the pf2 to the pf3 protein the lysine in the pf3 protein is the most important site for the conversion of the pf3 to the pf4 protein the lysine in the pf4 protein is the most important site for the conversion of the pf4 to the pf5 protein the lysine in the pf5 protein is the most important site for the conversion of the pf5 to the pf6 protein the lysine in the pf6 protein is the most important site for the conversion of the pf6 to the pf7 protein the lysine in the pf7 protein is the most important site for the conversion of the pf7 to the pf8 protein the lysine in the pf8 protein is the most important site for the conversion of the pf8 to the pf9 protein the lysine in the pf9 protein is the most important site for the conversion of the pf9 to the pf10 protein the lysine in the pf10 protein is the most important site for the conversion of the pf10 to the pf11 protein the lysine in the pf11 protein is the most important site for the conversion of the pf11 to the pf12 protein the lysine in the pf12 protein is the most important site for the conversion of the pf12 to the pf13 protein the lysine in the pf13 protein is the most important site for the conversion of the pf13 to the pf14 protein the lysine in the pf14 protein is the most important site for the conversion of the pf14 to the pf15 protein the lysine in the pf15 protein is the most important site for the conversion of the pf15 to the pf16\n",
      "BLEU: 0.15741695991156462, ROUGE-L: {'r': 0.3442622950819672, 'p': 0.65625, 'f': 0.4516128987119899}, Perplexity: 2.1131668090820312, Cosine Similarity: 0.5667\n",
      "Average BLEU: 0.17665555209815692\n",
      "Average ROUGE-L: 0.5638450877762092\n",
      "Average Perplexity: 4.2744570672512054\n",
      "Average Cosine Similarity: 0.582488611991641\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import torch\n",
    "from transformers import AutoTokenizer, AutoModelForCausalLM\n",
    "from nltk.translate.bleu_score import sentence_bleu\n",
    "from rouge import Rouge\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "texts = test_dataset[\"text\"][:200]\n",
    "\n",
    "# Ensure tokenizer has a pad token\n",
    "if tokenizer.pad_token is None:\n",
    "    tokenizer.pad_token = tokenizer.eos_token\n",
    "\n",
    "# Create prompts from the first 50 words\n",
    "prompts = [' '.join(str(text).split()[:50]) for text in texts]\n",
    "\n",
    "def generate_long_text(model, tokenizer, prompt, max_length=300):    \n",
    "    input_ids = tokenizer(prompt, return_tensors=\"pt\").input_ids.to(device)\n",
    "    output_ids = model.generate(input_ids, max_length=max_length, num_return_sequences=1, pad_token_id=tokenizer.eos_token_id)\n",
    "    generated_text = tokenizer.decode(output_ids[0], skip_special_tokens=True)\n",
    "    return generated_text\n",
    "\n",
    "def calculate_perplexity(model, tokenizer, text):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\").input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids, labels=input_ids)\n",
    "        loss = outputs.loss\n",
    "    return torch.exp(loss).item()\n",
    "\n",
    "def evaluate_generated_texts(reference_text, generated_text):\n",
    "    reference_list = reference_text.split()\n",
    "    generated_list = generated_text.split()\n",
    "\n",
    "    # BLEU Score\n",
    "    bleu_score = sentence_bleu([reference_list], generated_list)\n",
    "\n",
    "    # ROUGE Scores\n",
    "    rouge = Rouge()\n",
    "    rouge_scores = rouge.get_scores(generated_text, reference_text)[0]\n",
    "    P = rouge_scores['rouge-l']['p']\n",
    "    R = rouge_scores['rouge-l']['r']\n",
    "    F1 = rouge_scores['rouge-l']['f']\n",
    "\n",
    "    # Cosine Similarity\n",
    "    vectorizer = CountVectorizer().fit_transform([reference_text, generated_text])\n",
    "    vectors = vectorizer.toarray()\n",
    "    cos_sim = cosine_similarity(vectors)[0][1]\n",
    "\n",
    "    return bleu_score, rouge_scores, P, R, F1, cos_sim\n",
    "\n",
    "# Evaluation Loop\n",
    "total_bleu, total_rougeL, total_perplexity, total_sim = 0, 0, 0, 0\n",
    "for i, prompt in enumerate(prompts):\n",
    "    reference_text = texts[i]\n",
    "    generated_text_str = generate_long_text(model, tokenizer, prompt, max_length=500)\n",
    "\n",
    "    print(f\"Reference Text: {reference_text}\")\n",
    "    print(f\"Generated Text: {generated_text_str}\")\n",
    "\n",
    "    bleu_score, rouge_scores, P, R, F1, cos_sim = evaluate_generated_texts(reference_text, generated_text_str)\n",
    "    perplexity = calculate_perplexity(model, tokenizer, generated_text_str)\n",
    "\n",
    "    print(f\"BLEU: {bleu_score}, ROUGE-L: {rouge_scores['rouge-l']}, Perplexity: {perplexity}, Cosine Similarity: {cos_sim:.4f}\")\n",
    "    \n",
    "    # Accumulate scores\n",
    "    total_bleu += bleu_score\n",
    "    total_rougeL += rouge_scores['rouge-l']['f']\n",
    "    total_perplexity += perplexity\n",
    "    total_sim += cos_sim\n",
    "\n",
    "# Averages\n",
    "num_samples = len(prompts)\n",
    "print(\"Average BLEU:\", total_bleu / num_samples)\n",
    "print(\"Average ROUGE-L:\", total_rougeL / num_samples)\n",
    "print(\"Average Perplexity:\", total_perplexity / num_samples)\n",
    "print(\"Average Cosine Similarity:\", total_sim / num_samples)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "4a67fb71-2428-448d-bd4a-0c13dac18a94",
   "metadata": {},
   "outputs": [],
   "source": [
    "torch.cuda.empty_cache()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "bd24a0b2-ad6d-43c6-8fb1-44cde2261831",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The attention mask is not set and cannot be inferred from input because pad token is same as eos token. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sample 0: Perplexity = 2.6905\n",
      "Sample 1: Perplexity = 18.0844\n",
      "Sample 2: Perplexity = 2.4421\n",
      "Sample 3: Perplexity = 2.0793\n",
      "Sample 4: Perplexity = 2.8342\n",
      "Sample 5: Perplexity = 3.3709\n",
      "Sample 6: Perplexity = 15.1486\n",
      "Sample 7: Perplexity = 3.0409\n",
      "Sample 8: Perplexity = 2.6689\n",
      "Sample 9: Perplexity = 3.9201\n",
      "Sample 10: Perplexity = 4.3097\n",
      "Sample 11: Perplexity = 12.6837\n",
      "Sample 12: Perplexity = 16.5291\n",
      "Sample 13: Perplexity = 3.5909\n",
      "Sample 14: Perplexity = 2.8302\n",
      "Sample 15: Perplexity = 2.9699\n",
      "Sample 16: Perplexity = 7.4280\n",
      "Sample 17: Perplexity = 2.7809\n",
      "Sample 18: Perplexity = 3.4783\n",
      "Sample 19: Perplexity = 2.8837\n",
      "Sample 20: Perplexity = 2.9696\n",
      "Sample 21: Perplexity = 2.5931\n",
      "Sample 22: Perplexity = 3.2353\n",
      "Sample 23: Perplexity = 3.0787\n",
      "Sample 24: Perplexity = 2.1995\n",
      "Sample 25: Perplexity = 3.4005\n",
      "Sample 26: Perplexity = 3.7915\n",
      "Sample 27: Perplexity = 2.7329\n",
      "Sample 28: Perplexity = 8.2271\n",
      "Sample 29: Perplexity = 2.2513\n",
      "Sample 30: Perplexity = 1.8076\n",
      "Sample 31: Perplexity = 4.2295\n",
      "Sample 32: Perplexity = 2.5001\n",
      "Sample 33: Perplexity = 2.6800\n",
      "Sample 34: Perplexity = 3.5857\n",
      "Sample 35: Perplexity = 3.0938\n",
      "Sample 36: Perplexity = 3.0369\n",
      "Sample 37: Perplexity = 2.6743\n",
      "Sample 38: Perplexity = 2.2904\n",
      "Sample 39: Perplexity = 2.1626\n",
      "Sample 40: Perplexity = 3.9383\n",
      "Sample 41: Perplexity = 6.8730\n",
      "Sample 42: Perplexity = 15.3359\n",
      "Sample 43: Perplexity = 5.8968\n",
      "Sample 44: Perplexity = 2.9053\n",
      "Sample 45: Perplexity = 11.8498\n",
      "Sample 46: Perplexity = 2.5837\n",
      "Sample 47: Perplexity = 2.9897\n",
      "Sample 48: Perplexity = 2.3963\n",
      "Sample 49: Perplexity = 3.0011\n",
      "Sample 50: Perplexity = 2.3850\n",
      "Sample 51: Perplexity = 4.0059\n",
      "Sample 52: Perplexity = 3.4472\n",
      "Sample 53: Perplexity = 2.7055\n",
      "Sample 54: Perplexity = 2.6174\n",
      "Sample 55: Perplexity = 4.4138\n",
      "Sample 56: Perplexity = 3.1398\n",
      "Sample 57: Perplexity = 3.5851\n",
      "Sample 58: Perplexity = 5.5065\n",
      "Sample 59: Perplexity = 2.1158\n",
      "Sample 60: Perplexity = 3.3375\n",
      "Sample 61: Perplexity = 3.6122\n",
      "Sample 62: Perplexity = 3.3217\n",
      "Sample 63: Perplexity = 2.8169\n",
      "Sample 64: Perplexity = 3.1525\n",
      "Sample 65: Perplexity = 2.7208\n",
      "Sample 66: Perplexity = 2.4821\n",
      "Sample 67: Perplexity = 2.4161\n",
      "Sample 68: Perplexity = 2.8051\n",
      "Sample 69: Perplexity = 1.8929\n",
      "Sample 70: Perplexity = 3.4021\n",
      "Sample 71: Perplexity = 3.6960\n",
      "Sample 72: Perplexity = 1.5163\n",
      "Sample 73: Perplexity = 3.3475\n",
      "Sample 74: Perplexity = 12.8710\n",
      "Sample 75: Perplexity = 5.3104\n",
      "Sample 76: Perplexity = 3.2228\n",
      "Sample 77: Perplexity = 2.8701\n",
      "Sample 78: Perplexity = 8.7136\n",
      "Sample 79: Perplexity = 2.2592\n",
      "Sample 80: Perplexity = 3.1997\n",
      "Sample 81: Perplexity = 2.8126\n",
      "Sample 82: Perplexity = 7.7044\n",
      "Sample 83: Perplexity = 3.0504\n",
      "Sample 84: Perplexity = 3.1373\n",
      "Sample 85: Perplexity = 3.0520\n",
      "Sample 86: Perplexity = 2.8449\n",
      "Sample 87: Perplexity = 2.5042\n",
      "Sample 88: Perplexity = 1.9195\n",
      "Sample 89: Perplexity = 2.5269\n",
      "Sample 90: Perplexity = 2.3049\n",
      "Sample 91: Perplexity = 3.0725\n",
      "Sample 92: Perplexity = 2.7667\n",
      "Sample 93: Perplexity = 2.5925\n",
      "Sample 94: Perplexity = 2.2585\n",
      "Sample 95: Perplexity = 3.1665\n",
      "Sample 96: Perplexity = 10.8551\n",
      "Sample 97: Perplexity = 14.3450\n",
      "Sample 98: Perplexity = 3.4176\n",
      "Sample 99: Perplexity = 4.5050\n",
      "Sample 100: Perplexity = 2.6035\n",
      "Sample 101: Perplexity = 3.0103\n",
      "Sample 102: Perplexity = 4.9621\n",
      "Sample 103: Perplexity = 2.6561\n",
      "Sample 104: Perplexity = 3.4484\n",
      "Sample 105: Perplexity = 30.1743\n",
      "Sample 106: Perplexity = 3.9428\n",
      "Sample 107: Perplexity = 2.5616\n",
      "Sample 108: Perplexity = 3.0118\n",
      "Sample 109: Perplexity = 3.2395\n",
      "Sample 110: Perplexity = 3.3144\n",
      "Sample 111: Perplexity = 2.5986\n",
      "Sample 112: Perplexity = 2.9619\n",
      "Sample 113: Perplexity = 2.6834\n",
      "Sample 114: Perplexity = 2.9693\n",
      "Sample 115: Perplexity = 3.5542\n",
      "Sample 116: Perplexity = 51.8752\n",
      "Sample 117: Perplexity = 2.3762\n",
      "Sample 118: Perplexity = 2.0262\n",
      "Sample 119: Perplexity = 10.4154\n",
      "Sample 120: Perplexity = 3.7080\n",
      "Sample 121: Perplexity = 4.9634\n",
      "Sample 122: Perplexity = 2.5716\n",
      "Sample 123: Perplexity = 3.3087\n",
      "Sample 124: Perplexity = 24.0934\n",
      "Sample 125: Perplexity = 19.9654\n",
      "Sample 126: Perplexity = 3.7354\n",
      "Sample 127: Perplexity = 3.6085\n",
      "Sample 128: Perplexity = 10.3865\n",
      "Sample 129: Perplexity = 2.6819\n",
      "Sample 130: Perplexity = 2.6261\n",
      "Sample 131: Perplexity = 3.1234\n",
      "Sample 132: Perplexity = 3.1134\n",
      "Sample 133: Perplexity = 2.8807\n",
      "Sample 134: Perplexity = 2.8682\n",
      "Sample 135: Perplexity = 3.9721\n",
      "Sample 136: Perplexity = 6.5143\n",
      "Sample 137: Perplexity = 58.8026\n",
      "Sample 138: Perplexity = 3.3686\n",
      "Sample 139: Perplexity = 3.0226\n",
      "Sample 140: Perplexity = 2.7806\n",
      "Sample 141: Perplexity = 2.7605\n",
      "Sample 142: Perplexity = 24.1466\n",
      "Sample 143: Perplexity = 8.0596\n",
      "Sample 144: Perplexity = 2.0365\n",
      "Sample 145: Perplexity = 2.1914\n",
      "Sample 146: Perplexity = 2.9797\n",
      "Sample 147: Perplexity = 10.3284\n",
      "Sample 148: Perplexity = 11.6387\n",
      "Sample 149: Perplexity = 3.5887\n",
      "Sample 150: Perplexity = 8.9406\n",
      "Sample 151: Perplexity = 2.4495\n",
      "Sample 152: Perplexity = 4.8006\n",
      "Sample 153: Perplexity = 3.5185\n",
      "Sample 154: Perplexity = 2.1270\n",
      "Sample 155: Perplexity = 3.5909\n",
      "Sample 156: Perplexity = 3.2017\n",
      "Sample 157: Perplexity = 2.5451\n",
      "Sample 158: Perplexity = 3.8637\n",
      "Sample 159: Perplexity = 2.2901\n",
      "Sample 160: Perplexity = 4.2116\n",
      "Sample 161: Perplexity = 11.8205\n",
      "Sample 162: Perplexity = 3.8941\n",
      "Sample 163: Perplexity = 2.8318\n",
      "Sample 164: Perplexity = 2.7087\n",
      "Sample 165: Perplexity = 2.7141\n",
      "Sample 166: Perplexity = 4.1058\n",
      "Sample 167: Perplexity = 9.2399\n",
      "Sample 168: Perplexity = 2.7626\n",
      "Sample 169: Perplexity = 2.8936\n",
      "Sample 170: Perplexity = 2.1165\n",
      "Sample 171: Perplexity = 3.3163\n",
      "Sample 172: Perplexity = 2.7461\n",
      "Sample 173: Perplexity = 3.3744\n",
      "Sample 174: Perplexity = 18.1326\n",
      "Sample 175: Perplexity = 2.0929\n",
      "Sample 176: Perplexity = 2.7414\n",
      "Sample 177: Perplexity = 2.8962\n",
      "Sample 178: Perplexity = 3.2291\n",
      "Sample 179: Perplexity = 7.6299\n",
      "Sample 180: Perplexity = 3.2174\n",
      "Sample 181: Perplexity = 3.3792\n",
      "Sample 182: Perplexity = 3.1952\n",
      "Sample 183: Perplexity = 3.0976\n",
      "Sample 184: Perplexity = 3.3683\n",
      "Sample 185: Perplexity = 3.3771\n",
      "Sample 186: Perplexity = 2.7437\n",
      "Sample 187: Perplexity = 2.4298\n",
      "Sample 188: Perplexity = 2.9627\n",
      "Sample 189: Perplexity = 6.3994\n",
      "Sample 190: Perplexity = 3.2390\n",
      "Sample 191: Perplexity = 2.6487\n",
      "Sample 192: Perplexity = 2.7286\n",
      "Sample 193: Perplexity = 2.3501\n",
      "Sample 194: Perplexity = 2.2930\n",
      "Sample 195: Perplexity = 3.2580\n",
      "Sample 196: Perplexity = 19.2037\n",
      "Sample 197: Perplexity = 2.8688\n",
      "Sample 198: Perplexity = 2.5356\n",
      "Sample 199: Perplexity = 3.4545\n",
      "Perplexity scores saved to perplexity_scores.csv\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import torch\n",
    "import matplotlib.pyplot as plt\n",
    "from transformers import AutoTokenizer, AutoModelForCausalLM\n",
    "from nltk.translate.bleu_score import sentence_bleu\n",
    "from rouge import Rouge\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "\n",
    "texts = test_dataset[\"text\"][:200]\n",
    "\n",
    "# Ensure tokenizer has a pad token\n",
    "if tokenizer.pad_token is None:\n",
    "    tokenizer.pad_token = tokenizer.eos_token\n",
    "\n",
    "# Create prompts from the first 50 words\n",
    "prompts = [' '.join(str(text).split()[:50]) for text in texts]\n",
    "\n",
    "def generate_long_text(model, tokenizer, prompt, max_length=300):    \n",
    "    input_ids = tokenizer(prompt, return_tensors=\"pt\").input_ids.to(device)\n",
    "    output_ids = model.generate(input_ids, max_length=max_length, num_return_sequences=1, pad_token_id=tokenizer.eos_token_id)\n",
    "    generated_text = tokenizer.decode(output_ids[0], skip_special_tokens=True)\n",
    "    return generated_text\n",
    "\n",
    "def calculate_perplexity(model, tokenizer, text):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\").input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids, labels=input_ids)\n",
    "        loss = outputs.loss\n",
    "    return torch.exp(loss).item()\n",
    "\n",
    "# Loop over prompts, generate text, and record perplexity scores\n",
    "perplexity_scores = []\n",
    "for i, prompt in enumerate(prompts):\n",
    "    generated_text_str = generate_long_text(generator_model, tokenizer, prompt, max_length=300)\n",
    "    perplexity = calculate_perplexity(generator_model, tokenizer, generated_text_str)\n",
    "    perplexity_scores.append(perplexity)\n",
    "    print(f\"Sample {i}: Perplexity = {perplexity:.4f}\")\n",
    "\n",
    "# Save perplexity scores to a CSV file\n",
    "df = pd.DataFrame({\n",
    "    \"Index\": range(len(perplexity_scores)),\n",
    "    \"Perplexity\": perplexity_scores\n",
    "})\n",
    "df.to_csv(\"dp_lora_medal_gpt_perplexity_scores_new.csv\", index=False)\n",
    "print(\"Perplexity scores saved to perplexity_scores.csv\")\n",
    "\n",
    "# Group perplexity scores into defined ranges.\n",
    "# For this example, we group scores as: 0-20, 20-40, 40-60, 60-80, 80-100, and 100+\n",
    "bins = [0,2,3,4,5,6,7,8,9,10,20, 40, 60, 80, 100, float('inf')]\n",
    "labels = [\"0-2\", \"2-3\",\"3-4\",\"4-5\",\"5-6\",\"6-7\",\"7-8\",\"8-9\",\"9-10\",\"10-20\",\"20-40\", \"40-60\", \"60-80\", \"80-100\", \"100+\"]\n",
    "df[\"Perplexity Group\"] = pd.cut(df[\"Perplexity\"], bins=bins, labels=labels)\n",
    "\n",
    "# Create a scatter plot of perplexity scores.\n",
    "plt.figure(figsize=(10, 6))\n",
    "# Color-code by perplexity group using categorical codes.\n",
    "scatter = plt.scatter(df[\"Index\"], df[\"Perplexity\"], \n",
    "                      c=df[\"Perplexity Group\"].cat.codes, cmap=\"viridis\", s=60, edgecolor=\"k\")\n",
    "plt.xlabel(\"Sample Index\")\n",
    "plt.ylabel(\"Perplexity Score\")\n",
    "plt.title(\"Scatter Plot of Perplexity Scores Grouped by Range\")\n",
    "plt.yscale(\"log\")  # Use logarithmic scale to better visualize a wide range of values.\n",
    "# Create a colorbar with group labels.\n",
    "cbar = plt.colorbar(scatter, ticks=range(len(labels)))\n",
    "cbar.ax.set_yticklabels(labels)\n",
    "plt.savefig(\"dp_lora_medal_gpt_perplexity_scatter_plot_new.png\", dpi=300, bbox_inches=\"tight\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "7d394fde-7230-47c8-ab64-e38dffa1a5d9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: panda in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.3.1)\n",
      "Requirement already satisfied: setuptools in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from panda) (75.1.0)\n",
      "Requirement already satisfied: requests in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from panda) (2.32.3)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->panda) (3.3.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->panda) (3.7)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->panda) (2.2.3)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from requests->panda) (2024.8.30)\n"
     ]
    }
   ],
   "source": [
    "!pip install panda"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "a8f15127-1f59-4b6d-bf48-4ff4b82bf8dc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "df = pd.read_csv(\"dp_lora_medal_gpt_perplexity_scores.csv\")\n",
    "# Group perplexity scores into defined ranges.\n",
    "# For this example, we group scores as: 0-20, 20-40, 40-60, 60-80, 80-100, and 100+\n",
    "bins = [0,2,3,4,5,6,7,8,9,10,20, 40, 60, 80, 100, float('inf')]\n",
    "labels = [\"0-2\", \"2-3\",\"3-4\",\"4-5\",\"5-6\",\"6-7\",\"7-8\",\"8-9\",\"9-10\",\"10-20\",\"20-40\", \"40-60\", \"60-80\", \"80-100\", \"100+\"]\n",
    "df[\"Perplexity Group\"] = pd.cut(df[\"Perplexity\"], bins=bins, labels=labels)\n",
    "\n",
    "# Create a scatter plot of perplexity scores.\n",
    "plt.figure(figsize=(10, 6))\n",
    "# Color-code by perplexity group using categorical codes.\n",
    "scatter = plt.scatter(df[\"Index\"], df[\"Perplexity\"], \n",
    "                      c=df[\"Perplexity Group\"].cat.codes, cmap=\"viridis\", s=60, edgecolor=\"k\")\n",
    "plt.xlabel(\"Sample Index\", fontweight=\"bold\", fontsize=14)\n",
    "plt.ylabel(\"Perplexity Score\", fontweight=\"bold\", fontsize=14)\n",
    "plt.xticks(fontsize=14, fontweight='bold')  # Increase font size and make it bold\n",
    "plt.yticks(fontsize=14, fontweight='bold')  # Increase font size and make it bold\n",
    "\n",
    "plt.title(\"\", fontweight=\"bold\", fontsize=16)\n",
    "\n",
    "# Fix y-axis range from 0 to 100\n",
    "plt.ylim(0, 40)\n",
    "\n",
    "# Create a colorbar with group labels.\n",
    "cbar = plt.colorbar(scatter, ticks=range(len(labels)))\n",
    "cbar.ax.set_yticklabels(labels)\n",
    "\n",
    "plt.savefig(\"lora_dp_medal_gpt_perplexity_scatter_plot.png\", dpi=300, bbox_inches=\"tight\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "6d0954f5-5855-4a90-9730-7854d196a732",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "5.117731845378875"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import numpy as np\n",
    "np.mean(perplexity_scores)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "fad9f941-7e8e-4051-846a-58f10a30763a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[LightGBM] [Info] Number of positive: 404, number of negative: 396\n",
      "[LightGBM] [Info] Auto-choosing col-wise multi-threading, the overhead of testing was 0.000136 seconds.\n",
      "You can set `force_col_wise=true` to remove the overhead.\n",
      "[LightGBM] [Info] Total Bins 1020\n",
      "[LightGBM] [Info] Number of data points in the train set: 800, number of used features: 4\n",
      "[LightGBM] [Info] [binary:BoostFromScore]: pavg=0.500000 -> initscore=0.000000\n",
      "[LightGBM] [Info] Start training from score 0.000000\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "[LightGBM] [Warning] No further splits with positive gain, best gain: -inf\n",
      "Classification Report:\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.53      0.45      0.49       104\n",
      "           1       0.49      0.56      0.52        96\n",
      "\n",
      "    accuracy                           0.51       200\n",
      "   macro avg       0.51      0.51      0.50       200\n",
      "weighted avg       0.51      0.51      0.50       200\n",
      "\n",
      "ROC-AUC: 0.49\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import torch\n",
    "from transformers import AutoTokenizer, AutoModelForCausalLM\n",
    "from sklearn.model_selection import train_test_split\n",
    "from sklearn.metrics import classification_report, roc_auc_score, roc_curve\n",
    "from lightgbm import LGBMClassifier\n",
    "from scipy.stats import entropy\n",
    "from sklearn.preprocessing import MinMaxScaler\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "train_texts = train_dataset[\"text\"][:500]\n",
    "test_texts = test_dataset[\"text\"][:500]\n",
    "\n",
    "# Function to calculate perplexity\n",
    "def calculate_perplexity(model, tokenizer, text, device):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids, labels=input_ids)\n",
    "        loss = outputs.loss\n",
    "    return torch.exp(loss).item()\n",
    "\n",
    "# Function to calculate prediction confidence\n",
    "def calculate_prediction_confidence(model, tokenizer, text, device):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids)\n",
    "        probabilities = torch.softmax(outputs.logits, dim=-1)\n",
    "        return probabilities.max().item()\n",
    "\n",
    "# Function to calculate entropy\n",
    "def calculate_entropy(model, tokenizer, text, device):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids)\n",
    "        probabilities = torch.softmax(outputs.logits, dim=-1)\n",
    "        return entropy(probabilities.cpu().numpy().flatten())\n",
    "\n",
    "# Function to calculate feature representation distance\n",
    "def calculate_feature_representation_distance(model, tokenizer, text, centroid, device):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        embeddings = model.transformer.wte(input_ids).mean(dim=1).cpu().numpy()\n",
    "    return np.linalg.norm(embeddings - centroid)\n",
    "\n",
    "# Calculate centroid for training set embeddings\n",
    "def calculate_centroid(model, tokenizer, texts, device):\n",
    "    embeddings = []\n",
    "    for text in texts:\n",
    "        input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "        with torch.no_grad():\n",
    "            embedding = model.transformer.wte(input_ids).mean(dim=1).cpu().numpy()\n",
    "        embeddings.append(embedding)\n",
    "    return np.mean(embeddings, axis=0)\n",
    "\n",
    "# Calculate centroid for training texts\n",
    "train_centroid = calculate_centroid(generator_model, tokenizer, train_texts, device)\n",
    "\n",
    "# Calculate features for training and test texts\n",
    "def calculate_features(model, tokenizer, texts, centroid, device):\n",
    "    perplexities, confidences, entropies, frd_distances = [], [], [], []\n",
    "    for text in texts:\n",
    "        perplexities.append(calculate_perplexity(model, tokenizer, text, device))\n",
    "        confidences.append(calculate_prediction_confidence(model, tokenizer, text, device))\n",
    "        entropies.append(calculate_entropy(model, tokenizer, text, device))\n",
    "        frd_distances.append(calculate_feature_representation_distance(model, tokenizer, text, centroid, device))\n",
    "    return perplexities, confidences, entropies, frd_distances\n",
    "\n",
    "train_features = calculate_features(generator_model, tokenizer, train_texts, train_centroid, device)\n",
    "test_features = calculate_features(generator_model, tokenizer, test_texts, train_centroid, device)\n",
    "\n",
    "# Combine features and labels\n",
    "train_labels = [1] * len(train_texts)  # Members\n",
    "test_labels = [0] * len(test_texts)    # Non-members\n",
    "\n",
    "combined_features = np.vstack((\n",
    "    np.column_stack(train_features),\n",
    "    np.column_stack(test_features)\n",
    "))\n",
    "combined_labels = np.array(train_labels + test_labels)\n",
    "\n",
    "# Normalize features\n",
    "scaler = MinMaxScaler()\n",
    "normalized_features = scaler.fit_transform(combined_features)\n",
    "\n",
    "# Split data for training the attack model\n",
    "X_train, X_test, y_train, y_test = train_test_split(normalized_features, combined_labels, test_size=0.2, random_state=42)\n",
    "\n",
    "# Train LightGBM attack model\n",
    "clf = LGBMClassifier(class_weight=\"balanced\", learning_rate=0.1, n_estimators=100)\n",
    "clf.fit(X_train, y_train)\n",
    "\n",
    "# Evaluate the attack model\n",
    "y_pred = clf.predict(X_test)\n",
    "y_pred_prob = clf.predict_proba(X_test)[:, 1]\n",
    "\n",
    "print(\"Classification Report:\")\n",
    "print(classification_report(y_test, y_pred))\n",
    "\n",
    "roc_auc = roc_auc_score(y_test, y_pred_prob)\n",
    "print(f\"ROC-AUC: {roc_auc:.2f}\")\n",
    "\n",
    "# Plot ROC Curve\n",
    "fpr, tpr, _ = roc_curve(y_test, y_pred_prob)\n",
    "plt.figure()\n",
    "plt.plot(fpr, tpr, color=\"darkorange\", lw=2, label=f\"ROC Curve (area = {roc_auc:.2f})\")\n",
    "plt.plot([0, 1], [0, 1], color=\"navy\", lw=2, linestyle=\"--\")\n",
    "plt.xlabel(\"False Positive Rate\")\n",
    "plt.ylabel(\"True Positive Rate\")\n",
    "plt.title(\"ROC Curve\")\n",
    "plt.legend(loc=\"lower right\")\n",
    "#plt.savefig(\"lora_dp_medal_txt_gen_roc_plots.jpg\", dpi=300, bbox_inches=\"tight\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "793ecc72-0cd9-4c1d-8268-220710b6b167",
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'train_dataset' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[1], line 15\u001b[0m\n\u001b[0;32m     13\u001b[0m \u001b[38;5;66;03m# Set up device\u001b[39;00m\n\u001b[0;32m     14\u001b[0m device \u001b[38;5;241m=\u001b[39m torch\u001b[38;5;241m.\u001b[39mdevice(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mcuda:0\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m torch\u001b[38;5;241m.\u001b[39mcuda\u001b[38;5;241m.\u001b[39mis_available() \u001b[38;5;28;01melse\u001b[39;00m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mcpu\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m---> 15\u001b[0m train_texts \u001b[38;5;241m=\u001b[39m train_dataset[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtext\u001b[39m\u001b[38;5;124m\"\u001b[39m][:\u001b[38;5;241m1000\u001b[39m]\n\u001b[0;32m     16\u001b[0m test_texts \u001b[38;5;241m=\u001b[39m test_dataset[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtext\u001b[39m\u001b[38;5;124m\"\u001b[39m][:\u001b[38;5;241m1000\u001b[39m]\n\u001b[0;32m     17\u001b[0m \u001b[38;5;66;03m# Ensure tokenizer has a pad token\u001b[39;00m\n",
      "\u001b[1;31mNameError\u001b[0m: name 'train_dataset' is not defined"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import torch\n",
    "from transformers import AutoTokenizer, AutoModelForCausalLM\n",
    "from sklearn.model_selection import train_test_split\n",
    "from sklearn.metrics import classification_report, roc_auc_score, roc_curve\n",
    "from lightgbm import LGBMClassifier\n",
    "from scipy.stats import entropy\n",
    "from sklearn.preprocessing import MinMaxScaler\n",
    "import matplotlib.pyplot as plt\n",
    "import csv\n",
    "\n",
    "# Set up device\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "train_texts = train_dataset[\"text\"][:1000]\n",
    "test_texts = test_dataset[\"text\"][:1000]\n",
    "# Ensure tokenizer has a pad token\n",
    "if tokenizer.pad_token is None:\n",
    "    tokenizer.pad_token = tokenizer.eos_token\n",
    "\n",
    "def generate_long_text(model, tokenizer, prompt, max_length=300):    \n",
    "    input_ids = tokenizer(prompt, return_tensors=\"pt\").input_ids.to(device)\n",
    "    output_ids = model.generate(input_ids, max_length=max_length, pad_token_id=tokenizer.eos_token_id)\n",
    "    generated_text = tokenizer.decode(output_ids[0], skip_special_tokens=True)\n",
    "    return generated_text\n",
    "\n",
    "# Function to calculate perplexity\n",
    "def calculate_perplexity(model, tokenizer, text, device):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids, labels=input_ids)\n",
    "        loss = outputs.loss\n",
    "    return torch.exp(loss).item()\n",
    "\n",
    "# Function to calculate prediction confidence\n",
    "def calculate_prediction_confidence(model, tokenizer, text, device):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids)\n",
    "        probabilities = torch.softmax(outputs.logits, dim=-1)\n",
    "        return probabilities.max().item()\n",
    "\n",
    "# Function to calculate entropy\n",
    "def calculate_entropy(model, tokenizer, text, device):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids)\n",
    "        probabilities = torch.softmax(outputs.logits, dim=-1)\n",
    "        return entropy(probabilities.cpu().numpy().flatten())\n",
    "\n",
    "# Function to calculate feature representation distance\n",
    "def calculate_feature_representation_distance(model, tokenizer, text, centroid, device):\n",
    "    input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "    with torch.no_grad():\n",
    "        embeddings = model.transformer.wte(input_ids).mean(dim=1).cpu().numpy()\n",
    "    return np.linalg.norm(embeddings - centroid)\n",
    "\n",
    "# Calculate centroid for training set embeddings\n",
    "def calculate_centroid(model, tokenizer, texts, device):\n",
    "    embeddings = []\n",
    "    for text in texts:\n",
    "        input_ids = tokenizer(text, return_tensors=\"pt\", padding=True, truncation=True).input_ids.to(device)\n",
    "        with torch.no_grad():\n",
    "            embedding = model.transformer.wte(input_ids).mean(dim=1).cpu().numpy()\n",
    "        embeddings.append(embedding)\n",
    "    return np.mean(embeddings, axis=0)\n",
    "\n",
    "# Calculate centroid for training texts\n",
    "train_centroid = calculate_centroid(generator_model, tokenizer, train_texts, device)\n",
    "test_centroid = calculate_centroid(generator_model, tokenizer, test_texts, device)\n",
    "# Calculate features for training and test texts\n",
    "def calculate_features(model, tokenizer, texts, centroid, device):\n",
    "    perplexities, confidences, entropies, frd_distances = [], [], [], []\n",
    "    for text in texts:\n",
    "        prompt = ' '.join(str(text).split()[:50])\n",
    "        #print(prompt)\n",
    "        text = generate_long_text(model, tokenizer, prompt, max_length=300)\n",
    "        perplexities.append(calculate_perplexity(model, tokenizer, text, device))\n",
    "        confidences.append(calculate_prediction_confidence(model, tokenizer, text, device))\n",
    "        entropies.append(calculate_entropy(model, tokenizer, text, device))\n",
    "        frd_distances.append(calculate_feature_representation_distance(model, tokenizer, text, centroid, device))\n",
    "    return perplexities, confidences, entropies, frd_distances\n",
    "\n",
    "# Open CSV file to store results\n",
    "csv_filename = \"lora_dp_medal_txt_gen_attack_model_results.csv\"\n",
    "with open(csv_filename, mode=\"w\", newline=\"\") as file:\n",
    "    writer = csv.writer(file)\n",
    "    writer.writerow([\"Run\", \"Precision\", \"Recall\", \"F1-Score\", \"ROC-AUC\"])\n",
    "    train_features = calculate_features(generator_model, tokenizer, train_texts, train_centroid, device)\n",
    "    test_features = calculate_features(generator_model, tokenizer, test_texts, test_centroid, device)\n",
    "\n",
    "    # Combine features and labels\n",
    "    train_labels = [1] * len(train_texts)  # Members\n",
    "    test_labels = [0] * len(test_texts)    # Non-members\n",
    "\n",
    "    combined_features = np.vstack((\n",
    "        np.column_stack(train_features),\n",
    "        np.column_stack(test_features)\n",
    "    ))\n",
    "    combined_labels = np.array(train_labels + test_labels)\n",
    "    # Normalize features\n",
    "    scaler = MinMaxScaler()\n",
    "    normalized_features = scaler.fit_transform(combined_features)\n",
    "\n",
    "    for run in range(1, 11):  # Run 10 times\n",
    "        print(f\"Run {run}...\")      \n",
    "        \n",
    "        # Split data for training the attack model\n",
    "        X_train, X_test, y_train, y_test = train_test_split(normalized_features, combined_labels, test_size=0.2, random_state=42 + run)\n",
    "\n",
    "        # Train LightGBM attack model\n",
    "        clf = LGBMClassifier(class_weight=\"balanced\", learning_rate=0.1, n_estimators=100)\n",
    "        clf.fit(X_train, y_train)\n",
    "\n",
    "        # Evaluate the attack model\n",
    "        y_pred = clf.predict(X_test)\n",
    "        y_pred_prob = clf.predict_proba(X_test)[:, 1]\n",
    "\n",
    "        report = classification_report(y_test, y_pred, output_dict=True)\n",
    "        precision = report[\"macro avg\"][\"precision\"]\n",
    "        recall = report[\"macro avg\"][\"recall\"]\n",
    "        f1_score = report[\"macro avg\"][\"f1-score\"]\n",
    "        roc_auc = roc_auc_score(y_test, y_pred_prob)\n",
    "\n",
    "        print(f\"Precision: {precision:.4f}, Recall: {recall:.4f}, F1-Score: {f1_score:.4f}, ROC-AUC: {roc_auc:.4f}\")\n",
    "\n",
    "        # Save to CSV\n",
    "        writer.writerow([run, precision, recall, f1_score, roc_auc])\n",
    "\n",
    "print(f\"Results saved to {csv_filename}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "050c7df4-5468-4b60-ad11-084531b3e29a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: seaborn in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (0.13.2)\n",
      "Requirement already satisfied: numpy!=1.24.0,>=1.20 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from seaborn) (1.26.4)\n",
      "Requirement already satisfied: pandas>=1.2 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from seaborn) (2.2.3)\n",
      "Requirement already satisfied: matplotlib!=3.6.1,>=3.4 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from seaborn) (3.9.3)\n",
      "Requirement already satisfied: contourpy>=1.0.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib!=3.6.1,>=3.4->seaborn) (1.3.1)\n",
      "Requirement already satisfied: cycler>=0.10 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib!=3.6.1,>=3.4->seaborn) (0.12.1)\n",
      "Requirement already satisfied: fonttools>=4.22.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib!=3.6.1,>=3.4->seaborn) (4.55.2)\n",
      "Requirement already satisfied: kiwisolver>=1.3.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib!=3.6.1,>=3.4->seaborn) (1.4.7)\n",
      "Requirement already satisfied: packaging>=20.0 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib!=3.6.1,>=3.4->seaborn) (24.1)\n",
      "Requirement already satisfied: pillow>=8 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib!=3.6.1,>=3.4->seaborn) (10.4.0)\n",
      "Requirement already satisfied: pyparsing>=2.3.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib!=3.6.1,>=3.4->seaborn) (3.2.0)\n",
      "Requirement already satisfied: python-dateutil>=2.7 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from matplotlib!=3.6.1,>=3.4->seaborn) (2.9.0.post0)\n",
      "Requirement already satisfied: pytz>=2020.1 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from pandas>=1.2->seaborn) (2024.1)\n",
      "Requirement already satisfied: tzdata>=2022.7 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from pandas>=1.2->seaborn) (2024.2)\n",
      "Requirement already satisfied: six>=1.5 in c:\\users\\my pc\\.ai-navigator\\micromamba\\envs\\cuda\\lib\\site-packages (from python-dateutil>=2.7->matplotlib!=3.6.1,>=3.4->seaborn) (1.16.0)\n"
     ]
    }
   ],
   "source": [
    "!pip install seaborn"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "1ee9dc08-b6cd-44c9-bfd0-0a918b4ad189",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\my pc\\AppData\\Local\\Temp\\ipykernel_10864\\3420984457.py:24: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(filename)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model loaded from lora_dp_medal_gpt2.pth\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The attention mask is not set and cannot be inferred from input because pad token is same as eos token. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[ 6.04124799  6.06067682  5.28289876  5.56743281  5.41644673  5.61957791\n",
      "  4.28271055 10.33875187  4.91949363  5.48804447  6.02848498  6.32414567\n",
      "  5.44755499  5.41562965  5.18210123  5.76919841  5.79793227  4.42822284\n",
      "  5.25125458  5.51666761  5.5573791   5.89242486  5.84113096  5.0765286\n",
      "  4.84687895  6.63693277  5.05037923  6.63678324  5.11800201  5.5950716\n",
      "  6.2843697   5.21543513  5.44692567  6.55907546  5.40187199  5.27516408\n",
      "  5.86697893  6.17786046  5.4839891   8.36068373  4.90515362  5.46925008\n",
      "  6.00767833  5.05097094  4.74022936  4.95852681  5.70544115  5.75065093\n",
      "  5.49080796  8.71693877  5.76280482  5.47158631  6.21599668  5.01513872\n",
      "  5.05242067  4.92054496  6.88434634  6.04623293  7.23082761  4.95666356\n",
      "  5.52426082  6.79246207 10.6398366   8.32162112  6.10069952  5.58121266\n",
      "  5.31772467  4.60613466  5.03526663  6.13388885  5.95297872  5.85250416\n",
      "  5.51296177  8.02436203  5.3153882   6.01241558  4.54671927  7.32856369\n",
      "  6.01564635  5.1577157   4.96415967  6.47117301  4.6639172   5.23099857\n",
      "  5.69299718  5.92116987  5.43980235  5.83919373  6.04547998  5.2983743\n",
      "  5.37378019  3.91949368  5.49669357  6.4847509   6.0061618   7.6659255\n",
      "  5.99799144  3.60056271  5.61223599  5.03371161  5.66768396  5.73452213\n",
      "  6.46678024  6.4073934   6.16213726  6.57806597  5.84051445  4.86446187\n",
      "  6.6594138   4.99267846  4.82583662  5.48163918  5.76311346  5.39378143\n",
      "  4.56378549  5.41382263  6.41274759  5.48735816  6.09036872  5.81941221\n",
      "  6.46331745  5.21541878  5.8549787   3.20965301  6.23961566  4.10038639\n",
      "  8.60219542  6.27625229  4.62441195  5.11620387  5.60190904  5.33982383\n",
      "  5.13311264  5.31024469  5.65565958  5.68947929  5.41901308  5.21898205\n",
      "  7.39479599  6.36454923  4.91270386  6.06113263  5.50649061  5.73391821\n",
      "  5.75097284  6.40747691  7.19953838  6.29749198  9.93870926  7.68212421\n",
      "  5.64152483  6.66216155  5.42717926  5.78165887  9.32253745  5.1687958\n",
      "  5.73591619  6.22900187  5.60187821  5.09671534  5.49304696  5.8922708\n",
      "  5.76491214  5.97536972  5.80344999  5.57040357  5.05570804  5.03386316\n",
      "  5.79515582  4.83516561  5.87619932  5.98996262  5.86364205  5.73356224\n",
      "  5.60003512  5.05599091  6.0820432   5.14976746  8.78676004 10.34057002\n",
      "  6.39558257  4.43555438  5.78675586  6.23727465  4.61330228  5.35405854\n",
      "  6.15481032  5.94696433  9.96140173  5.12717076  6.35745429  5.93083607\n",
      "  8.07538963  5.0881923   5.88078797  6.58488661  6.24761063  6.70056228\n",
      "  8.36860782  5.30988578  5.56198791  9.8434573   7.2331258   4.99123894\n",
      "  5.05246887  5.94598103  6.02893939  7.72521774  5.86990818  5.36967468\n",
      "  6.34921856  6.10321553  5.74037761  5.76029614  5.58688964  5.72410616\n",
      "  5.27822892  5.35495871  5.92893885  6.12107949  5.19267639  4.89510474\n",
      "  5.71537682  5.73757831  7.7788126   6.55868664  6.41170936  6.70875371\n",
      "  4.36800913  4.69737671  4.54023642  9.02645612  4.99605975  5.76376152\n",
      "  6.23755898  5.83923136  5.51351813  9.80922219  6.1384375   8.33898578\n",
      "  6.48425016  5.82389423  5.56003668  7.27785875  5.36350698  5.135232\n",
      "  5.60686988  5.50640708  5.3836559   6.34832349  5.5399022   4.76834697\n",
      "  6.01668028  6.17964739  6.22405347  6.88977334  5.61365206  6.04458485\n",
      " 11.76519966  5.23790211  6.37109691  6.31769393  9.72886575  5.15898808\n",
      "  5.81807764  5.60725139  5.14978594  7.37943518  5.74241342  6.72019165\n",
      "  6.17704371  6.24779441  5.07748801  5.8851643   5.31224026  6.15852088\n",
      "  5.3693077   9.44899314  4.22239696  5.42429142  5.50700069  5.70544771\n",
      "  5.88767653  5.30913177  6.23796003  5.68726768  5.76152896  6.53186709\n",
      "  4.7038896   5.50870902  5.70684561  5.82151068  5.78673336  5.66010925\n",
      "  5.59072293  6.62419754  6.05880713  5.60069861  5.66298331  6.42562058\n",
      "  5.7875466   5.89412737  4.1668263   5.03699155  5.55944827  5.05310132\n",
      "  4.06243556  5.46468934  5.53015461  6.63192151  5.89714421  4.82063691\n",
      "  5.80527266  7.45160374 11.06049252 10.16340811  5.66018267  6.974068\n",
      "  5.3082816   5.21846705  6.41716205  5.16805835  5.40928899  5.08276704\n",
      "  5.17564658  5.49045847  5.80655332  6.15133663  5.22961098  5.01980283\n",
      "  6.1433746   5.73284037  5.29685185  5.72670279  5.91339776  5.00627149\n",
      "  5.4132787   5.88171081  6.14628461  6.32946819  5.05395355  5.82237623\n",
      "  5.52572157  5.68226533  6.75546534  4.87712741  4.75714154  5.93026762\n",
      "  5.84209638  5.72046878  4.92312294  4.97968853  4.32485311  6.36768017\n",
      "  4.7092633   5.57164881  5.57431775  4.46814903  5.46929821  4.79493241\n",
      "  5.79885566  6.23354587  6.00781752  5.80133307  5.59038221  4.59080492\n",
      "  5.57852692  6.38674432  5.17949912  5.80435702  5.15769358  8.29742188\n",
      "  5.09349202  6.10805834  8.65579292  4.85152576  5.05374312  5.78561304\n",
      "  5.09761541  4.51168748  6.32617186  6.83837111  4.12882193  4.0531983\n",
      "  5.81555429  6.12190016  4.82907376  5.68563663  5.21653667  4.59413199\n",
      "  5.14092664  7.17336253  6.84655672  6.19976896  4.9916222   7.53950562\n",
      "  5.51217256  4.73931892  5.7742111   6.09894112]\n",
      "\n",
      "=== Min-k% Probability MIA Results ===\n",
      "k%: 20.0\n",
      "ROC-AUC: 0.4999\n",
      "F1: 0.5275\n"
     ]
    }
   ],
   "source": [
    "import math\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import torch\n",
    "from sklearn.model_selection import train_test_split\n",
    "from sklearn.metrics import f1_score, auc, roc_auc_score, roc_curve, classification_report\n",
    "from transformers import AutoTokenizer, AutoModelForCausalLM\n",
    "from tqdm import tqdm\n",
    "\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "\n",
    "max_samples = 200   # Limit for speed; set None for all\n",
    "batch_size = 4\n",
    "max_length = 300\n",
    "k_percent = 20.0    # k% from algorithm\n",
    "threshold_epsilon = None  # Will be tuned on training set\n",
    "\n",
    "model_name = \"gpt2-large\"\n",
    "tokenizer = AutoTokenizer.from_pretrained(model_name)\n",
    "tokenizer.pad_token = tokenizer.eos_token\n",
    "model = AutoModelForCausalLM.from_pretrained(model_name)\n",
    "def load_model(model,filename='lora_dp_medal_gpt2.pth'):\n",
    "    # Load the state_dict from the saved file\n",
    "    checkpoint = torch.load(filename)\n",
    "    epoch = checkpoint['epoch']\n",
    "    model.resize_token_embeddings(len(tokenizer))\n",
    "    model.load_state_dict(checkpoint['model_state_dict'], strict=False)\n",
    "    print(f\"Model loaded from {filename}\")\n",
    "    return model, epoch\n",
    "model, start_epoch = load_model(model)\n",
    "if tokenizer.pad_token is None:\n",
    "    tokenizer.pad_token = tokenizer.eos_token\n",
    "model.to(device)\n",
    "model.eval()\n",
    "\n",
    "train_dataset = dataset[\"train\"]\n",
    "test_dataset = dataset[\"test\"]\n",
    "train_eval_texts = train_dataset[\"text\"][:200]\n",
    "test_eval_texts = test_dataset[\"text\"][:200]\n",
    "\n",
    "def generate_long_text(eval_texts):\n",
    "    # Build non-member texts by prompting with first 50 tokens\n",
    "    prompted_texts = []\n",
    "    gen_texts = []\n",
    "    for text in eval_texts:\n",
    "        enc = tokenizer(text, truncation=True, max_length=50, return_tensors=\"pt\").to(device)\n",
    "        prompt = tokenizer.decode(enc.input_ids[0], skip_special_tokens=True)\n",
    "        prompted_texts.append(prompt)\n",
    "    \n",
    "        # Generate continuation\n",
    "        out = model.generate(\n",
    "            enc.input_ids,\n",
    "            max_length=300,          # continuation length\n",
    "            do_sample=True,\n",
    "            top_k=50,\n",
    "            top_p=0.95,\n",
    "            temperature=0.8,\n",
    "            pad_token_id=tokenizer.eos_token_id\n",
    "        )\n",
    "        gen_text = tokenizer.decode(out[0], skip_special_tokens=True)\n",
    "        gen_texts.append(gen_text)\n",
    "        \n",
    "    #print(\"Sample prompt:\\n\", prompted_texts[0])\n",
    "    #print(\"Generated continuation:\\n\", gen_texts[0])\n",
    "    return gen_texts\n",
    "\n",
    "\n",
    "@torch.no_grad()\n",
    "def seq_nll_list(model, tokenizer, txt, device, max_length=300, batch_size=4):\n",
    "    \"\"\"\n",
    "    Returns: list of 1D numpy arrays (per-token NLL) for each sequence\n",
    "    \"\"\"\n",
    "    enc = tokenizer(txt, return_tensors=\"pt\", padding=True,\n",
    "                        truncation=True, max_length=max_length).to(device)\n",
    "    input_ids = enc.input_ids\n",
    "        \n",
    "    with torch.no_grad():\n",
    "        outputs = model(input_ids, labels=input_ids)\n",
    "    loss, logits = outputs[:2]\n",
    "    # Apply softmax to the logits to get probabilities\n",
    "    probabilities = torch.nn.functional.log_softmax(logits, dim=-1)\n",
    "    # probabilities = torch.nn.functional.softmax(logits, dim=-1)\n",
    "    all_prob = []\n",
    "    input_ids_processed = input_ids[0][1:]\n",
    "    for i, token_id in enumerate(input_ids_processed):\n",
    "        probability = probabilities[0, i, token_id].item()\n",
    "        all_prob.append(probability)\n",
    "    return torch.exp(loss).item(), all_prob, loss.item()\n",
    "\n",
    "def min_k_percent_nll_score(all_prob, k_percent): \n",
    "    k_length = int(len(all_prob)*0.2)    \n",
    "    topk_prob = np.sort(all_prob)[:k_length]\n",
    "    #print(len(topk_prob))\n",
    "    return -np.mean(topk_prob).item()\n",
    "member_scores = []\n",
    "nonmember_scores = []\n",
    "train_gen_texts = generate_long_text(train_eval_texts)\n",
    "test_gen_texts = generate_long_text(test_eval_texts)\n",
    "\n",
    "for text in train_gen_texts:\n",
    "    _, all_prob_members, _ = seq_nll_list(model, tokenizer, text, device, max_length, batch_size)\n",
    "    member_scores.append(min_k_percent_nll_score(all_prob_members, k_percent))\n",
    "    \n",
    "for text in test_gen_texts:\n",
    "    _, all_prob_nonmembers, _ = seq_nll_list(model, tokenizer, text, device, max_length, batch_size)\n",
    "    nonmember_scores.append(min_k_percent_nll_score(all_prob_nonmembers, k_percent))\n",
    "    \n",
    "scores = np.concatenate([member_scores, nonmember_scores])\n",
    "labels = np.concatenate([np.ones(len(member_scores)), np.zeros(len(nonmember_scores))])\n",
    "print(scores)\n",
    "fpr, tpr, thresholds = roc_curve(labels, -scores)\n",
    "roc_auc = auc(fpr, tpr)\n",
    "f1 = np.max(1-(fpr+(1-tpr))/2)\n",
    "\n",
    "print(\"\\n=== Min-k% Probability MIA Results ===\")\n",
    "print(f\"k%: {k_percent}\")\n",
    "print(f\"ROC-AUC: {roc_auc:.4f}\")\n",
    "print(f\"F1: {f1:.4f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "3cbf99d1-8af3-4776-a4fc-7dc1682b9b72",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\my pc\\AppData\\Local\\Temp\\ipykernel_7344\\2123613296.py:27: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  checkpoint = torch.load(filename)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model loaded from lora_dp_medal_gpt2.pth\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Samples:   0%|          | 0/500 [00:00<?, ?it/s]The attention mask is not set and cannot be inferred from input because pad token is same as eos token. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
      "Samples: 100%|| 500/500 [06:31<00:00,  1.28it/s]\n",
      "Samples: 100%|| 500/500 [06:34<00:00,  1.27it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Results ===\n",
      "AUROC: 0.528\n",
      "F1: 0.547\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "from collections import defaultdict\n",
    "from tqdm import tqdm\n",
    "\n",
    "import torch\n",
    "import torch.nn.functional as F\n",
    "from transformers import AutoTokenizer, AutoModelForCausalLM\n",
    "\n",
    "from sklearn.metrics import roc_curve, auc, accuracy_score\n",
    "\n",
    "# ----------------------------\n",
    "# Settings\n",
    "# ----------------------------\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "\n",
    "NUM_NEIGHBORS = 1                            # number of neighbors to generate per text\n",
    "MAX_GEN_LEN = 64                             # max length for neighbor generation\n",
    "\n",
    "model_name = \"gpt2-large\"\n",
    "tokenizer = AutoTokenizer.from_pretrained(model_name)\n",
    "tokenizer.pad_token = tokenizer.eos_token\n",
    "model = AutoModelForCausalLM.from_pretrained(model_name)\n",
    "def load_model(model,filename='lora_dp_medal_gpt2.pth'):\n",
    "    # Load the state_dict from the saved file\n",
    "    checkpoint = torch.load(filename)\n",
    "    epoch = checkpoint['epoch']\n",
    "    model.resize_token_embeddings(len(tokenizer))\n",
    "    model.load_state_dict(checkpoint['model_state_dict'], strict=False)\n",
    "    print(f\"Model loaded from {filename}\")\n",
    "    return model, epoch\n",
    "model, start_epoch = load_model(model)\n",
    "if tokenizer.pad_token is None:\n",
    "    tokenizer.pad_token = tokenizer.eos_token\n",
    "model.to(device)\n",
    "model.eval()\n",
    "\n",
    "train_dataset = dataset[\"train\"]\n",
    "test_dataset = dataset[\"test\"]\n",
    "train_texts = train_dataset[\"text\"][:500]\n",
    "test_texts = test_dataset[\"text\"][:500]\n",
    "\n",
    "# ----------------------------\n",
    "# Inference: log-likelihood\n",
    "# ----------------------------\n",
    "def compute_log_likelihood(text, model, tokenizer):\n",
    "    inputs = tokenizer(text, return_tensors=\"pt\", truncation=True, max_length=512).to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(**inputs, labels=inputs[\"input_ids\"])\n",
    "        loss = outputs.loss\n",
    "    return -loss.item()   # higher = more likely under model\n",
    "\n",
    "# ----------------------------\n",
    "# Generate neighbor texts\n",
    "# ----------------------------\n",
    "def generate_neighbors(text, model, tokenizer, num_neighbors=NUM_NEIGHBORS, max_length=MAX_GEN_LEN):\n",
    "    enc = tokenizer(text, truncation=True, max_length=50, return_tensors=\"pt\").to(device)\n",
    "    neighbors = []\n",
    "    with torch.no_grad():\n",
    "        for _ in range(num_neighbors):\n",
    "            output = model.generate(\n",
    "                enc.input_ids,\n",
    "                max_length=128,\n",
    "                do_sample=True,\n",
    "                top_k=50,\n",
    "                top_p=0.95,\n",
    "                temperature=0.8,\n",
    "                pad_token_id=tokenizer.eos_token_id\n",
    "            )\n",
    "            gen_text = tokenizer.decode(output[0], skip_special_tokens=True)\n",
    "            neighbors.append(gen_text)\n",
    "    return neighbors\n",
    "\n",
    "# ----------------------------\n",
    "# Compute neighbor scores\n",
    "# ----------------------------\n",
    "member_scores = []\n",
    "for i, text in enumerate(tqdm(train_texts, desc=\"Samples\")):\n",
    "    ll = compute_log_likelihood(text, model, tokenizer)\n",
    "    neighbors = generate_neighbors(text, model, tokenizer, NUM_NEIGHBORS, MAX_GEN_LEN)\n",
    "    ll_neighbors = [compute_log_likelihood(nb, model, tokenizer) for nb in neighbors]\n",
    "    score = ll - np.mean(ll_neighbors)\n",
    "    member_scores.append(score)\n",
    "nonmember_scores = []\n",
    "for i, text in enumerate(tqdm(test_texts, desc=\"Samples\")):\n",
    "    ll = compute_log_likelihood(text, model, tokenizer)\n",
    "    neighbors = generate_neighbors(text, model, tokenizer, NUM_NEIGHBORS, MAX_GEN_LEN)\n",
    "    ll_neighbors = [compute_log_likelihood(nb, model, tokenizer) for nb in neighbors]\n",
    "    score = ll - np.mean(ll_neighbors)\n",
    "    nonmember_scores.append(score)\n",
    "scores = np.concatenate([member_scores, nonmember_scores])\n",
    "labels = np.concatenate([np.ones(len(member_scores)), np.zeros(len(nonmember_scores))])\n",
    "# ----------------------------\n",
    "# Compute Metrics\n",
    "# ----------------------------\n",
    "fpr, tpr, thresholds = roc_curve(labels, scores)\n",
    "auroc = auc(fpr, tpr)\n",
    "f1 = np.max(1-(fpr+(1-tpr))/2)\n",
    "print(\"=== Results ===\")\n",
    "print(f\"AUROC: {auroc:.3f}\")\n",
    "print(f\"F1: {f1:.3f}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "13e96af0-5139-43a7-8db5-d934841a8c60",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Results ===\n",
      "AUROC: 0.51643\n",
      "F1: 0.53500\n"
     ]
    }
   ],
   "source": [
    "fpr, tpr, thresholds = roc_curve(labels, scores)\n",
    "auroc = auc(fpr, tpr)\n",
    "f1 = np.max(1-(fpr+(1-tpr))/2)\n",
    "print(\"=== Results ===\")\n",
    "print(f\"AUROC: {auroc:.5f}\")\n",
    "print(f\"F1: {f1:.5f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "404f04c6-40e1-470c-b030-615c82f1f165",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x1000 with 4 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "\n",
    "# Extract individual feature arrays\n",
    "train_perplexities, train_confidences, train_entropies, train_frd = train_features\n",
    "test_perplexities, test_confidences, test_entropies, test_frd = test_features\n",
    "\n",
    "# Combine train and test features for each category\n",
    "perplexities = np.concatenate([train_perplexities, test_perplexities])\n",
    "confidences = np.concatenate([train_confidences, test_confidences])\n",
    "entropies = np.concatenate([train_entropies, test_entropies])\n",
    "frd_distances = np.concatenate([train_frd, test_frd])\n",
    "\n",
    "# Combine member (1) and non-member (0) labels\n",
    "labels = np.concatenate([[1] * len(train_perplexities), [0] * len(test_perplexities)])\n",
    "\n",
    "df = pd.DataFrame({\n",
    "    \"Perplexity\": perplexities,\n",
    "    \"Confidence\": confidences,\n",
    "    \"Entropy\": entropies,\n",
    "    \"FRD\": frd_distances,\n",
    "    \"Membership\": labels\n",
    "})\n",
    "\n",
    "# Convert Membership to categorical for seaborn\n",
    "df[\"Membership\"] = df[\"Membership\"].map({1: \"Member\", 0: \"Non-Member\"})\n",
    "# Set global font settings\n",
    "plt.rcParams.update({\n",
    "    \"font.size\": 16,      # Increase font size\n",
    "    \"axes.labelweight\": \"bold\",\n",
    "    \"axes.titleweight\": \"bold\",\n",
    "    \"axes.titlesize\": 18,\n",
    "    \"xtick.labelsize\": 14,\n",
    "    \"ytick.labelsize\": 14,\n",
    "    \"legend.fontsize\": 14,\n",
    "    \"legend.title_fontsize\": 16,\n",
    "    \"axes.labelsize\": 16,\n",
    "})\n",
    "# Plot KDE for each feature\n",
    "features = [\"Perplexity\", \"Confidence\", \"Entropy\", \"FRD\"]\n",
    "plt.figure(figsize=(15, 10))\n",
    "\n",
    "for i, feature in enumerate(features, 1):\n",
    "    plt.subplot(2, 2, i)\n",
    "    sns.kdeplot(data=df, x=feature, hue=\"Membership\", fill=True, common_norm=False, alpha=0.5, palette={\"Member\": \"blue\", \"Non-Member\": \"orange\"} )\n",
    "    plt.title(f\"KDE of {feature}\",fontweight=\"bold\",fontsize=18)\n",
    "    plt.xlabel(feature,fontweight=\"bold\",fontsize=16)\n",
    "    plt.ylabel(\"Density\",fontweight=\"bold\",fontsize=16)\n",
    "    plt.legend(\n",
    "        title=\"Membership\", \n",
    "        loc=\"upper right\", \n",
    "        labels=[\"Member\", \"Non-Member\"], \n",
    "        frameon=True\n",
    "    )\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.savefig(\"lora_dp_medal_txt_gen_kde_plots.jpg\", dpi=300, bbox_inches=\"tight\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "56be3cf1-a694-47a1-b57d-8d2401a5b98b",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The attention mask is not set and cannot be inferred from input because pad token is same as eos token. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
      "01/28/2025 18:35:22:WARNING:Using 379 background data samples could cause slower run times. Consider using shap.sample(data, K) or shap.kmeans(data, K) to summarize the background as K samples.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Previous studies support the presence of an upper airway reflex mechanism that contributes to the maintenance of upper airway patency during sleep. We investigated the possibility that this reflex may contribute to the development of obstructive sleep apnoea (OSA) following topical ophthalmic anesthesia. Twenty-four patients with snoring were randomly assigned to one of three groups: 1) oral ophthalmic lidocaine, 2) topical lidocaine alone, or 3) a combination of oral lidocaine and lidocaine plus lidocaine. OSA was assessed at baseline and at 6, 12, 24, 36, 48, 72, 96, and 120 hours postoperatively. Oral lidocaine was associated with a significant reduction in OSA (P < 0.001). However, there was no significant difference in OSA between the three groups (P > 0.05). There was a significant increase in OSA in the lidocaine group compared with the other two groups (P = 0.03). These data suggest that the upper airway response to ophthalmic administration of lidocaine may contribute to OSA.\n",
      "\n",
      "INTRODUCTION\n",
      "\n",
      "Osteoporosis is a leading cause of morbidity and mortality in the United States. The prevalence of osteoporosis has been estimated to be as high as 20% in women and as high as 40% in men (1). Osteop\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|| 310/310 [00:18<00:00, 16.83it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "310\n",
      "310\n"
     ]
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import shap\n",
    "\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "\n",
    "model.to(device)\n",
    "model.eval()\n",
    "PROMPT_LENGTH=50\n",
    "def tokenize_text(text):\n",
    "    inputs = tokenizer(text, return_tensors=\"pt\", truncation=True)\n",
    "    return inputs\n",
    "\n",
    "def decode_tokens(tokens):\n",
    "    return [tokenizer.decode([token]) for token in tokens]\n",
    "\n",
    "def compute_shap_values(model, tokenizer, text, max_length=300):\n",
    "    inputs = tokenize_text(text)\n",
    "    input_ids = inputs[\"input_ids\"].to(device)  # Extract the 'input_ids' tensor\n",
    "    #print(f\"INPUT IDS: {input_ids} and SHAPE: {input_ids.shape}\")\n",
    "    # Generate synthetic texts with prompts (subset of input_ids)\n",
    "    prompts = input_ids[:, :PROMPT_LENGTH]  # Slice to use only the first 50 tokens as the prompt\n",
    "    generated_ids = model.generate(input_ids=prompts,max_length=300+10,do_sample=True,top_k=90,temperature=0.8,top_p=0.95, num_beams=8, \n",
    "                                       no_repeat_ngram_size=4,early_stopping=True, repetition_penalty=1.5, length_penalty=1.0,\n",
    "                                       pad_token_id=tokenizer.pad_token_id,eos_token_id=tokenizer.eos_token_id)\n",
    "    #input_texts = tokenizer.batch_decode(input_ids, skip_special_tokens=True)      \n",
    "    tokens = tokenizer.tokenize(text)\n",
    "    input_texts_np = np.array(tokens).reshape(-1, 1)\n",
    "    #print(f\"INPUT IDS: {input_texts_np} and SHAPE: {input_texts_np.shape}\")\n",
    "    explainer = shap.KernelExplainer(\n",
    "           lambda texts: model(**tokenizer(list(texts.flatten()), return_tensors=\"pt\", \n",
    "                                                      padding=True, truncation=True).to(device)).logits[:, -1, :].cpu().detach().numpy(), input_texts_np  # Baseline as 2D NumPy array\n",
    "    )\n",
    "    #shap_values = explainer.shap_values(input_texts_np, nsamples=100)\n",
    "    #token_importances = np.mean(np.abs(shap_values), axis=-1).flatten()\n",
    "    #print(f\"TOKEN IMP: {token_importances}\")\n",
    "    shap_texts = tokenizer.batch_decode(generated_ids, skip_special_tokens=True)   \n",
    "    print(shap_texts[0])\n",
    "    gen_inputs = tokenize_text(shap_texts[0])\n",
    "    gen_input_ids = gen_inputs[\"input_ids\"].to(device)  # Extract the 'input_ids' tensor    \n",
    "    gen_tokens = tokenizer.tokenize(shap_texts[0])\n",
    "    shap_texts_np = np.array(gen_tokens).reshape(-1, 1) \n",
    "    shap_values = explainer.shap_values(shap_texts_np, nsamples=100)    \n",
    "    return shap_texts[0], shap_values\n",
    "text = \"Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Previous studies support the presence of an upper airway reflex mechanism that contributes to the maintenance of upper airway patency during sleep. We investigated the possibility that interference with this reflex mechanism contributes to the development of obstructive sleep apnea. Eight otherwise asymptomatic snorers (seven male and one female), age 39 +/- 5.3 yr (mean +/- SEM), underwent overnight sleep studies on three successive nights. An acclimatization night was followed by two study nights randomly assigned to control (C) and oropharyngeal anesthesia (OPA). On the OPA night topical anesthesia was induced using 10% lidocaine spray and 0.25% bupivacaine gargle. A saline placebo was used on night C. All subjects slept well on both study nights (mean sleep duration was 6.2 h on both study nights), and sleep stage distribution was similar on both nights. Obstructive apneas and hypopneas (OAH) rose from 114 +/- 43 during C to 170 +/- 49 during OPA (p less than 0.02). Central apneas and hypopneas (CAH) were unchanged between the two nights (8 +/- 4.9 versus 7 +/- 3). The duration of OAH was similar on both study nights (20 +/- 1.9 s during C versus 20 +/- 1.5 s during OPA). The frequency of movement arousals terminating OAH tended to be higher during OPA (7 +/- 2.9/h) than during C (3 +/- 0.7); P = NS. The frequency of oxyhemoglobin desaturations was also higher during OPA (5 +/- 2.1/h) than during C (3 +/- 1.4), p less than 0.07.\"\n",
    "# Compute SHAP values for tokens\n",
    "text, shap_values = compute_shap_values(model, tokenizer, text)\n",
    "#print(f\"Raw SHAP values:{shap_values} SHAPE:{shap_values.shape}\")\n",
    "# Extract token importance\n",
    "#token_importances = np.mean(np.abs(shap_values), axis=-1).flatten()\n",
    "token_importances = np.mean(shap_values, axis=-1).flatten()\n",
    "# Decode tokens\n",
    "tokens = decode_tokens(tokenizer(text, return_tensors=\"pt\")[\"input_ids\"][0].tolist())\n",
    "print(len(tokens))\n",
    "print(len(token_importances))\n",
    "#for i, (token, importance) in enumerate(zip(tokens, token_importances)):\n",
    "#    #if i < 10:  # Limit to the first 10 for debug purposes\n",
    "#    print(f\"I:  {i} Token: {token} | SHAP Value: {importance}\")\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "f5e26052-0278-464b-9107-f632b2f7d6aa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Initialize empty lists for tokens and SHAP values\n",
    "tokens_list = []\n",
    "shap_values_list = []\n",
    "\n",
    "# Iterate through the tokens and their corresponding SHAP values\n",
    "for i, (token, importance) in enumerate(zip(tokens, token_importances)):\n",
    "    # Add token and importance to the lists\n",
    "    tokens_list.append(token)\n",
    "    shap_values_list.append(importance)\n",
    "\n",
    "# Create a list of tuples (token, shap_value) and sort by shap_value in descending order\n",
    "sorted_tokens_shap = sorted(zip(tokens_list, shap_values_list), key=lambda x: abs(x[1]), reverse=True)\n",
    "\n",
    "# Get the top 50 tokens and SHAP values\n",
    "top_50_tokens, top_50_shap_values = zip(*sorted_tokens_shap[:150])\n",
    "\n",
    "# Plotting the top 50 SHAP values\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.bar(top_50_tokens, top_50_shap_values, color='skyblue')\n",
    "plt.xlabel('Tokens')\n",
    "plt.ylabel('SHAP Value')\n",
    "plt.xticks(rotation=90)\n",
    "plt.title('Top 50 Tokens by SHAP Value')\n",
    "plt.tight_layout()  # Adjust layout to avoid overlapping labels\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "6e4f19b1-25c0-4b4e-9233-edfe912fddb7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x1000 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "\n",
    "# Plot the bar chart\n",
    "plt.figure(figsize=(12, 10))\n",
    "plt.barh(top_50_tokens, top_50_shap_values, color=\"skyblue\")\n",
    "plt.xlabel(\"SHAP Value\", fontsize=14)\n",
    "plt.ylabel(\"Tokens\", fontsize=14)\n",
    "plt.title(\"Top-N Tokens by SHAP Values\", fontsize=16)\n",
    "plt.gca().invert_yaxis()  # Invert y-axis to display highest SHAP value at the top\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "e6d4560b-1973-47b4-b1a1-97be3ed55d16",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "`GPT2SdpaAttention` is used but `torch.nn.functional.scaled_dot_product_attention` does not support `output_attentions=True` or `head_mask`. Falling back to the manual attention implementation, but specifying the manual implementation will be required from Transformers version v5.0.0 onwards. This warning can be removed using the argument `attn_implementation=\"eager\"` when loading the model.\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import torch\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import numpy as np\n",
    "# Input text\n",
    "text = \"Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers.\"\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "\n",
    "model.to(device)\n",
    "model.eval()\n",
    "# Tokenize input\n",
    "inputs = tokenizer(text, return_tensors=\"pt\").to(device)\n",
    "\n",
    "# Forward pass with attention outputs\n",
    "with torch.no_grad():\n",
    "    outputs = model(**inputs, output_attentions=True)\n",
    "attentions = outputs.attentions  # List of attention tensors (layers, batch, heads, seq_len, seq_len)\n",
    "\n",
    "# Select a specific layer and head for visualization\n",
    "layer_idx = -1  # Last layer\n",
    "head_idx = 0    # First attention head\n",
    "\n",
    "attention_matrix = attentions[layer_idx][0, head_idx].cpu().numpy()\n",
    "\n",
    "# Plot attention heatmap\n",
    "plt.figure(figsize=(10, 8))\n",
    "sns.heatmap(attention_matrix, cmap=\"Blues\", xticklabels=tokenizer.convert_ids_to_tokens(inputs[\"input_ids\"][0]),\n",
    "            yticklabels=tokenizer.convert_ids_to_tokens(inputs[\"input_ids\"][0]), annot=False)\n",
    "plt.xlabel(\"Key Positions\")\n",
    "plt.ylabel(\"Query Positions\")\n",
    "plt.title(f\"Attention Heatmap - Layer {layer_idx+1}, Head {head_idx+1}\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "ded59267-5701-4762-ab77-ef2638a4c3b2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x300 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import numpy as np\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "def compute_token_sensitivity(text):\n",
    "    \"\"\"Compute token sensitivity by measuring logit differences when modifying tokens.\"\"\"\n",
    "    tokens = tokenizer(text, return_tensors=\"pt\", add_special_tokens=True).to(\"cuda\")\n",
    "    input_ids = tokens[\"input_ids\"]\n",
    "\n",
    "    with torch.no_grad():\n",
    "        base_logits = generator_model(**tokens).logits[:, :-1, :]  # Exclude final token prediction\n",
    "\n",
    "    sensitivities = []\n",
    "\n",
    "    for i in range(input_ids.shape[1] - 1):  # Exclude last token\n",
    "        perturbed_ids = input_ids.clone()\n",
    "        perturbed_ids[:, i] = tokenizer.eos_token_id  # Use end-of-text token instead of MASK\n",
    "\n",
    "        with torch.no_grad():\n",
    "            perturbed_logits = generator_model(input_ids=perturbed_ids).logits[:, :-1, :]\n",
    "\n",
    "        # Compute sensitivity as logit difference norm\n",
    "        diff = torch.norm(base_logits - perturbed_logits, dim=-1).mean().item()\n",
    "        sensitivities.append(diff)\n",
    "\n",
    "    # Normalize scores to [0,1]\n",
    "    sensitivities = np.array(sensitivities)\n",
    "    sensitivities = (sensitivities - sensitivities.min()) / (sensitivities.max() - sensitivities.min() + 1e-8)\n",
    "\n",
    "    return tokenizer.convert_ids_to_tokens(input_ids[0][:-1].tolist()), sensitivities\n",
    "\n",
    "def plot_token_sensitivity(text, threshold_high=0.7, threshold_low=0.3):\n",
    "    \"\"\"\n",
    "    Plot heatmap for token sensitivity visualization, highlighting high and low sensitivity tokens.\n",
    "\n",
    "    Args:\n",
    "        text: The input text string.\n",
    "        threshold_high: Threshold for considering a token as having high sensitivity (between 0 and 1).\n",
    "        threshold_low: Threshold for considering a token as having low sensitivity (between 0 and 1).\n",
    "    \"\"\"\n",
    "    tokens, scores = compute_token_sensitivity(text)\n",
    "\n",
    "    # Identify high and low sensitivity tokens\n",
    "    high_sensitive_tokens = [\n",
    "        (token, score) for token, score in zip(tokens, scores) if score >= threshold_high\n",
    "    ]\n",
    "    low_sensitive_tokens = [\n",
    "        (token, score) for token, score in zip(tokens, scores) if score <= threshold_low\n",
    "    ]\n",
    "\n",
    "    # Print high and low sensitive tokens\n",
    "    #print(\"High Sensitivity Tokens (Sensitivity >= {:.2f}):\".format(threshold_high))\n",
    "    #for token, score in high_sensitive_tokens:\n",
    "    #    print(f\"  {token}: {score:.2f}\")\n",
    "\n",
    "    #print(\"\\nLow Sensitivity Tokens (Sensitivity <= {:.2f}):\".format(threshold_low))\n",
    "    #for token, score in low_sensitive_tokens:\n",
    "    #    print(f\"  {token}: {score:.2f}\")\n",
    "\n",
    "   # Create a list of labels for the heatmap\n",
    "    labels =[]\n",
    "    # Create a new list of scores, where intermediate sensitivity tokens are masked\n",
    "    masked_scores =[]\n",
    "    for i, score in enumerate(scores):\n",
    "        if 0.3 <= score <= 1.0 or 0.0 <= score <= 0.3:\n",
    "            masked_scores.append(score)\n",
    "            labels.append(tokens[i])  # Keep the label for high/low sensitivity\n",
    "        else:\n",
    "            masked_scores.append(np.nan)  # Use NaN to mask intermediate values\n",
    "            labels.append(\"\")  # Empty string for intermediate sensitivity\n",
    "\n",
    "\n",
    "    plt.figure(figsize=(12, 3))\n",
    "    sns.heatmap([masked_scores], cmap=\"coolwarm\", linewidths=0.5, cbar=True,\n",
    "                mask=np.isnan([masked_scores]))  # Use mask to hide NaN cells\n",
    "    plt.xticks(ticks=np.arange(len(tokens)) + 0.5, labels=labels, rotation=45, ha=\"right\", fontweight=\"bold\", fontsize=8)\n",
    "    plt.xlabel(\"Tokens\",fontweight=\"bold\",fontsize=16)\n",
    "    plt.yticks(fontweight=\"bold\",fontsize=8)\n",
    "    plt.ylabel(\"Token Sensitivity Score\",fontweight=\"bold\",fontsize=8)\n",
    "    plt.title(\"\")\n",
    "    plt.tight_layout()\n",
    "    plt.savefig('lora_dp_medal_txt_gen_tkn_smap.jpg')\n",
    "    plt.show()\n",
    "text = \"we developed an animal model of chronic allergic airway disease by repeatedly exposing nine sheep to tracheal instillation of ascaris antigen until stable increase in RL at three times control in six reactive sheep group c was obtained they were then compared to the three nonreactive sheep group b and a\"\n",
    "device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "generator_model.to(device)\n",
    "generator_model.eval()\n",
    "plot_token_sensitivity(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "3ad3e958-734c-456c-9a8f-8b88b66aae65",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x1000 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import torch\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "\n",
    "def visualize_attention(model, tokenizer, text, layer_idx=-1, head_idx=0, top_n_tokens=150, filename=\"attention_heatmap.jpg\"):\n",
    "    device = torch.device(\"cuda:0\" if torch.cuda.is_available() else \"cpu\")\n",
    "    model.to(device)\n",
    "    model.eval()\n",
    "\n",
    "    inputs = tokenizer(text, return_tensors=\"pt\", truncation=True, max_length=512).to(device)\n",
    "\n",
    "    with torch.no_grad():\n",
    "        outputs = model(**inputs, output_attentions=True)\n",
    "\n",
    "    attentions = outputs.attentions\n",
    "    attention_matrix = attentions[layer_idx][0, head_idx].cpu().numpy()\n",
    "\n",
    "    tokens = tokenizer.convert_ids_to_tokens(inputs[\"input_ids\"][0])\n",
    "\n",
    "    avg_attention = attention_matrix.mean(axis=0)\n",
    "    top_indices = np.argsort(avg_attention)[-top_n_tokens:]\n",
    "    top_tokens = [tokens[i] for i in top_indices]\n",
    "    top_attention_matrix = attention_matrix[np.ix_(top_indices, top_indices)]\n",
    "    df = pd.DataFrame(top_attention_matrix, index=top_tokens, columns=top_tokens)\n",
    "    df.to_csv(\"lora_dp_medal_txt_gen_top_attention_matrix.csv\")\n",
    "    plt.figure(figsize=(15, 10))\n",
    "    # Create the heatmap and store the result (QuadMesh object)\n",
    "    heatmap = sns.heatmap(\n",
    "        top_attention_matrix,\n",
    "        cmap=\"Blues\",\n",
    "        linewidths=0.5,\n",
    "        linecolor=\"gray\",\n",
    "        square=True,\n",
    "        cbar=False,\n",
    "        vmin=0, vmax=1,\n",
    "        xticklabels=top_tokens, yticklabels=top_tokens\n",
    "    )\n",
    "    plt.xticks(rotation=90, fontsize=16, fontweight='bold')\n",
    "    plt.yticks(fontsize=13, fontweight='bold')\n",
    "    plt.xlabel(\"Key Positions\", fontsize=16, fontweight='bold')\n",
    "    plt.ylabel(\"Query Positions\", fontsize=16, fontweight='bold')\n",
    "    plt.title(f\"Top {top_n_tokens} Tokens Attention Weights - Layer {layer_idx+1}, Head {head_idx+1}\")\n",
    "    plt.colorbar(heatmap.collections[0], label=\"Attention Weight\") # Pass the QuadMesh object to colorbar\n",
    "\n",
    "    plt.savefig(filename)\n",
    "    plt.show()\n",
    "text = \"we developed an animal model of chronic allergic airway disease by repeatedly exposing nine sheep to tracheal instillation of ascaris antigen until stable increase in RL at three times control in six reactive sheep group c was obtained they were then compared to the three nonreactive sheep group b\"\n",
    "\n",
    "# Example usage\n",
    "visualize_attention(generator_model, tokenizer, text, layer_idx=-1, head_idx=0, top_n_tokens=100, filename=\"lora_dp_medal_txt_gen_attn_map.jpg\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "02b1e61c-95e3-4a5a-92b6-c5d9bf6f568e",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\my pc\\AppData\\Local\\Temp\\ipykernel_15540\\2835648521.py:29: FutureWarning: \n",
      "\n",
      "Passing `palette` without assigning `hue` is deprecated and will be removed in v0.14.0. Assign the `x` variable to `hue` and set `legend=False` for the same effect.\n",
      "\n",
      "  sns.barplot(x=\"Method\", y=\"Cosine Similarity\", data=df_sim, palette=\"coolwarm\")\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "# Load attention weight matrices\n",
    "attn_lora = pd.read_csv(\"lora_medal_txt_gen_top_attention_matrix.csv\", index_col=0).values  \n",
    "attn_dp = pd.read_csv(\"lora_dp_medal_txt_gen_top_attention_matrix.csv\", index_col=0).values  \n",
    "attn_fi_lora_dp = pd.read_csv(\"fi_lora_dp_high_medal_txt_gen_top_attention_matrix.csv\", index_col=0).values  \n",
    "\n",
    "# Flatten matrices for cosine similarity computation\n",
    "vec_lora = attn_lora.flatten().reshape(1, -1)\n",
    "vec_dp = attn_dp.flatten().reshape(1, -1)\n",
    "vec_fi_lora_dp = attn_fi_lora_dp.flatten().reshape(1, -1)\n",
    "\n",
    "# Compute cosine similarities with LoRA fine-tuning as the baseline\n",
    "cos_sim_dp = cosine_similarity(vec_lora, vec_dp)[0][0]\n",
    "cos_sim_fi_lora_dp = cosine_similarity(vec_lora, vec_fi_lora_dp)[0][0]\n",
    "\n",
    "# Create DataFrame for visualization\n",
    "df_sim = pd.DataFrame({\n",
    "    \"Method\": [\"LoRA vs DP-LoRA\", \"LoRA vs FIBNA-LoRA\"],\n",
    "    \"Cosine Similarity\": [cos_sim_dp, cos_sim_fi_lora_dp]\n",
    "})\n",
    "\n",
    "# ---- Visualization ----\n",
    "plt.figure(figsize=(6, 4))\n",
    "sns.barplot(x=\"Method\", y=\"Cosine Similarity\", data=df_sim, palette=\"coolwarm\")\n",
    "plt.ylim(0, 1)  # Cosine similarity range\n",
    "plt.ylabel(\"Cosine Similarity\", fontsize=12, fontweight=\"bold\")\n",
    "plt.xlabel(\"\",fontsize=14, fontweight=\"bold\")\n",
    "plt.title(\"\", fontsize=14, fontweight=\"bold\")\n",
    "plt.xticks(fontsize=14, fontweight=\"bold\")\n",
    "plt.yticks(fontsize=14, fontweight=\"bold\")\n",
    "\n",
    "# Annotate bars with similarity values\n",
    "for index, row in df_sim.iterrows():\n",
    "    plt.text(index, row[\"Cosine Similarity\"] + 0.02, f\"{row['Cosine Similarity']:.4f}\", ha='center', fontsize=12, fontweight=\"bold\")\n",
    "\n",
    "# Save & Show Plot\n",
    "plt.savefig(\"medal_txt_gen_cosine_similarity_comparison.jpg\", dpi=300, bbox_inches=\"tight\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fa08ad0a-857c-4fb6-aaf0-1db6c56195e0",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
